601953	108643899	21111008840	@@##	----------	----------
601953	108643899	21111008841	@@108643899		FO
601953	108643899	21111008842	@4043899/		NN1_VV0
601953	108643899	21111008843	<h>		NULL
601953	108643899	21111008844	Who	who	PNQS
601953	108643899	21111008845	We	we	PPIS2
601953	108643899	21111008846	Are	be	VBR
601953	108643899	21111008847	<h>		NULL
601953	108643899	21111008848	Science	science	NN1
601953	108643899	21111008849	.	.	.
601953	108643899	21111008850	Technology	technology	NN1
601953	108643899	21111008851	.	.	.
601953	108643899	21111008852	Service	service	NN1_VV0@
601953	108643899	21111008853	.	.	.
601953	108643899	21111008854	<p>		NULL
601953	108643899	21111008855	We	we	PPIS2
601953	108643899	21111008856	offer	offer	VV0
601953	108643899	21111008857	a	a	AT1
601953	108643899	21111008858	unique	unique	JJ
601953	108643899	21111008859	suite	suite	NN1
601953	108643899	21111008860	of	of	IO
601953	108643899	21111008861	solutions	solution	NN2
601953	108643899	21111008862	,	,	,
601953	108643899	21111008863	with	with	IW
601953	108643899	21111008864	a	a	AT1
601953	108643899	21111008865	unique	unique	JJ
601953	108643899	21111008866	perspective	perspective	NN1
601953	108643899	21111008867	on	on	II
601953	108643899	21111008868	clinical	clinical	JJ
601953	108643899	21111008869	research	research	NN1
601953	108643899	21111008870	development	development	NN1
601953	108643899	21111008871	.	.	.
601953	108643899	21111008872	We	we	PPIS2
601953	108643899	21111008873	focus	focus	VV0
601953	108643899	21111008874	on	on	II_RP@
601953	108643899	21111008875	bringing	bring	VVG
601953	108643899	21111008876	together	together	RL
601953	108643899	21111008877	best-in-class	best-in-class	JJ
601953	108643899	21111008878	science	science	NN1
601953	108643899	21111008879	,	,	,
601953	108643899	21111008880	technology	technology	NN1
601953	108643899	21111008881	and	and	CC
601953	108643899	21111008882	service	service	NN1_VV0@
601953	108643899	21111008883	to	to	TO
601953	108643899	21111008884	drive	drive	VVI
601953	108643899	21111008885	superior	superior	JJ
601953	108643899	21111008886	clinical	clinical	JJ
601953	108643899	21111008887	outcome	outcome	NN1
601953	108643899	21111008888	results	result	NN2_VVZ@
601953	108643899	21111008889	for	for	IF
601953	108643899	21111008890	our	our	APPGE
601953	108643899	21111008891	clients	client	NN2
601953	108643899	21111008892	and	and	CC
601953	108643899	21111008893	for	for	IF
601953	108643899	21111008894	their	their	APPGE
601953	108643899	21111008895	patients	patient	NN2
601953	108643899	21111008896	.	.	.
601953	108643899	21111008897	<p>		NULL
601953	108643899	21111008898	Increasing	increase	VVG
601953	108643899	21111008899	the	the	AT
601953	108643899	21111008900	Power	power	NN1
601953	108643899	21111008901	of	of	IO
601953	108643899	21111008902	Clinical	clinical	JJ
601953	108643899	21111008903	Research	research	NN1
601953	108643899	21111008904	Data	data	NN
601953	108643899	21111008905	.	.	.
601953	108643899	21111008906	<h>		NULL
601953	108643899	21111008907	What	what	DDQ
601953	108643899	21111008908	We	we	PPIS2
601953	108643899	21111008909	Do	do	VD0
601953	108643899	21111008910	<p>		NULL
601953	108643899	21111008911	Bracket	bracket	NN1
601953	108643899	21111008912	innovates	innovate	VVZ
601953	108643899	21111008913	at	at	II
601953	108643899	21111008914	the	the	AT
601953	108643899	21111008915	leading-edge		NN1
601953	108643899	21111008916	of	of	IO
601953	108643899	21111008917	clinical	clinical	JJ
601953	108643899	21111008918	research	research	NN1
601953	108643899	21111008919	data	data	NN
601953	108643899	21111008920	,	,	,
601953	108643899	21111008921	one	one	MC1
601953	108643899	21111008922	exceptional	exceptional	JJ
601953	108643899	21111008923	service	service	NN1
601953	108643899	21111008924	at	at	II
601953	108643899	21111008925	a	a	AT1
601953	108643899	21111008926	time	time	NNT1
601953	108643899	21111008927	.	.	.
601953	108643899	21111008928	From	from	II
601953	108643899	21111008929	the	the	AT
601953	108643899	21111008930	advanced	advanced	JJ
601953	108643899	21111008931	technology	technology	NN1
601953	108643899	21111008932	of	of	IO
601953	108643899	21111008933	our	our	APPGE
601953	108643899	21111008934	eCOA		NN1
601953	108643899	21111008935	electronic	electronic	JJ
601953	108643899	21111008936	Clinical	clinical	JJ
601953	108643899	21111008937	Outcomes	outcome	NN2
601953	108643899	21111008938	Assessments	assessment	NN2
601953	108643899	21111008939	flexible	flexible	JJ
601953	108643899	21111008940	platform	platform	NN1
601953	108643899	21111008941	,	,	,
601953	108643899	21111008942	to	to	II
601953	108643899	21111008943	the	the	AT
601953	108643899	21111008944	efficiency	efficiency	NN1
601953	108643899	21111008945	of	of	IO
601953	108643899	21111008946	our	our	APPGE
601953	108643899	21111008947	scalable	scalable	JJ
601953	108643899	21111008948	and	and	CC
601953	108643899	21111008949	configurable	configurable	JJ
601953	108643899	21111008950	Randomization	randomization	NN1
601953	108643899	21111008951	and	and	CC
601953	108643899	21111008952	Trial	trial	NN1
601953	108643899	21111008953	Supply	supply	NN1_VV0
601953	108643899	21111008954	Management	management	NN1
601953	108643899	21111008955	(	(	(
601953	108643899	21111008956	RTSM		NP1
601953	108643899	21111008957	)	)	)
601953	108643899	21111008958	Clinical	clinical	JJ
601953	108643899	21111008959	IRT	irt	NN1
601953	108643899	21111008960	solution	solution	NN1
601953	108643899	21111008961	,	,	,
601953	108643899	21111008962	to	to	II
601953	108643899	21111008963	our	our	APPGE
601953	108643899	21111008964	science-focused		JJ_NN1
601953	108643899	21111008965	Rater	rater	NP1
601953	108643899	21111008966	Training	training	NN1
601953	108643899	21111008967	and	and	CC
601953	108643899	21111008968	Quality	quality	NN1
601953	108643899	21111008969	Assurance	assurance	NN1
601953	108643899	21111008970	programs	program	NN2
601953	108643899	21111008971	,	,	,
601953	108643899	21111008972	Bracket	bracket	NN1
601953	108643899	21111008973	does	do	VDZ
601953	108643899	21111008974	it	it	PPH1
601953	108643899	21111008975	faster	fast	RRR_JJR
601953	108643899	21111008976	,	,	,
601953	108643899	21111008977	better	better	RRR_JJR
601953	108643899	21111008978	and	and	CC
601953	108643899	21111008979	with	with	IW
601953	108643899	21111008980	an	a	AT1
601953	108643899	21111008981	eye	eye	NN1
601953	108643899	21111008982	on	on	II
601953	108643899	21111008983	the	the	AT
601953	108643899	21111008984	future	future	NN1
601953	108643899	21111008985	of	of	IO
601953	108643899	21111008986	our	our	APPGE
601953	108643899	21111008987	industry	industry	NN1
601953	108643899	21111008988	.	.	.
601953	108643899	21111008989	<h>		NULL
601953	108643899	21111008990	Why	why	RRQ
601953	108643899	21111008991	Wait	wait	VV0
601953	108643899	21111008992	?	?	?
601953	108643899	21111008993	<p>		NULL
601953	108643899	21111008994	Sign	sign	VV0
601953	108643899	21111008995	up	up	RP
601953	108643899	21111008996	now	now	RT
601953	108643899	21111008997	to	to	TO
601953	108643899	21111008998	have	have	VHI
601953	108643899	21111008999	someone	someone	PN1
601953	108643899	21111009000	from	from	II
601953	108643899	21111009001	Bracket	bracket	NN1
601953	108643899	21111009002	contact	contact	VV0_NN1
601953	108643899	21111009003	you	you	PPY
601953	108643899	21111009004	.	.	.
601953	108643899	21111009005	Let	let	VV0
601953	108643899	21111009006	us	us	PPIO2
601953	108643899	21111009007	show	show	VVI
601953	108643899	21111009008	you	you	PPY
601953	108643899	21111009009	how	how	RRQ
601953	108643899	21111009010	Bracket	bracket	NN1
601953	108643899	21111009011	eclipses	eclipse	VVZ@_NN2
601953	108643899	21111009012	the	the	AT
601953	108643899	21111009013	industry	industry	NN1
601953	108643899	21111009014	through	through	II
601953	108643899	21111009015	Science	science	NN1
601953	108643899	21111009016	,	,	,
601953	108643899	21111009017	Technology	technology	NN1
601953	108643899	21111009018	,	,	,
601953	108643899	21111009019	and	and	CC
601953	108643899	21111009020	Service	service	NN1
601953	108643899	21111009021	.	.	.
601953	108643907	21111009041	@@##	----------	----------
601953	108643907	21111009042	@@108643907		FO
601953	108643907	21111009043	@4043907/		JJ_NN1_VV0
601953	108643907	21111009044	<h>		NULL
601953	108643907	21111009045	Bracket	bracket	NN1
601953	108643907	21111009046	eCOAG		NN1_VV0
601953	108643907	21111009047	<h>		NULL
601953	108643907	21111009048	Outcomes	outcome	NN2
601953	108643907	21111009049	and	and	CC
601953	108643907	21111009050	Technology	technology	NN1
601953	108643907	21111009051	<h>		NULL
601953	108643907	21111009052	Bracket	bracket	NN1
601953	108643907	21111009053	eCOAG		NN1
601953	108643907	21111009054	is	be	VBZ
601953	108643907	21111009055	the	the	AT
601953	108643907	21111009056	result	result	NN1
601953	108643907	21111009057	of	of	IO
601953	108643907	21111009058	forging	forge	VVG
601953	108643907	21111009059	technological	technological	JJ
601953	108643907	21111009060	advances	advance	NN2
601953	108643907	21111009061	combined	combine	VVN
601953	108643907	21111009062	with	with	IW
601953	108643907	21111009063	an	a	AT1
601953	108643907	21111009064	understanding	understanding	NN1
601953	108643907	21111009065	of	of	IO
601953	108643907	21111009066	our	our	APPGE
601953	108643907	21111009067	clients	client	NN2
601953	108643907	21111009068	'	'	GE
601953	108643907	21111009069	most	most	RGT
601953	108643907	21111009070	important	important	JJ
601953	108643907	21111009071	objectives	objective	NN2
601953	108643907	21111009072	.	.	.
601953	108643907	21111009073	<p>		NULL
601953	108643907	21111009074	Outcomes	outcome	NN2
601953	108643907	21111009075	are	be	VBR
601953	108643907	21111009076	the	the	AT
601953	108643907	21111009077	product	product	NN1
601953	108643907	21111009078	of	of	IO
601953	108643907	21111009079	human	human	JJ_NN1
601953	108643907	21111009080	observation	observation	NN1
601953	108643907	21111009081	and	and	CC
601953	108643907	21111009082	state-of-the-art	state-of-the-art	JJ_NN1
601953	108643907	21111009083	reporting	reporting	NN1
601953	108643907	21111009084	,	,	,
601953	108643907	21111009085	including	including	II_VVG@
601953	108643907	21111009086	the	the	AT
601953	108643907	21111009087	use	use	NN1
601953	108643907	21111009088	of	of	IO
601953	108643907	21111009089	barcode	bar-code	NN1
601953	108643907	21111009090	scanning	scan	VVG_NN1@
601953	108643907	21111009091	,	,	,
601953	108643907	21111009092	mobile	mobile	JJ_NN1
601953	108643907	21111009093	apps	app	NN2
601953	108643907	21111009094	and	and	CC
601953	108643907	21111009095	seamless	seamless	JJ
601953	108643907	21111009096	integration	integration	NN1
601953	108643907	21111009097	with	with	IW
601953	108643907	21111009098	other	other	JJ
601953	108643907	21111009099	programs	program	NN2
601953	108643907	21111009100	.	.	.
601953	108643907	21111009101	Our	our	APPGE
601953	108643907	21111009102	program	program	NN1
601953	108643907	21111009103	designs	design	NN2
601953	108643907	21111009104	have	have	VH0
601953	108643907	21111009105	put	put	VVN
601953	108643907	21111009106	Bracket	bracket	NN1
601953	108643907	21111009107	at	at	II
601953	108643907	21111009108	the	the	AT
601953	108643907	21111009109	forefront	forefront	NN1
601953	108643907	21111009110	of	of	IO
601953	108643907	21111009111	electronic	electronic	JJ
601953	108643907	21111009112	Clinical	clinical	JJ
601953	108643907	21111009113	Outcomes	outcome	NN2
601953	108643907	21111009114	Assessments	assessment	NN2
601953	108643907	21111009115	.	.	.
601953	108643907	21111009116	<h>		NULL
601953	108643907	21111009117	ePRO		NN1
601953	108643907	21111009118	and	and	CC
601953	108643907	21111009119	eDiary		NN1_JJ
601953	108643907	21111009120	<p>		NULL
601953	108643907	21111009121	As	as	II_CSA
601953	108643907	21111009122	a	a	AT1
601953	108643907	21111009123	proud	proud	JJ
601953	108643907	21111009124	and	and	CC
601953	108643907	21111009125	active	active	JJ
601953	108643907	21111009126	member	member	NN1
601953	108643907	21111009127	of	of	IO
601953	108643907	21111009128	the	the	AT
601953	108643907	21111009129	Critical	critical	JJ
601953	108643907	21111009130	Path	path	NN1
601953	108643907	21111009131	Institute	institute	NN1
601953	108643907	21111009132	's	's	GE
601953	108643907	21111009133	(	(	(
601953	108643907	21111009134	C-Path		NP1
601953	108643907	21111009135	)	)	)
601953	108643907	21111009136	ePRO		NN1
601953	108643907	21111009137	Consortium	consortium	NN1
601953	108643907	21111009138	,	,	,
601953	108643907	21111009139	Bracket	bracket	NN1
601953	108643907	21111009140	collaborates	collaborate	VVZ
601953	108643907	21111009141	with	with	IW
601953	108643907	21111009142	industry	industry	NN1
601953	108643907	21111009143	leaders	leader	NN2
601953	108643907	21111009144	to	to	TO
601953	108643907	21111009145	advance	advance	VVI
601953	108643907	21111009146	the	the	AT
601953	108643907	21111009147	application	application	NN1
601953	108643907	21111009148	and	and	CC
601953	108643907	21111009149	value	value	NN1
601953	108643907	21111009150	of	of	IO
601953	108643907	21111009151	electronic	electronic	JJ
601953	108643907	21111009152	modalities	modality	NN2
601953	108643907	21111009153	in	in	II
601953	108643907	21111009154	clinical	clinical	JJ
601953	108643907	21111009155	endpoint	endpoint	NN1
601953	108643907	21111009156	assessments	assessment	NN2
601953	108643907	21111009157	.	.	.
601953	108643907	21111009158	<h>		NULL
601953	108643907	21111009159	Support	support	VV0_NN1
601953	108643907	21111009160	for	for	IF
601953	108643907	21111009161	off-the-shelf	off-the-shelf	JJ_NN1
601953	108643907	21111009162	scales	scale	NN2
601953	108643907	21111009163	,	,	,
601953	108643907	21111009164	surveys	survey	NN2
601953	108643907	21111009165	and	and	CC
601953	108643907	21111009166	questionnaires	questionnaire	NN2
601953	108643907	21111009167	<h>		NULL
601953	108643907	21111009168	Fully	fully	RR
601953	108643907	21111009169	customizable	customizable	JJ
601953	108643907	21111009170	compliance	compliance	NN1
601953	108643907	21111009171	reports	report	VVZ_NN2
601953	108643907	21111009172	<h>		NULL
601953	108643907	21111009173	eClinRO		NN1
601953	108643907	21111009174	<h>		NULL
601953	108643907	21111009175	Enhanced	enhance	VVD_VVN_JJ
601953	108643907	21111009176	Electronic	electronic	JJ
601953	108643907	21111009177	Clinician-Reported		JJ_NN1
601953	108643907	21111009178	Outcome	outcome	NN1
601953	108643907	21111009179	<p>		NULL
601953	108643907	21111009180	Bracket	bracket	NN1
601953	108643907	21111009181	's	's	GE_VBZ
601953	108643907	21111009182	Rater	rater	NP1
601953	108643907	21111009183	StationG		NP1
601953	108643907	21111009184	,	,	,
601953	108643907	21111009185	an	a	AT1
601953	108643907	21111009186	enhanced	enhanced	JJ
601953	108643907	21111009187	type	type	NN1
601953	108643907	21111009188	of	of	IO
601953	108643907	21111009189	electronic	electronic	JJ
601953	108643907	21111009190	Clinician-Reported		JJ_NN1
601953	108643907	21111009191	Outcome	outcome	NN1
601953	108643907	21111009192	(	(	(
601953	108643907	21111009193	eClinRO		NN1
601953	108643907	21111009194	)	)	)
601953	108643907	21111009195	,	,	,
601953	108643907	21111009196	uniquely	uniquely	RR
601953	108643907	21111009197	features	feature	VVZ@
601953	108643907	21111009198	intelligent	intelligent	JJ
601953	108643907	21111009199	design	design	NN1
601953	108643907	21111009200	that	that	CST_DD1
601953	108643907	21111009201	provides	provide	VVZ
601953	108643907	21111009202	added	added	JJ
601953	108643907	21111009203	clinical	clinical	JJ
601953	108643907	21111009204	value	value	NN1
601953	108643907	21111009205	and	and	CC
601953	108643907	21111009206	quality	quality	NN1
601953	108643907	21111009207	control	control	NN1
601953	108643907	21111009208	.	.	.
601953	108643907	21111009209	The	the	AT
601953	108643907	21111009210	Rater	rater	NP1
601953	108643907	21111009211	StationG		NP1_NN1
601953	108643907	21111009212	is	be	VBZ
601953	108643907	21111009213	an	a	AT1
601953	108643907	21111009214	FDA	fda	NN1
601953	108643907	21111009215	21	21	MC
601953	108643907	21111009216	CFR	cfr	NP1
601953	108643907	21111009217	part	part	NN1
601953	108643907	21111009218	11	11	MC
601953	108643907	21111009219	and	and	CC
601953	108643907	21111009220	EMEA		NP1_NN1
601953	108643907	21111009221	Annex	annex	NN1_VV0
601953	108643907	21111009222	11	11	MC
601953	108643907	21111009223	compliant	compliant	JJ
601953	108643907	21111009224	computer	computer	NN1
601953	108643907	21111009225	device	device	NN1
601953	108643907	21111009226	that	that	CST_DD1
601953	108643907	21111009227	has	have	VHZ
601953	108643907	21111009228	been	be	VBN
601953	108643907	21111009229	used	use	VVN
601953	108643907	21111009230	in	in	II_RP@
601953	108643907	21111009231	dozens	dozen	NNO2
601953	108643907	21111009232	of	of	IO
601953	108643907	21111009233	@		II
601953	108643907	21111009234	@		II
601953	108643907	21111009235	@		II
601953	108643907	21111009236	@		II
601953	108643907	21111009237	@		II
601953	108643907	21111009238	@		II
601953	108643907	21111009239	@		II
601953	108643907	21111009240	@		II
601953	108643907	21111009241	@		II
601953	108643907	21111009242	@		II
601953	108643907	21111009243	Errors	error	NN2
601953	108643907	21111009244	<p>		NULL
601953	108643907	21111009245	The	the	AT
601953	108643907	21111009246	Rater	rater	NP1
601953	108643907	21111009247	StationG		NP1_VV0
601953	108643907	21111009248	intelligent	intelligent	JJ
601953	108643907	21111009249	design	design	NN1
601953	108643907	21111009250	improves	improve	VVZ
601953	108643907	21111009251	interview	interview	NN1
601953	108643907	21111009252	quality	quality	NN1
601953	108643907	21111009253	while	while	CS
601953	108643907	21111009254	reducing	reduce	VVG_JJ@
601953	108643907	21111009255	administration	administration	NN1
601953	108643907	21111009256	and	and	CC
601953	108643907	21111009257	scoring	score	VVG_NN1_JJ@
601953	108643907	21111009258	errors	error	NN2
601953	108643907	21111009259	.	.	.
601953	108643907	21111009260	Outcomes	outcome	NN2
601953	108643907	21111009261	can	can	VM
601953	108643907	21111009262	be	be	VBI
601953	108643907	21111009263	programmed	program	VVN
601953	108643907	21111009264	to	to	TO
601953	108643907	21111009265	enforce	enforce	VVI
601953	108643907	21111009266	a	a	AT1
601953	108643907	21111009267	structured	structured	JJ
601953	108643907	21111009268	interview	interview	NN1
601953	108643907	21111009269	format	format	NN1_VV0
601953	108643907	21111009270	,	,	,
601953	108643907	21111009271	and	and	CC
601953	108643907	21111009272	can	can	VM
601953	108643907	21111009273	be	be	VBI
601953	108643907	21111009274	applied	apply	VVN
601953	108643907	21111009275	to	to	II
601953	108643907	21111009276	a	a	AT1
601953	108643907	21111009277	wide	wide	JJ
601953	108643907	21111009278	range	range	NN1
601953	108643907	21111009279	of	of	IO
601953	108643907	21111009280	therapeutic	therapeutic	JJ
601953	108643907	21111009281	areas	area	NN2
601953	108643907	21111009282	and	and	CC
601953	108643907	21111009283	Clinician-Reported		JJ_NN1
601953	108643907	21111009284	Outcomes	outcome	NN2
601953	108643907	21111009285	.	.	.
601953	108643907	21111009286	<h>		NULL
601953	108643907	21111009287	Bring	bring	VV0
601953	108643907	21111009288	Your	your	APPGE
601953	108643907	21111009289	Own	own	DA
601953	108643907	21111009290	Device	device	NN1
601953	108643907	21111009291	<p>		NULL
601953	108643907	21111009292	Low	low	JJ
601953	108643907	21111009293	cost	cost	NN1
601953	108643907	21111009294	solutions	solution	NN2
601953	108643907	21111009295	supported	support	VVN
601953	108643907	21111009296	by	by	II
601953	108643907	21111009297	Bracket	bracket	NN1
601953	108643907	21111009298	's	's	GE
601953	108643907	21111009299	Bring	bring	VV0
601953	108643907	21111009300	Your	your	APPGE
601953	108643907	21111009301	Own	own	DA
601953	108643907	21111009302	Device	device	NN1
601953	108643907	21111009303	(	(	(
601953	108643907	21111009304	BYOD		NP1
601953	108643907	21111009305	)	)	)
601953	108643907	21111009306	mobile	mobile	JJ_NN1
601953	108643907	21111009307	app	app	NN1
601953	108643907	21111009308	solution	solution	NN1
601953	108643907	21111009309	.	.	.
601953	108643907	21111009310	Brackets	bracket	NN2_VVZ@
601953	108643907	21111009311	mobile	mobile	JJ_NN1
601953	108643907	21111009312	app	app	NN1
601953	108643907	21111009313	is	be	VBZ
601953	108643907	21111009314	available	available	JJ
601953	108643907	21111009315	on	on	II
601953	108643907	21111009316	iOS		NN2
601953	108643907	21111009317	and	and	CC
601953	108643907	21111009318	Android	android	NN1
601953	108643907	21111009319	,	,	,
601953	108643907	21111009320	so	so	CS@_RR
601953	108643907	21111009321	you	you	PPY
601953	108643907	21111009322	can	can	VM
601953	108643907	21111009323	use	use	VVI
601953	108643907	21111009324	what	what	DDQ
601953	108643907	21111009325	works	work	VVZ
601953	108643907	21111009326	best	best	RRT
601953	108643907	21111009327	for	for	IF_CS%
601953	108643907	21111009328	you	you	PPY
601953	108643907	21111009329	.	.	.
601953	108643907	21111009330	<h>		NULL
601953	108643907	21111009331	Support	support	VV0
601953	108643907	21111009332	Large	large	JJ
601953	108643907	21111009333	Dataset	dataset	NN1
601953	108643907	21111009334	Analysis	analysis	NN1
601953	108643907	21111009335	<p>		NULL
601953	108643907	21111009336	Scalable	scalable	JJ
601953	108643907	21111009337	reporting	reporting	NN1
601953	108643907	21111009338	and	and	CC
601953	108643907	21111009339	data	data	NN
601953	108643907	21111009340	management	management	NN1
601953	108643907	21111009341	capabilities	capability	NN2
601953	108643907	21111009342	to	to	TO
601953	108643907	21111009343	support	support	VVI
601953	108643907	21111009344	large	large	JJ
601953	108643907	21111009345	dataset	dataset	NN1
601953	108643907	21111009346	analysis	analysis	NN1
601953	108643907	21111009347	and	and	CC
601953	108643907	21111009348	industry-compliant		JJ
601953	108643907	21111009349	data	data	NN
601953	108643907	21111009350	delivery	delivery	NN1
601953	108643907	21111009351	methods	method	NN2
601953	108643907	21111009352	.	.	.
601953	108643907	21111009353	<h>		NULL
601953	108643907	21111009354	The	the	AT
601953	108643907	21111009355	CDR	cdr	NP1
601953	108643907	21111009356	SystemG		NP1_NN1
601953	108643907	21111009357	<p>		NULL
601953	108643907	21111009358	Developed	develop	VVN
601953	108643907	21111009359	by	by	II
601953	108643907	21111009360	Professor	professor	NNB
601953	108643907	21111009361	Keith	keith	NP1
601953	108643907	21111009362	Wesnes		NP2
601953	108643907	21111009363	,	,	,
601953	108643907	21111009364	the	the	AT
601953	108643907	21111009365	CDR	cdr	NP1
601953	108643907	21111009366	SystemG		NP1
601953	108643907	21111009367	has	have	VHZ
601953	108643907	21111009368	become	become	VVN@
601953	108643907	21111009369	the	the	AT
601953	108643907	21111009370	industry	industry	NN1
601953	108643907	21111009371	standard	standard	NN1
601953	108643907	21111009372	for	for	IF
601953	108643907	21111009373	automated	automated	JJ
601953	108643907	21111009374	assessment	assessment	NN1
601953	108643907	21111009375	of	of	IO
601953	108643907	21111009376	cognitive	cognitive	JJ
601953	108643907	21111009377	function	function	NN1
601953	108643907	21111009378	in	in	II
601953	108643907	21111009379	clinical	clinical	JJ
601953	108643907	21111009380	trials	trial	NN2
601953	108643907	21111009381	for	for	IF
601953	108643907	21111009382	the	the	AT
601953	108643907	21111009383	last	last	MD
601953	108643907	21111009384	20	20	MC
601953	108643907	21111009385	years	year	NNT2
601953	108643907	21111009386	.	.	.
601953	108643907	21111009387	Supported	support	VVN
601953	108643907	21111009388	by	by	II
601953	108643907	21111009389	an	a	AT1
601953	108643907	21111009390	unparalleled	unparalleled	JJ
601953	108643907	21111009391	publication	publication	NN1
601953	108643907	21111009392	record	record	NN1
601953	108643907	21111009393	and	and	CC
601953	108643907	21111009394	the	the	AT
601953	108643907	21111009395	most	most	RGT
601953	108643907	21111009396	comprehensive	comprehensive	JJ
601953	108643907	21111009397	neuropsychopharmacology		NN1
601953	108643907	21111009398	databases	database	NN2
601953	108643907	21111009399	ever	ever	RR
601953	108643907	21111009400	assembled	assemble	VVN_VVD_JJ
601953	108643907	21111009401	,	,	,
601953	108643907	21111009402	the	the	AT
601953	108643907	21111009403	CDR	cdr	NP1
601953	108643907	21111009404	SystemG		NP1
601953	108643907	21111009405	provides	provide	VVZ
601953	108643907	21111009406	clients	client	NN2
601953	108643907	21111009407	with	with	IW
601953	108643907	21111009408	the	the	AT
601953	108643907	21111009409	most	most	RGT
601953	108643907	21111009410	sensitive	sensitive	JJ
601953	108643907	21111009411	set	set	NN1
601953	108643907	21111009412	of	of	IO
601953	108643907	21111009413	tests	test	NN2
601953	108643907	21111009414	ever	ever	RR
601953	108643907	21111009415	developed	develop	VVN_VVD
601953	108643907	21111009416	to	to	TO
601953	108643907	21111009417	assess	assess	VVI
601953	108643907	21111009418	improvements	improvement	NN2
601953	108643907	21111009419	and	and	CC
601953	108643907	21111009420	impairments	impairment	NN2
601953	108643907	21111009421	in	in	II
601953	108643907	21111009422	cognitive	cognitive	JJ
601953	108643907	21111009423	function	function	NN1
601953	108643907	21111009424	.	.	.
601953	108643907	21111009425	<p>		NULL
601953	108643907	21111009426	The	the	AT
601953	108643907	21111009427	CDR	cdr	NP1
601953	108643907	21111009428	SystemG		NP1
601953	108643907	21111009429	assesses	assess	VVZ
601953	108643907	21111009430	the	the	AT
601953	108643907	21111009431	major	major	JJ
601953	108643907	21111009432	domains	domain	NN2
601953	108643907	21111009433	@		II
601953	108643907	21111009434	@		II
601953	108643907	21111009435	@		II
601953	108643907	21111009436	@		II
601953	108643907	21111009437	@		II
601953	108643907	21111009438	@		II
601953	108643907	21111009439	@		II
601953	108643907	21111009440	@		II
601953	108643907	21111009441	@		II
601953	108643907	21111009442	@		II
601953	108643907	21111009443	,	,	,
601953	108643907	21111009444	disease	disease	NN1
601953	108643907	21111009445	,	,	,
601953	108643907	21111009446	pathology	pathology	NN1
601953	108643907	21111009447	,	,	,
601953	108643907	21111009448	trauma	trauma	NN1
601953	108643907	21111009449	,	,	,
601953	108643907	21111009450	diet	diet	NN1
601953	108643907	21111009451	and	and	CC
601953	108643907	21111009452	pharmaceuticals	pharmaceutical	NN2
601953	108643907	21111009453	.	.	.
601953	108643907	21111009454	<p>		NULL
601953	108643907	21111009455	Used	use	VVN_VVD_JJ
601953	108643907	21111009456	in	in	II_RP@
601953	108643907	21111009457	more	more	DAR
601953	108643907	21111009458	than	than	CSN
601953	108643907	21111009459	1,200	1,200	MC
601953	108643907	21111009460	trials	trial	NN2
601953	108643907	21111009461	across	across	II
601953	108643907	21111009462	50	50	MC
601953	108643907	21111009463	indications	indication	NN2
601953	108643907	21111009464	and	and	CC
601953	108643907	21111009465	available	available	JJ
601953	108643907	21111009466	in	in	II_RP@
601953	108643907	21111009467	over	over	RG
601953	108643907	21111009468	30	30	MC
601953	108643907	21111009469	languages	language	NN2
601953	108643907	21111009470	,	,	,
601953	108643907	21111009471	the	the	AT
601953	108643907	21111009472	CDR	cdr	NP1
601953	108643907	21111009473	SystemG		NP1
601953	108643907	21111009474	works	work	VVZ
601953	108643907	21111009475	in	in	II_RP@
601953	108643907	21111009476	all	all	DB
601953	108643907	21111009477	clinical	clinical	JJ
601953	108643907	21111009478	settings	setting	NN2
601953	108643907	21111009479	with	with	IW
601953	108643907	21111009480	any	any	DD
601953	108643907	21111009481	patient	patient	JJ_NN1
601953	108643907	21111009482	population	population	NN1
601953	108643907	21111009483	throughout	throughout	II
601953	108643907	21111009484	the	the	AT
601953	108643907	21111009485	drug	drug	NN1
601953	108643907	21111009486	development	development	NN1
601953	108643907	21111009487	process	process	NN1
601953	108643907	21111009488	.	.	.
601953	108643907	21111009489	<h>		NULL
601953	108643907	21111009490	The	the	AT
601953	108643907	21111009491	CDR	cdr	NP1
601953	108643907	21111009492	SystemG		NP1
601953	108643907	21111009493	provides	provide	VVZ
601953	108643907	21111009494	the	the	AT
601953	108643907	21111009495	following	following	JJ
601953	108643907	21111009496	benefits	benefit	NN2
601953	108643907	21111009497	:	:	:
601953	108643907	21111009498	<h>		NULL
601953	108643907	21111009499	Core	core	NN1
601953	108643907	21111009500	assessments	assessment	NN2
601953	108643907	21111009501	can	can	VM
601953	108643907	21111009502	be	be	VBI
601953	108643907	21111009503	completed	complete	VVN
601953	108643907	21111009504	in	in	II_RP@
601953	108643907	21111009505	less	less	DAR
601953	108643907	21111009506	than	than	CSN
601953	108643907	21111009507	20	20	MC
601953	108643907	21111009508	minutes	minute	NNT2
601953	108643907	21111009509	and	and	CC
601953	108643907	21111009510	can	can	VM
601953	108643907	21111009511	be	be	VBI
601953	108643907	21111009512	administered	administer	VVN
601953	108643907	21111009513	by	by	II
601953	108643907	21111009514	non-specialists	nonspecialist	NN2
601953	108643907	21111009515	with	with	IW
601953	108643907	21111009516	brief	brief	JJ
601953	108643907	21111009517	training	training	NN1
601953	108643907	21111009518	<h>		NULL
601953	108643907	21111009519	Data	data	NN
601953	108643907	21111009520	is	be	VBZ
601953	108643907	21111009521	automatically	automatically	RR
601953	108643907	21111009522	and	and	CC
601953	108643907	21111009523	securely	securely	RR
601953	108643907	21111009524	recorded	record	VVN_VVD
601953	108643907	21111009525	and	and	CC
601953	108643907	21111009526	uploaded	upload	VVN
601953	108643907	21111009527	directly	directly	RR
601953	108643907	21111009528	into	into	II
601953	108643907	21111009529	Bracket	bracket	NN1
601953	108643907	21111009530	's	's	GE
601953	108643907	21111009531	databases	database	NN2
601953	108643907	21111009532	,	,	,
601953	108643907	21111009533	readily	readily	RR
601953	108643907	21111009534	available	available	JJ
601953	108643907	21111009535	for	for	IF
601953	108643907	21111009536	review	review	NN1
601953	108643907	21111009537	<h>		NULL
601953	108643907	21111009538	Continuity	continuity	NN1
601953	108643907	21111009539	both	both	RR
601953	108643907	21111009540	within	within	RL@_II
601953	108643907	21111009541	and	and	CC
601953	108643907	21111009542	between	between	II
601953	108643907	21111009543	research	research	NN1
601953	108643907	21111009544	programs	program	NN2
601953	108643907	21111009545	<h>		NULL
601953	108643907	21111009546	Characterization	characterization	NN1
601953	108643907	21111009547	of	of	IO
601953	108643907	21111009548	the	the	AT
601953	108643907	21111009549	cognitive	cognitive	JJ
601953	108643907	21111009550	effect	effect	NN1
601953	108643907	21111009551	of	of	IO
601953	108643907	21111009552	therapeutic	therapeutic	JJ
601953	108643907	21111009553	substances	substance	NN2
601953	108643907	21111009554	<h>		NULL
601953	108643907	21111009555	Measurement	measurement	NN1
601953	108643907	21111009556	of	of	IO
601953	108643907	21111009557	change	change	NN1
601953	108643907	21111009558	in	in	II
601953	108643907	21111009559	function	function	NN1
601953	108643907	21111009560	with	with	IW
601953	108643907	21111009561	high	high	JJ
601953	108643907	21111009562	degree	degree	NN1
601953	108643907	21111009563	of	of	IO
601953	108643907	21111009564	sensitivity	sensitivity	NN1
601953	108643907	21111009565	<h>		NULL
601953	108643907	21111009566	Determination	determination	NN1
601953	108643907	21111009567	of	of	IO
601953	108643907	21111009568	the	the	AT
601953	108643907	21111009569	cognitive	cognitive	JJ
601953	108643907	21111009570	potential	potential	NN1_JJ
601953	108643907	21111009571	and	and	CC
601953	108643907	21111009572	effect	effect	NN1
601953	108643907	21111009573	of	of	IO
601953	108643907	21111009574	therapeutic	therapeutic	JJ
601953	108643907	21111009575	substances	substance	NN2
601953	108643907	21111009576	<h>		NULL
601953	108643907	21111009577	In	in	II31
601953	108643907	21111009578	addition	addition	II32
601953	108643907	21111009579	to	to	II33
601953	108643907	21111009580	assessing	assess	VVG
601953	108643907	21111009581	the	the	AT
601953	108643907	21111009582	safety	safety	NN1
601953	108643907	21111009583	of	of	IO
601953	108643907	21111009584	new	new	JJ
601953	108643907	21111009585	treatments	treatment	NN2
601953	108643907	21111009586	,	,	,
601953	108643907	21111009587	the	the	AT
601953	108643907	21111009588	CDR	cdr	NP1
601953	108643907	21111009589	SystemG		NP1_NN1
601953	108643907	21111009590	is	be	VBZ
601953	108643907	21111009591	widely	widely	RR
601953	108643907	21111009592	used	use	VVN_VVD
601953	108643907	21111009593	in	in	II
601953	108643907	21111009594	the	the	AT
601953	108643907	21111009595	rapidly	rapidly	RR
601953	108643907	21111009596	expanding	expanding	JJ_VVG
601953	108643907	21111009597	field	field	NN1
601953	108643907	21111009598	of	of	IO
601953	108643907	21111009599	identifying	identify	VVG_JJ@
601953	108643907	21111009600	cognition	cognition	NN1
601953	108643907	21111009601	enhancement	enhancement	NN1
601953	108643907	21111009602	<h>		NULL
601953	108643907	21111009603	Why	why	RRQ
601953	108643907	21111009604	Wait	wait	VV0
601953	108643907	21111009605	?	?	?
601953	108643907	21111009606	<p>		NULL
601953	108643907	21111009607	Sign	sign	VV0
601953	108643907	21111009608	up	up	RP
601953	108643907	21111009609	now	now	RT
601953	108643907	21111009610	to	to	TO
601953	108643907	21111009611	have	have	VHI
601953	108643907	21111009612	someone	someone	PN1
601953	108643907	21111009613	from	from	II
601953	108643907	21111009614	Bracket	bracket	NN1
601953	108643907	21111009615	contact	contact	VV0_NN1
601953	108643907	21111009616	you	you	PPY
601953	108643907	21111009617	.	.	.
601953	108643907	21111009618	Let	let	VV0
601953	108643907	21111009619	us	us	PPIO2
601953	108643907	21111009620	show	show	VVI
601953	108643907	21111009621	you	you	PPY
601953	108643907	21111009622	how	how	RRQ
601953	108643907	21111009623	Bracket	bracket	NN1
601953	108643907	21111009624	eclipses	eclipse	VVZ@_NN2
601953	108643907	21111009625	the	the	AT
601953	108643907	21111009626	industry	industry	NN1
601953	108643907	21111009627	through	through	II
601953	108643907	21111009628	Science	science	NN1
601953	108643907	21111009629	,	,	,
601953	108643907	21111009630	Technology	technology	NN1
601953	108643907	21111009631	,	,	,
601953	108643907	21111009632	and	and	CC
601953	108643907	21111009633	Service	service	NN1
601953	108643907	21111009634	.	.	.
601953	108643908	21111009654	@@##	----------	----------
601953	108643908	21111009655	@@108643908		FO
601953	108643908	21111009656	@4043908/		JJ_VV0_NN1
601953	108643908	21111009657	<h>		NULL
601953	108643908	21111009658	Visit	visit	NN1_VV0
601953	108643908	21111009659	Booth	booth	NN1_NP1
601953	108643908	21111009660	202	202	MC
601953	108643908	21111009661	During	during	II
601953	108643908	21111009662	SCDM		NP1
601953	108643908	21111009663	to	to	TO
601953	108643908	21111009664	see	see	VVI
601953	108643908	21111009665	the	the	AT
601953	108643908	21111009666	Latest	late	JJT
601953	108643908	21111009667	Technology	technology	NN1
601953	108643908	21111009668	from	from	II
601953	108643908	21111009669	Bracket	bracket	NN1
601953	108643908	21111009670	<p>		NULL
601953	108643908	21111009671	September	september	NPM1
601953	108643908	21111009672	9	9	MC
601953	108643908	21111009673	,	,	,
601953	108643908	21111009674	2016	2016	MC
601953	108643908	21111009675	<p>		NULL
601953	108643908	21111009676	The	the	AT
601953	108643908	21111009677	SCDM		NP1
601953	108643908	21111009678	2016	2016	MC
601953	108643908	21111009679	Annual	annual	JJ
601953	108643908	21111009680	Conference	conference	NN1
601953	108643908	21111009681	on	on	II
601953	108643908	21111009682	September	september	NPM1
601953	108643908	21111009683	11-14	11-14	MCMC
601953	108643908	21111009684	,	,	,
601953	108643908	21111009685	in	in	II
601953	108643908	21111009686	San	san	NP1
601953	108643908	21111009687	Diego	diego	NP1
601953	108643908	21111009688	,	,	,
601953	108643908	21111009689	CA	ca	NP1@
601953	108643908	21111009690	is	be	VBZ
601953	108643908	21111009691	rapidly	rapidly	RR
601953	108643908	21111009692	approaching	approach	VVG
601953	108643908	21111009693	.	.	.
601953	108643908	21111009694	As	as	II_CSA
601953	108643908	21111009695	the	the	AT
601953	108643908	21111009696	date	date	NN1
601953	108643908	21111009697	approaches	approach	NN2_VVZ
601953	108643908	21111009698	,	,	,
601953	108643908	21111009699	we	we	PPIS2
601953	108643908	21111009700	are	be	VBR
601953	108643908	21111009701	excited	excite	VVN@_JJ
601953	108643908	21111009702	to	to	TO
601953	108643908	21111009703	announce	announce	VVI
601953	108643908	21111009704	that	that	CST
601953	108643908	21111009705	we	we	PPIS2
601953	108643908	21111009706	will	will	VM
601953	108643908	21111009707	be	be	VBI
601953	108643908	21111009708	exhibiting	exhibit	VVG
601953	108643908	21111009709	at	at	II
601953	108643908	21111009710	booth	booth	NN1
601953	108643908	21111009711	202	202	MC
601953	108643908	21111009712	,	,	,
601953	108643908	21111009713	and	and	CC
601953	108643908	21111009714	a	a	AT1
601953	108643908	21111009715	panel	panel	NN1
601953	108643908	21111009716	discussion	discussion	NN1
601953	108643908	21111009717	will	will	VM
601953	108643908	21111009718	be	be	VBI
601953	108643908	21111009719	presented	present	VVN
601953	108643908	21111009720	on	on	II
601953	108643908	21111009721	Challenges	challenge	NN2
601953	108643908	21111009722	to	to	II
601953	108643908	21111009723	the	the	AT
601953	108643908	21111009724	Adoption	adoption	NN1
601953	108643908	21111009725	of	of	IO
601953	108643908	21111009726	Bring	bring	VV0
601953	108643908	21111009727	Your	your	APPGE
601953	108643908	21111009728	Own	own	DA
601953	108643908	21111009729	Device	device	NN1
601953	108643908	21111009730	in	in	II
601953	108643908	21111009731	Clinical	clinical	JJ
601953	108643908	21111009732	Trials	trial	NN2
601953	108643908	21111009733	by	by	II
601953	108643908	21111009734	our	our	APPGE
601953	108643908	21111009735	very	very	RG
601953	108643908	21111009736	own	own	DA
601953	108643908	21111009737	,	,	,
601953	108643908	21111009738	Adam	adam	NP1
601953	108643908	21111009739	Butler	butler	NP1
601953	108643908	21111009740	,	,	,
601953	108643908	21111009741	Senior	senior	JJ
601953	108643908	21111009742	Vice	vice	JJ_NN1
601953	108643908	21111009743	President	president	NN1
601953	108643908	21111009744	,	,	,
601953	108643908	21111009745	Strategic	strategic	JJ
601953	108643908	21111009746	Development	development	NN1
601953	108643908	21111009747	.	.	.
601953	108643908	21111009748	This	this	DD1
601953	108643908	21111009749	panel	panel	NN1
601953	108643908	21111009750	will	will	VM
601953	108643908	21111009751	gather	gather	VVI
601953	108643908	21111009752	representatives	representative	NN2
601953	108643908	21111009753	from	from	II
601953	108643908	21111009754	sponsors	sponsor	NN2
601953	108643908	21111009755	,	,	,
601953	108643908	21111009756	CRO	cro	NP1
601953	108643908	21111009757	's	's	GE_VBZ
601953	108643908	21111009758	,	,	,
601953	108643908	21111009759	and	and	CC
601953	108643908	21111009760	investigator	investigator	NN1
601953	108643908	21111009761	sites	site	NN2
601953	108643908	21111009762	who	who	PNQS
601953	108643908	21111009763	have	have	VH0
601953	108643908	21111009764	already	already	RR
601953	108643908	21111009765	utilized	utilize	VVN
601953	108643908	21111009766	BYOB		VV0_NN1_NP1
601953	108643908	21111009767	to	to	TO
601953	108643908	21111009768	discuss	discuss	VVI
601953	108643908	21111009769	what	what	DDQ
601953	108643908	21111009770	has	have	VHZ
601953	108643908	21111009771	worked	work	VVN
601953	108643908	21111009772	,	,	,
601953	108643908	21111009773	and	and	CC
601953	108643908	21111009774	what	what	DDQ
601953	108643908	21111009775	has	have	VHZ
601953	108643908	21111009776	not	not	XX
601953	108643908	21111009777	.	.	.
601953	108643908	21111009778	<p>		NULL
601953	108643908	21111009779	If	if	CS
601953	108643908	21111009780	you	you	PPY
601953	108643908	21111009781	are	be	VBR
601953	108643908	21111009782	looking	look	VVG
601953	108643908	21111009783	to	to	TO
601953	108643908	21111009784	implement	implement	VVI
601953	108643908	21111009785	BYOD		NN1_NP1_VV0
601953	108643908	21111009786	in	in	II
601953	108643908	21111009787	your	your	APPGE
601953	108643908	21111009788	next	next	MD
601953	108643908	21111009789	trial	trial	NN1
601953	108643908	21111009790	or	or	CC
601953	108643908	21111009791	simply	simply	RR
601953	108643908	21111009792	leverage	leverage	NN1
601953	108643908	21111009793	new	new	JJ
601953	108643908	21111009794	technologies	technology	NN2
601953	108643908	21111009795	for	for	IF
601953	108643908	21111009796	your	your	APPGE
601953	108643908	21111009797	RTQA		NN1
601953	108643908	21111009798	,	,	,
601953	108643908	21111009799	eCOA		NN1
601953	108643908	21111009800	or	or	CC
601953	108643908	21111009801	RTSM		NP1
601953	108643908	21111009802	needs	need	VVZ_NN2
601953	108643908	21111009803	,	,	,
601953	108643908	21111009804	then	then	RT
601953	108643908	21111009805	stop	stop	VV0
601953	108643908	21111009806	by	by	II
601953	108643908	21111009807	booth	booth	NN1
601953	108643908	21111009808	202	202	MC
601953	108643908	21111009809	during	during	II
601953	108643908	21111009810	SCDM		NP1
601953	108643908	21111009811	for	for	IF
601953	108643908	21111009812	more	more	DAR
601953	108643908	21111009813	information	information	NN1
601953	108643908	21111009814	!	!	!
601953	108643910	21111009834	@@##	----------	----------
601953	108643910	21111009835	@@108643910		FO
601953	108643910	21111009836	@4043910/		VV0_NN1
601953	108643910	21111009837	<h>		NULL
601953	108643910	21111009838	By	by	II
601953	108643910	21111009839	David	david	NP1
601953	108643910	21111009840	Miller	miller	NP1
601953	108643910	21111009841	,	,	,
601953	108643910	21111009842	MD	md	NNA
601953	108643910	21111009843	,	,	,
601953	108643910	21111009844	-	-	-
601953	108643910	21111009845	Clinical	clinical	JJ
601953	108643910	21111009846	Vice	vice	JJ_NN1
601953	108643910	21111009847	President	president	NN1
601953	108643910	21111009848	at	at	II
601953	108643910	21111009849	Bracket	bracket	NN1
601953	108643910	21111009850	<p>		NULL
601953	108643910	21111009851	Cognitive	cognitive	JJ
601953	108643910	21111009852	and	and	CC
601953	108643910	21111009853	Functional	functional	JJ
601953	108643910	21111009854	outcomes	outcome	NN2
601953	108643910	21111009855	are	be	VBR
601953	108643910	21111009856	generally	generally	RR
601953	108643910	21111009857	the	the	AT
601953	108643910	21111009858	co-primary		JJ_NN1
601953	108643910	21111009859	endpoints	endpoint	NN2
601953	108643910	21111009860	in	in	II
601953	108643910	21111009861	most	most	DAT
601953	108643910	21111009862	symptomatic	symptomatic	JJ
601953	108643910	21111009863	and	and	CC
601953	108643910	21111009864	disease-modifying	disease-modifying	JJ
601953	108643910	21111009865	clinical	clinical	JJ
601953	108643910	21111009866	trials	trial	NN2
601953	108643910	21111009867	of	of	IO
601953	108643910	21111009868	Alzheimer	alzheimer	NP1
601953	108643910	21111009869	's	's	GE
601953	108643910	21111009870	disease	disease	NN1
601953	108643910	21111009871	.	.	.
601953	108643910	21111009872	But	but	CCB
601953	108643910	21111009873	Quality	quality	NN1
601953	108643910	21111009874	of	of	IO
601953	108643910	21111009875	Life	life	NN1
601953	108643910	21111009876	(	(	(
601953	108643910	21111009877	QOL	qol	NP1
601953	108643910	21111009878	)	)	)
601953	108643910	21111009879	is	be	VBZ
601953	108643910	21111009880	an	a	AT1
601953	108643910	21111009881	important	important	JJ
601953	108643910	21111009882	component	component	NN1
601953	108643910	21111009883	in	in	II
601953	108643910	21111009884	understanding	understand	VVG
601953	108643910	21111009885	the	the	AT
601953	108643910	21111009886	disease	disease	NN1
601953	108643910	21111009887	,	,	,
601953	108643910	21111009888	and	and	CC
601953	108643910	21111009889	measuring	measure	VVG
601953	108643910	21111009890	it	it	PPH1
601953	108643910	21111009891	can	can	VM
601953	108643910	21111009892	be	be	VBI
601953	108643910	21111009893	difficult	difficult	JJ
601953	108643910	21111009894	.	.	.
601953	108643910	21111009895	<p>		NULL
601953	108643910	21111009896	There	there	EX
601953	108643910	21111009897	are	be	VBR
601953	108643910	21111009898	a	a	AT1
601953	108643910	21111009899	handful	handful	NN1
601953	108643910	21111009900	of	of	IO
601953	108643910	21111009901	measures	measure	NN2
601953	108643910	21111009902	currently	currently	RR
601953	108643910	21111009903	used	use	VVN_VVD
601953	108643910	21111009904	in	in	II
601953	108643910	21111009905	clinical	clinical	JJ
601953	108643910	21111009906	trials	trial	NN2
601953	108643910	21111009907	to	to	TO
601953	108643910	21111009908	evaluate	evaluate	VVI
601953	108643910	21111009909	QOL	qol	NN1_NP1
601953	108643910	21111009910	.	.	.
601953	108643910	21111009911	However	however	RR
601953	108643910	21111009912	,	,	,
601953	108643910	21111009913	like	like	II
601953	108643910	21111009914	other	other	JJ
601953	108643910	21111009915	clinical	clinical	JJ
601953	108643910	21111009916	outcomes	outcome	NN2
601953	108643910	21111009917	in	in	II
601953	108643910	21111009918	Alzheimer	alzheimer	NP1
601953	108643910	21111009919	's	's	GE
601953	108643910	21111009920	disease	disease	NN1
601953	108643910	21111009921	,	,	,
601953	108643910	21111009922	there	there	EX
601953	108643910	21111009923	are	be	VBR
601953	108643910	21111009924	unique	unique	JJ
601953	108643910	21111009925	challenges	challenge	NN2
601953	108643910	21111009926	to	to	TO
601953	108643910	21111009927	understand	understand	VVI
601953	108643910	21111009928	QOL	qol	NP1_NN1
601953	108643910	21111009929	and	and	CC
601953	108643910	21111009930	difficulties	difficulty	NN2
601953	108643910	21111009931	to	to	TO
601953	108643910	21111009932	measure	measure	VVI
601953	108643910	21111009933	its	its	APPGE
601953	108643910	21111009934	change	change	NN1
601953	108643910	21111009935	.	.	.
601953	108643910	21111009936	<p>		NULL
601953	108643910	21111009937	One	one	MC1
601953	108643910	21111009938	important	important	JJ
601953	108643910	21111009939	consideration	consideration	NN1
601953	108643910	21111009940	is	be	VBZ
601953	108643910	21111009941	that	that	CST_DD1
601953	108643910	21111009942	as	as	II_CSA
601953	108643910	21111009943	the	the	AT
601953	108643910	21111009944	dementia	dementia	NN1
601953	108643910	21111009945	progresses	progress	VVZ
601953	108643910	21111009946	,	,	,
601953	108643910	21111009947	insight	insight	NN1
601953	108643910	21111009948	worsens	worsen	VVZ
601953	108643910	21111009949	.	.	.
601953	108643910	21111009950	Therefore	therefore	RR
601953	108643910	21111009951	,	,	,
601953	108643910	21111009952	determining	determine	VVG
601953	108643910	21111009953	when	when	RRQ_CS
601953	108643910	21111009954	a	a	AT1
601953	108643910	21111009955	reported	reported	JJ@
601953	108643910	21111009956	change	change	NN1
601953	108643910	21111009957	is	be	VBZ
601953	108643910	21111009958	real	real	JJ
601953	108643910	21111009959	and	and	CC
601953	108643910	21111009960	when	when	CS_RRQ
601953	108643910	21111009961	it	it	PPH1
601953	108643910	21111009962	it	it	PPH1
601953	108643910	21111009963	's	be	VBZ
601953	108643910	21111009964	colored	color	VVN
601953	108643910	21111009965	by	by	II
601953	108643910	21111009966	diminished	diminished	JJ@
601953	108643910	21111009967	insight	insight	NN1
601953	108643910	21111009968	can	can	VM
601953	108643910	21111009969	prove	prove	VVI
601953	108643910	21111009970	challenging.		NNU
601953	108643910	21111009971	-	-	-
601953	108643910	21111009972	Often	often	RR
601953	108643910	21111009973	,	,	,
601953	108643910	21111009974	caregivers	caregiver	NN2
601953	108643910	21111009975	are	be	VBR
601953	108643910	21111009976	asked	ask	VVN@
601953	108643910	21111009977	to	to	TO
601953	108643910	21111009978	serve	serve	VVI
601953	108643910	21111009979	as	as	II
601953	108643910	21111009980	a	a	AT1
601953	108643910	21111009981	proxy	proxy	NN1
601953	108643910	21111009982	for	for	IF
601953	108643910	21111009983	the	the	AT
601953	108643910	21111009984	patient	patient	NN1_JJ
601953	108643910	21111009985	.	.	.
601953	108643910	21111009986	However	however	RR
601953	108643910	21111009987	,	,	,
601953	108643910	21111009988	this	this	DD1
601953	108643910	21111009989	raises	raise	VVZ
601953	108643910	21111009990	the	the	AT
601953	108643910	21111009991	question	question	NN1
601953	108643910	21111009992	of	of	IO
601953	108643910	21111009993	when	when	RRQ
601953	108643910	21111009994	in	in	II
601953	108643910	21111009995	the	the	AT
601953	108643910	21111009996	illness	illness	NN1
601953	108643910	21111009997	course	course	NN1
601953	108643910	21111009998	the	the	AT
601953	108643910	21111009999	patient	patient	NN1
601953	108643910	21111010000	's	's	GE
601953	108643910	21111010001	insight	insight	NN1
601953	108643910	21111010002	is	be	VBZ
601953	108643910	21111010003	better	better	JJR_RRR
601953	108643910	21111010004	(	(	(
601953	108643910	21111010005	earlier	early	RRR
601953	108643910	21111010006	in	in	II
601953	108643910	21111010007	the	the	AT
601953	108643910	21111010008	course	course	NN1
601953	108643910	21111010009	)	)	)
601953	108643910	21111010010	and	and	CC
601953	108643910	21111010011	when	when	CS_RRQ
601953	108643910	21111010012	the	the	AT
601953	108643910	21111010013	caregiver	caregiver	NN1
601953	108643910	21111010014	's	's	GE
601953	108643910	21111010015	becomes	become	VVZ
601953	108643910	21111010016	more	more	RGR_DAR
601953	108643910	21111010017	reliable	reliable	JJ
601953	108643910	21111010018	.	.	.
601953	108643910	21111010019	<p>		NULL
601953	108643910	21111010020	A	a	AT1_ZZ1
601953	108643910	21111010021	recent	recent	JJ
601953	108643910	21111010022	article	article	NN1
601953	108643910	21111010023	in	in	II
601953	108643910	21111010024	Alzheimer	alzheimer	NP1
601953	108643910	21111010025	's	's	GE
601953	108643910	21111010026	@		II
601953	108643910	21111010027	@		II
601953	108643910	21111010028	@		II
601953	108643910	21111010029	@		II
601953	108643910	21111010030	@		II
601953	108643910	21111010031	@		II
601953	108643910	21111010032	@		II
601953	108643910	21111010033	@		II
601953	108643910	21111010034	@		II
601953	108643910	21111010035	@		II
601953	108643910	21111010036	challenges	challenge	NN2
601953	108643910	21111010037	.	.	.
601953	108643910	21111010038	In	in	II
601953	108643910	21111010039	this	this	DD1
601953	108643910	21111010040	study	study	NN1
601953	108643910	21111010041	,	,	,
601953	108643910	21111010042	the	the	AT
601953	108643910	21111010043	researchers	researcher	NN2
601953	108643910	21111010044	examined	examine	VVD_VVN
601953	108643910	21111010045	a	a	AT1
601953	108643910	21111010046	cohort	cohort	NN1
601953	108643910	21111010047	of	of	IO
601953	108643910	21111010048	patients	patient	NN2
601953	108643910	21111010049	and	and	CC
601953	108643910	21111010050	caregivers	caregiver	NN2_VVZ
601953	108643910	21111010051	and	and	CC
601953	108643910	21111010052	analyzed	analyze	VVD
601953	108643910	21111010053	both	both	RR
601953	108643910	21111010054	patient	patient	JJ
601953	108643910	21111010055	and	and	CC
601953	108643910	21111010056	caregiver	caregiver	VV0_NN1
601953	108643910	21111010057	reports	report	NN2
601953	108643910	21111010058	of	of	IO
601953	108643910	21111010059	QOL	qol	NN1_NP1
601953	108643910	21111010060	to	to	TO
601953	108643910	21111010061	try	try	VVI
601953	108643910	21111010062	and	and	CC
601953	108643910	21111010063	better	better	RRR
601953	108643910	21111010064	understand	understand	VVI
601953	108643910	21111010065	the	the	AT
601953	108643910	21111010066	differences	difference	NN2
601953	108643910	21111010067	.	.	.
601953	108643910	21111010068	There	there	EX
601953	108643910	21111010069	were	be	VBDR
601953	108643910	21111010070	several	several	DA2
601953	108643910	21111010071	important	important	JJ
601953	108643910	21111010072	results	result	NN2
601953	108643910	21111010073	in	in	II
601953	108643910	21111010074	this	this	DD1
601953	108643910	21111010075	study	study	NN1
601953	108643910	21111010076	,	,	,
601953	108643910	21111010077	including	including	II_VVG@
601953	108643910	21111010078	this	this	DD1
601953	108643910	21111010079	;	;	;
601953	108643910	21111010080	<p>		NULL
601953	108643910	21111010081	Older	old	JJR
601953	108643910	21111010082	patient	patient	JJ_NN1
601953	108643910	21111010083	age	age	NN1
601953	108643910	21111010084	was	be	VBDZ
601953	108643910	21111010085	associated	associate	VVN
601953	108643910	21111010086	with	with	IW
601953	108643910	21111010087	overestimation	overestimation	NN1
601953	108643910	21111010088	of	of	IO
601953	108643910	21111010089	QOL	qol	NN1_NP1
601953	108643910	21111010090	by	by	II
601953	108643910	21111010091	caregivers	caregiver	NN2
601953	108643910	21111010092	,	,	,
601953	108643910	21111010093	whereas	whereas	CS
601953	108643910	21111010094	neuropsychiatric	neuropsychiatric	JJ
601953	108643910	21111010095	inventory	inventory	NN1
601953	108643910	21111010096	score	score	NN1
601953	108643910	21111010097	and	and	CC
601953	108643910	21111010098	caregiver	caregiver	VV0_NN1
601953	108643910	21111010099	burden	burden	NN1
601953	108643910	21111010100	were	be	VBDR
601953	108643910	21111010101	associated	associate	VVN
601953	108643910	21111010102	with	with	IW
601953	108643910	21111010103	underestimation	underestimation	NN1
601953	108643910	21111010104	.	.	.
601953	108643910	21111010105	<p>		NULL
601953	108643910	21111010106	At	at	II
601953	108643910	21111010107	Bracket	bracket	NN1
601953	108643910	21111010108	,	,	,
601953	108643910	21111010109	we	we	PPIS2
601953	108643910	21111010110	've	have	VH0
601953	108643910	21111010111	focused	focus	VVN
601953	108643910	21111010112	on	on	II
601953	108643910	21111010113	making	make	VVG
601953	108643910	21111010114	sure	sure	JJ
601953	108643910	21111010115	the	the	AT
601953	108643910	21111010116	QOL	qol	NN1_NP1
601953	108643910	21111010117	outcome	outcome	NN1
601953	108643910	21111010118	measures	measure	NN2
601953	108643910	21111010119	are	be	VBR
601953	108643910	21111010120	implemented	implement	VVN
601953	108643910	21111010121	in	in	II
601953	108643910	21111010122	a	a	AT1
601953	108643910	21111010123	valid	valid	JJ
601953	108643910	21111010124	and	and	CC
601953	108643910	21111010125	reliable	reliable	JJ
601953	108643910	21111010126	way	way	NN1
601953	108643910	21111010127	.	.	.
601953	108643910	21111010128	Clear	clear	JJ_VV0@
601953	108643910	21111010129	and	and	CC
601953	108643910	21111010130	concise	concise	JJ
601953	108643910	21111010131	training	training	NN1
601953	108643910	21111010132	for	for	IF
601953	108643910	21111010133	investigators	investigator	NN2
601953	108643910	21111010134	and	and	CC
601953	108643910	21111010135	raters	rater	NN2
601953	108643910	21111010136	on	on	II
601953	108643910	21111010137	how	how	RRQ
601953	108643910	21111010138	QOL	qol	NP1_NN1_VV0
601953	108643910	21111010139	information	information	NN1
601953	108643910	21111010140	should	should	VM
601953	108643910	21111010141	be	be	VBI
601953	108643910	21111010142	collected	collect	VVN
601953	108643910	21111010143	is	be	VBZ
601953	108643910	21111010144	essential	essential	JJ
601953	108643910	21111010145	.	.	.
601953	108643910	21111010146	Distinguishing	distinguish	VVG_JJ
601953	108643910	21111010147	between	between	II
601953	108643910	21111010148	patient	patient	NN1_JJ
601953	108643910	21111010149	and	and	CC
601953	108643910	21111010150	proxy	proxy	NN1
601953	108643910	21111010151	versions	version	NN2
601953	108643910	21111010152	is	be	VBZ
601953	108643910	21111010153	important	important	JJ
601953	108643910	21111010154	,	,	,
601953	108643910	21111010155	as	as	CSA
601953	108643910	21111010156	is	be	VBZ
601953	108643910	21111010157	effectively	effectively	RR
601953	108643910	21111010158	outlining	outline	VVG
601953	108643910	21111010159	how	how	RRQ
601953	108643910	21111010160	the	the	AT
601953	108643910	21111010161	sponsor	sponsor	NN1
601953	108643910	21111010162	company	company	NN1
601953	108643910	21111010163	wants	want	VVZ
601953	108643910	21111010164	caregivers	caregiver	NN2_VVZ
601953	108643910	21111010165	to	to	TO
601953	108643910	21111010166	provide	provide	VVI
601953	108643910	21111010167	the	the	AT
601953	108643910	21111010168	information	information	NN1
601953	108643910	21111010169	.	.	.
601953	108643910	21111010170	For	for	REX21
601953	108643910	21111010171	example	example	REX22
601953	108643910	21111010172	,	,	,
601953	108643910	21111010173	distinguishing	distinguish	VVG
601953	108643910	21111010174	for	for	IF
601953	108643910	21111010175	a	a	AT1
601953	108643910	21111010176	caregiver	caregiver	NN1
601953	108643910	21111010177	between	between	II
601953	108643910	21111010178	their	their	APPGE
601953	108643910	21111010179	own	own	DA
601953	108643910	21111010180	estimate	estimate	NN1
601953	108643910	21111010181	of	of	IO
601953	108643910	21111010182	a	a	AT1
601953	108643910	21111010183	patient	patient	NN1
601953	108643910	21111010184	's	's	GE
601953	108643910	21111010185	health	health	NN1
601953	108643910	21111010186	OR	or	CC
601953	108643910	21111010187	their	their	APPGE
601953	108643910	21111010188	estimate	estimate	NN1
601953	108643910	21111010189	of	of	IO
601953	108643910	21111010190	how	how	RRQ
601953	108643910	21111010191	the	the	AT
601953	108643910	21111010192	caregiver	caregiver	NN1
601953	108643910	21111010193	thinks	think	VVZ
601953	108643910	21111010194	a	a	AT1
601953	108643910	21111010195	patient	patient	NN1
601953	108643910	21111010196	would	would	VM
601953	108643910	21111010197	answer	answer	VVI
601953	108643910	21111010198	on	on	II_RP@
601953	108643910	21111010199	their	their	APPGE
601953	108643910	21111010200	own	own	DA
601953	108643910	21111010201	,	,	,
601953	108643910	21111010202	if	if	CS
601953	108643910	21111010203	they	they	PPHS2
601953	108643910	21111010204	could	could	VM
601953	108643910	21111010205	.	.	.
601953	108643910	21111010206	Generally	generally	RR
601953	108643910	21111010207	,	,	,
601953	108643910	21111010208	the	the	AT
601953	108643910	21111010209	way	way	NN1
601953	108643910	21111010210	QOL	qol	NN1_NP1
601953	108643910	21111010211	is	be	VBZ
601953	108643910	21111010212	handled	handle	VVN
601953	108643910	21111010213	is	be	VBZ
601953	108643910	21111010214	specified	specify	VVN
601953	108643910	21111010215	in	in	II
601953	108643910	21111010216	the	the	AT
601953	108643910	21111010217	protocol	protocol	NN1
601953	108643910	21111010218	"	"	"
601953	108643910	21111010219	whether	whether	CSW
601953	108643910	21111010220	subject	subject	NN1
601953	108643910	21111010221	and/or	and/or	CC
601953	108643910	21111010222	proxy	proxy	NN1
601953	108643910	21111010223	"	"	"
601953	108643910	21111010224	-	-	-
601953	108643910	21111010225	and	and	CC
601953	108643910	21111010226	@		II
601953	108643910	21111010227	@		II
601953	108643910	21111010228	@		II
601953	108643910	21111010229	@		II
601953	108643910	21111010230	@		II
601953	108643910	21111010231	@		II
601953	108643910	21111010232	@		II
601953	108643910	21111010233	@		II
601953	108643910	21111010234	@		II
601953	108643910	21111010235	@		II
601953	108643910	21111010236	way	way	NN1
601953	108643910	21111010237	to	to	TO
601953	108643910	21111010238	administer	administer	VVI
601953	108643910	21111010239	it	it	PPH1
601953	108643910	21111010240	.	.	.
601953	108643910	21111010241	<p>		NULL
601953	108643910	21111010242	These	these	DD2
601953	108643910	21111010243	nuances	nuance	NN2
601953	108643910	21111010244	are	be	VBR
601953	108643910	21111010245	important	important	JJ
601953	108643910	21111010246	,	,	,
601953	108643910	21111010247	and	and	CC
601953	108643910	21111010248	are	be	VBR
601953	108643910	21111010249	incorporated	incorporate	VVN
601953	108643910	21111010250	into	into	II
601953	108643910	21111010251	Bracket	bracket	NN1
601953	108643910	21111010252	's	's	GE
601953	108643910	21111010253	customized	customized	JJ@_VVN@
601953	108643910	21111010254	training	training	NN1
601953	108643910	21111010255	programs	program	NN2
601953	108643910	21111010256	.	.	.
601953	108643910	21111010257	Through	through	II
601953	108643910	21111010258	effective	effective	JJ
601953	108643910	21111010259	training	training	NN1
601953	108643910	21111010260	and	and	CC
601953	108643910	21111010261	remediation	remediation	NN1
601953	108643910	21111010262	efforts	effort	NN2
601953	108643910	21111010263	,	,	,
601953	108643910	21111010264	hopefully	hopefully	RR
601953	108643910	21111010265	researchers	researcher	NN2
601953	108643910	21111010266	are	be	VBR
601953	108643910	21111010267	better	better	RRR
601953	108643910	21111010268	prepared	prepare	VVN
601953	108643910	21111010269	for	for	IF
601953	108643910	21111010270	handling	handle	VVG
601953	108643910	21111010271	these	these	DD2
601953	108643910	21111010272	issues	issue	NN2
601953	108643910	21111010273	when	when	CS_RRQ
601953	108643910	21111010274	they	they	PPHS2
601953	108643910	21111010275	arise	arise	VV0
601953	108643910	21111010276	with	with	IW
601953	108643910	21111010277	their	their	APPGE
601953	108643910	21111010278	patients	patient	NN2
601953	108643910	21111010279	in	in	II
601953	108643910	21111010280	a	a	AT1
601953	108643910	21111010281	clinical	clinical	JJ
601953	108643910	21111010282	trial	trial	NN1
601953	108643910	21111010283	.	.	.
601953	108643911	21111010303	@@##	----------	----------
601953	108643911	21111010304	@@108643911		FO
601953	108643911	21111010305	@4043911/		JJ_NN1_VV0
601953	108643911	21111010306	<h>		NULL
601953	108643911	21111010307	Bracket	bracket	NN1
601953	108643911	21111010308	Welcomes	welcome	VVZ
601953	108643911	21111010309	Jennifer	jennifer	NP1
601953	108643911	21111010310	Peters	peter	VVZ@
601953	108643911	21111010311	as	as	RG@_CSA
601953	108643911	21111010312	Senior	senior	JJ
601953	108643911	21111010313	VP	vp	NP1
601953	108643911	21111010314	and	and	CC
601953	108643911	21111010315	General	general	JJ_NN1
601953	108643911	21111010316	Manager	manager	NN1
601953	108643911	21111010317	to	to	II
601953	108643911	21111010318	Scientific	scientific	JJ
601953	108643911	21111010319	Services	service	NN2
601953	108643911	21111010320	<p>		NULL
601953	108643911	21111010321	January	january	NPM1
601953	108643911	21111010322	25	25	MC
601953	108643911	21111010323	,	,	,
601953	108643911	21111010324	2017	2017	MC
601953	108643911	21111010325	<p>		NULL
601953	108643911	21111010326	WAYNE	wayne	NP1
601953	108643911	21111010327	,	,	,
601953	108643911	21111010328	PA-		NN1_JJ
601953	108643911	21111010329	-	-	-
601953	108643911	21111010330	Bracket	bracket	NN1_VV0@
601953	108643911	21111010331	,	,	,
601953	108643911	21111010332	a	a	AT1
601953	108643911	21111010333	leading	leading	JJ
601953	108643911	21111010334	clinical	clinical	JJ
601953	108643911	21111010335	trial	trial	NN1
601953	108643911	21111010336	technology	technology	NN1
601953	108643911	21111010337	and	and	CC
601953	108643911	21111010338	specialty	specialty	NN1
601953	108643911	21111010339	services	service	NN2
601953	108643911	21111010340	provider	provider	NN1
601953	108643911	21111010341	,	,	,
601953	108643911	21111010342	today	today	RT
601953	108643911	21111010343	announced	announce	VVD_VVN
601953	108643911	21111010344	the	the	AT
601953	108643911	21111010345	addition	addition	NN1
601953	108643911	21111010346	of	of	IO
601953	108643911	21111010347	Jennifer	jennifer	NP1
601953	108643911	21111010348	Peters	peter	VVZ@
601953	108643911	21111010349	to	to	II
601953	108643911	21111010350	its	its	APPGE
601953	108643911	21111010351	growing	growing	JJ
601953	108643911	21111010352	team	team	NN1
601953	108643911	21111010353	as	as	II_CSA
601953	108643911	21111010354	the	the	AT
601953	108643911	21111010355	Companys	company	NN2
601953	108643911	21111010356	new	new	JJ
601953	108643911	21111010357	Senior	senior	JJ_NN1@
601953	108643911	21111010358	Vice	vice	JJ_NN1_II
601953	108643911	21111010359	President	president	NN1
601953	108643911	21111010360	and	and	CC
601953	108643911	21111010361	General	general	JJ_NN1
601953	108643911	21111010362	Manager	manager	NN1
601953	108643911	21111010363	for	for	IF
601953	108643911	21111010364	the	the	AT
601953	108643911	21111010365	Scientific	scientific	JJ
601953	108643911	21111010366	Services	service	NN2
601953	108643911	21111010367	division	division	NN1
601953	108643911	21111010368	.	.	.
601953	108643911	21111010369	In	in	II
601953	108643911	21111010370	this	this	DD1
601953	108643911	21111010371	role	role	NN1
601953	108643911	21111010372	,	,	,
601953	108643911	21111010373	Ms.		NNB
601953	108643911	21111010374	Peters	peters	NP1
601953	108643911	21111010375	will	will	VM
601953	108643911	21111010376	be	be	VBI
601953	108643911	21111010377	responsible	responsible	JJ
601953	108643911	21111010378	for	for	IF
601953	108643911	21111010379	Brackets	bracket	NN2
601953	108643911	21111010380	work	work	VV0
601953	108643911	21111010381	in	in	II
601953	108643911	21111010382	Rater	rater	NP1
601953	108643911	21111010383	Training	training	NN1
601953	108643911	21111010384	,	,	,
601953	108643911	21111010385	Quality	quality	NN1
601953	108643911	21111010386	Assurance	assurance	NN1
601953	108643911	21111010387	,	,	,
601953	108643911	21111010388	and	and	CC
601953	108643911	21111010389	Electronic	electronic	JJ
601953	108643911	21111010390	Clinical	clinical	JJ
601953	108643911	21111010391	Outcomes	outcome	NN2
601953	108643911	21111010392	Assessments	assessment	NN2
601953	108643911	21111010393	(	(	(
601953	108643911	21111010394	eCOA		NN1
601953	108643911	21111010395	.	.	.
601953	108643911	21111010396	)	)	)
601953	108643911	21111010397	Ms.		NNB
601953	108643911	21111010398	Peters	peters	NP1
601953	108643911	21111010399	joins	join	VVZ_NN2
601953	108643911	21111010400	Bracket	bracket	NN1
601953	108643911	21111010401	with	with	IW
601953	108643911	21111010402	a	a	AT1
601953	108643911	21111010403	strong	strong	JJ
601953	108643911	21111010404	skillset	skillset	NN1
601953	108643911	21111010405	and	and	CC
601953	108643911	21111010406	demonstrated	demonstrated	JJ@_VVD_VVN
601953	108643911	21111010407	record	record	NN1
601953	108643911	21111010408	building	building	NN1_VVG@
601953	108643911	21111010409	technology-based	technology-based	NN1_JJ
601953	108643911	21111010410	businesses	business	NN2
601953	108643911	21111010411	in	in	II
601953	108643911	21111010412	life	life	NN1
601953	108643911	21111010413	sciences	science	NN2
601953	108643911	21111010414	.	.	.
601953	108643911	21111010415	<p>		NULL
601953	108643911	21111010416	With	with	IW
601953	108643911	21111010417	more	more	DAR
601953	108643911	21111010418	than	than	CSN
601953	108643911	21111010419	14	14	MC
601953	108643911	21111010420	years	year	NNT2
601953	108643911	21111010421	of	of	IO
601953	108643911	21111010422	life	life	NN1
601953	108643911	21111010423	sciences	science	NN2
601953	108643911	21111010424	industry	industry	NN1
601953	108643911	21111010425	experience	experience	NN1
601953	108643911	21111010426	,	,	,
601953	108643911	21111010427	Ms.		NNB
601953	108643911	21111010428	Peters	peters	NP1
601953	108643911	21111010429	most	most	RGT
601953	108643911	21111010430	recently	recently	RR
601953	108643911	21111010431	served	serve	VVN_VVD
601953	108643911	21111010432	as	as	II
601953	108643911	21111010433	a	a	AT1
601953	108643911	21111010434	Founder	founder	NN1
601953	108643911	21111010435	and	and	CC
601953	108643911	21111010436	Chief	chief	JJ_NN1
601953	108643911	21111010437	Experience	experience	NN1
601953	108643911	21111010438	Officer	officer	NN1
601953	108643911	21111010439	of	of	IO
601953	108643911	21111010440	Greenphire		NP1_NN1
601953	108643911	21111010441	,	,	,
601953	108643911	21111010442	a	a	AT1
601953	108643911	21111010443	global	global	JJ
601953	108643911	21111010444	provider	provider	NN1
601953	108643911	21111010445	of	of	IO
601953	108643911	21111010446	disruptive	disruptive	JJ
601953	108643911	21111010447	clinical	clinical	JJ
601953	108643911	21111010448	trials	trial	NN2
601953	108643911	21111010449	payment	payment	NN1
601953	108643911	21111010450	and	and	CC
601953	108643911	21111010451	process	process	VV0_NN1
601953	108643911	21111010452	optimization	optimization	NN1
601953	108643911	21111010453	technology	technology	NN1
601953	108643911	21111010454	products	product	NN2
601953	108643911	21111010455	serving	serve	VVG
601953	108643911	21111010456	pharmaceutical	pharmaceutical	JJ
601953	108643911	21111010457	sponsors	sponsor	NN2
601953	108643911	21111010458	,	,	,
601953	108643911	21111010459	biotech	biotech	VV0_NN1
601953	108643911	21111010460	companies	company	NN2
601953	108643911	21111010461	and	and	CC
601953	108643911	21111010462	CROs	cro	NN2_NP2
601953	108643911	21111010463	.	.	.
601953	108643911	21111010464	She	she	PPHS1
601953	108643911	21111010465	led	lead	VVD
601953	108643911	21111010466	Greenphire		NP1_NN1
601953	108643911	21111010467	from	from	II
601953	108643911	21111010468	an	a	AT1
601953	108643911	21111010469	idea-stage		JJ_NN1
601953	108643911	21111010470	startup	start-up	NN1
601953	108643911	21111010471	,	,	,
601953	108643911	21111010472	with	with	IW
601953	108643911	21111010473	three	three	MC
601953	108643911	21111010474	founding	founding	JJ@_VVG
601953	108643911	21111010475	employees	employee	NN2
601953	108643911	21111010476	at	at	II
601953	108643911	21111010477	its	its	APPGE
601953	108643911	21111010478	inception	inception	NN1
601953	108643911	21111010479	in	in	II
601953	108643911	21111010480	October	october	NPM1
601953	108643911	21111010481	2007	2007	MC
601953	108643911	21111010482	to	to	II
601953	108643911	21111010483	a	a	AT1
601953	108643911	21111010484	global	global	JJ
601953	108643911	21111010485	technology	technology	NN1
601953	108643911	21111010486	enterprise	enterprise	NN1
601953	108643911	21111010487	with	with	IW
601953	108643911	21111010488	more	more	DAR
601953	108643911	21111010489	than	than	CSN
601953	108643911	21111010490	100	100	MC
601953	108643911	21111010491	employees	employee	NN2
601953	108643911	21111010492	and	and	CC
601953	108643911	21111010493	500+	500+	FO
601953	108643911	21111010494	clients	client	NN2
601953	108643911	21111010495	@		II
601953	108643911	21111010496	@		II
601953	108643911	21111010497	@		II
601953	108643911	21111010498	@		II
601953	108643911	21111010499	@		II
601953	108643911	21111010500	@		II
601953	108643911	21111010501	@		II
601953	108643911	21111010502	@		II
601953	108643911	21111010503	@		II
601953	108643911	21111010504	@		II
601953	108643911	21111010505	2014	2014	MC
601953	108643911	21111010506	.	.	.
601953	108643911	21111010507	<p>		NULL
601953	108643911	21111010508	"	"	"
601953	108643911	21111010509	Were	be	VBDR
601953	108643911	21111010510	very	very	RG
601953	108643911	21111010511	fortunate	fortunate	JJ
601953	108643911	21111010512	to	to	TO
601953	108643911	21111010513	have	have	VHI
601953	108643911	21111010514	someone	someone	PN1
601953	108643911	21111010515	with	with	IW
601953	108643911	21111010516	Ms.		NNB
601953	108643911	21111010517	Peters	peters	NP1
601953	108643911	21111010518	background	background	NN1
601953	108643911	21111010519	join	join	VV0
601953	108643911	21111010520	our	our	APPGE
601953	108643911	21111010521	senior	senior	JJ
601953	108643911	21111010522	leadership	leadership	NN1
601953	108643911	21111010523	team	team	NN1
601953	108643911	21111010524	at	at	II
601953	108643911	21111010525	a	a	AT1
601953	108643911	21111010526	time	time	NNT1
601953	108643911	21111010527	when	when	RRQ
601953	108643911	21111010528	we	we	PPIS2
601953	108643911	21111010529	are	be	VBR
601953	108643911	21111010530	experiencing	experience	VVG
601953	108643911	21111010531	solid	solid	JJ
601953	108643911	21111010532	growth	growth	NN1
601953	108643911	21111010533	due	due	II21
601953	108643911	21111010534	to	to	II22
601953	108643911	21111010535	the	the	AT
601953	108643911	21111010536	adoption	adoption	NN1
601953	108643911	21111010537	of	of	IO
601953	108643911	21111010538	technology	technology	NN1
601953	108643911	21111010539	and	and	CC
601953	108643911	21111010540	deployment	deployment	NN1
601953	108643911	21111010541	of	of	IO
601953	108643911	21111010542	proprietary	proprietary	JJ
601953	108643911	21111010543	methodologies	methodology	NN2
601953	108643911	21111010544	,	,	,
601953	108643911	21111010545	"	"	"
601953	108643911	21111010546	said	say	VVD
601953	108643911	21111010547	Jeff	jeff	NP1
601953	108643911	21111010548	Kinell		NP1
601953	108643911	21111010549	,	,	,
601953	108643911	21111010550	CEO	ceo	NN1
601953	108643911	21111010551	at	at	II
601953	108643911	21111010552	Bracket	bracket	NN1
601953	108643911	21111010553	.	.	.
601953	108643911	21111010554	"	"	"
601953	108643911	21111010555	Our	our	APPGE
601953	108643911	21111010556	growth	growth	NN1
601953	108643911	21111010557	has	have	VHZ
601953	108643911	21111010558	created	create	VVN
601953	108643911	21111010559	the	the	AT
601953	108643911	21111010560	need	need	NN1
601953	108643911	21111010561	to	to	TO
601953	108643911	21111010562	be	be	VBI
601953	108643911	21111010563	innovative	innovative	JJ
601953	108643911	21111010564	in	in	II
601953	108643911	21111010565	both	both	DB2
601953	108643911	21111010566	the	the	AT
601953	108643911	21111010567	way	way	NN1
601953	108643911	21111010568	were	be	VBDR
601953	108643911	21111010569	organized	organize	VVN
601953	108643911	21111010570	and	and	CC
601953	108643911	21111010571	the	the	AT
601953	108643911	21111010572	way	way	NN1
601953	108643911	21111010573	we	we	PPIS2
601953	108643911	21111010574	deliver	deliver	VV0
601953	108643911	21111010575	on	on	II_RP@
601953	108643911	21111010576	our	our	APPGE
601953	108643911	21111010577	commitments	commitment	NN2
601953	108643911	21111010578	to	to	II
601953	108643911	21111010579	clients	client	NN2
601953	108643911	21111010580	.	.	.
601953	108643911	21111010581	We	we	PPIS2
601953	108643911	21111010582	are	be	VBR
601953	108643911	21111010583	confident	confident	JJ
601953	108643911	21111010584	that	that	CST
601953	108643911	21111010585	Ms.		NNB
601953	108643911	21111010586	Peters	peters	NP1
601953	108643911	21111010587	will	will	VM
601953	108643911	21111010588	bring	bring	VVI
601953	108643911	21111010589	fresh	fresh	JJ
601953	108643911	21111010590	ideas	idea	NN2
601953	108643911	21111010591	to	to	TO
601953	108643911	21111010592	help	help	VVI
601953	108643911	21111010593	lead	lead	VVI
601953	108643911	21111010594	us	us	PPIO2
601953	108643911	21111010595	to	to	II
601953	108643911	21111010596	continued	continued	JJ
601953	108643911	21111010597	success	success	NN1
601953	108643911	21111010598	.	.	.
601953	108643911	21111010599	"	"	"
601953	108643911	21111010600	<p>		NULL
601953	108643911	21111010601	Prior	prior	II21
601953	108643911	21111010602	to	to	II22
601953	108643911	21111010603	her	her	APPGE
601953	108643911	21111010604	tenure	tenure	NN1
601953	108643911	21111010605	at	at	II
601953	108643911	21111010606	Greenphire		NP1_NN1
601953	108643911	21111010607	,	,	,
601953	108643911	21111010608	Ms.		NNB
601953	108643911	21111010609	Peters	peters	NP1
601953	108643911	21111010610	held	hold	VVD
601953	108643911	21111010611	a	a	AT1
601953	108643911	21111010612	series	series	NN
601953	108643911	21111010613	of	of	IO
601953	108643911	21111010614	progressively	progressively	RR
601953	108643911	21111010615	senior	senior	JJ
601953	108643911	21111010616	leadership	leadership	NN1
601953	108643911	21111010617	positions	position	NN2_VVZ@
601953	108643911	21111010618	beginning	begin	VVG
601953	108643911	21111010619	in	in	II
601953	108643911	21111010620	2002	2002	MC
601953	108643911	21111010621	at	at	II
601953	108643911	21111010622	Transperfect		NP1_NN1
601953	108643911	21111010623	Translations	translation	NN2
601953	108643911	21111010624	,	,	,
601953	108643911	21111010625	a	a	AT1
601953	108643911	21111010626	global	global	JJ
601953	108643911	21111010627	provider	provider	NN1
601953	108643911	21111010628	of	of	IO
601953	108643911	21111010629	translation	translation	NN1
601953	108643911	21111010630	services	service	NN2
601953	108643911	21111010631	and	and	CC
601953	108643911	21111010632	localization	localization	NN1
601953	108643911	21111010633	technology	technology	NN1
601953	108643911	21111010634	to	to	II
601953	108643911	21111010635	clinical	clinical	JJ
601953	108643911	21111010636	trial	trial	NN1
601953	108643911	21111010637	sponsors	sponsor	NN2
601953	108643911	21111010638	and	and	CC
601953	108643911	21111010639	CROs	cro	NN2_NP2
601953	108643911	21111010640	.	.	.
601953	108643911	21111010641	<p>		NULL
601953	108643911	21111010642	Ms.		NNB
601953	108643911	21111010643	Peters	peters	NP1
601953	108643911	21111010644	holds	hold	VVZ
601953	108643911	21111010645	a	a	AT1
601953	108643911	21111010646	Masters	master	NN2
601953	108643911	21111010647	of	of	IO
601953	108643911	21111010648	Science	science	NN1
601953	108643911	21111010649	degree	degree	NN1
601953	108643911	21111010650	from	from	II
601953	108643911	21111010651	Pace	pace	NN1
601953	108643911	21111010652	University	university	NN1
601953	108643911	21111010653	and	and	CC
601953	108643911	21111010654	will	will	VM
601953	108643911	21111010655	be	be	VBI
601953	108643911	21111010656	based	base	VVN
601953	108643911	21111010657	in	in	II
601953	108643911	21111010658	Brackets	bracket	NN2
601953	108643911	21111010659	Wayne	wayne	NP1
601953	108643911	21111010660	,	,	,
601953	108643911	21111010661	PA	pa	NN1_NP1@
601953	108643911	21111010662	headquarters	headquarters	NN
601953	108643911	21111010663	.	.	.
601953	108643911	21111010664	<p>		NULL
601953	108643911	21111010665	About	about	II
601953	108643911	21111010666	BracketBracket		NP1_NN1
601953	108643911	21111010667	,	,	,
601953	108643911	21111010668	with	with	IW
601953	108643911	21111010669	nine	nine	MC
601953	108643911	21111010670	offices	office	NN2
601953	108643911	21111010671	and	and	CC
601953	108643911	21111010672	more	more	DAR
601953	108643911	21111010673	than	than	CSN
601953	108643911	21111010674	700	700	MC
601953	108643911	21111010675	employees	employee	NN2
601953	108643911	21111010676	worldwide	worldwide	RL
601953	108643911	21111010677	,	,	,
601953	108643911	21111010678	is	be	VBZ
601953	108643911	21111010679	a	a	AT1
601953	108643911	21111010680	clinical	clinical	JJ
601953	108643911	21111010681	trial	trial	NN1
601953	108643911	21111010682	technology	technology	NN1
601953	108643911	21111010683	and	and	CC
601953	108643911	21111010684	specialty	specialty	NN1
601953	108643911	21111010685	services	service	NN2
601953	108643911	21111010686	provider	provider	NN1
601953	108643911	21111010687	dedicated	dedicate	VVN_VVD
601953	108643911	21111010688	to	to	II
601953	108643911	21111010689	helping	help	VVG
601953	108643911	21111010690	biopharmaceutical	biopharmaceutical	JJ
601953	108643911	21111010691	sponsors	sponsor	NN2
601953	108643911	21111010692	and	and	CC
601953	108643911	21111010693	contract	contract	NN1
601953	108643911	21111010694	research	research	NN1
601953	108643911	21111010695	@		II
601953	108643911	21111010696	@		II
601953	108643911	21111010697	@		II
601953	108643911	21111010698	@		II
601953	108643911	21111010699	@		II
601953	108643911	21111010700	@		II
601953	108643911	21111010701	@		II
601953	108643911	21111010702	@		II
601953	108643911	21111010703	@		II
601953	108643911	21111010704	@		II
601953	108643911	21111010705	leveraging	leverage	VVG_JJ@
601953	108643911	21111010706	core	core	NN1
601953	108643911	21111010707	competencies	competency	NN2
601953	108643911	21111010708	in	in	II
601953	108643911	21111010709	Science	science	NN1
601953	108643911	21111010710	,	,	,
601953	108643911	21111010711	Technology	technology	NN1
601953	108643911	21111010712	,	,	,
601953	108643911	21111010713	and	and	CC
601953	108643911	21111010714	Service	service	NN1
601953	108643911	21111010715	.	.	.
601953	108643911	21111010716	Bracket	bracket	NN1_VV0@
601953	108643911	21111010717	eCOAG		NN1
601953	108643911	21111010718	is	be	VBZ
601953	108643911	21111010719	a	a	AT1
601953	108643911	21111010720	flexible	flexible	JJ
601953	108643911	21111010721	platform	platform	NN1
601953	108643911	21111010722	for	for	IF
601953	108643911	21111010723	electronic	electronic	JJ
601953	108643911	21111010724	clinical	clinical	JJ
601953	108643911	21111010725	outcomes	outcome	NN2
601953	108643911	21111010726	assessments	assessment	NN2
601953	108643911	21111010727	.	.	.
601953	108643911	21111010728	Bracket	bracket	VV0@_NN1
601953	108643911	21111010729	RTSMG		NP1
601953	108643911	21111010730	is	be	VBZ
601953	108643911	21111010731	a	a	AT1
601953	108643911	21111010732	best-in-breed		NN1_JJ
601953	108643911	21111010733	,	,	,
601953	108643911	21111010734	scalable	scalable	JJ
601953	108643911	21111010735	and	and	CC
601953	108643911	21111010736	configurable	configurable	JJ
601953	108643911	21111010737	clinical	clinical	JJ
601953	108643911	21111010738	IRT	irt	NN1
601953	108643911	21111010739	solution	solution	NN1
601953	108643911	21111010740	for	for	IF
601953	108643911	21111010741	the	the	AT
601953	108643911	21111010742	life	life	NN1
601953	108643911	21111010743	sciences	science	NN2
601953	108643911	21111010744	industry	industry	NN1
601953	108643911	21111010745	.	.	.
601953	108643911	21111010746	Bracket	bracket	VV0@_NN1
601953	108643911	21111010747	Rater	rater	NP1
601953	108643911	21111010748	Training	training	NN1
601953	108643911	21111010749	and	and	CC
601953	108643911	21111010750	Quality	quality	NN1
601953	108643911	21111010751	Assurance	assurance	NN1
601953	108643911	21111010752	improve	improve	VV0
601953	108643911	21111010753	outcomes	outcome	NN2
601953	108643911	21111010754	through	through	II
601953	108643911	21111010755	customized	customized	JJ@
601953	108643911	21111010756	training	training	NN1
601953	108643911	21111010757	and	and	CC
601953	108643911	21111010758	quality	quality	NN1
601953	108643911	21111010759	assurance	assurance	NN1
601953	108643911	21111010760	programs	program	NN2
601953	108643911	21111010761	.	.	.
601953	108643912	21111010781	@@##	----------	----------
601953	108643912	21111010782	@@108643912		FO
601953	108643912	21111010783	@4043912/		VV0_NN1
601953	108643912	21111010784	<h>		NULL
601953	108643912	21111010785	Using	use	VVG
601953	108643912	21111010786	SMS	sms	NP1
601953	108643912	21111010787	and	and	CC
601953	108643912	21111010788	Text	text	NN1
601953	108643912	21111010789	Messaging	message	VVG_NN1
601953	108643912	21111010790	to	to	TO_II
601953	108643912	21111010791	Improve	improve	VV0
601953	108643912	21111010792	Patient	patient	JJ_NN1
601953	108643912	21111010793	Compliance	compliance	NN1
601953	108643912	21111010794	<p>		NULL
601953	108643912	21111010795	December	december	NPM1
601953	108643912	21111010796	8	8	MC
601953	108643912	21111010797	,	,	,
601953	108643912	21111010798	2015	2015	MC
601953	108643912	21111010799	<p>		NULL
601953	108643912	21111010800	Medication	medication	NN1
601953	108643912	21111010801	compliance	compliance	NN1
601953	108643912	21111010802	and	and	CC
601953	108643912	21111010803	adherence	adherence	NN1
601953	108643912	21111010804	are	be	VBR
601953	108643912	21111010805	critical	critical	JJ
601953	108643912	21111010806	factors	factor	NN2
601953	108643912	21111010807	to	to	II
601953	108643912	21111010808	understanding	understand	VVG
601953	108643912	21111010809	clinical	clinical	JJ
601953	108643912	21111010810	trial	trial	NN1
601953	108643912	21111010811	success	success	NN1
601953	108643912	21111010812	.	.	.
601953	108643912	21111010813	In	in	II
601953	108643912	21111010814	a	a	AT1
601953	108643912	21111010815	randomized	randomized	JJ@
601953	108643912	21111010816	trial	trial	NN1
601953	108643912	21111010817	,	,	,
601953	108643912	21111010818	ensuring	ensure	VVG
601953	108643912	21111010819	that	that	CST
601953	108643912	21111010820	patients	patient	NN2
601953	108643912	21111010821	are	be	VBR
601953	108643912	21111010822	taking	take	VVG
601953	108643912	21111010823	their	their	APPGE
601953	108643912	21111010824	medication	medication	NN1
601953	108643912	21111010825	is	be	VBZ
601953	108643912	21111010826	an	a	AT1
601953	108643912	21111010827	important	important	JJ
601953	108643912	21111010828	quality	quality	NN1
601953	108643912	21111010829	step	step	NN1_VV0
601953	108643912	21111010830	for	for	IF
601953	108643912	21111010831	investigators	investigator	NN2
601953	108643912	21111010832	.	.	.
601953	108643912	21111010833	Bracket	bracket	NN1
601953	108643912	21111010834	has	have	VHZ
601953	108643912	21111010835	announced	announce	VVN
601953	108643912	21111010836	the	the	AT
601953	108643912	21111010837	addition	addition	NN1
601953	108643912	21111010838	of	of	IO
601953	108643912	21111010839	an	a	AT1
601953	108643912	21111010840	SMS	sms	NP1
601953	108643912	21111010841	text	text	NN1
601953	108643912	21111010842	messaging	messaging	NN1_VVG
601953	108643912	21111010843	component	component	NN1
601953	108643912	21111010844	to	to	II
601953	108643912	21111010845	our	our	APPGE
601953	108643912	21111010846	Bracket	bracket	NN1
601953	108643912	21111010847	RTSM		NP1
601953	108643912	21111010848	platform	platform	NN1
601953	108643912	21111010849	.	.	.
601953	108643912	21111010850	This	this	DD1
601953	108643912	21111010851	platform	platform	NN1
601953	108643912	21111010852	will	will	VM
601953	108643912	21111010853	be	be	VBI
601953	108643912	21111010854	used	use	VVN
601953	108643912	21111010855	to	to	TO
601953	108643912	21111010856	issue	issue	VVI
601953	108643912	21111010857	Patient	patient	JJ_NN1
601953	108643912	21111010858	Reminders	reminder	NN2
601953	108643912	21111010859	via	via	II
601953	108643912	21111010860	SMS	sms	NP1
601953	108643912	21111010861	and	and	CC
601953	108643912	21111010862	help	help	VVI
601953	108643912	21111010863	keep	keep	VV0
601953	108643912	21111010864	patients	patient	NN2
601953	108643912	21111010865	compliant	compliant	JJ
601953	108643912	21111010866	throughout	throughout	II
601953	108643912	21111010867	a	a	AT1
601953	108643912	21111010868	clinical	clinical	JJ
601953	108643912	21111010869	trial	trial	NN1
601953	108643912	21111010870	.	.	.
601953	108643912	21111010871	<p>		NULL
601953	108643912	21111010872	SMS	sms	NP1
601953	108643912	21111010873	text	text	NN1
601953	108643912	21111010874	messaging	messaging	NN1
601953	108643912	21111010875	has	have	VHZ
601953	108643912	21111010876	shown	show	VVN
601953	108643912	21111010877	to	to	TO
601953	108643912	21111010878	be	be	VBI
601953	108643912	21111010879	a	a	AT1
601953	108643912	21111010880	useful	useful	JJ
601953	108643912	21111010881	intervention	intervention	NN1
601953	108643912	21111010882	for	for	IF
601953	108643912	21111010883	improving	improving	JJ_VVG
601953	108643912	21111010884	compliance	compliance	NN1
601953	108643912	21111010885	and	and	CC
601953	108643912	21111010886	adherence	adherence	NN1
601953	108643912	21111010887	in	in	II
601953	108643912	21111010888	numerous	numerous	JJ
601953	108643912	21111010889	published	published	JJ@
601953	108643912	21111010890	studies	study	NN2
601953	108643912	21111010891	.	.	.
601953	108643912	21111010892	Diabetes	diabetes	NN1
601953	108643912	21111010893	,	,	,
601953	108643912	21111010894	psychiatry	psychiatry	NN1
601953	108643912	21111010895	,	,	,
601953	108643912	21111010896	and	and	CC
601953	108643912	21111010897	gastrointestinal	gastrointestinal	JJ
601953	108643912	21111010898	studies	study	NN2
601953	108643912	21111010899	are	be	VBR
601953	108643912	21111010900	just	just	RR
601953	108643912	21111010901	a	a	AT1
601953	108643912	21111010902	few	few	DA2
601953	108643912	21111010903	that	that	CST
601953	108643912	21111010904	have	have	VH0
601953	108643912	21111010905	shown	show	VVN
601953	108643912	21111010906	patient	patient	JJ_NN1
601953	108643912	21111010907	compliance	compliance	NN1
601953	108643912	21111010908	can	can	VM
601953	108643912	21111010909	be	be	VBI
601953	108643912	21111010910	improved	improve	VVN
601953	108643912	21111010911	through	through	II
601953	108643912	21111010912	daily	daily	JJ_RR
601953	108643912	21111010913	SMS	sms	NP1
601953	108643912	21111010914	reminders	reminder	NN2
601953	108643912	21111010915	.	.	.
601953	108643912	21111010916	<p>		NULL
601953	108643912	21111010917	Bracket	bracket	VV0@_NN1
601953	108643912	21111010918	SMS	sms	NP1
601953	108643912	21111010919	Patient	patient	JJ_NN1
601953	108643912	21111010920	Reminders	reminder	NN2
601953	108643912	21111010921	are	be	VBR
601953	108643912	21111010922	managed	manage	VVN
601953	108643912	21111010923	through	through	II
601953	108643912	21111010924	our	our	APPGE
601953	108643912	21111010925	Bracket	bracket	NN1
601953	108643912	21111010926	RTSM		NP1
601953	108643912	21111010927	platform	platform	NN1
601953	108643912	21111010928	.	.	.
601953	108643912	21111010929	All	all	DB
601953	108643912	21111010930	messages	message	NN2
601953	108643912	21111010931	and	and	CC
601953	108643912	21111010932	patient	patient	JJ
601953	108643912	21111010933	data	data	NN
601953	108643912	21111010934	are	be	VBR
601953	108643912	21111010935	encrypted	encrypt	VVN@_JJ@
601953	108643912	21111010936	and	and	CC
601953	108643912	21111010937	stored	store	VVN
601953	108643912	21111010938	safely	safely	RR
601953	108643912	21111010939	.	.	.
601953	108643912	21111010940	The	the	AT
601953	108643912	21111010941	service	service	NN1
601953	108643912	21111010942	is	be	VBZ
601953	108643912	21111010943	available	available	JJ
601953	108643912	21111010944	globally	globally	RR
601953	108643912	21111010945	,	,	,
601953	108643912	21111010946	and	and	CC
601953	108643912	21111010947	the	the	AT
601953	108643912	21111010948	reminders	reminder	NN2
601953	108643912	21111010949	can	can	VM
601953	108643912	21111010950	be	be	VBI
601953	108643912	21111010951	tailored	tailor	VVN
601953	108643912	21111010952	to	to	II
601953	108643912	21111010953	specific	specific	JJ
601953	108643912	21111010954	dosing	dosing	NN1
601953	108643912	21111010955	regimens	regimen	NN2
601953	108643912	21111010956	and	and	CC
601953	108643912	21111010957	communications	communication	NN2
601953	108643912	21111010958	types	type	NN2
601953	108643912	21111010959	on	on	II
601953	108643912	21111010960	a	a	AT1
601953	108643912	21111010961	study-by-study		JJ_NN1
601953	108643912	21111010962	basis	basis	NN1
601953	108643912	21111010963	.	.	.
601953	108643912	21111010964	<p>		NULL
601953	108643912	21111010965	For	for	IF
601953	108643912	21111010966	more	more	DAR
601953	108643912	21111010967	information	information	NN1
601953	108643912	21111010968	on	on	II
601953	108643912	21111010969	how	how	RRQ
601953	108643912	21111010970	you	you	PPY
601953	108643912	21111010971	can	can	VM
601953	108643912	21111010972	utilize	utilize	VVI
601953	108643912	21111010973	@		II
601953	108643912	21111010974	@		II
601953	108643912	21111010975	@		II
601953	108643912	21111010976	@		II
601953	108643912	21111010977	@		II
601953	108643912	21111010978	@		II
601953	108643912	21111010979	@		II
601953	108643912	21111010980	@		II
601953	108643912	21111010981	@		II
601953	108643912	21111010982	@		II
601953	108643912	21111010983	Bracket	bracket	NN1
601953	108643912	21111010984	.	.	.
601953	108643916	21111011004	@@##	----------	----------
601953	108643916	21111011005	@@108643916		FO
601953	108643916	21111011006	@4043916/		JJ_NN1_VV0
601953	108643916	21111011007	<h>		NULL
601953	108643916	21111011008	Bracket	bracket	NN1
601953	108643916	21111011009	Attends	attend	VVZ
601953	108643916	21111011010	Two	two	MC
601953	108643916	21111011011	Outsourcing	outsource	VVG_NP1
601953	108643916	21111011012	in	in	II
601953	108643916	21111011013	Clinical	clinical	JJ
601953	108643916	21111011014	Trials	trial	NN2
601953	108643916	21111011015	Conferences	conference	NN2
601953	108643916	21111011016	in	in	II
601953	108643916	21111011017	May	may	NPM1
601953	108643916	21111011018	<p>		NULL
601953	108643916	21111011019	May	may	NPM1
601953	108643916	21111011020	12	12	MC
601953	108643916	21111011021	,	,	,
601953	108643916	21111011022	2016	2016	MC
601953	108643916	21111011023	<p>		NULL
601953	108643916	21111011024	Bracket	bracket	NN1
601953	108643916	21111011025	is	be	VBZ
601953	108643916	21111011026	excited	excited	JJ_VVN@
601953	108643916	21111011027	to	to	TO
601953	108643916	21111011028	announce	announce	VVI
601953	108643916	21111011029	that	that	CST
601953	108643916	21111011030	the	the	AT
601953	108643916	21111011031	company	company	NN1
601953	108643916	21111011032	will	will	VM
601953	108643916	21111011033	be	be	VBI
601953	108643916	21111011034	attending	attend	VVG
601953	108643916	21111011035	two	two	MC
601953	108643916	21111011036	Outsourcing	outsource	VVG_NP1
601953	108643916	21111011037	in	in	II
601953	108643916	21111011038	Clinical	clinical	JJ
601953	108643916	21111011039	Trials	trial	NN2
601953	108643916	21111011040	conferences	conference	NN2
601953	108643916	21111011041	this	this	DD1_RG%
601953	108643916	21111011042	May-		JJ_NN1
601953	108643916	21111011043	OCT	oct	NPM1
601953	108643916	21111011044	Europe	europe	NP1
601953	108643916	21111011045	and	and	CC
601953	108643916	21111011046	East	east	ND1
601953	108643916	21111011047	Coast	coast	NN1
601953	108643916	21111011048	.	.	.
601953	108643916	21111011049	Information	information	NN1
601953	108643916	21111011050	regarding	regarding	II_VVG
601953	108643916	21111011051	these	these	DD2
601953	108643916	21111011052	conferences	conference	NN2
601953	108643916	21111011053	can	can	VM
601953	108643916	21111011054	be	be	VBI
601953	108643916	21111011055	found	find	VVN
601953	108643916	21111011056	at	at	II
601953	108643916	21111011057	the	the	AT
601953	108643916	21111011058	links	link	NN2
601953	108643916	21111011059	below	below	RL
601953	108643916	21111011060	.	.	.
601953	108643916	21111011061	<p>		NULL
601953	108643916	21111011062	Bracket	bracket	NN1
601953	108643916	21111011063	will	will	VM
601953	108643916	21111011064	be	be	VBI
601953	108643916	21111011065	exhibiting	exhibit	VVG
601953	108643916	21111011066	at	at	II
601953	108643916	21111011067	the	the	AT
601953	108643916	21111011068	Outsourcing		NP1_NN1@_JJ@
601953	108643916	21111011069	in	in	II
601953	108643916	21111011070	Clinical	clinical	JJ
601953	108643916	21111011071	Trials	trial	NN2
601953	108643916	21111011072	"	"	"
601953	108643916	21111011073	Europe.		NP1
601953	108643916	21111011074	-	-	-
601953	108643916	21111011075	The	the	AT
601953	108643916	21111011076	Europe	europe	NP1
601953	108643916	21111011077	event	event	NN1
601953	108643916	21111011078	will	will	VM
601953	108643916	21111011079	take	take	VVI
601953	108643916	21111011080	place	place	NN1
601953	108643916	21111011081	on	on	II
601953	108643916	21111011082	the	the	AT
601953	108643916	21111011083	17th	17th	MD
601953	108643916	21111011084	of	of	IO
601953	108643916	21111011085	May	may	NPM1
601953	108643916	21111011086	to	to	II
601953	108643916	21111011087	the	the	AT
601953	108643916	21111011088	18th	18th	MD
601953	108643916	21111011089	-	-	-
601953	108643916	21111011090	at	at	II
601953	108643916	21111011091	the	the	AT
601953	108643916	21111011092	New	new	NP1
601953	108643916	21111011093	York	york	NP1
601953	108643916	21111011094	Hotel	hotel	NN1
601953	108643916	21111011095	&amp;		CC
601953	108643916	21111011096	Conference	conference	NN1
601953	108643916	21111011097	Centre	centre	NN1
601953	108643916	21111011098	,	,	,
601953	108643916	21111011099	in	in	II
601953	108643916	21111011100	Disneyland	disneyland	NP1
601953	108643916	21111011101	Paris	paris	NP1
601953	108643916	21111011102	.	.	.
601953	108643916	21111011103	This	this	DD1
601953	108643916	21111011104	two-day	two-day	JJ
601953	108643916	21111011105	conference	conference	NN1
601953	108643916	21111011106	gives	give	VVZ
601953	108643916	21111011107	senior-level	senior-level	JJ
601953	108643916	21111011108	pharmaceutical	pharmaceutical	JJ
601953	108643916	21111011109	and	and	CC
601953	108643916	21111011110	biotech	biotech	VV0_NN1
601953	108643916	21111011111	companies	company	NN2
601953	108643916	21111011112	from	from	II
601953	108643916	21111011113	across	across	II
601953	108643916	21111011114	Europe	europe	NP1
601953	108643916	21111011115	to	to	II
601953	108643916	21111011116	network	network	NN1
601953	108643916	21111011117	and	and	CC
601953	108643916	21111011118	enhance	enhance	VV0
601953	108643916	21111011119	strategies	strategy	NN2
601953	108643916	21111011120	within	within	II
601953	108643916	21111011121	clinical	clinical	JJ
601953	108643916	21111011122	trials	trial	NN2
601953	108643916	21111011123	.	.	.
601953	108643916	21111011124	If	if	CS
601953	108643916	21111011125	you	you	PPY
601953	108643916	21111011126	are	be	VBR
601953	108643916	21111011127	attending	attend	VVG
601953	108643916	21111011128	,	,	,
601953	108643916	21111011129	please	please	RR
601953	108643916	21111011130	stop	stop	VV0
601953	108643916	21111011131	by	by	II
601953	108643916	21111011132	booth	booth	NN1
601953	108643916	21111011133	71	71	MC
601953	108643916	21111011134	!	!	!
601953	108643916	21111011135	<p>		NULL
601953	108643916	21111011136	Bracket	bracket	NN1
601953	108643916	21111011137	will	will	VM
601953	108643916	21111011138	also	also	RR
601953	108643916	21111011139	be	be	VBI
601953	108643916	21111011140	exhibiting	exhibit	VVG
601953	108643916	21111011141	at	at	II
601953	108643916	21111011142	the	the	AT
601953	108643916	21111011143	Outsourcing		NP1_NN1@_JJ@
601953	108643916	21111011144	in	in	II
601953	108643916	21111011145	Clinical	clinical	JJ
601953	108643916	21111011146	Trials	trial	NN2
601953	108643916	21111011147	"	"	"
601953	108643916	21111011148	East	east	ND1
601953	108643916	21111011149	Coast	coast	NN1
601953	108643916	21111011150	.	.	.
601953	108643916	21111011151	This	this	DD1
601953	108643916	21111011152	East	east	ND1
601953	108643916	21111011153	Coast	coast	NN1
601953	108643916	21111011154	event	event	NN1
601953	108643916	21111011155	will	will	VM
601953	108643916	21111011156	take	take	VVI
601953	108643916	21111011157	place	place	NN1
601953	108643916	21111011158	on	on	II
601953	108643916	21111011159	the	the	AT
601953	108643916	21111011160	25th	25th	MD
601953	108643916	21111011161	of	of	IO
601953	108643916	21111011162	May	may	NPM1
601953	108643916	21111011163	to	to	II
601953	108643916	21111011164	the	the	AT
601953	108643916	21111011165	26th	26th	MD
601953	108643916	21111011166	-	-	-
601953	108643916	21111011167	at	at	II
601953	108643916	21111011168	the	the	AT
601953	108643916	21111011169	Radisson	radisson	NP1_NN1@
601953	108643916	21111011170	Valley	valley	NP1@_NN1
601953	108643916	21111011171	Forge	forge	NP1_NN1
601953	108643916	21111011172	Casino	casino	NN1
601953	108643916	21111011173	,	,	,
601953	108643916	21111011174	in	in	II
601953	108643916	21111011175	King	king	NN1
601953	108643916	21111011176	of	of	IO
601953	108643916	21111011177	Prussia	prussia	NP1
601953	108643916	21111011178	.	.	.
601953	108643916	21111011179	-	-	-
601953	108643916	21111011180	This	this	DD1
601953	108643916	21111011181	well	well	RR_NN1@
601953	108643916	21111011182	established	establish	VVN_VVD
601953	108643916	21111011183	two-day	two-day	JJ
601953	108643916	21111011184	event	event	NN1
601953	108643916	21111011185	will	will	VM
601953	108643916	21111011186	explore	explore	VVI
601953	108643916	21111011187	in-depth	in-depth	JJ
601953	108643916	21111011188	specific	specific	JJ
601953	108643916	21111011189	challenges	challenge	NN2
601953	108643916	21111011190	faced	face	VVN_VVD
601953	108643916	21111011191	in	in	II
601953	108643916	21111011192	company	company	NN1
601953	108643916	21111011193	trials	trial	NN2
601953	108643916	21111011194	.	.	.
601953	108643916	21111011195	Additionally	additionally	RR
601953	108643916	21111011196	@		II
601953	108643916	21111011197	@		II
601953	108643916	21111011198	@		II
601953	108643916	21111011199	@		II
601953	108643916	21111011200	@		II
601953	108643916	21111011201	@		II
601953	108643916	21111011202	@		II
601953	108643916	21111011203	@		II
601953	108643916	21111011204	@		II
601953	108643916	21111011205	@		II
601953	108643916	21111011206	innovation	innovation	NN1
601953	108643916	21111011207	and	and	CC
601953	108643916	21111011208	patient	patient	JJ_NN1
601953	108643916	21111011209	&amp;		CC
601953	108643916	21111011210	site	site	NN1
601953	108643916	21111011211	engagement	engagement	NN1
601953	108643916	21111011212	,	,	,
601953	108643916	21111011213	with	with	IW
601953	108643916	21111011214	presentations	presentation	NN2
601953	108643916	21111011215	from	from	II
601953	108643916	21111011216	leading	leading	JJ_VVG
601953	108643916	21111011217	companies	company	NN2
601953	108643916	21111011218	in	in	II
601953	108643916	21111011219	the	the	AT
601953	108643916	21111011220	area	area	NN1
601953	108643916	21111011221	providing	provide	VVG
601953	108643916	21111011222	their	their	APPGE
601953	108643916	21111011223	expertise	expertise	NN1
601953	108643916	21111011224	on	on	II
601953	108643916	21111011225	these	these	DD2
601953	108643916	21111011226	highly	highly	RR
601953	108643916	21111011227	topical	topical	JJ
601953	108643916	21111011228	issues	issue	NN2
601953	108643916	21111011229	.	.	.
601953	108643916	21111011230	Please	please	RR
601953	108643916	21111011231	stop	stop	VV0
601953	108643916	21111011232	by	by	II
601953	108643916	21111011233	booth	booth	NN1
601953	108643916	21111011234	69	69	MC
601953	108643916	21111011235	to	to	TO
601953	108643916	21111011236	see	see	VVI
601953	108643916	21111011237	what	what	DDQ
601953	108643916	21111011238	we	we	PPIS2
601953	108643916	21111011239	have	have	VH0
601953	108643916	21111011240	to	to	TO
601953	108643916	21111011241	offer	offer	VVI
601953	108643916	21111011242	!	!	!
601953	108643917	21111011262	@@##	----------	----------
601953	108643917	21111011263	@@108643917		FO
601953	108643917	21111011264	@4043917/		VV0_NN1
601953	108643917	21111011265	<h>		NULL
601953	108643917	21111011266	Why	why	RRQ
601953	108643917	21111011267	Bracket	bracket	NN1_VV0@
601953	108643917	21111011268	RTSMG		NP1
601953	108643917	21111011269	?	?	?
601953	108643917	21111011270	<p>		NULL
601953	108643917	21111011271	Bracket	bracket	NN1
601953	108643917	21111011272	's	's	GE
601953	108643917	21111011273	Randomization	randomization	NN1
601953	108643917	21111011274	and	and	CC
601953	108643917	21111011275	Trial	trial	NN1
601953	108643917	21111011276	Supply	supply	NN1_VV0
601953	108643917	21111011277	Management	management	NN1
601953	108643917	21111011278	(	(	(
601953	108643917	21111011279	RTSM		NP1
601953	108643917	21111011280	)	)	)
601953	108643917	21111011281	represents	represent	VVZ
601953	108643917	21111011282	a	a	AT1
601953	108643917	21111011283	best-in-breed		NN1_JJ
601953	108643917	21111011284	,	,	,
601953	108643917	21111011285	scalable	scalable	JJ
601953	108643917	21111011286	and	and	CC
601953	108643917	21111011287	configurable	configurable	JJ
601953	108643917	21111011288	Clinical	clinical	JJ
601953	108643917	21111011289	IRT	irt	NN1
601953	108643917	21111011290	solution	solution	NN1
601953	108643917	21111011291	for	for	IF
601953	108643917	21111011292	the	the	AT
601953	108643917	21111011293	life	life	NN1
601953	108643917	21111011294	sciences	science	NN2
601953	108643917	21111011295	industry	industry	NN1
601953	108643917	21111011296	.	.	.
601953	108643917	21111011297	Bracket	bracket	NN1
601953	108643917	21111011298	's	's	GE
601953	108643917	21111011299	Randomization	randomization	NN1
601953	108643917	21111011300	and	and	CC
601953	108643917	21111011301	Trial	trial	NN1
601953	108643917	21111011302	Supply	supply	NN1_VV0
601953	108643917	21111011303	Management	management	NN1
601953	108643917	21111011304	(	(	(
601953	108643917	21111011305	RTSM		NP1
601953	108643917	21111011306	)	)	)
601953	108643917	21111011307	platform	platform	NN1
601953	108643917	21111011308	provides	provide	VVZ
601953	108643917	21111011309	quality	quality	NN1
601953	108643917	21111011310	optimization	optimization	NN1
601953	108643917	21111011311	,	,	,
601953	108643917	21111011312	consistency	consistency	NN1
601953	108643917	21111011313	within	within	II
601953	108643917	21111011314	clinical	clinical	JJ
601953	108643917	21111011315	program	program	NN1
601953	108643917	21111011316	and	and	CC
601953	108643917	21111011317	sponsor-specific		JJ
601953	108643917	21111011318	needs	need	NN2
601953	108643917	21111011319	,	,	,
601953	108643917	21111011320	and	and	CC
601953	108643917	21111011321	timeline	timeline	VV0_NN1
601953	108643917	21111011322	acceleration	acceleration	NN1
601953	108643917	21111011323	with	with	IW
601953	108643917	21111011324	a	a	AT1
601953	108643917	21111011325	fully	fully	RR
601953	108643917	21111011326	live	live	JJ_VV0
601953	108643917	21111011327	and	and	CC
601953	108643917	21111011328	operational	operational	JJ
601953	108643917	21111011329	system	system	NN1
601953	108643917	21111011330	in	in	II
601953	108643917	21111011331	four	four	MC
601953	108643917	21111011332	weeks	week	NNT2
601953	108643917	21111011333	.	.	.
601953	108643917	21111011334	<p>		NULL
601953	108643917	21111011335	By	by	II
601953	108643917	21111011336	leveraging	leverage	VVG_JJ@
601953	108643917	21111011337	Bracket	bracket	NN1
601953	108643917	21111011338	's	's	GE
601953	108643917	21111011339	deep	deep	JJ_RR
601953	108643917	21111011340	experience	experience	NN1_VV0
601953	108643917	21111011341	and	and	CC
601953	108643917	21111011342	innovative	innovative	JJ
601953	108643917	21111011343	Randomization	randomization	NN1
601953	108643917	21111011344	and	and	CC
601953	108643917	21111011345	Trial	trial	NN1
601953	108643917	21111011346	Supply	supply	NN1_VV0
601953	108643917	21111011347	Management	management	NN1
601953	108643917	21111011348	(	(	(
601953	108643917	21111011349	RTSM		NP1
601953	108643917	21111011350	)	)	)
601953	108643917	21111011351	solution	solution	NN1
601953	108643917	21111011352	,	,	,
601953	108643917	21111011353	we	we	PPIS2
601953	108643917	21111011354	enable	enable	VV0
601953	108643917	21111011355	clients	client	NN2
601953	108643917	21111011356	to	to	TO
601953	108643917	21111011357	implement	implement	VVI
601953	108643917	21111011358	standardized	standardized	JJ
601953	108643917	21111011359	or	or	CC
601953	108643917	21111011360	complex	complex	JJ
601953	108643917	21111011361	system	system	NN1
601953	108643917	21111011362	delivery	delivery	NN1
601953	108643917	21111011363	requirements	requirement	NN2
601953	108643917	21111011364	,	,	,
601953	108643917	21111011365	well-suited	well-suited	JJ_NN1
601953	108643917	21111011366	to	to	TO
601953	108643917	21111011367	manage	manage	VVI
601953	108643917	21111011368	simple	simple	JJ
601953	108643917	21111011369	or	or	CC
601953	108643917	21111011370	highly	highly	RR
601953	108643917	21111011371	innovative	innovative	JJ
601953	108643917	21111011372	,	,	,
601953	108643917	21111011373	large	large	JJ
601953	108643917	21111011374	or	or	CC
601953	108643917	21111011375	small	small	JJ
601953	108643917	21111011376	clinical	clinical	JJ
601953	108643917	21111011377	trials	trial	NN2
601953	108643917	21111011378	.	.	.
601953	108643917	21111011379	<h>		NULL
601953	108643917	21111011380	Project	project	NN1_NP1@_VV0@
601953	108643917	21111011381	Management	management	NN1
601953	108643917	21111011382	<h>		NULL
601953	108643917	21111011383	Bracket	bracket	NN1
601953	108643917	21111011384	operates	operate	VVZ
601953	108643917	21111011385	in	in	II_RP@
601953	108643917	21111011386	a	a	AT1
601953	108643917	21111011387	team	team	NN1
601953	108643917	21111011388	structure	structure	NN1
601953	108643917	21111011389	designed	design	VVN_VVD
601953	108643917	21111011390	to	to	TO
601953	108643917	21111011391	optimize	optimize	VVI
601953	108643917	21111011392	our	our	APPGE
601953	108643917	21111011393	ability	ability	NN1
601953	108643917	21111011394	to	to	TO
601953	108643917	21111011395	service	service	VVI
601953	108643917	21111011396	our	our	APPGE
601953	108643917	21111011397	clients	client	NN2
601953	108643917	21111011398	and	and	CC
601953	108643917	21111011399	to	to	TO
601953	108643917	21111011400	provide	provide	VVI
601953	108643917	21111011401	senior	senior	JJ
601953	108643917	21111011402	leadership	leadership	NN1
601953	108643917	21111011403	from	from	II
601953	108643917	21111011404	both	both	RR
601953	108643917	21111011405	a	a	AT1
601953	108643917	21111011406	technical	technical	JJ
601953	108643917	21111011407	and	and	CC
601953	108643917	21111011408	project	project	NN1
601953	108643917	21111011409	management	management	NN1
601953	108643917	21111011410	perspective	perspective	NN1
601953	108643917	21111011411	.	.	.
601953	108643917	21111011412	<p>		NULL
601953	108643917	21111011413	Bracket	bracket	NN1
601953	108643917	21111011414	operates	operate	VVZ
601953	108643917	21111011415	in	in	II_RP@
601953	108643917	21111011416	a	a	AT1
601953	108643917	21111011417	team	team	NN1
601953	108643917	21111011418	structure	structure	NN1
601953	108643917	21111011419	designed	design	VVN_VVD
601953	108643917	21111011420	to	to	TO
601953	108643917	21111011421	optimize	optimize	VVI
601953	108643917	21111011422	our	our	APPGE
601953	108643917	21111011423	ability	ability	NN1
601953	108643917	21111011424	to	to	TO
601953	108643917	21111011425	service	service	VVI
601953	108643917	21111011426	our	our	APPGE
601953	108643917	21111011427	clients	client	NN2
601953	108643917	21111011428	.	.	.
601953	108643917	21111011429	-	-	-
601953	108643917	21111011430	We	we	PPIS2
601953	108643917	21111011431	provide	provide	VV0
601953	108643917	21111011432	senior	senior	JJ
601953	108643917	21111011433	leadership	leadership	NN1
601953	108643917	21111011434	from	from	II
601953	108643917	21111011435	both	both	RR
601953	108643917	21111011436	a	a	AT1
601953	108643917	21111011437	technical	technical	JJ
601953	108643917	21111011438	and	and	CC
601953	108643917	21111011439	project	project	NN1
601953	108643917	21111011440	management	management	NN1
601953	108643917	21111011441	perspective	perspective	NN1
601953	108643917	21111011442	.	.	.
601953	108643917	21111011443	Our	our	APPGE
601953	108643917	21111011444	goal	goal	NN1
601953	108643917	21111011445	is	be	VBZ
601953	108643917	21111011446	to	to	TO
601953	108643917	21111011447	continue	continue	VVI
601953	108643917	21111011448	building	build	VVG@_NN1
601953	108643917	21111011449	a	a	AT1
601953	108643917	21111011450	highly-scalable		JJ
601953	108643917	21111011451	resource	resource	NN1
601953	108643917	21111011452	model	model	NN1
601953	108643917	21111011453	while	while	CS
601953	108643917	21111011454	@		II
601953	108643917	21111011455	@		II
601953	108643917	21111011456	@		II
601953	108643917	21111011457	@		II
601953	108643917	21111011458	@		II
601953	108643917	21111011459	@		II
601953	108643917	21111011460	@		II
601953	108643917	21111011461	@		II
601953	108643917	21111011462	@		II
601953	108643917	21111011463	@		II
601953	108643917	21111011464	serve	serve	VVI
601953	108643917	21111011465	our	our	APPGE
601953	108643917	21111011466	clients	client	NN2
601953	108643917	21111011467	.	.	.
601953	108643917	21111011468	our	our	APPGE
601953	108643917	21111011469	cross-functional	cross-functional	JJ
601953	108643917	21111011470	team	team	NN1
601953	108643917	21111011471	offers	offer	NN2
601953	108643917	21111011472	support	support	VV0
601953	108643917	21111011473	from	from	II
601953	108643917	21111011474	the	the	AT
601953	108643917	21111011475	time	time	NNT1
601953	108643917	21111011476	of	of	IO
601953	108643917	21111011477	project	project	NN1
601953	108643917	21111011478	kickoff	kickoff	NN1_VV0
601953	108643917	21111011479	through	through	II
601953	108643917	21111011480	solution	solution	NN1
601953	108643917	21111011481	implementation	implementation	NN1
601953	108643917	21111011482	.	.	.
601953	108643917	21111011483	Ongoing	ongoing	JJ
601953	108643917	21111011484	support	support	NN1
601953	108643917	21111011485	includes	include	VVZ
601953	108643917	21111011486	:	:	:
601953	108643917	21111011487	<p>		NULL
601953	108643917	21111011488	Experienced	experienced	JJ
601953	108643917	21111011489	project	project	NN1
601953	108643917	21111011490	managers	manager	NN2
601953	108643917	21111011491	and	and	CC
601953	108643917	21111011492	support	support	VV0_NN1
601953	108643917	21111011493	staff	staff	NN
601953	108643917	21111011494	to	to	TO
601953	108643917	21111011495	execute	execute	VVI
601953	108643917	21111011496	on	on	II_RP@
601953	108643917	21111011497	a	a	AT1
601953	108643917	21111011498	comprehensive	comprehensive	JJ
601953	108643917	21111011499	project	project	NN1
601953	108643917	21111011500	lifecycle	life-cycle	NN1
601953	108643917	21111011501	(	(	(
601953	108643917	21111011502	PLC	plc	NN1
601953	108643917	21111011503	)	)	)
601953	108643917	21111011504	<h>		NULL
601953	108643917	21111011505	End	end	VV0_NN1
601953	108643917	21111011506	User	user	NN1
601953	108643917	21111011507	Support	support	NN1_VV0
601953	108643917	21111011508	<h>		NULL
601953	108643917	21111011509	Bracket	bracket	NN1
601953	108643917	21111011510	provides	provide	VVZ
601953	108643917	21111011511	direct	direct	JJ_RR@
601953	108643917	21111011512	support	support	NN1_VV0
601953	108643917	21111011513	across	across	II
601953	108643917	21111011514	our	our	APPGE
601953	108643917	21111011515	entire	entire	JJ
601953	108643917	21111011516	portfolio	portfolio	NN1
601953	108643917	21111011517	of	of	IO
601953	108643917	21111011518	solutions	solution	NN2
601953	108643917	21111011519	,	,	,
601953	108643917	21111011520	providing	provide	VVG
601953	108643917	21111011521	a	a	AT1
601953	108643917	21111011522	seamless	seamless	JJ
601953	108643917	21111011523	end	end	NN1
601953	108643917	21111011524	user	user	NN1
601953	108643917	21111011525	experience	experience	NN1_VV0
601953	108643917	21111011526	unique	unique	JJ
601953	108643917	21111011527	to	to	II
601953	108643917	21111011528	the	the	AT
601953	108643917	21111011529	technology	technology	NN1
601953	108643917	21111011530	and	and	CC
601953	108643917	21111011531	service	service	NN1
601953	108643917	21111011532	implemented	implement	VVN
601953	108643917	21111011533	in	in	II31
601953	108643917	21111011534	support	support	II32
601953	108643917	21111011535	of	of	II33
601953	108643917	21111011536	our	our	APPGE
601953	108643917	21111011537	clients	client	NN2
601953	108643917	21111011538	'	'	GE
601953	108643917	21111011539	clinical	clinical	JJ
601953	108643917	21111011540	needs	need	NN2
601953	108643917	21111011541	.	.	.
601953	108643917	21111011542	<p>		NULL
601953	108643917	21111011543	Bracket	bracket	NN1
601953	108643917	21111011544	provides	provide	VVZ
601953	108643917	21111011545	direct	direct	JJ_RR@
601953	108643917	21111011546	support	support	NN1_VV0
601953	108643917	21111011547	across	across	II
601953	108643917	21111011548	our	our	APPGE
601953	108643917	21111011549	entire	entire	JJ
601953	108643917	21111011550	portfolio	portfolio	NN1
601953	108643917	21111011551	of	of	IO
601953	108643917	21111011552	solutions	solution	NN2
601953	108643917	21111011553	,	,	,
601953	108643917	21111011554	providing	provide	VVG
601953	108643917	21111011555	a	a	AT1
601953	108643917	21111011556	seamless	seamless	JJ
601953	108643917	21111011557	end	end	NN1
601953	108643917	21111011558	user	user	NN1
601953	108643917	21111011559	experience	experience	NN1_VV0
601953	108643917	21111011560	unique	unique	JJ
601953	108643917	21111011561	to	to	II
601953	108643917	21111011562	the	the	AT
601953	108643917	21111011563	technology	technology	NN1
601953	108643917	21111011564	and	and	CC
601953	108643917	21111011565	service	service	NN1
601953	108643917	21111011566	implemented	implement	VVN
601953	108643917	21111011567	in	in	II31
601953	108643917	21111011568	support	support	II32
601953	108643917	21111011569	of	of	II33
601953	108643917	21111011570	our	our	APPGE
601953	108643917	21111011571	clients	client	NN2
601953	108643917	21111011572	'	'	GE
601953	108643917	21111011573	clinical	clinical	JJ
601953	108643917	21111011574	needs	need	NN2
601953	108643917	21111011575	.	.	.
601953	108643917	21111011576	<p>		NULL
601953	108643917	21111011577	24x7x365		FO
601953	108643917	21111011578	global	global	JJ
601953	108643917	21111011579	end	end	NN1
601953	108643917	21111011580	user	user	NN1
601953	108643917	21111011581	support	support	NN1_VV0
601953	108643917	21111011582	to	to	TO
601953	108643917	21111011583	meet	meet	VVI
601953	108643917	21111011584	the	the	AT
601953	108643917	21111011585	requirements	requirement	NN2
601953	108643917	21111011586	of	of	IO
601953	108643917	21111011587	global	global	JJ
601953	108643917	21111011588	clinical	clinical	JJ
601953	108643917	21111011589	trials	trial	NN2
601953	108643917	21111011590	<p>		NULL
601953	108643917	21111011591	Regulatory-trained		JJ_NN1
601953	108643917	21111011592	support	support	NN1
601953	108643917	21111011593	personnel	personnel	NN2
601953	108643917	21111011594	to	to	TO
601953	108643917	21111011595	ensure	ensure	VVI
601953	108643917	21111011596	21	21	MC
601953	108643917	21111011597	CFR	cfr	NP1
601953	108643917	21111011598	Part	part	NN1
601953	108643917	21111011599	11	11	MC
601953	108643917	21111011600	,	,	,
601953	108643917	21111011601	HIPAA	hipaa	NP1_NN1
601953	108643917	21111011602	,	,	,
601953	108643917	21111011603	and	and	CC
601953	108643917	21111011604	Safe	safe	JJ
601953	108643917	21111011605	Harbor	harbor	NN1
601953	108643917	21111011606	Compliance	compliance	NN1
601953	108643917	21111011607	throughout	throughout	II
601953	108643917	21111011608	the	the	AT
601953	108643917	21111011609	support	support	NN1
601953	108643917	21111011610	process	process	VV0_NN1
601953	108643917	21111011611	<h>		NULL
601953	108643917	21111011612	Biostatistical		JJ_NP1
601953	108643917	21111011613	Expertise	expertise	NN1
601953	108643917	21111011614	<p>		NULL
601953	108643917	21111011615	Bracket	bracket	NN1_VV0@
601953	108643917	21111011616	offers	offer	NN2_VVZ@
601953	108643917	21111011617	randomization	randomization	NN1
601953	108643917	21111011618	and	and	CC
601953	108643917	21111011619	kit	kit	NN1
601953	108643917	21111011620	lists	list	VVZ_NN2
601953	108643917	21111011621	generation	generation	NN1
601953	108643917	21111011622	and	and	CC
601953	108643917	21111011623	management	management	NN1
601953	108643917	21111011624	,	,	,
601953	108643917	21111011625	leveraging	leverage	VVG
601953	108643917	21111011626	over	over	RG
601953	108643917	21111011627	25	25	MC
601953	108643917	21111011628	years	year	NNT2
601953	108643917	21111011629	of	of	IO
601953	108643917	21111011630	industry	industry	NN1
601953	108643917	21111011631	leading	lead	VVG_JJ
601953	108643917	21111011632	biostatistical	biostatistical	JJ
601953	108643917	21111011633	design	design	NN1
601953	108643917	21111011634	.	.	.
601953	108643917	21111011635	Our	our	APPGE
601953	108643917	21111011636	statistical	statistical	JJ
601953	108643917	21111011637	department	department	NN1
601953	108643917	21111011638	utilizes	utilize	VVZ
601953	108643917	21111011639	the	the	AT
601953	108643917	21111011640	latest	late	JJT
601953	108643917	21111011641	SAS	sa	NP1
601953	108643917	21111011642	software	software	NN1
601953	108643917	21111011643	and	and	CC
601953	108643917	21111011644	relies	rely	VVZ
601953	108643917	21111011645	on	on	II
601953	108643917	21111011646	established	established	JJ@
601953	108643917	21111011647	and	and	CC
601953	108643917	21111011648	controlled	control	VVD_JJ@_VVN
601953	108643917	21111011649	processes	process	NN2
601953	108643917	21111011650	to	to	TO
601953	108643917	21111011651	maintain	maintain	VVI
601953	108643917	21111011652	blind	blind	JJ_NN1@
601953	108643917	21111011653	.	.	.
601953	108643917	21111011654	@		II
601953	108643917	21111011655	@		II
601953	108643917	21111011656	@		II
601953	108643917	21111011657	@		II
601953	108643917	21111011658	@		II
601953	108643917	21111011659	@		II
601953	108643917	21111011660	@		II
601953	108643917	21111011661	@		II
601953	108643917	21111011662	@		II
601953	108643917	21111011663	@		II
601953	108643917	21111011664	simple	simple	JJ
601953	108643917	21111011665	and	and	CC
601953	108643917	21111011666	highly	highly	RR
601953	108643917	21111011667	innovative	innovative	JJ
601953	108643917	21111011668	trial	trial	NN1
601953	108643917	21111011669	designs	design	NN2
601953	108643917	21111011670	<h>		NULL
601953	108643917	21111011671	Error-proof		JJ_VV0@
601953	108643917	21111011672	titration	titration	NN1
601953	108643917	21111011673	lookups	lookup	NN2_VVZ
601953	108643917	21111011674	and	and	CC
601953	108643917	21111011675	calculations	calculation	NN2
601953	108643917	21111011676	<h>		NULL
601953	108643917	21111011677	Seamless	seamless	JJ
601953	108643917	21111011678	cohort	cohort	NN1
601953	108643917	21111011679	&amp;		CC
601953	108643917	21111011680	dose	dose	NN1
601953	108643917	21111011681	escalation	escalation	NN1
601953	108643917	21111011682	management	management	NN1
601953	108643917	21111011683	<h>		NULL
601953	108643917	21111011684	Biostatistical		JJ_NP1
601953	108643917	21111011685	Methodologies	methodology	NN2
601953	108643917	21111011686	<p>		NULL
601953	108643917	21111011687	Bracket	bracket	NN1
601953	108643917	21111011688	can	can	VM
601953	108643917	21111011689	design	design	VVI
601953	108643917	21111011690	and	and	CC
601953	108643917	21111011691	implement	implement	VVI
601953	108643917	21111011692	,	,	,
601953	108643917	21111011693	within	within	II
601953	108643917	21111011694	its	its	APPGE
601953	108643917	21111011695	RTSM		NP1
601953	108643917	21111011696	solution	solution	NN1
601953	108643917	21111011697	,	,	,
601953	108643917	21111011698	a	a	AT1
601953	108643917	21111011699	variety	variety	NN1
601953	108643917	21111011700	of	of	IO
601953	108643917	21111011701	randomization	randomization	NN1
601953	108643917	21111011702	methodologies	methodology	NN2
601953	108643917	21111011703	to	to	TO
601953	108643917	21111011704	meet	meet	VVI
601953	108643917	21111011705	protocol	protocol	NN1
601953	108643917	21111011706	design	design	NN1
601953	108643917	21111011707	constructs	construct	NN2
601953	108643917	21111011708	across	across	II
601953	108643917	21111011709	every	every	AT1
601953	108643917	21111011710	phase	phase	NN1
601953	108643917	21111011711	of	of	IO
601953	108643917	21111011712	clinical	clinical	JJ
601953	108643917	21111011713	research	research	NN1
601953	108643917	21111011714	.	.	.
601953	108643917	21111011715	Bracket	bracket	VV0@_NN1
601953	108643917	21111011716	developed	developed	JJ_VVD_VVN
601953	108643917	21111011717	Precision	precision	NN1
601953	108643917	21111011718	Block	block	NN1
601953	108643917	21111011719	DesignG		NN1_VV0
601953	108643917	21111011720	for	for	IF
601953	108643917	21111011721	sponsors	sponsor	NN2
601953	108643917	21111011722	who	who	PNQS
601953	108643917	21111011723	want	want	VV0
601953	108643917	21111011724	or	or	CC
601953	108643917	21111011725	need	need	VV0_NN1
601953	108643917	21111011726	to	to	TO
601953	108643917	21111011727	utilize	utilize	VVI
601953	108643917	21111011728	block	block	NN1
601953	108643917	21111011729	pattern	pattern	NN1
601953	108643917	21111011730	distribution	distribution	NN1
601953	108643917	21111011731	in	in	II
601953	108643917	21111011732	their	their	APPGE
601953	108643917	21111011733	randomization	randomization	NN1
601953	108643917	21111011734	lists	list	NN2_VVZ
601953	108643917	21111011735	when	when	CS
601953	108643917	21111011736	using	use	VVG
601953	108643917	21111011737	Bracket	bracket	NN1
601953	108643917	21111011738	RTSMG		NP1
601953	108643917	21111011739	.	.	.
601953	108643917	21111011740	Bracket	bracket	NN1
601953	108643917	21111011741	's	's	GE
601953	108643917	21111011742	methodologies	methodology	NN2
601953	108643917	21111011743	include	include	VV0
601953	108643917	21111011744	:	:	:
601953	108643917	21111011745	<p>		NULL
601953	108643917	21111011746	All	all	DB
601953	108643917	21111011747	messages	message	NN2
601953	108643917	21111011748	and	and	CC
601953	108643917	21111011749	patient	patient	JJ
601953	108643917	21111011750	data	data	NN
601953	108643917	21111011751	are	be	VBR
601953	108643917	21111011752	encrypted	encrypt	VVN@_JJ@
601953	108643917	21111011753	and	and	CC
601953	108643917	21111011754	stored	store	VVN
601953	108643917	21111011755	safely	safely	RR
601953	108643917	21111011756	.	.	.
601953	108643917	21111011757	The	the	AT
601953	108643917	21111011758	service	service	NN1
601953	108643917	21111011759	is	be	VBZ
601953	108643917	21111011760	now	now	RT
601953	108643917	21111011761	available	available	JJ
601953	108643917	21111011762	globally	globally	RR
601953	108643917	21111011763	,	,	,
601953	108643917	21111011764	and	and	CC
601953	108643917	21111011765	the	the	AT
601953	108643917	21111011766	reminders	reminder	NN2
601953	108643917	21111011767	can	can	VM
601953	108643917	21111011768	be	be	VBI
601953	108643917	21111011769	tailored	tailor	VVN
601953	108643917	21111011770	to	to	II
601953	108643917	21111011771	specific	specific	JJ
601953	108643917	21111011772	dosing	dosing	NN1
601953	108643917	21111011773	regimens	regimen	NN2
601953	108643917	21111011774	and	and	CC
601953	108643917	21111011775	communications	communication	NN2
601953	108643917	21111011776	types	type	NN2
601953	108643917	21111011777	on	on	II
601953	108643917	21111011778	a	a	AT1
601953	108643917	21111011779	study-by-study		JJ_NN1
601953	108643917	21111011780	basis	basis	NN1
601953	108643917	21111011781	.	.	.
601953	108643918	21111011801	@@##	----------	----------
601953	108643918	21111011802	@@108643918		FO
601953	108643918	21111011803	@4043918/		JJ_NN1_VV0
601953	108643918	21111011804	<h>		NULL
601953	108643918	21111011805	Bracket	bracket	NN1
601953	108643918	21111011806	Expands	expand	VVZ
601953	108643918	21111011807	North	north	NP1
601953	108643918	21111011808	American	american	JJ
601953	108643918	21111011809	Presence	presence	NN1
601953	108643918	21111011810	with	with	IW
601953	108643918	21111011811	New	new	JJ
601953	108643918	21111011812	Boston	boston	NP1
601953	108643918	21111011813	Location	location	NN1
601953	108643918	21111011814	<p>		NULL
601953	108643918	21111011815	August	august	NPM1
601953	108643918	21111011816	25	25	MC
601953	108643918	21111011817	,	,	,
601953	108643918	21111011818	2016	2016	MC
601953	108643918	21111011819	<p>		NULL
601953	108643918	21111011820	WAYNE	wayne	NP1
601953	108643918	21111011821	,	,	,
601953	108643918	21111011822	PA-		JJ_NN1
601953	108643918	21111011823	Bracket	bracket	NN1
601953	108643918	21111011824	,	,	,
601953	108643918	21111011825	a	a	AT1
601953	108643918	21111011826	leading	leading	JJ
601953	108643918	21111011827	clinical	clinical	JJ
601953	108643918	21111011828	trial	trial	NN1
601953	108643918	21111011829	technology	technology	NN1
601953	108643918	21111011830	and	and	CC
601953	108643918	21111011831	specialty	specialty	NN1
601953	108643918	21111011832	services	service	NN2
601953	108643918	21111011833	provider	provider	NN1
601953	108643918	21111011834	,	,	,
601953	108643918	21111011835	today	today	RT
601953	108643918	21111011836	announced	announce	VVD_VVN
601953	108643918	21111011837	the	the	AT
601953	108643918	21111011838	opening	opening	NN1
601953	108643918	21111011839	of	of	IO
601953	108643918	21111011840	a	a	AT1
601953	108643918	21111011841	new	new	JJ
601953	108643918	21111011842	office	office	NN1
601953	108643918	21111011843	in	in	II
601953	108643918	21111011844	Boston	boston	NP1
601953	108643918	21111011845	,	,	,
601953	108643918	21111011846	Massachusetts	massachusetts	NP1
601953	108643918	21111011847	.	.	.
601953	108643918	21111011848	The	the	AT
601953	108643918	21111011849	9,000	9,000	MC
601953	108643918	21111011850	square	square	JJ
601953	108643918	21111011851	foot	foot	NN1
601953	108643918	21111011852	office	office	NN1
601953	108643918	21111011853	space	space	NN1
601953	108643918	21111011854	is	be	VBZ
601953	108643918	21111011855	located	locate	VVN
601953	108643918	21111011856	in	in	II
601953	108643918	21111011857	close	close	JJ
601953	108643918	21111011858	proximity	proximity	NN1
601953	108643918	21111011859	to	to	II
601953	108643918	21111011860	the	the	AT
601953	108643918	21111011861	city	city	NN1
601953	108643918	21111011862	of	of	IO
601953	108643918	21111011863	Cambridge	cambridge	NP1
601953	108643918	21111011864	,	,	,
601953	108643918	21111011865	a	a	AT1
601953	108643918	21111011866	critical	critical	JJ
601953	108643918	21111011867	hub	hub	NN1
601953	108643918	21111011868	of	of	IO
601953	108643918	21111011869	science	science	NN1
601953	108643918	21111011870	,	,	,
601953	108643918	21111011871	medicine	medicine	NN1
601953	108643918	21111011872	and	and	CC
601953	108643918	21111011873	clinical	clinical	JJ
601953	108643918	21111011874	trial	trial	NN1
601953	108643918	21111011875	research	research	NN1
601953	108643918	21111011876	,	,	,
601953	108643918	21111011877	and	and	CC
601953	108643918	21111011878	expands	expand	VVZ
601953	108643918	21111011879	the	the	AT
601953	108643918	21111011880	companys	company	NN2
601953	108643918	21111011881	support	support	VV0
601953	108643918	21111011882	for	for	IF
601953	108643918	21111011883	clinical	clinical	JJ
601953	108643918	21111011884	research	research	NN1
601953	108643918	21111011885	study	study	NN1
601953	108643918	21111011886	sponsors	sponsor	NN2_VVZ@
601953	108643918	21111011887	in	in	II
601953	108643918	21111011888	the	the	AT
601953	108643918	21111011889	Boston	boston	NP1
601953	108643918	21111011890	area	area	NN1
601953	108643918	21111011891	.	.	.
601953	108643918	21111011892	<p>		NULL
601953	108643918	21111011893	Bracket	bracket	NN1_VV0@
601953	108643918	21111011894	today	today	RT
601953	108643918	21111011895	provides	provide	VVZ
601953	108643918	21111011896	services	service	NN2
601953	108643918	21111011897	and	and	CC
601953	108643918	21111011898	support	support	VV0_NN1
601953	108643918	21111011899	to	to	II
601953	108643918	21111011900	more	more	DAR
601953	108643918	21111011901	than	than	CSN
601953	108643918	21111011902	20	20	MC
601953	108643918	21111011903	Boston-area	boston-area	JJ
601953	108643918	21111011904	pharmaceutical	pharmaceutical	JJ
601953	108643918	21111011905	and	and	CC
601953	108643918	21111011906	biotech	biotech	VV0_NN1
601953	108643918	21111011907	companies	company	NN2
601953	108643918	21111011908	.	.	.
601953	108643918	21111011909	The	the	AT
601953	108643918	21111011910	new	new	JJ
601953	108643918	21111011911	office	office	NN1
601953	108643918	21111011912	gives	give	VVZ
601953	108643918	21111011913	Bracket	bracket	NN1_VV0@
601953	108643918	21111011914	the	the	AT
601953	108643918	21111011915	capacity	capacity	NN1
601953	108643918	21111011916	to	to	TO
601953	108643918	21111011917	nearly	nearly	RR
601953	108643918	21111011918	double	double	VVI
601953	108643918	21111011919	their	their	APPGE
601953	108643918	21111011920	existing	existing	JJ
601953	108643918	21111011921	staff	staff	NN
601953	108643918	21111011922	in	in	II
601953	108643918	21111011923	the	the	AT
601953	108643918	21111011924	area	area	NN1
601953	108643918	21111011925	,	,	,
601953	108643918	21111011926	and	and	CC
601953	108643918	21111011927	continue	continue	VV0
601953	108643918	21111011928	to	to	TO
601953	108643918	21111011929	support	support	VVI
601953	108643918	21111011930	its	its	APPGE
601953	108643918	21111011931	highly	highly	RR
601953	108643918	21111011932	collaborative	collaborative	JJ
601953	108643918	21111011933	and	and	CC
601953	108643918	21111011934	innovative	innovative	JJ
601953	108643918	21111011935	environment	environment	NN1
601953	108643918	21111011936	.	.	.
601953	108643918	21111011937	<p>		NULL
601953	108643918	21111011938	According	according	II21
601953	108643918	21111011939	to	to	II22
601953	108643918	21111011940	a	a	AT1
601953	108643918	21111011941	recent	recent	JJ
601953	108643918	21111011942	report	report	NN1
601953	108643918	21111011943	from	from	II
601953	108643918	21111011944	Massachusetts	massachusetts	NP1
601953	108643918	21111011945	Biotechnology	biotechnology	NN1
601953	108643918	21111011946	Council	council	NN1
601953	108643918	21111011947	,	,	,
601953	108643918	21111011948	Massachusetts	massachusetts	NP1
601953	108643918	21111011949	continues	continue	VVZ
601953	108643918	21111011950	to	to	TO
601953	108643918	21111011951	far	far	RR
601953	108643918	21111011952	outpace	outpace	VVI
601953	108643918	21111011953	the	the	AT
601953	108643918	21111011954	nation	nation	NN1
601953	108643918	21111011955	in	in	II
601953	108643918	21111011956	biopharma	biopharma	NN1
601953	108643918	21111011957	manufacturing	manufacturing	NN1
601953	108643918	21111011958	employment	employment	NN1
601953	108643918	21111011959	growth	growth	NN1
601953	108643918	21111011960	,	,	,
601953	108643918	21111011961	stating	state	VVG
601953	108643918	21111011962	that	that	CST_DD1
601953	108643918	21111011963	in	in	II
601953	108643918	21111011964	the	the	AT
601953	108643918	21111011965	last	last	MD
601953	108643918	21111011966	10	10	MC
601953	108643918	21111011967	years	year	NNT2
601953	108643918	21111011968	,	,	,
601953	108643918	21111011969	the	the	AT
601953	108643918	21111011970	states	state	NN2
601953	108643918	21111011971	biopharma	biopharma	NN1
601953	108643918	21111011972	manufacturing	manufacturing	NN1
601953	108643918	21111011973	employment	employment	NN1
601953	108643918	21111011974	has	have	VHZ
601953	108643918	21111011975	grown	grow	VVN
601953	108643918	21111011976	by	by	II
601953	108643918	21111011977	28.4%	28.4%	FO
601953	108643918	21111011978	to	to	II
601953	108643918	21111011979	9,989		MC
601953	108643918	21111011980	jobs	job	NN2
601953	108643918	21111011981	statewide	statewide	RR_JJ
601953	108643918	21111011982	.	.	.
601953	108643918	21111011983	<p>		NULL
601953	108643918	21111011984	"	"	"
601953	108643918	21111011985	We	we	PPIS2
601953	108643918	21111011986	are	be	VBR
601953	108643918	21111011987	so	so	RG_RR
601953	108643918	21111011988	pleased	pleased	JJ_VVN@
601953	108643918	21111011989	to	to	TO
601953	108643918	21111011990	expand	expand	VVI
601953	108643918	21111011991	our	our	APPGE
601953	108643918	21111011992	North	north	NP1
601953	108643918	21111011993	@		II
601953	108643918	21111011994	@		II
601953	108643918	21111011995	@		II
601953	108643918	21111011996	@		II
601953	108643918	21111011997	@		II
601953	108643918	21111011998	@		II
601953	108643918	21111011999	@		II
601953	108643918	21111012000	@		II
601953	108643918	21111012001	@		II
601953	108643918	21111012002	@		II
601953	108643918	21111012003	our	our	APPGE
601953	108643918	21111012004	team	team	NN1
601953	108643918	21111012005	of	of	IO
601953	108643918	21111012006	more	more	DAR
601953	108643918	21111012007	than	than	CSN
601953	108643918	21111012008	500	500	MC
601953	108643918	21111012009	employees	employee	NN2
601953	108643918	21111012010	worldwide	worldwide	RL
601953	108643918	21111012011	,	,	,
601953	108643918	21111012012	"	"	"
601953	108643918	21111012013	said	say	VVD
601953	108643918	21111012014	Jeff	jeff	NP1
601953	108643918	21111012015	Kinell		NP1
601953	108643918	21111012016	,	,	,
601953	108643918	21111012017	Chief	chief	JJ_NN1
601953	108643918	21111012018	Executive	executive	NN1_JJ@
601953	108643918	21111012019	Officer	officer	NN1
601953	108643918	21111012020	for	for	IF
601953	108643918	21111012021	Bracket	bracket	NN1
601953	108643918	21111012022	.	.	.
601953	108643918	21111012023	"	"	"
601953	108643918	21111012024	As	as	CSA
601953	108643918	21111012025	we	we	PPIS2
601953	108643918	21111012026	continue	continue	VV0
601953	108643918	21111012027	to	to	TO
601953	108643918	21111012028	improve	improve	VVI
601953	108643918	21111012029	clinical	clinical	JJ
601953	108643918	21111012030	research	research	NN1
601953	108643918	21111012031	development	development	NN1
601953	108643918	21111012032	through	through	II
601953	108643918	21111012033	science	science	NN1
601953	108643918	21111012034	,	,	,
601953	108643918	21111012035	technology	technology	NN1
601953	108643918	21111012036	and	and	CC
601953	108643918	21111012037	service	service	NN1
601953	108643918	21111012038	,	,	,
601953	108643918	21111012039	it	it	PPH1
601953	108643918	21111012040	is	be	VBZ
601953	108643918	21111012041	important	important	JJ
601953	108643918	21111012042	that	that	CST
601953	108643918	21111012043	we	we	PPIS2
601953	108643918	21111012044	maintain	maintain	VV0
601953	108643918	21111012045	a	a	AT1
601953	108643918	21111012046	strong	strong	JJ
601953	108643918	21111012047	presence	presence	NN1
601953	108643918	21111012048	in	in	II
601953	108643918	21111012049	all	all	DB
601953	108643918	21111012050	major	major	JJ
601953	108643918	21111012051	medical	medical	JJ
601953	108643918	21111012052	research	research	NN1
601953	108643918	21111012053	hubs	hub	NN2
601953	108643918	21111012054	and	and	CC
601953	108643918	21111012055	it	it	PPH1
601953	108643918	21111012056	is	be	VBZ
601953	108643918	21111012057	clear	clear	JJ
601953	108643918	21111012058	that	that	CST
601953	108643918	21111012059	Boston	boston	NP1
601953	108643918	21111012060	is	be	VBZ
601953	108643918	21111012061	ripe	ripe	JJ
601953	108643918	21111012062	with	with	IW
601953	108643918	21111012063	the	the	AT
601953	108643918	21111012064	resources	resource	NN2
601953	108643918	21111012065	needed	need	VVN_VVD
601953	108643918	21111012066	to	to	TO
601953	108643918	21111012067	move	move	VVI
601953	108643918	21111012068	the	the	AT
601953	108643918	21111012069	industry	industry	NN1
601953	108643918	21111012070	forward	forward	RL
601953	108643918	21111012071	.	.	.
601953	108643918	21111012072	"	"	"
601953	108643918	21111012073	<p>		NULL
601953	108643918	21111012074	About	about	II
601953	108643918	21111012075	BracketBracket		NP1_NN1
601953	108643918	21111012076	,	,	,
601953	108643918	21111012077	with	with	IW
601953	108643918	21111012078	seven	seven	MC
601953	108643918	21111012079	offices	office	NN2
601953	108643918	21111012080	and	and	CC
601953	108643918	21111012081	more	more	DAR
601953	108643918	21111012082	than	than	CSN
601953	108643918	21111012083	500	500	MC
601953	108643918	21111012084	employees	employee	NN2
601953	108643918	21111012085	worldwide	worldwide	RL
601953	108643918	21111012086	,	,	,
601953	108643918	21111012087	is	be	VBZ
601953	108643918	21111012088	a	a	AT1
601953	108643918	21111012089	technology	technology	NN1
601953	108643918	21111012090	and	and	CC
601953	108643918	21111012091	special	special	JJ
601953	108643918	21111012092	services	service	NN2
601953	108643918	21111012093	provider	provider	NN1
601953	108643918	21111012094	dedicated	dedicate	VVN_VVD
601953	108643918	21111012095	to	to	II
601953	108643918	21111012096	helping	help	VVG
601953	108643918	21111012097	biopharmaceutical	biopharmaceutical	JJ
601953	108643918	21111012098	sponsors	sponsor	NN2
601953	108643918	21111012099	and	and	CC
601953	108643918	21111012100	contract	contract	NN1
601953	108643918	21111012101	research	research	NN1
601953	108643918	21111012102	organizations	organization	NN2
601953	108643918	21111012103	increase	increase	VV0
601953	108643918	21111012104	the	the	AT
601953	108643918	21111012105	power	power	NN1
601953	108643918	21111012106	of	of	IO
601953	108643918	21111012107	their	their	APPGE
601953	108643918	21111012108	clinical	clinical	JJ
601953	108643918	21111012109	research	research	NN1
601953	108643918	21111012110	data	data	NN
601953	108643918	21111012111	by	by	II
601953	108643918	21111012112	leveraging	leverage	VVG_JJ@
601953	108643918	21111012113	core	core	NN1
601953	108643918	21111012114	competencies	competency	NN2
601953	108643918	21111012115	in	in	II
601953	108643918	21111012116	Science	science	NN1
601953	108643918	21111012117	,	,	,
601953	108643918	21111012118	Technology	technology	NN1
601953	108643918	21111012119	,	,	,
601953	108643918	21111012120	and	and	CC
601953	108643918	21111012121	Service	service	NN1
601953	108643918	21111012122	.	.	.
601953	108643918	21111012123	Bracket	bracket	NN1_VV0@
601953	108643918	21111012124	eCOAG		NN1
601953	108643918	21111012125	is	be	VBZ
601953	108643918	21111012126	a	a	AT1
601953	108643918	21111012127	flexible	flexible	JJ
601953	108643918	21111012128	platform	platform	NN1
601953	108643918	21111012129	for	for	IF
601953	108643918	21111012130	electronic	electronic	JJ
601953	108643918	21111012131	clinical	clinical	JJ
601953	108643918	21111012132	outcomes	outcome	NN2
601953	108643918	21111012133	assessments	assessment	NN2
601953	108643918	21111012134	.	.	.
601953	108643918	21111012135	Bracket	bracket	VV0@_NN1
601953	108643918	21111012136	RTSMG		NP1
601953	108643918	21111012137	is	be	VBZ
601953	108643918	21111012138	a	a	AT1
601953	108643918	21111012139	best-in-breed		NN1_JJ
601953	108643918	21111012140	,	,	,
601953	108643918	21111012141	scalable	scalable	JJ
601953	108643918	21111012142	and	and	CC
601953	108643918	21111012143	configurable	configurable	JJ
601953	108643918	21111012144	clinical	clinical	JJ
601953	108643918	21111012145	IRT	irt	NN1
601953	108643918	21111012146	solution	solution	NN1
601953	108643918	21111012147	for	for	IF
601953	108643918	21111012148	the	the	AT
601953	108643918	21111012149	life	life	NN1
601953	108643918	21111012150	sciences	science	NN2
601953	108643918	21111012151	industry	industry	NN1
601953	108643918	21111012152	.	.	.
601953	108643918	21111012153	Bracket	bracket	VV0@_NN1
601953	108643918	21111012154	Rater	rater	NP1
601953	108643918	21111012155	Training	training	NN1
601953	108643918	21111012156	and	and	CC
601953	108643918	21111012157	Quality	quality	NN1
601953	108643918	21111012158	Assurance	assurance	NN1
601953	108643918	21111012159	improve	improve	VV0
601953	108643918	21111012160	outcomes	outcome	NN2
601953	108643918	21111012161	through	through	II
601953	108643918	21111012162	customized	customized	JJ@
601953	108643918	21111012163	training	training	NN1
601953	108643918	21111012164	and	and	CC
601953	108643918	21111012165	quality	quality	NN1
601953	108643918	21111012166	assurance	assurance	NN1
601953	108643918	21111012167	programs	program	NN2
601953	108643918	21111012168	.	.	.
601953	108643918	21111012169	Learn	learn	VV0
601953	108643918	21111012170	more	more	RRR_DAR
601953	108643918	21111012171	about	about	II
601953	108643918	21111012172	Bracket	bracket	NN1
601953	108643918	21111012173	at	at	II
601953	108643918	21111012174	www.bracketglobal.com.		NNU
601953	108643919	21111012194	@@##	----------	----------
601953	108643919	21111012195	@@108643919		FO
601953	108643919	21111012196	@4043919/		VV0_JJ
601953	108643919	21111012197	<h>		NULL
601953	108643919	21111012198	Charitable	charitable	JJ
601953	108643919	21111012199	Efforts	effort	NN2
601953	108643919	21111012200	Across	across	II
601953	108643919	21111012201	Bracket	bracket	NN1
601953	108643919	21111012202	<p>		NULL
601953	108643919	21111012203	January	january	NPM1
601953	108643919	21111012204	18	18	MC
601953	108643919	21111012205	,	,	,
601953	108643919	21111012206	2016	2016	MC
601953	108643919	21111012207	<p>		NULL
601953	108643919	21111012208	Around	around	II
601953	108643919	21111012209	the	the	AT
601953	108643919	21111012210	world	world	NN1
601953	108643919	21111012211	,	,	,
601953	108643919	21111012212	Bracket	bracket	NN1_VV0@
601953	108643919	21111012213	employees	employee	NN2
601953	108643919	21111012214	have	have	VH0
601953	108643919	21111012215	supported	support	VVN
601953	108643919	21111012216	various	various	JJ
601953	108643919	21111012217	charitable	charitable	JJ
601953	108643919	21111012218	initiatives	initiative	NN2
601953	108643919	21111012219	throughout	throughout	II
601953	108643919	21111012220	2015	2015	MC
601953	108643919	21111012221	.	.	.
601953	108643919	21111012222	Employees	employee	NN2
601953	108643919	21111012223	at	at	II
601953	108643919	21111012224	Bracket	bracket	NN1
601953	108643919	21111012225	believe	believe	VV0
601953	108643919	21111012226	in	in	II_RP@
601953	108643919	21111012227	giving	give	VVG
601953	108643919	21111012228	back	back	RP
601953	108643919	21111012229	to	to	II
601953	108643919	21111012230	our	our	APPGE
601953	108643919	21111012231	local	local	JJ
601953	108643919	21111012232	communities	community	NN2
601953	108643919	21111012233	and	and	CC
601953	108643919	21111012234	collectively	collectively	RR
601953	108643919	21111012235	we	we	PPIS2
601953	108643919	21111012236	have	have	VH0
601953	108643919	21111012237	donated	donate	VVN
601953	108643919	21111012238	and	and	CC
601953	108643919	21111012239	volunteered	volunteer	VVN
601953	108643919	21111012240	countless	countless	JJ
601953	108643919	21111012241	hours	hour	NNT2
601953	108643919	21111012242	for	for	IF
601953	108643919	21111012243	several	several	DA2
601953	108643919	21111012244	charitable	charitable	JJ
601953	108643919	21111012245	events	event	NN2
601953	108643919	21111012246	.	.	.
601953	108643919	21111012247	<p>		NULL
601953	108643919	21111012248	Through	through	II
601953	108643919	21111012249	company	company	NN1
601953	108643919	21111012250	and	and	CC
601953	108643919	21111012251	employee	employee	NN1
601953	108643919	21111012252	donations	donation	NN2
601953	108643919	21111012253	,	,	,
601953	108643919	21111012254	Bracket	bracket	NN1_VV0@
601953	108643919	21111012255	office	office	NN1
601953	108643919	21111012256	locations	location	NN2
601953	108643919	21111012257	have	have	VH0
601953	108643919	21111012258	maximized	maximize	VVN
601953	108643919	21111012259	charitable	charitable	JJ
601953	108643919	21111012260	efforts	effort	NN2
601953	108643919	21111012261	by	by	II
601953	108643919	21111012262	supporting	support	VVG
601953	108643919	21111012263	the	the	AT
601953	108643919	21111012264	following	following	JJ
601953	108643919	21111012265	charities	charity	NN2
601953	108643919	21111012266	:	:	:
601953	108643919	21111012267	<p>		NULL
601953	108643919	21111012268	Bracket	bracket	NN1_VV0@
601953	108643919	21111012269	in	in	II
601953	108643919	21111012270	Langhorne	langhorne	NP1
601953	108643919	21111012271	,	,	,
601953	108643919	21111012272	PA	pa	NP1@_NN1
601953	108643919	21111012273	collected	collect	VVD_VVN
601953	108643919	21111012274	100lbs		NNU2
601953	108643919	21111012275	of	of	IO
601953	108643919	21111012276	food	food	NN1
601953	108643919	21111012277	during	during	II
601953	108643919	21111012278	the	the	AT
601953	108643919	21111012279	2015	2015	MC
601953	108643919	21111012280	holiday	holiday	NN1
601953	108643919	21111012281	Food	food	NN1
601953	108643919	21111012282	drive	drive	NN1
601953	108643919	21111012283	.	.	.
601953	108643919	21111012284	The	the	AT
601953	108643919	21111012285	contribution	contribution	NN1
601953	108643919	21111012286	was	be	VBDZ
601953	108643919	21111012287	made	make	VVN
601953	108643919	21111012288	to	to	II
601953	108643919	21111012289	Preston	preston	NP1
601953	108643919	21111012290	and	and	CC
601953	108643919	21111012291	Steve	steve	NP1
601953	108643919	21111012292	WMMR		NP1
601953	108643919	21111012293	Campout		NP1_NN1_VV0
601953	108643919	21111012294	for	for	IF
601953	108643919	21111012295	Hunger	hunger	NN1
601953	108643919	21111012296	,	,	,
601953	108643919	21111012297	which	which	DDQ
601953	108643919	21111012298	directly	directly	RR
601953	108643919	21111012299	benefited	benefit	VVD_VVN
601953	108643919	21111012300	Philabundance		NP1
601953	108643919	21111012301	.	.	.
601953	108643919	21111012302	This	this	DD1
601953	108643919	21111012303	food	food	NN1
601953	108643919	21111012304	drive	drive	NN1
601953	108643919	21111012305	collected	collect	VVD_VVN
601953	108643919	21111012306	a	a	AT1
601953	108643919	21111012307	total	total	NN1_JJ
601953	108643919	21111012308	of	of	IO
601953	108643919	21111012309	1,161,290lbs		NNU2
601953	108643919	21111012310	of	of	IO
601953	108643919	21111012311	food	food	NN1
601953	108643919	21111012312	,	,	,
601953	108643919	21111012313	which	which	DDQ
601953	108643919	21111012314	comes	come	VVZ
601953	108643919	21111012315	out	out	RP
601953	108643919	21111012316	to	to	II
601953	108643919	21111012317	580	580	MC
601953	108643919	21111012318	tons	ton	NNU2
601953	108643919	21111012319	!	!	!
601953	108643919	21111012320	<p>		NULL
601953	108643919	21111012321	The	the	AT
601953	108643919	21111012322	San	san	NP1
601953	108643919	21111012323	Francisco	francisco	NP1
601953	108643919	21111012324	,	,	,
601953	108643919	21111012325	CA	ca	NP1@
601953	108643919	21111012326	location	location	NN1
601953	108643919	21111012327	supported	support	VVD
601953	108643919	21111012328	California	california	NP1
601953	108643919	21111012329	's	's	GE
601953	108643919	21111012330	foster	foster	JJ
601953	108643919	21111012331	children	child	NN2
601953	108643919	21111012332	by	by	II
601953	108643919	21111012333	donating	donate	VVG
601953	108643919	21111012334	toys	toy	NN2
601953	108643919	21111012335	to	to	II
601953	108643919	21111012336	Sleep	sleep	NN1
601953	108643919	21111012337	Train.		NP1
601953	108643919	21111012338	-	-	-
601953	108643919	21111012339	This	this	DD1
601953	108643919	21111012340	toy	toy	NN1_JJ@
601953	108643919	21111012341	drive	drive	NN1_VV0
601953	108643919	21111012342	helps	help	NN2@_VVZ
601953	108643919	21111012343	provide	provide	VVI
601953	108643919	21111012344	foster	foster	JJ
601953	108643919	21111012345	children	child	NN2
601953	108643919	21111012346	with	with	IW
601953	108643919	21111012347	supplies	supply	NN2
601953	108643919	21111012348	,	,	,
601953	108643919	21111012349	shoes	shoe	NN2
601953	108643919	21111012350	,	,	,
601953	108643919	21111012351	clothing	clothing	NN1_VVG@
601953	108643919	21111012352	,	,	,
601953	108643919	21111012353	and	and	CC
601953	108643919	21111012354	toys	toy	NN2
601953	108643919	21111012355	throughout	throughout	II
601953	108643919	21111012356	the	the	AT
601953	108643919	21111012357	year	year	NNT1
601953	108643919	21111012358	.	.	.
601953	108643919	21111012359	<p>		NULL
601953	108643919	21111012360	Bracket	bracket	NN1_VV0@
601953	108643919	21111012361	headquarters	headquarters	NN
601953	108643919	21111012362	in	in	II
601953	108643919	21111012363	Wayne	wayne	NP1
601953	108643919	21111012364	,	,	,
601953	108643919	21111012365	PA	pa	NP1@_NN1
601953	108643919	21111012366	supported	support	VVD_VVN
601953	108643919	21111012367	charities	charity	NN2
601953	108643919	21111012368	throughout	throughout	II
601953	108643919	21111012369	the	the	AT
601953	108643919	21111012370	year	year	NNT1
601953	108643919	21111012371	by	by	II
601953	108643919	21111012372	participating	participate	VVG
601953	108643919	21111012373	in	in	RP@_II
601953	108643919	21111012374	:	:	:
601953	108643919	21111012375	<p>		NULL
601953	108643919	21111012376	Cradles-2-Crayons		NN2
601953	108643919	21111012377	<p>		NULL
601953	108643919	21111012378	Stop	stop	VV0
601953	108643919	21111012379	Hunger	hunger	NN1
601953	108643919	21111012380	Now	now	RT
601953	108643919	21111012381	<p>		NULL
601953	108643919	21111012382	One	one	MC1
601953	108643919	21111012383	Warm	warm	JJ
601953	108643919	21111012384	Coat	coat	NN1
601953	108643919	21111012385	<p>		NULL
601953	108643919	21111012386	@		II
601953	108643919	21111012387	@		II
601953	108643919	21111012388	@		II
601953	108643919	21111012389	@		II
601953	108643919	21111012390	@		II
601953	108643919	21111012391	@		II
601953	108643919	21111012392	@		II
601953	108643919	21111012393	@		II
601953	108643919	21111012394	@		II
601953	108643919	21111012395	@		II
601953	108643919	21111012396	a	a	AT1
601953	108643919	21111012397	Family	family	NN1
601953	108643919	21111012398	Christmas	christmas	NNT1
601953	108643919	21111012399	<p>		NULL
601953	108643919	21111012400	Bracket	bracket	VV0@_NN1
601953	108643919	21111012401	international	international	JJ
601953	108643919	21111012402	office	office	NN1
601953	108643919	21111012403	in	in	II
601953	108643919	21111012404	Reading	reading	NP1
601953	108643919	21111012405	,	,	,
601953	108643919	21111012406	UK	uk	NP1
601953	108643919	21111012407	took	take	VVD
601953	108643919	21111012408	part	part	NN1
601953	108643919	21111012409	in	in	II
601953	108643919	21111012410	Mencap		NP1_NN1
601953	108643919	21111012411	,	,	,
601953	108643919	21111012412	where	where	RRQ
601953	108643919	21111012413	Bracket	bracket	NN1
601953	108643919	21111012414	employees	employee	NN2
601953	108643919	21111012415	volunteered	volunteer	VVD_VVN
601953	108643919	21111012416	their	their	APPGE
601953	108643919	21111012417	day	day	NNT1
601953	108643919	21111012418	to	to	TO
601953	108643919	21111012419	paint	paint	VVI
601953	108643919	21111012420	a	a	AT1
601953	108643919	21111012421	day	day	NNT1
601953	108643919	21111012422	care	care	VV0_NN1
601953	108643919	21111012423	center.		NNU
601953	108643919	21111012424	-	-	-
601953	108643919	21111012425	In	in	RR21
601953	108643919	21111012426	addition	addition	RR22
601953	108643919	21111012427	,	,	,
601953	108643919	21111012428	the	the	AT
601953	108643919	21111012429	UK	uk	NP1
601953	108643919	21111012430	office	office	NN1
601953	108643919	21111012431	also	also	RR
601953	108643919	21111012432	held	hold	VVN_VVD
601953	108643919	21111012433	a	a	AT1
601953	108643919	21111012434	coffee	coffee	NN1
601953	108643919	21111012435	morning	morning	NNT1
601953	108643919	21111012436	for	for	IF
601953	108643919	21111012437	the	the	AT
601953	108643919	21111012438	MacMillan	macmillan	NP1
601953	108643919	21111012439	Cancer	cancer	NN1
601953	108643919	21111012440	Support	support	NN1_VV0
601953	108643919	21111012441	Charity	charity	NN1
601953	108643919	21111012442	,	,	,
601953	108643919	21111012443	-	-	-
601953	108643919	21111012444	and	and	CC
601953	108643919	21111012445	on	on	II
601953	108643919	21111012446	the	the	AT
601953	108643919	21111012447	8th	8th	MD
601953	108643919	21111012448	of	of	IO
601953	108643919	21111012449	December	december	NPM1
601953	108643919	21111012450	,	,	,
601953	108643919	21111012451	-	-	-
601953	108643919	21111012452	staff	staff	NN
601953	108643919	21111012453	continued	continue	VVD_VVN
601953	108643919	21111012454	to	to	TO
601953	108643919	21111012455	volunteer	volunteer	VVI
601953	108643919	21111012456	their	their	APPGE
601953	108643919	21111012457	time	time	NNT1
601953	108643919	21111012458	for	for	IF
601953	108643919	21111012459	Reading	reading	NP1_VVG@
601953	108643919	21111012460	Family	family	NN1
601953	108643919	21111012461	Aid	aid	NN1
601953	108643919	21111012462	,	,	,
601953	108643919	21111012463	where	where	CS_RRQ
601953	108643919	21111012464	they	they	PPHS2
601953	108643919	21111012465	helped	help	VVD
601953	108643919	21111012466	pack	pack	NN1
601953	108643919	21111012467	and	and	CC
601953	108643919	21111012468	sort	sort	NN1_VV0@
601953	108643919	21111012469	toys	toy	NN2
601953	108643919	21111012470	for	for	IF
601953	108643919	21111012471	distribution	distribution	NN1
601953	108643919	21111012472	to	to	II
601953	108643919	21111012473	families	family	NN2
601953	108643919	21111012474	in	in	II
601953	108643919	21111012475	need	need	NN1
601953	108643919	21111012476	.	.	.
601953	108643919	21111012477	<p>		NULL
601953	108643919	21111012478	We	we	PPIS2
601953	108643919	21111012479	at	at	II
601953	108643919	21111012480	Bracket	bracket	NN1
601953	108643919	21111012481	know	know	VV0
601953	108643919	21111012482	our	our	APPGE
601953	108643919	21111012483	support	support	NN1
601953	108643919	21111012484	is	be	VBZ
601953	108643919	21111012485	making	make	VVG
601953	108643919	21111012486	a	a	AT1
601953	108643919	21111012487	difference	difference	NN1
601953	108643919	21111012488	,	,	,
601953	108643919	21111012489	and	and	CC
601953	108643919	21111012490	we	we	PPIS2
601953	108643919	21111012491	are	be	VBR
601953	108643919	21111012492	excited	excite	VVN@_JJ
601953	108643919	21111012493	to	to	TO
601953	108643919	21111012494	see	see	VVI
601953	108643919	21111012495	how	how	RRQ
601953	108643919	21111012496	we	we	PPIS2
601953	108643919	21111012497	can	can	VM
601953	108643919	21111012498	help	help	VVI
601953	108643919	21111012499	our	our	APPGE
601953	108643919	21111012500	communities	community	NN2
601953	108643919	21111012501	throughout	throughout	II
601953	108643919	21111012502	2016	2016	MC
601953	108643919	21111012503	!	!	!
601953	108643921	21111012523	@@##	----------	----------
601953	108643921	21111012524	@@108643921		FO
601953	108643921	21111012525	@4043921/		NN1_VV0
601953	108643921	21111012526	<p>		NULL
601953	108643921	21111012527	-	-	-
601953	108643921	21111012528	David	david	NP1
601953	108643921	21111012529	G.		NP1
601953	108643921	21111012530	Daniel	daniel	NP1
601953	108643921	21111012531	,	,	,
601953	108643921	21111012532	MD	md	NNA
601953	108643921	21111012533	,	,	,
601953	108643921	21111012534	Senior	senior	JJ
601953	108643921	21111012535	Vice	vice	JJ_NN1
601953	108643921	21111012536	President	president	NN1
601953	108643921	21111012537	and	and	CC
601953	108643921	21111012538	Chief	chief	JJ
601953	108643921	21111012539	Medical	medical	JJ
601953	108643921	21111012540	Officer	officer	NN1
601953	108643921	21111012541	,	,	,
601953	108643921	21111012542	Bracket	bracket	NN1_VV0@
601953	108643921	21111012543	,	,	,
601953	108643921	21111012544	and	and	CC
601953	108643921	21111012545	Professor	professor	NN1
601953	108643921	21111012546	of	of	IO
601953	108643921	21111012547	Psychiatry	psychiatry	NP1_NN1
601953	108643921	21111012548	,	,	,
601953	108643921	21111012549	George	george	NP1
601953	108643921	21111012550	Washington	washington	NP1
601953	108643921	21111012551	University	university	NN1
601953	108643921	21111012552	<p>		NULL
601953	108643921	21111012553	Measurement	measurement	NN1
601953	108643921	21111012554	error	error	NN1
601953	108643921	21111012555	and	and	CC
601953	108643921	21111012556	data	data	NN
601953	108643921	21111012557	recording	record	VVG_NN1_JJ@
601953	108643921	21111012558	errors	error	NN2
601953	108643921	21111012559	(	(	(
601953	108643921	21111012560	including	including	II_VVG@
601953	108643921	21111012561	data	data	NN
601953	108643921	21111012562	fabrication	fabrication	NN1
601953	108643921	21111012563	)	)	)
601953	108643921	21111012564	(	(	(
601953	108643921	21111012565	Baigent	baigent	NP1
601953	108643921	21111012566	,	,	,
601953	108643921	21111012567	2008	2008	MC
601953	108643921	21111012568	)	)	)
601953	108643921	21111012569	are	be	VBR
601953	108643921	21111012570	frequent	frequent	JJ
601953	108643921	21111012571	and	and	CC
601953	108643921	21111012572	often	often	RR
601953	108643921	21111012573	non-randomly	non-randomly	RR
601953	108643921	21111012574	distributed	distribute	VVN
601953	108643921	21111012575	in	in	II
601953	108643921	21111012576	clinical	clinical	JJ
601953	108643921	21111012577	trial	trial	NN1
601953	108643921	21111012578	datasets	dataset	NN2
601953	108643921	21111012579	.	.	.
601953	108643921	21111012580	Even	even	CS21
601953	108643921	21111012581	when	when	CS22
601953	108643921	21111012582	accumulated	accumulate	VVN
601953	108643921	21111012583	at	at	II
601953	108643921	21111012584	a	a	AT1
601953	108643921	21111012585	single	single	JJ
601953	108643921	21111012586	site	site	NN1
601953	108643921	21111012587	or	or	CC
601953	108643921	21111012588	a	a	AT1
601953	108643921	21111012589	small	small	JJ
601953	108643921	21111012590	number	number	NN1
601953	108643921	21111012591	of	of	IO
601953	108643921	21111012592	sites	site	NN2
601953	108643921	21111012593	their	their	APPGE
601953	108643921	21111012594	impact	impact	NN1
601953	108643921	21111012595	may	may	VM
601953	108643921	21111012596	be	be	VBI
601953	108643921	21111012597	devastating	devastating	JJ_VVG@
601953	108643921	21111012598	to	to	II
601953	108643921	21111012599	the	the	AT
601953	108643921	21111012600	success	success	NN1
601953	108643921	21111012601	of	of	IO
601953	108643921	21111012602	a	a	AT1
601953	108643921	21111012603	CNS	cns	NP1
601953	108643921	21111012604	clinical	clinical	JJ
601953	108643921	21111012605	trial	trial	NN1
601953	108643921	21111012606	.	.	.
601953	108643921	21111012607	It	it	PPH1
601953	108643921	21111012608	is	be	VBZ
601953	108643921	21111012609	therefore	therefore	RR
601953	108643921	21111012610	critical	critical	JJ
601953	108643921	21111012611	to	to	TO
601953	108643921	21111012612	identify	identify	VVI
601953	108643921	21111012613	those	those	DD2
601953	108643921	21111012614	sites	site	NN2
601953	108643921	21111012615	and	and	CC
601953	108643921	21111012616	raters	rater	NN2
601953	108643921	21111012617	who	who	PNQS
601953	108643921	21111012618	are	be	VBR
601953	108643921	21111012619	at	at	II
601953	108643921	21111012620	greatest	greatest	JJT
601953	108643921	21111012621	risk	risk	NN1
601953	108643921	21111012622	of	of	IO
601953	108643921	21111012623	providing	provide	VVG
601953	108643921	21111012624	erroneous	erroneous	JJ
601953	108643921	21111012625	or	or	CC
601953	108643921	21111012626	otherwise	otherwise	RR
601953	108643921	21111012627	compromised	compromised	JJ_VVN_VVD
601953	108643921	21111012628	data	data	NN
601953	108643921	21111012629	.	.	.
601953	108643921	21111012630	<p>		NULL
601953	108643921	21111012631	Central	central	JJ
601953	108643921	21111012632	statistical	statistical	JJ
601953	108643921	21111012633	monitoring	monitoring	NN1
601953	108643921	21111012634	techniques	technique	NN2
601953	108643921	21111012635	have	have	VH0
601953	108643921	21111012636	been	be	VBN
601953	108643921	21111012637	shown	show	VVN
601953	108643921	21111012638	to	to	TO
601953	108643921	21111012639	successfully	successfully	RR
601953	108643921	21111012640	identify	identify	VVI
601953	108643921	21111012641	fraudulent/fabricated		JJ
601953	108643921	21111012642	data	data	NN
601953	108643921	21111012643	in	in	II
601953	108643921	21111012644	clinical	clinical	JJ
601953	108643921	21111012645	trials	trial	NN2
601953	108643921	21111012646	using	use	VVG
601953	108643921	21111012647	objective	objective	JJ_NN1
601953	108643921	21111012648	outcomes	outcome	NN2
601953	108643921	21111012649	(	(	(
601953	108643921	21111012650	Knepper	knepper	NP1_NN1
601953	108643921	21111012651	,	,	,
601953	108643921	21111012652	2016	2016	MC
601953	108643921	21111012653	)	)	)
601953	108643921	21111012654	but	but	CCB
601953	108643921	21111012655	have	have	VH0
601953	108643921	21111012656	been	be	VBN
601953	108643921	21111012657	less	less	RGR
601953	108643921	21111012658	effective	effective	JJ
601953	108643921	21111012659	in	in	II
601953	108643921	21111012660	clinical	clinical	JJ
601953	108643921	21111012661	trials	trial	NN2
601953	108643921	21111012662	using	use	VVG
601953	108643921	21111012663	subjective	subjective	JJ
601953	108643921	21111012664	outcome	outcome	NN1
601953	108643921	21111012665	measures	measure	NN2_VVZ@
601953	108643921	21111012666	such	such	II21
601953	108643921	21111012667	as	as	II22
601953	108643921	21111012668	psychiatric	psychiatric	JJ
601953	108643921	21111012669	rating	rating	NN1
601953	108643921	21111012670	scales	scale	NN2
601953	108643921	21111012671	(	(	(
601953	108643921	21111012672	O'Kelly	o'kelly	NP1
601953	108643921	21111012673	,	,	,
601953	108643921	21111012674	2004	2004	MC
601953	108643921	21111012675	)	)	)
601953	108643921	21111012676	.	.	.
601953	108643921	21111012677	It	it	PPH1
601953	108643921	21111012678	is	be	VBZ
601953	108643921	21111012679	however	however	RR
601953	108643921	21111012680	exactly	exactly	RR
601953	108643921	21111012681	these	these	DD2
601953	108643921	21111012682	subjective	subjective	JJ
601953	108643921	21111012683	outcome	outcome	NN1
601953	108643921	21111012684	'	'	GE
601953	108643921	21111012685	trials	trial	NN2
601953	108643921	21111012686	that	that	CST
601953	108643921	21111012687	are	be	VBR
601953	108643921	21111012688	in	in	II
601953	108643921	21111012689	the	the	AT
601953	108643921	21111012690	greatest	greatest	JJT
601953	108643921	21111012691	need	need	NN1
601953	108643921	21111012692	of	of	IO
601953	108643921	21111012693	effective	effective	JJ
601953	108643921	21111012694	data	data	NN
601953	108643921	21111012695	quality	quality	NN1
601953	108643921	21111012696	monitoring	monitoring	NN1_VVG
601953	108643921	21111012697	programs	program	NN2
601953	108643921	21111012698	.	.	.
601953	108643921	21111012699	<p>		NULL
601953	108643921	21111012700	At	at	II
601953	108643921	21111012701	Bracket	bracket	NN1
601953	108643921	21111012702	,	,	,
601953	108643921	21111012703	we	we	PPIS2
601953	108643921	21111012704	have	have	VH0
601953	108643921	21111012705	successfully	successfully	RR
601953	108643921	21111012706	implemented	implement	VVN
601953	108643921	21111012707	risk-based	risk-based	JJ
601953	108643921	21111012708	data	data	NN
601953	108643921	21111012709	quality	quality	NN1
601953	108643921	21111012710	monitoring	monitoring	NN1_VVG
601953	108643921	21111012711	programs	program	NN2
601953	108643921	21111012712	(	(	(
601953	108643921	21111012713	Blinded	blinded	JJ@_VVN
601953	108643921	21111012714	Data	data	NN
601953	108643921	21111012715	@		II
601953	108643921	21111012716	@		II
601953	108643921	21111012717	@		II
601953	108643921	21111012718	@		II
601953	108643921	21111012719	@		II
601953	108643921	21111012720	@		II
601953	108643921	21111012721	@		II
601953	108643921	21111012722	@		II
601953	108643921	21111012723	@		II
601953	108643921	21111012724	@		II
601953	108643921	21111012725	numerous	numerous	JJ
601953	108643921	21111012726	indications	indication	NN2
601953	108643921	21111012727	.	.	.
601953	108643921	21111012728	These	these	DD2
601953	108643921	21111012729	programs	program	NN2
601953	108643921	21111012730	combined	combine	VVN_VVD
601953	108643921	21111012731	near	near	II_RL
601953	108643921	21111012732	real	real	JJ
601953	108643921	21111012733	time	time	NNT1
601953	108643921	21111012734	central	central	JJ
601953	108643921	21111012735	statistical	statistical	JJ
601953	108643921	21111012736	monitoring	monitoring	NN1
601953	108643921	21111012737	approaches	approach	VVZ_NN2
601953	108643921	21111012738	with	with	IW
601953	108643921	21111012739	comprehensive	comprehensive	JJ
601953	108643921	21111012740	clinical	clinical	JJ
601953	108643921	21111012741	review	review	NN1
601953	108643921	21111012742	and	and	CC
601953	108643921	21111012743	where	where	CS_RRQ
601953	108643921	21111012744	indicated	indicate	VVN
601953	108643921	21111012745	targeted	targeted	JJ%_VVN_VVD
601953	108643921	21111012746	follow-up	follow-up	NN1_JJ
601953	108643921	21111012747	with	with	IW
601953	108643921	21111012748	the	the	AT
601953	108643921	21111012749	identified	identified	JJ%
601953	108643921	21111012750	raters/sites		NN2
601953	108643921	21111012751	.	.	.
601953	108643921	21111012752	In	in	II
601953	108643921	21111012753	many	many	DA2
601953	108643921	21111012754	of	of	IO
601953	108643921	21111012755	these	these	DD2
601953	108643921	21111012756	CNS	cns	NP1
601953	108643921	21111012757	clinical	clinical	JJ
601953	108643921	21111012758	trials	trial	NN2
601953	108643921	21111012759	,	,	,
601953	108643921	21111012760	central	central	JJ
601953	108643921	21111012761	statistical	statistical	JJ
601953	108643921	21111012762	monitoring	monitoring	NN1
601953	108643921	21111012763	worked	work	VVN_VVD
601953	108643921	21111012764	in	in	II
601953	108643921	21111012765	concert	concert	NN1
601953	108643921	21111012766	with	with	IW
601953	108643921	21111012767	intelligent	intelligent	JJ
601953	108643921	21111012768	eCOA		NN1
601953	108643921	21111012769	and	and	CC
601953	108643921	21111012770	remote	remote	JJ
601953	108643921	21111012771	audio/video	audio/video	NN1
601953	108643921	21111012772	monitoring	monitoring	NN1_VVG
601953	108643921	21111012773	programs	program	NN2
601953	108643921	21111012774	.	.	.
601953	108643921	21111012775	<p>		NULL
601953	108643921	21111012776	In	in	II
601953	108643921	21111012777	this	this	DD1
601953	108643921	21111012778	webinar	webinar	NN1_JJ
601953	108643921	21111012779	,	,	,
601953	108643921	21111012780	we	we	PPIS2
601953	108643921	21111012781	will	will	VM
601953	108643921	21111012782	discuss	discuss	VVI
601953	108643921	21111012783	examples	example	NN2
601953	108643921	21111012784	of	of	IO
601953	108643921	21111012785	identified	identified	JJ%
601953	108643921	21111012786	data	data	NN
601953	108643921	21111012787	quality	quality	NN1
601953	108643921	21111012788	concerns	concern	NN2_VVZ
601953	108643921	21111012789	coming	come	VVG
601953	108643921	21111012790	from	from	II
601953	108643921	21111012791	CNS	cns	NP1
601953	108643921	21111012792	clinical	clinical	JJ
601953	108643921	21111012793	trials	trial	NN2
601953	108643921	21111012794	and	and	CC
601953	108643921	21111012795	the	the	AT
601953	108643921	21111012796	impact	impact	NN1
601953	108643921	21111012797	of	of	IO
601953	108643921	21111012798	their	their	APPGE
601953	108643921	21111012799	presence	presence	NN1
601953	108643921	21111012800	on	on	II
601953	108643921	21111012801	study	study	NN1
601953	108643921	21111012802	outcomes	outcome	NN2
601953	108643921	21111012803	.	.	.
601953	108643921	21111012804	We	we	PPIS2
601953	108643921	21111012805	will	will	VM
601953	108643921	21111012806	show	show	VVI
601953	108643921	21111012807	that	that	CST
601953	108643921	21111012808	many	many	DA2
601953	108643921	21111012809	of	of	IO
601953	108643921	21111012810	the	the	AT
601953	108643921	21111012811	data	data	NN
601953	108643921	21111012812	quality	quality	NN1
601953	108643921	21111012813	concerns	concern	NN2
601953	108643921	21111012814	are	be	VBR
601953	108643921	21111012815	clustering	cluster	VVG@
601953	108643921	21111012816	at	at	II
601953	108643921	21111012817	a	a	AT1
601953	108643921	21111012818	small	small	JJ
601953	108643921	21111012819	number	number	NN1
601953	108643921	21111012820	of	of	IO
601953	108643921	21111012821	centers	center	NN2
601953	108643921	21111012822	and	and	CC
601953	108643921	21111012823	many	many	DA2
601953	108643921	21111012824	post-randomization		JJ
601953	108643921	21111012825	data	data	NN
601953	108643921	21111012826	quality	quality	NN1
601953	108643921	21111012827	concerns	concern	NN2_VVZ
601953	108643921	21111012828	can	can	VM
601953	108643921	21111012829	be	be	VBI
601953	108643921	21111012830	predicted	predict	VVN
601953	108643921	21111012831	by	by	II
601953	108643921	21111012832	the	the	AT
601953	108643921	21111012833	occurrence	occurrence	NN1
601953	108643921	21111012834	of	of	IO
601953	108643921	21111012835	similar	similar	JJ
601953	108643921	21111012836	concerns	concern	NN2
601953	108643921	21111012837	in	in	II
601953	108643921	21111012838	the	the	AT
601953	108643921	21111012839	screening	screening	NN1
601953	108643921	21111012840	period	period	NN1
601953	108643921	21111012841	.	.	.
601953	108643921	21111012842	We	we	PPIS2
601953	108643921	21111012843	will	will	VM
601953	108643921	21111012844	conclude	conclude	VVI
601953	108643921	21111012845	by	by	II
601953	108643921	21111012846	demonstrating	demonstrate	VVG
601953	108643921	21111012847	the	the	AT
601953	108643921	21111012848	positive	positive	JJ
601953	108643921	21111012849	impact	impact	NN1
601953	108643921	21111012850	of	of	IO
601953	108643921	21111012851	implementing	implement	VVG
601953	108643921	21111012852	eCOA		NN1
601953	108643921	21111012853	and	and	CC
601953	108643921	21111012854	remote	remote	JJ
601953	108643921	21111012855	audio/video	audio/video	NN1
601953	108643921	21111012856	monitoring	monitoring	NN1_VVG
601953	108643921	21111012857	programs	program	NN2
601953	108643921	21111012858	on	on	II
601953	108643921	21111012859	data	data	NN
601953	108643921	21111012860	quality	quality	NN1
601953	108643921	21111012861	.	.	.
601953	108643926	21111012881	@@##	----------	----------
601953	108643926	21111012882	@@108643926		FO
601953	108643926	21111012883	@4043926/		NN1_VV0
601953	108643926	21111012884	<p>		NULL
601953	108643926	21111012885	Bracket	bracket	NN1_VV0@
601953	108643926	21111012886	,	,	,
601953	108643926	21111012887	a	a	AT1
601953	108643926	21111012888	leading	leading	JJ
601953	108643926	21111012889	clinical	clinical	JJ
601953	108643926	21111012890	trial	trial	NN1
601953	108643926	21111012891	technology	technology	NN1
601953	108643926	21111012892	and	and	CC
601953	108643926	21111012893	specialty	specialty	NN1
601953	108643926	21111012894	services	service	NN2
601953	108643926	21111012895	provider	provider	NN1
601953	108643926	21111012896	,	,	,
601953	108643926	21111012897	will	will	VM
601953	108643926	21111012898	launch	launch	VVI
601953	108643926	21111012899	its	its	APPGE
601953	108643926	21111012900	next	next	MD
601953	108643926	21111012901	generation	generation	NN1
601953	108643926	21111012902	clinical	clinical	JJ
601953	108643926	21111012903	outcomes	outcome	NN2
601953	108643926	21111012904	platform	platform	NN1
601953	108643926	21111012905	,	,	,
601953	108643926	21111012906	Bracket	bracket	NN1_VV0@
601953	108643926	21111012907	eCOAG		NN1_VV0
601953	108643926	21111012908	6.0	6.0	MC
601953	108643926	21111012909	,	,	,
601953	108643926	21111012910	at	at	II
601953	108643926	21111012911	the	the	AT
601953	108643926	21111012912	52nd	52nd	MD
601953	108643926	21111012913	Annual	annual	JJ
601953	108643926	21111012914	DIA	dia	NN1
601953	108643926	21111012915	Meeting	meeting	NN1
601953	108643926	21111012916	held	hold	VVN_VVD
601953	108643926	21111012917	on	on	II
601953	108643926	21111012918	June	june	NPM1
601953	108643926	21111012919	26	26	MC
601953	108643926	21111012920	"	"	"
601953	108643926	21111012921	30	30	MC
601953	108643926	21111012922	,	,	,
601953	108643926	21111012923	2016	2016	MC
601953	108643926	21111012924	in	in	II
601953	108643926	21111012925	Philadelphia	philadelphia	NP1
601953	108643926	21111012926	,	,	,
601953	108643926	21111012927	Pennsylvania.		NP1
601953	108643926	21111012928	-	-	-
601953	108643926	21111012929	A	a	AT1@_ZZ1
601953	108643926	21111012930	demonstration	demonstration	NN1
601953	108643926	21111012931	of	of	IO
601953	108643926	21111012932	eCOA		NN1
601953	108643926	21111012933	6.0	6.0	MC
601953	108643926	21111012934	,	,	,
601953	108643926	21111012935	the	the	AT
601953	108643926	21111012936	first	first	MD
601953	108643926	21111012937	electronic	electronic	JJ
601953	108643926	21111012938	Clinical	clinical	JJ
601953	108643926	21111012939	Outcome	outcome	NN1
601953	108643926	21111012940	Assessment	assessment	NN1
601953	108643926	21111012941	product	product	NN1
601953	108643926	21111012942	of	of	IO
601953	108643926	21111012943	its	its	APPGE
601953	108643926	21111012944	kind	kind	NN1
601953	108643926	21111012945	to	to	TO
601953	108643926	21111012946	fully	fully	RR
601953	108643926	21111012947	integrate	integrate	VVI
601953	108643926	21111012948	with	with	IW
601953	108643926	21111012949	RTSM		NP1
601953	108643926	21111012950	,	,	,
601953	108643926	21111012951	will	will	VM
601953	108643926	21111012952	be	be	VBI
601953	108643926	21111012953	held	hold	VVN
601953	108643926	21111012954	at	at	II
601953	108643926	21111012955	DIA	dia	NN1
601953	108643926	21111012956	Booth	booth	NN1_NP1
601953	108643926	21111012957	#715		NNU
601953	108643926	21111012958	.	.	.
601953	108643926	21111012959	<p>		NULL
601953	108643926	21111012960	Bracket	bracket	NN1_VV0@
601953	108643926	21111012961	eCOA		NN1
601953	108643926	21111012962	6.0	6.0	MC
601953	108643926	21111012963	is	be	VBZ
601953	108643926	21111012964	a	a	AT1
601953	108643926	21111012965	flexible	flexible	JJ
601953	108643926	21111012966	platform	platform	NN1
601953	108643926	21111012967	for	for	IF
601953	108643926	21111012968	electronic	electronic	JJ
601953	108643926	21111012969	clinical	clinical	JJ
601953	108643926	21111012970	outcomes	outcome	NN2
601953	108643926	21111012971	assessments	assessment	NN2
601953	108643926	21111012972	that	that	CST_DD1
601953	108643926	21111012973	is	be	VBZ
601953	108643926	21111012974	driving	driving	JJ_VVG
601953	108643926	21111012975	digitization	digitization	NN1
601953	108643926	21111012976	in	in	II
601953	108643926	21111012977	clinical	clinical	JJ
601953	108643926	21111012978	trials	trial	NN2
601953	108643926	21111012979	.	.	.
601953	108643926	21111012980	The	the	AT
601953	108643926	21111012981	platform	platform	NN1
601953	108643926	21111012982	integrates	integrate	VVZ
601953	108643926	21111012983	with	with	IW
601953	108643926	21111012984	industry-leading	industry-leading	JJ_NN1
601953	108643926	21111012985	Samsung	samsung	JJ@_NP1_VVD
601953	108643926	21111012986	Galaxy	galaxy	NN1
601953	108643926	21111012987	smartphones		NN2_VVZ
601953	108643926	21111012988	and	and	CC
601953	108643926	21111012989	tablets	tablet	NN2
601953	108643926	21111012990	,	,	,
601953	108643926	21111012991	and	and	CC
601953	108643926	21111012992	Microsofts	microsoft	NP2
601953	108643926	21111012993	Surface	surface	NN1
601953	108643926	21111012994	Pro	pro	II
601953	108643926	21111012995	Windows	windows	NP1
601953	108643926	21111012996	tablets	tablet	NN2
601953	108643926	21111012997	to	to	TO
601953	108643926	21111012998	support	support	VVI
601953	108643926	21111012999	ePRO		NN1
601953	108643926	21111013000	,	,	,
601953	108643926	21111013001	eClinRO		NN1
601953	108643926	21111013002	and	and	CC
601953	108643926	21111013003	eObsRO		NN1
601953	108643926	21111013004	,	,	,
601953	108643926	21111013005	and	and	CC
601953	108643926	21111013006	features	feature	NN2_VVZ@
601953	108643926	21111013007	fully	fully	RR
601953	108643926	21111013008	integrated	integrated	JJ_VVN
601953	108643926	21111013009	clinician	clinician	NN1
601953	108643926	21111013010	and	and	CC
601953	108643926	21111013011	patient-facing		JJ_NN1
601953	108643926	21111013012	tools	tool	NN2
601953	108643926	21111013013	,	,	,
601953	108643926	21111013014	to	to	TO
601953	108643926	21111013015	ensure	ensure	VVI
601953	108643926	21111013016	the	the	AT
601953	108643926	21111013017	experience	experience	NN1
601953	108643926	21111013018	is	be	VBZ
601953	108643926	21111013019	fully	fully	RR
601953	108643926	21111013020	harmonized	harmonize	VVN
601953	108643926	21111013021	for	for	IF
601953	108643926	21111013022	any	any	DD
601953	108643926	21111013023	user	user	NN1
601953	108643926	21111013024	.	.	.
601953	108643926	21111013025	<p>		NULL
601953	108643926	21111013026	"	"	"
601953	108643926	21111013027	Bracket	bracket	NN1_VV0@
601953	108643926	21111013028	eCOA		NN1
601953	108643926	21111013029	combines	combine	VVZ
601953	108643926	21111013030	science	science	NN1
601953	108643926	21111013031	and	and	CC
601953	108643926	21111013032	technology	technology	NN1
601953	108643926	21111013033	to	to	TO
601953	108643926	21111013034	collect	collect	VVI
601953	108643926	21111013035	patient	patient	JJ_NN1
601953	108643926	21111013036	information	information	NN1
601953	108643926	21111013037	through	through	II
601953	108643926	21111013038	smartphones	smartphone	NN2
601953	108643926	21111013039	or	or	CC
601953	108643926	21111013040	tablets	tablet	NN2
601953	108643926	21111013041	,	,	,
601953	108643926	21111013042	and	and	CC
601953	108643926	21111013043	ultimately	ultimately	RR
601953	108643926	21111013044	achieve	achieve	VV0
601953	108643926	21111013045	higher	high	JJR
601953	108643926	21111013046	quality	quality	NN1
601953	108643926	21111013047	outcomes	outcome	NN2
601953	108643926	21111013048	and	and	CC
601953	108643926	21111013049	efficiency	efficiency	NN1
601953	108643926	21111013050	in	in	II
601953	108643926	21111013051	clinical	clinical	JJ
601953	108643926	21111013052	trials	trial	NN2
601953	108643926	21111013053	,	,	,
601953	108643926	21111013054	"	"	"
601953	108643926	21111013055	said	say	VVD
601953	108643926	21111013056	Jeff	jeff	NP1
601953	108643926	21111013057	Kinell		NP1
601953	108643926	21111013058	,	,	,
601953	108643926	21111013059	Chief	chief	JJ_NN1
601953	108643926	21111013060	Executive	executive	NN1_JJ@
601953	108643926	21111013061	Officer	officer	NN1
601953	108643926	21111013062	for	for	IF
601953	108643926	21111013063	Bracket	bracket	NN1
601953	108643926	21111013064	.	.	.
601953	108643926	21111013065	"	"	"
601953	108643926	21111013066	We	we	PPIS2
601953	108643926	21111013067	are	be	VBR
601953	108643926	21111013068	pleased	pleased	JJ
601953	108643926	21111013069	to	to	TO
601953	108643926	21111013070	launch	launch	VVI
601953	108643926	21111013071	eCOA		NN1
601953	108643926	21111013072	6.0	6.0	MC
601953	108643926	21111013073	@		II
601953	108643926	21111013074	@		II
601953	108643926	21111013075	@		II
601953	108643926	21111013076	@		II
601953	108643926	21111013077	@		II
601953	108643926	21111013078	@		II
601953	108643926	21111013079	@		II
601953	108643926	21111013080	@		II
601953	108643926	21111013081	@		II
601953	108643926	21111013082	@		II
601953	108643926	21111013083	we	we	PPIS2
601953	108643926	21111013084	prepare	prepare	VV0
601953	108643926	21111013085	for	for	IF
601953	108643926	21111013086	the	the	AT
601953	108643926	21111013087	mobile	mobile	JJ_NN1
601953	108643926	21111013088	revolution	revolution	NN1
601953	108643926	21111013089	.	.	.
601953	108643926	21111013090	"	"	"
601953	108643926	21111013091	<p>		NULL
601953	108643926	21111013092	Bracket	bracket	NN1_VV0@
601953	108643926	21111013093	,	,	,
601953	108643926	21111013094	with	with	IW
601953	108643926	21111013095	seven	seven	MC
601953	108643926	21111013096	offices	office	NN2
601953	108643926	21111013097	and	and	CC
601953	108643926	21111013098	more	more	DAR
601953	108643926	21111013099	than	than	CSN
601953	108643926	21111013100	500	500	MC
601953	108643926	21111013101	employees	employee	NN2
601953	108643926	21111013102	worldwide	worldwide	RL
601953	108643926	21111013103	,	,	,
601953	108643926	21111013104	is	be	VBZ
601953	108643926	21111013105	a	a	AT1
601953	108643926	21111013106	clinical	clinical	JJ
601953	108643926	21111013107	trial	trial	NN1
601953	108643926	21111013108	technology	technology	NN1
601953	108643926	21111013109	and	and	CC
601953	108643926	21111013110	specialty	specialty	NN1
601953	108643926	21111013111	services	service	NN2
601953	108643926	21111013112	provider	provider	NN1
601953	108643926	21111013113	dedicated	dedicate	VVN_VVD
601953	108643926	21111013114	to	to	II
601953	108643926	21111013115	helping	help	VVG
601953	108643926	21111013116	biopharmaceutical	biopharmaceutical	JJ
601953	108643926	21111013117	sponsors	sponsor	NN2
601953	108643926	21111013118	and	and	CC
601953	108643926	21111013119	contract	contract	NN1
601953	108643926	21111013120	research	research	NN1
601953	108643926	21111013121	organizations	organization	NN2
601953	108643926	21111013122	increase	increase	VV0
601953	108643926	21111013123	the	the	AT
601953	108643926	21111013124	power	power	NN1
601953	108643926	21111013125	of	of	IO
601953	108643926	21111013126	their	their	APPGE
601953	108643926	21111013127	clinical	clinical	JJ
601953	108643926	21111013128	research	research	NN1
601953	108643926	21111013129	data	data	NN
601953	108643926	21111013130	by	by	II
601953	108643926	21111013131	leveraging	leverage	VVG_JJ@
601953	108643926	21111013132	core	core	NN1
601953	108643926	21111013133	competencies	competency	NN2
601953	108643926	21111013134	in	in	II
601953	108643926	21111013135	Science	science	NN1
601953	108643926	21111013136	,	,	,
601953	108643926	21111013137	Technology	technology	NN1
601953	108643926	21111013138	,	,	,
601953	108643926	21111013139	and	and	CC
601953	108643926	21111013140	Service	service	NN1
601953	108643926	21111013141	.	.	.
601953	108643926	21111013142	Bracket	bracket	NN1_VV0@
601953	108643926	21111013143	eCOAG		NN1
601953	108643926	21111013144	is	be	VBZ
601953	108643926	21111013145	a	a	AT1
601953	108643926	21111013146	flexible	flexible	JJ
601953	108643926	21111013147	platform	platform	NN1
601953	108643926	21111013148	for	for	IF
601953	108643926	21111013149	electronic	electronic	JJ
601953	108643926	21111013150	clinical	clinical	JJ
601953	108643926	21111013151	outcomes	outcome	NN2
601953	108643926	21111013152	assessments	assessment	NN2
601953	108643926	21111013153	.	.	.
601953	108643926	21111013154	Bracket	bracket	VV0@_NN1
601953	108643926	21111013155	RTSMG		NP1
601953	108643926	21111013156	is	be	VBZ
601953	108643926	21111013157	a	a	AT1
601953	108643926	21111013158	best-in-breed		NN1_JJ
601953	108643926	21111013159	,	,	,
601953	108643926	21111013160	scalable	scalable	JJ
601953	108643926	21111013161	and	and	CC
601953	108643926	21111013162	configurable	configurable	JJ
601953	108643926	21111013163	clinical	clinical	JJ
601953	108643926	21111013164	IRT	irt	NN1
601953	108643926	21111013165	solution	solution	NN1
601953	108643926	21111013166	for	for	IF
601953	108643926	21111013167	the	the	AT
601953	108643926	21111013168	life	life	NN1
601953	108643926	21111013169	sciences	science	NN2
601953	108643926	21111013170	industry	industry	NN1
601953	108643926	21111013171	.	.	.
601953	108643926	21111013172	Bracket	bracket	VV0@_NN1
601953	108643926	21111013173	Rater	rater	NP1
601953	108643926	21111013174	Training	training	NN1
601953	108643926	21111013175	and	and	CC
601953	108643926	21111013176	Quality	quality	NN1
601953	108643926	21111013177	Assurance	assurance	NN1
601953	108643926	21111013178	improve	improve	VV0
601953	108643926	21111013179	outcomes	outcome	NN2
601953	108643926	21111013180	through	through	II
601953	108643926	21111013181	customized	customized	JJ@
601953	108643926	21111013182	training	training	NN1
601953	108643926	21111013183	and	and	CC
601953	108643926	21111013184	quality	quality	NN1
601953	108643926	21111013185	assurance	assurance	NN1
601953	108643926	21111013186	programs	program	NN2
601953	108643926	21111013187	.	.	.
601953	108643929	21111013207	@@##	----------	----------
601953	108643929	21111013208	@@108643929		FO
601953	108643929	21111013209	@4043929/		NN1_VV0
601953	108643929	21111013210	<p>		NULL
601953	108643929	21111013211	(	(	(
601953	108643929	21111013212	WAYNE	wayne	NP1
601953	108643929	21111013213	,	,	,
601953	108643929	21111013214	Pennsylvania	pennsylvania	NP1
601953	108643929	21111013215	and	and	CC
601953	108643929	21111013216	BOSTON	boston	NP1
601953	108643929	21111013217	)	)	)
601953	108643929	21111013218	Bracket	bracket	VV0@_NN1
601953	108643929	21111013219	Global	global	JJ
601953	108643929	21111013220	,	,	,
601953	108643929	21111013221	LLC	llc	NP1
601953	108643929	21111013222	and	and	CC
601953	108643929	21111013223	Clintara		NP1
601953	108643929	21111013224	are	be	VBR
601953	108643929	21111013225	pleased	pleased	JJ
601953	108643929	21111013226	to	to	TO
601953	108643929	21111013227	announce	announce	VVI
601953	108643929	21111013228	the	the	AT
601953	108643929	21111013229	two	two	MC
601953	108643929	21111013230	companies	company	NN2
601953	108643929	21111013231	have	have	VH0
601953	108643929	21111013232	agreed	agree	VVN
601953	108643929	21111013233	to	to	TO
601953	108643929	21111013234	combine	combine	VVI
601953	108643929	21111013235	.	.	.
601953	108643929	21111013236	Bracket	bracket	NN1
601953	108643929	21111013237	will	will	VM
601953	108643929	21111013238	integrate	integrate	VVI
601953	108643929	21111013239	the	the	AT
601953	108643929	21111013240	Clintara		NP1_NN1@
601953	108643929	21111013241	platform	platform	NN1
601953	108643929	21111013242	of	of	IO
601953	108643929	21111013243	surveillance	surveillance	NN1
601953	108643929	21111013244	strategies	strategy	NN2
601953	108643929	21111013245	developed	develop	VVN
601953	108643929	21111013246	for	for	IF
601953	108643929	21111013247	clinical	clinical	JJ
601953	108643929	21111013248	trials	trial	NN2
601953	108643929	21111013249	within	within	II
601953	108643929	21111013250	Brackets	bracket	NN2
601953	108643929	21111013251	proprietary	proprietary	JJ
601953	108643929	21111013252	electronic	electronic	JJ
601953	108643929	21111013253	platform	platform	NN1
601953	108643929	21111013254	for	for	IF
601953	108643929	21111013255	Clinical	clinical	JJ
601953	108643929	21111013256	Outcome	outcome	NN1
601953	108643929	21111013257	Assessments	assessment	NN2
601953	108643929	21111013258	(	(	(
601953	108643929	21111013259	eCOA		NN1
601953	108643929	21111013260	)	)	)
601953	108643929	21111013261	.	.	.
601953	108643929	21111013262	The	the	AT
601953	108643929	21111013263	integration	integration	NN1
601953	108643929	21111013264	will	will	VM
601953	108643929	21111013265	include	include	VVI
601953	108643929	21111013266	Clintaras		NP2_NN2@
601953	108643929	21111013267	innovative	innovative	JJ
601953	108643929	21111013268	C-VISA		JJ_NN1
601953	108643929	21111013269	Subject	subject	NN1_JJ@
601953	108643929	21111013270	Eligibility	eligibility	NN1
601953	108643929	21111013271	Validation	validation	NN1
601953	108643929	21111013272	program	program	NN1
601953	108643929	21111013273	designed	design	VVN_VVD
601953	108643929	21111013274	to	to	TO
601953	108643929	21111013275	ensure	ensure	VVI
601953	108643929	21111013276	appropriate	appropriate	JJ
601953	108643929	21111013277	patients	patient	NN2
601953	108643929	21111013278	are	be	VBR
601953	108643929	21111013279	enrolled	enroll	VVN
601953	108643929	21111013280	in	in	II
601953	108643929	21111013281	clinical	clinical	JJ
601953	108643929	21111013282	trials	trial	NN2
601953	108643929	21111013283	.	.	.
601953	108643929	21111013284	<p>		NULL
601953	108643929	21111013285	The	the	AT
601953	108643929	21111013286	Clintara		NP1_NN1@
601953	108643929	21111013287	leadership	leadership	NN1
601953	108643929	21111013288	will	will	VM
601953	108643929	21111013289	assume	assume	VVI
601953	108643929	21111013290	expanded	expanded	JJ
601953	108643929	21111013291	roles	role	NN2
601953	108643929	21111013292	within	within	II
601953	108643929	21111013293	Bracket	bracket	NN1
601953	108643929	21111013294	.	.	.
601953	108643929	21111013295	Dr.		NNB
601953	108643929	21111013296	Targum		NP1
601953	108643929	21111013297	will	will	VM
601953	108643929	21111013298	become	become	VVI
601953	108643929	21111013299	the	the	AT
601953	108643929	21111013300	Scientific	scientific	JJ
601953	108643929	21111013301	Director	director	NN1
601953	108643929	21111013302	of	of	IO
601953	108643929	21111013303	Bracket	bracket	NN1
601953	108643929	21111013304	and	and	CC
601953	108643929	21111013305	will	will	VM
601953	108643929	21111013306	work	work	VVI
601953	108643929	21111013307	closely	closely	RR
601953	108643929	21111013308	with	with	IW
601953	108643929	21111013309	Brackets	bracket	NN2
601953	108643929	21111013310	Senior	senior	JJ
601953	108643929	21111013311	Vice	vice	JJ_NN1
601953	108643929	21111013312	President	president	NN1
601953	108643929	21111013313	and	and	CC
601953	108643929	21111013314	Chief	chief	JJ
601953	108643929	21111013315	Medical	medical	JJ
601953	108643929	21111013316	Officer	officer	NN1
601953	108643929	21111013317	,	,	,
601953	108643929	21111013318	David	david	NP1
601953	108643929	21111013319	Daniel	daniel	NP1
601953	108643929	21111013320	,	,	,
601953	108643929	21111013321	MD	md	NNA
601953	108643929	21111013322	.	.	.
601953	108643929	21111013323	Clintara		NN1_NP1@
601953	108643929	21111013324	CEO	ceo	NN1
601953	108643929	21111013325	Colin	colin	NP1
601953	108643929	21111013326	Bower	bower	NP1
601953	108643929	21111013327	will	will	VM
601953	108643929	21111013328	become	become	VVI
601953	108643929	21111013329	Vice	vice	JJ_II
601953	108643929	21111013330	President	president	NN1
601953	108643929	21111013331	,	,	,
601953	108643929	21111013332	Scientific	scientific	JJ
601953	108643929	21111013333	Services	service	NN2
601953	108643929	21111013334	and	and	CC
601953	108643929	21111013335	will	will	VM
601953	108643929	21111013336	work	work	VVI
601953	108643929	21111013337	with	with	IW
601953	108643929	21111013338	the	the	AT
601953	108643929	21111013339	Bracket	bracket	NN1
601953	108643929	21111013340	leadership	leadership	NN1
601953	108643929	21111013341	team	team	NN1
601953	108643929	21111013342	and	and	CC
601953	108643929	21111013343	Scientific	scientific	JJ
601953	108643929	21111013344	Advisory	advisory	JJ
601953	108643929	21111013345	Board	board	NN1
601953	108643929	21111013346	to	to	TO
601953	108643929	21111013347	develop	develop	VVI
601953	108643929	21111013348	cutting-edge	cutting-edge	JJ
601953	108643929	21111013349	solutions	solution	NN2
601953	108643929	21111013350	to	to	TO
601953	108643929	21111013351	improve	improve	VVI
601953	108643929	21111013352	the	the	AT
601953	108643929	21111013353	conduct	conduct	NN1
601953	108643929	21111013354	of	of	IO
601953	108643929	21111013355	clinical	clinical	JJ
601953	108643929	21111013356	trials	trial	NN2
601953	108643929	21111013357	.	.	.
601953	108643929	21111013358	<h>		NULL
601953	108643929	21111013359	About	about	II
601953	108643929	21111013360	Clintara		NP1
601953	108643929	21111013361	<p>		NULL
601953	108643929	21111013362	Clintara		NN1_NP1@
601953	108643929	21111013363	is	be	VBZ
601953	108643929	21111013364	a	a	AT1
601953	108643929	21111013365	privately-held		JJ
601953	108643929	21111013366	clinical	clinical	JJ
601953	108643929	21111013367	service	service	NN1
601953	108643929	21111013368	and	and	CC
601953	108643929	21111013369	technology	technology	NN1
601953	108643929	21111013370	company	company	NN1
601953	108643929	21111013371	headquartered	headquarter	VVD_VVN@
601953	108643929	21111013372	in	in	II
601953	108643929	21111013373	Boston	boston	NP1
601953	108643929	21111013374	,	,	,
601953	108643929	21111013375	MA	ma	NNA
601953	108643929	21111013376	.	.	.
601953	108643929	21111013377	Clintara		NN1_NP1@
601953	108643929	21111013378	was	be	VBDZ
601953	108643929	21111013379	founded	found	VVN
601953	108643929	21111013380	in	in	II
601953	108643929	21111013381	2009	2009	MC
601953	108643929	21111013382	by	by	II
601953	108643929	21111013383	Dr.		NNB
601953	108643929	21111013384	Steven	steven	NP1
601953	108643929	21111013385	Targum		NP1
601953	108643929	21111013386	,	,	,
601953	108643929	21111013387	MD	md	NNA
601953	108643929	21111013388	.	.	.
601953	108643929	21111013389	Clintara		NN1_NP1@
601953	108643929	21111013390	has	have	VHZ
601953	108643929	21111013391	conducted	conduct	VVN
601953	108643929	21111013392	over	over	RG
601953	108643929	21111013393	60	60	MC
601953	108643929	21111013394	trials	trial	NN2
601953	108643929	21111013395	which	which	DDQ
601953	108643929	21111013396	have	have	VH0
601953	108643929	21111013397	included	include	VVN
601953	108643929	21111013398	23,000	23,000	MC
601953	108643929	21111013399	@		II
601953	108643929	21111013400	@		II
601953	108643929	21111013401	@		II
601953	108643929	21111013402	@		II
601953	108643929	21111013403	@		II
601953	108643929	21111013404	@		II
601953	108643929	21111013405	@		II
601953	108643929	21111013406	@		II
601953	108643929	21111013407	@		II
601953	108643929	21111013408	@		II
601953	108643929	21111013409	About	about	II
601953	108643929	21111013410	Bracket	bracket	NN1
601953	108643929	21111013411	<p>		NULL
601953	108643929	21111013412	Bracket	bracket	NN1_VV0@
601953	108643929	21111013413	,	,	,
601953	108643929	21111013414	with	with	IW
601953	108643929	21111013415	seven	seven	MC
601953	108643929	21111013416	offices	office	NN2
601953	108643929	21111013417	and	and	CC
601953	108643929	21111013418	more	more	DAR
601953	108643929	21111013419	than	than	CSN
601953	108643929	21111013420	500	500	MC
601953	108643929	21111013421	employees	employee	NN2
601953	108643929	21111013422	worldwide	worldwide	RL
601953	108643929	21111013423	,	,	,
601953	108643929	21111013424	is	be	VBZ
601953	108643929	21111013425	focused	focus	VVN
601953	108643929	21111013426	on	on	II
601953	108643929	21111013427	bringing	bring	VVG
601953	108643929	21111013428	together	together	RL
601953	108643929	21111013429	best-in-class	best-in-class	JJ
601953	108643929	21111013430	science	science	NN1
601953	108643929	21111013431	,	,	,
601953	108643929	21111013432	technology	technology	NN1
601953	108643929	21111013433	and	and	CC
601953	108643929	21111013434	service	service	NN1_VV0@
601953	108643929	21111013435	to	to	TO
601953	108643929	21111013436	drive	drive	VVI
601953	108643929	21111013437	superior	superior	JJ
601953	108643929	21111013438	clinical	clinical	JJ
601953	108643929	21111013439	outcome	outcome	NN1
601953	108643929	21111013440	results	result	NN2_VVZ@
601953	108643929	21111013441	for	for	IF
601953	108643929	21111013442	pharmaceutical	pharmaceutical	JJ
601953	108643929	21111013443	companies	company	NN2
601953	108643929	21111013444	and	and	CC
601953	108643929	21111013445	for	for	IF
601953	108643929	21111013446	patients	patient	NN2
601953	108643929	21111013447	.	.	.
601953	108643929	21111013448	In	in	II
601953	108643929	21111013449	August	august	NPM1
601953	108643929	21111013450	2013	2013	MC
601953	108643929	21111013451	,	,	,
601953	108643929	21111013452	Bracket	bracket	NN1
601953	108643929	21111013453	became	become	VVD
601953	108643929	21111013454	an	a	AT1
601953	108643929	21111013455	independent	independent	JJ
601953	108643929	21111013456	portfolio	portfolio	NN1
601953	108643929	21111013457	company	company	NN1
601953	108643929	21111013458	of	of	IO
601953	108643929	21111013459	Parthenon	parthenon	NP1_NN1
601953	108643929	21111013460	Capital	capital	NN1_JJ@
601953	108643929	21111013461	Partners	partner	NN2
601953	108643929	21111013462	,	,	,
601953	108643929	21111013463	a	a	AT1
601953	108643929	21111013464	Boston-		NN1_JJ
601953	108643929	21111013465	and	and	CC
601953	108643929	21111013466	San	san	NP1
601953	108643929	21111013467	Francisco-based	francisco-based	NP1
601953	108643929	21111013468	growth-oriented	growth-oriented	JJ
601953	108643929	21111013469	private	private	JJ
601953	108643929	21111013470	equity	equity	NN1
601953	108643929	21111013471	firm	firm	NN1
601953	108643929	21111013472	that	that	CST_DD1
601953	108643929	21111013473	provides	provide	VVZ
601953	108643929	21111013474	capital	capital	NN1
601953	108643929	21111013475	and	and	CC
601953	108643929	21111013476	strategic	strategic	JJ
601953	108643929	21111013477	resources	resource	NN2
601953	108643929	21111013478	to	to	II
601953	108643929	21111013479	growing	grow	VVG_JJ
601953	108643929	21111013480	middle	middle	JJ_NN1
601953	108643929	21111013481	market	market	NN1
601953	108643929	21111013482	companies	company	NN2
601953	108643929	21111013483	for	for	IF
601953	108643929	21111013484	acquisitions	acquisition	NN2
601953	108643929	21111013485	and	and	CC
601953	108643929	21111013486	internal	internal	JJ
601953	108643929	21111013487	growth	growth	NN1
601953	108643929	21111013488	.	.	.
601953	108643932	21111013508	@@##	----------	----------
601953	108643932	21111013509	@@108643932		FO
601953	108643932	21111013510	@4043932/		JJ_VV0_NN1
601953	108643932	21111013511	<h>		NULL
601953	108643932	21111013512	Top	top	NN1_JJ
601953	108643932	21111013513	10	10	MC
601953	108643932	21111013514	Proposal	proposal	NN1
601953	108643932	21111013515	Questions	question	NN2
601953	108643932	21111013516	to	to	TO_II
601953	108643932	21111013517	Ask	ask	VV0
601953	108643932	21111013518	In	in	II_RP@
601953	108643932	21111013519	A	a	AT1@_ZZ1
601953	108643932	21111013520	Clinical	clinical	JJ
601953	108643932	21111013521	IxRS		NP1_NN2
601953	108643932	21111013522	RFP	rfp	NP1
601953	108643932	21111013523	<p>		NULL
601953	108643932	21111013524	May	may	NPM1
601953	108643932	21111013525	16	16	MC
601953	108643932	21111013526	,	,	,
601953	108643932	21111013527	2013	2013	MC
601953	108643932	21111013528	<h>		NULL
601953	108643932	21111013529	By	by	II
601953	108643932	21111013530	Jen	jen	NP1
601953	108643932	21111013531	Burstedt		NP1
601953	108643932	21111013532	,	,	,
601953	108643932	21111013533	Marketing	marketing	NN1_VVG@
601953	108643932	21111013534	&amp;		CC
601953	108643932	21111013535	Communications	communication	NN2
601953	108643932	21111013536	<p>		NULL
601953	108643932	21111013537	As	as	CSA
601953	108643932	21111013538	I	i	PPIS1
601953	108643932	21111013539	started	start	VVD
601953	108643932	21111013540	my	my	APPGE
601953	108643932	21111013541	career	career	NN1
601953	108643932	21111013542	in	in	II
601953	108643932	21111013543	the	the	AT
601953	108643932	21111013544	proposals	proposal	NN2
601953	108643932	21111013545	department	department	NN1
601953	108643932	21111013546	at	at	II
601953	108643932	21111013547	Bracket	bracket	NN1
601953	108643932	21111013548	,	,	,
601953	108643932	21111013549	I	i	PPIS1
601953	108643932	21111013550	have	have	VH0
601953	108643932	21111013551	read	read	VVN
601953	108643932	21111013552	through	through	II
601953	108643932	21111013553	my	my	APPGE
601953	108643932	21111013554	fair	fair	JJ
601953	108643932	21111013555	share	share	NN1
601953	108643932	21111013556	of	of	IO
601953	108643932	21111013557	protocols	protocol	NN2
601953	108643932	21111013558	and	and	CC
601953	108643932	21111013559	Request	request	VV0_NN1
601953	108643932	21111013560	for	for	IF
601953	108643932	21111013561	Proposals	proposal	NN2
601953	108643932	21111013562	(	(	(
601953	108643932	21111013563	RFPs	rfps	NP1
601953	108643932	21111013564	)	)	)
601953	108643932	21111013565	,	,	,
601953	108643932	21111013566	digging	dig	VVG
601953	108643932	21111013567	through	through	II
601953	108643932	21111013568	these	these	DD2
601953	108643932	21111013569	documents	document	NN2
601953	108643932	21111013570	for	for	IF
601953	108643932	21111013571	information	information	NN1
601953	108643932	21111013572	relevant	relevant	JJ
601953	108643932	21111013573	toward	toward	II
601953	108643932	21111013574	writing	write	VVG
601953	108643932	21111013575	a	a	AT1
601953	108643932	21111013576	proposal	proposal	NN1
601953	108643932	21111013577	and	and	CC
601953	108643932	21111013578	putting	put	VVG
601953	108643932	21111013579	together	together	RL
601953	108643932	21111013580	the	the	AT
601953	108643932	21111013581	budget	budget	NN1
601953	108643932	21111013582	for	for	IF
601953	108643932	21111013583	Interactive	interactive	JJ
601953	108643932	21111013584	Web	web	NN1
601953	108643932	21111013585	(	(	(
601953	108643932	21111013586	or	or	CC
601953	108643932	21111013587	Voice	voice	NN1
601953	108643932	21111013588	)	)	)
601953	108643932	21111013589	Response	response	NN1
601953	108643932	21111013590	Systems	system	NN2
601953	108643932	21111013591	(	(	(
601953	108643932	21111013592	IWRS/IVRS		NP2_NN2_VVZ
601953	108643932	21111013593	"	"	"
601953	108643932	21111013594	or	or	CC
601953	108643932	21111013595	IxRS		NP1_NN2_VVZ
601953	108643932	21111013596	,	,	,
601953	108643932	21111013597	as	as	CSA
601953	108643932	21111013598	it	it	PPH1
601953	108643932	21111013599	will	will	VM
601953	108643932	21111013600	be	be	VBI
601953	108643932	21111013601	referred	refer	VVN
601953	108643932	21111013602	here	here	RL
601953	108643932	21111013603	)	)	)
601953	108643932	21111013604	for	for	IF
601953	108643932	21111013605	clinical	clinical	JJ
601953	108643932	21111013606	trials	trial	NN2
601953	108643932	21111013607	from	from	II
601953	108643932	21111013608	Phase	phase	NN1
601953	108643932	21111013609	I	i	ZZ1%_MC1%
601953	108643932	21111013610	"	"	"
601953	108643932	21111013611	IV	iv	MC
601953	108643932	21111013612	.	.	.
601953	108643932	21111013613	<p>		NULL
601953	108643932	21111013614	There	there	EX
601953	108643932	21111013615	are	be	VBR
601953	108643932	21111013616	massive	massive	JJ
601953	108643932	21111013617	amounts	amount	NN2
601953	108643932	21111013618	of	of	IO
601953	108643932	21111013619	variation	variation	NN1
601953	108643932	21111013620	from	from	II
601953	108643932	21111013621	the	the	AT
601953	108643932	21111013622	RFPs	rfps	NP1
601953	108643932	21111013623	sent	send	VVD
601953	108643932	21111013624	it	it	PPH1
601953	108643932	21111013625	"	"	"
601953	108643932	21111013626	some	some	DD
601953	108643932	21111013627	proposals	proposal	NN2
601953	108643932	21111013628	which	which	DDQ
601953	108643932	21111013629	ask	ask	VV0
601953	108643932	21111013630	very	very	RG
601953	108643932	21111013631	few	few	DA2
601953	108643932	21111013632	questions	question	NN2
601953	108643932	21111013633	;	;	;
601953	108643932	21111013634	others	others	NN2
601953	108643932	21111013635	include	include	VV0
601953	108643932	21111013636	80	80	MC
601953	108643932	21111013637	questions	question	NN2
601953	108643932	21111013638	in	in	II31
601953	108643932	21111013639	addition	addition	II32
601953	108643932	21111013640	to	to	II33
601953	108643932	21111013641	the	the	AT
601953	108643932	21111013642	actual	actual	JJ
601953	108643932	21111013643	proposal	proposal	NN1
601953	108643932	21111013644	and	and	CC
601953	108643932	21111013645	budget	budget	NN1
601953	108643932	21111013646	.	.	.
601953	108643932	21111013647	<p>		NULL
601953	108643932	21111013648	This	this	DD1
601953	108643932	21111013649	top	top	NN1_JJ
601953	108643932	21111013650	10	10	MC
601953	108643932	21111013651	list	list	NN1
601953	108643932	21111013652	will	will	VM
601953	108643932	21111013653	be	be	VBI
601953	108643932	21111013654	helpful	helpful	JJ
601953	108643932	21111013655	if	if	CS_CSW@
601953	108643932	21111013656	you	you	PPY
601953	108643932	21111013657	:	:	:
601953	108643932	21111013658	<p>		NULL
601953	108643932	21111013659	Have	have	VH0
601953	108643932	21111013660	been	be	VBN
601953	108643932	21111013661	tasked	task	VVN@
601953	108643932	21111013662	with	with	IW
601953	108643932	21111013663	creating	create	VVG
601953	108643932	21111013664	an	a	AT1
601953	108643932	21111013665	RFP	rfp	NP1
601953	108643932	21111013666	to	to	TO
601953	108643932	21111013667	send	send	VVI
601953	108643932	21111013668	to	to	II
601953	108643932	21111013669	potential	potential	NN1_JJ
601953	108643932	21111013670	IxRS		VVZ_NN2_NP1
601953	108643932	21111013671	vendors	vendor	NN2
601953	108643932	21111013672	<p>		NULL
601953	108643932	21111013673	Are	be	VBR
601953	108643932	21111013674	curious	curious	JJ
601953	108643932	21111013675	if	if	CS_CSW@
601953	108643932	21111013676	there	there	EX
601953	108643932	21111013677	are	be	VBR
601953	108643932	21111013678	any	any	DD
601953	108643932	21111013679	key	key	JJ_NN1
601953	108643932	21111013680	questions	question	NN2
601953	108643932	21111013681	you	you	PPY
601953	108643932	21111013682	might	might	VM
601953	108643932	21111013683	be	be	VBI
601953	108643932	21111013684	omitting	omit	VVG
601953	108643932	21111013685	in	in	II_RP@
601953	108643932	21111013686	your	your	APPGE
601953	108643932	21111013687	RFP	rfp	NP1
601953	108643932	21111013688	process	process	NN1_VV0
601953	108643932	21111013689	<p>		NULL
601953	108643932	21111013690	Here	here	RL
601953	108643932	21111013691	are	be	VBR
601953	108643932	21111013692	the	the	AT
601953	108643932	21111013693	top	top	NN1_JJ
601953	108643932	21111013694	10	10	MC
601953	108643932	21111013695	questions	question	NN2
601953	108643932	21111013696	we	we	PPIS2
601953	108643932	21111013697	feel	feel	VV0
601953	108643932	21111013698	are	be	VBR
601953	108643932	21111013699	the	the	AT
601953	108643932	21111013700	@		II
601953	108643932	21111013701	@		II
601953	108643932	21111013702	@		II
601953	108643932	21111013703	@		II
601953	108643932	21111013704	@		II
601953	108643932	21111013705	@		II
601953	108643932	21111013706	@		II
601953	108643932	21111013707	@		II
601953	108643932	21111013708	@		II
601953	108643932	21111013709	@		II
601953	108643932	21111013710	.	.	.
601953	108643932	21111013711	Of	of	RR21
601953	108643932	21111013712	course	course	RR22
601953	108643932	21111013713	,	,	,
601953	108643932	21111013714	we	we	PPIS2
601953	108643932	21111013715	have	have	VH0
601953	108643932	21111013716	n't	n't	XX
601953	108643932	21111013717	included	include	VVN
601953	108643932	21111013718	therapeutic	therapeutic	JJ
601953	108643932	21111013719	area	area	NN1
601953	108643932	21111013720	or	or	CC
601953	108643932	21111013721	study-specific	study-specific	JJ
601953	108643932	21111013722	questions	question	NN2
601953	108643932	21111013723	.	.	.
601953	108643932	21111013724	This	this	DD1
601953	108643932	21111013725	top	top	NN1_JJ
601953	108643932	21111013726	10	10	MC
601953	108643932	21111013727	list	list	NN1
601953	108643932	21111013728	is	be	VBZ
601953	108643932	21111013729	meant	mean	VVN
601953	108643932	21111013730	to	to	TO
601953	108643932	21111013731	make	make	VVI
601953	108643932	21111013732	sure	sure	JJ
601953	108643932	21111013733	you	you	PPY
601953	108643932	21111013734	have	have	VH0
601953	108643932	21111013735	included	include	VVN
601953	108643932	21111013736	the	the	AT
601953	108643932	21111013737	most	most	RGT
601953	108643932	21111013738	important	important	JJ
601953	108643932	21111013739	ones	one	NN2
601953	108643932	21111013740	.	.	.
601953	108643932	21111013741	<p>		NULL
601953	108643932	21111013742	Vendor	vendor	NN1
601953	108643932	21111013743	Governance	governance	NN1
601953	108643932	21111013744	:	:	:
601953	108643932	21111013745	what	what	DDQ
601953	108643932	21111013746	is	be	VBZ
601953	108643932	21111013747	the	the	AT
601953	108643932	21111013748	internal	internal	JJ
601953	108643932	21111013749	management	management	NN1
601953	108643932	21111013750	structure	structure	NN1
601953	108643932	21111013751	of	of	IO
601953	108643932	21111013752	sponsor	sponsor	NN1
601953	108643932	21111013753	aligned	align	VVD_VVN
601953	108643932	21111013754	teams	team	NN2
601953	108643932	21111013755	?	?	?
601953	108643932	21111013756	How	how	RRQ
601953	108643932	21111013757	will	will	VM
601953	108643932	21111013758	these	these	DD2
601953	108643932	21111013759	teams	team	NN2
601953	108643932	21111013760	support	support	VVI
601953	108643932	21111013761	quality	quality	NN1
601953	108643932	21111013762	?	?	?
601953	108643932	21111013763	<p>		NULL
601953	108643932	21111013764	Research	research	NN1_VV0@
601953	108643932	21111013765	and	and	CC
601953	108643932	21111013766	Development	development	NN1
601953	108643932	21111013767	:	:	:
601953	108643932	21111013768	define	define	VV0
601953	108643932	21111013769	your	your	APPGE
601953	108643932	21111013770	three	three	MC
601953	108643932	21111013771	year	year	NNT1
601953	108643932	21111013772	plan	plan	NN1_VV0
601953	108643932	21111013773	,	,	,
601953	108643932	21111013774	your	your	APPGE
601953	108643932	21111013775	new	new	JJ
601953	108643932	21111013776	technologies	technology	NN2
601953	108643932	21111013777	and	and	CC
601953	108643932	21111013778	the	the	AT
601953	108643932	21111013779	direction	direction	NN1
601953	108643932	21111013780	you	you	PPY
601953	108643932	21111013781	see	see	VV0
601953	108643932	21111013782	the	the	AT
601953	108643932	21111013783	industry	industry	NN1
601953	108643932	21111013784	going	go	VVG
601953	108643932	21111013785	.	.	.
601953	108643932	21111013786	<p>		NULL
601953	108643932	21111013787	Incident	incident	NN1
601953	108643932	21111013788	Reporting	reporting	NN1
601953	108643932	21111013789	and	and	CC
601953	108643932	21111013790	CAPA	capa	NP1_NN1
601953	108643932	21111013791	:	:	:
601953	108643932	21111013792	define	define	VV0
601953	108643932	21111013793	channel(s)		NN2
601953	108643932	21111013794	for	for	IF
601953	108643932	21111013795	communication	communication	NN1
601953	108643932	21111013796	and	and	CC
601953	108643932	21111013797	escalation	escalation	NN1
601953	108643932	21111013798	process	process	NN1
601953	108643932	21111013799	(	(	(
601953	108643932	21111013800	internal	internal	JJ
601953	108643932	21111013801	and	and	CC
601953	108643932	21111013802	external	external	JJ
601953	108643932	21111013803	)	)	)
601953	108643932	21111013804	,	,	,
601953	108643932	21111013805	as	as	II31
601953	108643932	21111013806	well	well	II32
601953	108643932	21111013807	as	as	II33
601953	108643932	21111013808	the	the	AT
601953	108643932	21111013809	procedures	procedure	NN2
601953	108643932	21111013810	and	and	CC
601953	108643932	21111013811	processes	process	NN2_VVZ@
601953	108643932	21111013812	in	in	II
601953	108643932	21111013813	place	place	NN1
601953	108643932	21111013814	to	to	TO
601953	108643932	21111013815	support	support	VVI
601953	108643932	21111013816	issue	issue	NN1
601953	108643932	21111013817	identification	identification	NN1
601953	108643932	21111013818	,	,	,
601953	108643932	21111013819	resolution	resolution	NN1
601953	108643932	21111013820	,	,	,
601953	108643932	21111013821	reporting	report	VVG_NN1
601953	108643932	21111013822	and	and	CC
601953	108643932	21111013823	corrective	corrective	JJ_NN1
601953	108643932	21111013824	and	and	CC
601953	108643932	21111013825	preventive	preventive	JJ
601953	108643932	21111013826	actions	action	NN2
601953	108643932	21111013827	(	(	(
601953	108643932	21111013828	CAPA	capa	NP1
601953	108643932	21111013829	)	)	)
601953	108643932	21111013830	.	.	.
601953	108643932	21111013831	<p>		NULL
601953	108643932	21111013832	Infrastructure	infrastructure	NN1
601953	108643932	21111013833	:	:	:
601953	108643932	21111013834	define	define	VV0
601953	108643932	21111013835	the	the	AT
601953	108643932	21111013836	validation	validation	NN1
601953	108643932	21111013837	of	of	IO
601953	108643932	21111013838	your	your	APPGE
601953	108643932	21111013839	platform	platform	NN1
601953	108643932	21111013840	.	.	.
601953	108643932	21111013841	<p>		NULL
601953	108643932	21111013842	Business	business	NN1
601953	108643932	21111013843	Continuity	continuity	NN1
601953	108643932	21111013844	&amp;		CC
601953	108643932	21111013845	Disaster	disaster	NN1
601953	108643932	21111013846	Recovery	recovery	NN1
601953	108643932	21111013847	Plans	plan	VVZ_NN2
601953	108643932	21111013848	:	:	:
601953	108643932	21111013849	define	define	VV0
601953	108643932	21111013850	these	these	DD2
601953	108643932	21111013851	plans	plan	NN2
601953	108643932	21111013852	.	.	.
601953	108643932	21111013853	<p>		NULL
601953	108643932	21111013854	Security	security	NN1
601953	108643932	21111013855	:	:	:
601953	108643932	21111013856	define	define	VV0
601953	108643932	21111013857	your	your	APPGE
601953	108643932	21111013858	security	security	NN1
601953	108643932	21111013859	measures	measure	NN2
601953	108643932	21111013860	,	,	,
601953	108643932	21111013861	and	and	CC
601953	108643932	21111013862	what	what	DDQ
601953	108643932	21111013863	this	this	DD1
601953	108643932	21111013864	means	mean	VVZ
601953	108643932	21111013865	regarding	regarding	II_VVG
601953	108643932	21111013866	employee	employee	NN1
601953	108643932	21111013867	building	building	NN1
601953	108643932	21111013868	and	and	CC
601953	108643932	21111013869	network	network	NN1
601953	108643932	21111013870	access	access	NN1
601953	108643932	21111013871	.	.	.
601953	108643932	21111013872	Additionally	additionally	RR
601953	108643932	21111013873	,	,	,
601953	108643932	21111013874	address	address	NN1_VV0@
601953	108643932	21111013875	user	user	NN1
601953	108643932	21111013876	access	access	NN1
601953	108643932	21111013877	to	to	II
601953	108643932	21111013878	the	the	AT
601953	108643932	21111013879	system	system	NN1
601953	108643932	21111013880	.	.	.
601953	108643932	21111013881	What	what	DDQ
601953	108643932	21111013882	,	,	,
601953	108643932	21111013883	if	if	CS
601953	108643932	21111013884	any	any	DD
601953	108643932	21111013885	,	,	,
601953	108643932	21111013886	restrictions	restriction	NN2
601953	108643932	21111013887	are	be	VBR
601953	108643932	21111013888	there	there	RL
601953	108643932	21111013889	in	in	II
601953	108643932	21111013890	place	place	NN1
601953	108643932	21111013891	based	base	VVN
601953	108643932	21111013892	on	on	II
601953	108643932	21111013893	user	user	NN1
601953	108643932	21111013894	roles	role	NN2
601953	108643932	21111013895	?	?	?
601953	108643932	21111013896	<p>		NULL
601953	108643932	21111013897	Audit	audit	NN1_VV0@
601953	108643932	21111013898	Trails	trail	NN2_VVZ
601953	108643932	21111013899	and	and	CC
601953	108643932	21111013900	@		II
601953	108643932	21111013901	@		II
601953	108643932	21111013902	@		II
601953	108643932	21111013903	@		II
601953	108643932	21111013904	@		II
601953	108643932	21111013905	@		II
601953	108643932	21111013906	@		II
601953	108643932	21111013907	@		II
601953	108643932	21111013908	@		II
601953	108643932	21111013909	@		II
601953	108643932	21111013910	and	and	CC
601953	108643932	21111013911	the	the	AT
601953	108643932	21111013912	Data	data	NN
601953	108643932	21111013913	Change	change	VV0_NN1
601953	108643932	21111013914	process	process	NN1_VV0
601953	108643932	21111013915	in	in	II
601953	108643932	21111013916	place	place	NN1
601953	108643932	21111013917	.	.	.
601953	108643932	21111013918	<p>		NULL
601953	108643932	21111013919	Change	change	VV0_NN1
601953	108643932	21111013920	Control	control	NN1
601953	108643932	21111013921	Process	process	NN1_VV0
601953	108643932	21111013922	:	:	:
601953	108643932	21111013923	define	define	VV0
601953	108643932	21111013924	this	this	DD1
601953	108643932	21111013925	process	process	NN1
601953	108643932	21111013926	.	.	.
601953	108643932	21111013927	<p>		NULL
601953	108643932	21111013928	Development	development	NN1
601953	108643932	21111013929	of	of	IO
601953	108643932	21111013930	Standards	standard	NN2
601953	108643932	21111013931	:	:	:
601953	108643932	21111013932	if	if	CS
601953	108643932	21111013933	you	you	PPY
601953	108643932	21111013934	are	be	VBR
601953	108643932	21111013935	have	have	VH0
601953	108643932	21111013936	worked	work	VVN
601953	108643932	21111013937	with	with	IW
601953	108643932	21111013938	this	this	DD1
601953	108643932	21111013939	vendor	vendor	NN1
601953	108643932	21111013940	before	before	RT
601953	108643932	21111013941	,	,	,
601953	108643932	21111013942	is	be	VBZ
601953	108643932	21111013943	there	there	RL_EX
601953	108643932	21111013944	a	a	AT1
601953	108643932	21111013945	potential	potential	JJ_NN1
601953	108643932	21111013946	to	to	TO
601953	108643932	21111013947	develop	develop	VVI
601953	108643932	21111013948	standards	standard	NN2
601953	108643932	21111013949	for	for	IF
601953	108643932	21111013950	your	your	APPGE
601953	108643932	21111013951	studies	study	NN2
601953	108643932	21111013952	"	"	"
601953	108643932	21111013953	either	either	RR
601953	108643932	21111013954	on	on	II
601953	108643932	21111013955	a	a	AT1
601953	108643932	21111013956	program	program	NN1
601953	108643932	21111013957	of	of	IO
601953	108643932	21111013958	studies	study	NN2
601953	108643932	21111013959	or	or	CC
601953	108643932	21111013960	across	across	II
601953	108643932	21111013961	all	all	DB
601953	108643932	21111013962	studies	study	NN2
601953	108643932	21111013963	?	?	?
601953	108643932	21111013964	a	a	AT1
601953	108643932	21111013965	.	.	.
601953	108643932	21111013966	How	how	RRQ
601953	108643932	21111013967	would	would	VM
601953	108643932	21111013968	the	the	AT
601953	108643932	21111013969	development	development	NN1
601953	108643932	21111013970	of	of	IO
601953	108643932	21111013971	these	these	DD2
601953	108643932	21111013972	standards	standard	NN2
601953	108643932	21111013973	impact	impact	NN1_VV0%
601953	108643932	21111013974	pricing	pricing	NN1_VVG
601953	108643932	21111013975	,	,	,
601953	108643932	21111013976	timelines	timeline	NN2_VVZ
601953	108643932	21111013977	and	and	CC
601953	108643932	21111013978	quality	quality	NN1
601953	108643932	21111013979	processes	process	NN2_VVZ@
601953	108643932	21111013980	?	?	?
601953	108643932	21111013981	b	b	ZZ1
601953	108643932	21111013982	.	.	.
601953	108643932	21111013983	Define	define	VV0
601953	108643932	21111013984	potential	potential	JJ
601953	108643932	21111013985	efficiencies	efficiency	NN2
601953	108643932	21111013986	linked	link	VVN
601953	108643932	21111013987	to	to	II
601953	108643932	21111013988	volume	volume	NN1
601953	108643932	21111013989	and	and	CC
601953	108643932	21111013990	re-use	reuse	VV0_NN1@
601953	108643932	21111013991	.	.	.
601953	108643932	21111013992	c	c	ZZ1
601953	108643932	21111013993	.	.	.
601953	108643932	21111013994	Define	define	VV0
601953	108643932	21111013995	the	the	AT
601953	108643932	21111013996	Project	project	NN1_NP1@
601953	108643932	21111013997	Lifecycle	life-cycle	NN1_NP1
601953	108643932	21111013998	(	(	(
601953	108643932	21111013999	PLC	plc	NN1
601953	108643932	21111014000	,	,	,
601953	108643932	21111014001	including	including	II_VVG@
601953	108643932	21111014002	design	design	NN1
601953	108643932	21111014003	,	,	,
601953	108643932	21111014004	code	code	NN1
601953	108643932	21111014005	and	and	CC
601953	108643932	21111014006	testing	testing	NN1
601953	108643932	21111014007	of	of	IO
601953	108643932	21111014008	requirements	requirement	NN2
601953	108643932	21111014009	for	for	IF
601953	108643932	21111014010	custom	custom	NN1
601953	108643932	21111014011	and	and	CC
601953	108643932	21111014012	standard	standard	JJ_NN1
601953	108643932	21111014013	functionality	functionality	NN1
601953	108643932	21111014014	)	)	)
601953	108643932	21111014015	.	.	.
601953	108643932	21111014016	<p>		NULL
601953	108643932	21111014017	Whether	whether	CSW
601953	108643932	21111014018	asked	ask	VVN@
601953	108643932	21111014019	of	of	IO
601953	108643932	21111014020	new	new	JJ
601953	108643932	21111014021	IxRS		NN2_NP1
601953	108643932	21111014022	vendors	vendor	NN2
601953	108643932	21111014023	or	or	CC
601953	108643932	21111014024	with	with	IW
601953	108643932	21111014025	familiar	familiar	JJ
601953	108643932	21111014026	vendors	vendor	NN2
601953	108643932	21111014027	,	,	,
601953	108643932	21111014028	this	this	DD1
601953	108643932	21111014029	is	be	VBZ
601953	108643932	21111014030	a	a	AT1
601953	108643932	21111014031	starting	starting	NN1
601953	108643932	21111014032	point	point	NN1
601953	108643932	21111014033	to	to	TO
601953	108643932	21111014034	give	give	VVI
601953	108643932	21111014035	you	you	PPY
601953	108643932	21111014036	context	context	NN1
601953	108643932	21111014037	,	,	,
601953	108643932	21111014038	insight	insight	NN1
601953	108643932	21111014039	and	and	CC
601953	108643932	21111014040	a	a	AT1
601953	108643932	21111014041	general	general	JJ_NN1
601953	108643932	21111014042	feeling	feeling	NN1
601953	108643932	21111014043	of	of	IO
601953	108643932	21111014044	a	a	AT1
601953	108643932	21111014045	vendor	vendor	NN1
601953	108643932	21111014046	,	,	,
601953	108643932	21111014047	which	which	DDQ
601953	108643932	21111014048	"	"	"
601953	108643932	21111014049	along	along	II21
601953	108643932	21111014050	with	with	II22
601953	108643932	21111014051	the	the	AT
601953	108643932	21111014052	pricing	pricing	NN1
601953	108643932	21111014053	and	and	CC
601953	108643932	21111014054	actual	actual	JJ
601953	108643932	21111014055	proposal	proposal	NN1
601953	108643932	21111014056	"	"	"
601953	108643932	21111014057	can	can	VM
601953	108643932	21111014058	help	help	VVI
601953	108643932	21111014059	.	.	.
601953	108643932	21111014060	you	you	PPY
601953	108643932	21111014061	to	to	TO
601953	108643932	21111014062	decide	decide	VVI
601953	108643932	21111014063	if	if	CSW@_CS
601953	108643932	21111014064	the	the	AT
601953	108643932	21111014065	relationship	relationship	NN1
601953	108643932	21111014066	will	will	VM
601953	108643932	21111014067	be	be	VBI
601953	108643932	21111014068	one	one	PN1
601953	108643932	21111014069	that	that	CST_DD1
601953	108643932	21111014070	is	be	VBZ
601953	108643932	21111014071	a	a	AT1
601953	108643932	21111014072	mutual	mutual	JJ
601953	108643932	21111014073	fit	fit	NN1@_JJ
601953	108643932	21111014074	between	between	II
601953	108643932	21111014075	your	your	APPGE
601953	108643932	21111014076	organization	organization	NN1
601953	108643932	21111014077	and	and	CC
601953	108643932	21111014078	the	the	AT
601953	108643932	21111014079	IxRS		NP1_NN2
601953	108643932	21111014080	vendor	vendor	NN1
601953	108643932	21111014081	.	.	.
601953	108643933	21111014101	@@##	----------	----------
601953	108643933	21111014102	@@108643933		FO
601953	108643933	21111014103	@4043933/		JJ_VV0_NN1
601953	108643933	21111014104	<h>		NULL
601953	108643933	21111014105	ISPOR		NN1_NP1
601953	108643933	21111014106	21st	21st	MD
601953	108643933	21111014107	Annual	annual	JJ
601953	108643933	21111014108	International	international	JJ
601953	108643933	21111014109	Meeting	meeting	NN1
601953	108643933	21111014110	<p>		NULL
601953	108643933	21111014111	May	may	NPM1
601953	108643933	21111014112	20	20	MC
601953	108643933	21111014113	,	,	,
601953	108643933	21111014114	2016	2016	MC
601953	108643933	21111014115	<p>		NULL
601953	108643933	21111014116	This	this	DD1
601953	108643933	21111014117	year	year	NNT1
601953	108643933	21111014118	Bracket	bracket	NN1
601953	108643933	21111014119	will	will	VM
601953	108643933	21111014120	be	be	VBI
601953	108643933	21111014121	exhibiting	exhibit	VVG
601953	108643933	21111014122	and	and	CC
601953	108643933	21111014123	presenting	present	VVG
601953	108643933	21111014124	at	at	II
601953	108643933	21111014125	ISPOR		NP1
601953	108643933	21111014126	's	's	GE
601953	108643933	21111014127	21st	21st	MD
601953	108643933	21111014128	Annual	annual	JJ
601953	108643933	21111014129	International	international	JJ
601953	108643933	21111014130	Meeting	meeting	NN1
601953	108643933	21111014131	on	on	II
601953	108643933	21111014132	May	may	NPM1
601953	108643933	21111014133	21	21	MC
601953	108643933	21111014134	"	"	"
601953	108643933	21111014135	25	25	MC
601953	108643933	21111014136	,	,	,
601953	108643933	21111014137	in	in	II
601953	108643933	21111014138	Washington	washington	NP1
601953	108643933	21111014139	,	,	,
601953	108643933	21111014140	DC.		NP1
601953	108643933	21111014141	-	-	-
601953	108643933	21111014142	This	this	DD1
601953	108643933	21111014143	event	event	NN1
601953	108643933	21111014144	will	will	VM
601953	108643933	21111014145	discuss	discuss	VVI
601953	108643933	21111014146	information	information	NN1
601953	108643933	21111014147	surrounding	surround	VVG
601953	108643933	21111014148	the	the	AT
601953	108643933	21111014149	science	science	NN1
601953	108643933	21111014150	of	of	IO
601953	108643933	21111014151	health	health	NN1
601953	108643933	21111014152	economics	economics	NN1
601953	108643933	21111014153	and	and	CC
601953	108643933	21111014154	outcomes	outcome	NN2
601953	108643933	21111014155	research	research	NN1_VV0@
601953	108643933	21111014156	.	.	.
601953	108643933	21111014157	Bracket	bracket	NN1
601953	108643933	21111014158	will	will	VM
601953	108643933	21111014159	be	be	VBI
601953	108643933	21111014160	presenting	present	VVG
601953	108643933	21111014161	new	new	JJ
601953	108643933	21111014162	research-		NN1_JJ
601953	108643933	21111014163	that	that	CST_DD1
601953	108643933	21111014164	focuses	focus	VVZ
601953	108643933	21111014165	on	on	II
601953	108643933	21111014166	user	user	NN1
601953	108643933	21111014167	experience	experience	NN1
601953	108643933	21111014168	design	design	NN1
601953	108643933	21111014169	in	in	II
601953	108643933	21111014170	electronic	electronic	JJ
601953	108643933	21111014171	clinical	clinical	JJ
601953	108643933	21111014172	outcome	outcome	NN1
601953	108643933	21111014173	assessments	assessment	NN2
601953	108643933	21111014174	,	,	,
601953	108643933	21111014175	establishing	establish	VVG
601953	108643933	21111014176	equivalence	equivalence	NN1
601953	108643933	21111014177	of	of	IO
601953	108643933	21111014178	electronic	electronic	JJ
601953	108643933	21111014179	clinician-reported		JJ_NN1
601953	108643933	21111014180	outcome	outcome	NN1
601953	108643933	21111014181	measures	measure	NN2
601953	108643933	21111014182	,	,	,
601953	108643933	21111014183	and	and	CC
601953	108643933	21111014184	utilizing	utilize	VVG
601953	108643933	21111014185	a	a	AT1
601953	108643933	21111014186	BYOD		NN1
601953	108643933	21111014187	mobile	mobile	NN1_JJ
601953	108643933	21111014188	app	app	NN1_VV0
601953	108643933	21111014189	to	to	TO
601953	108643933	21111014190	collect	collect	VVI
601953	108643933	21111014191	patient	patient	JJ_NN1
601953	108643933	21111014192	diaries	diary	NN2
601953	108643933	21111014193	and	and	CC
601953	108643933	21111014194	dosing	dosing	NN1_VVG@
601953	108643933	21111014195	information	information	NN1
601953	108643933	21111014196	in	in	II
601953	108643933	21111014197	a	a	AT1
601953	108643933	21111014198	phase	phase	NN1
601953	108643933	21111014199	II	ii	MC
601953	108643933	21111014200	clinical	clinical	JJ
601953	108643933	21111014201	trial	trial	NN1
601953	108643933	21111014202	.	.	.
601953	108643934	21111014222	@@##	----------	----------
601953	108643934	21111014223	@@108643934		FO
601953	108643934	21111014224	@4043934/		NN1_VV0
601953	108643934	21111014225	<p>		NULL
601953	108643934	21111014226	A	a	AT1_ZZ1
601953	108643934	21111014227	recent	recent	JJ
601953	108643934	21111014228	paper	paper	NN1
601953	108643934	21111014229	published	publish	VVN
601953	108643934	21111014230	in	in	II
601953	108643934	21111014231	Innovations	innovation	NN2
601953	108643934	21111014232	in	in	II
601953	108643934	21111014233	Clinical	clinical	JJ
601953	108643934	21111014234	Neuroscience	neuroscience	NP1_NN1@
601953	108643934	21111014235	examined	examine	VVD
601953	108643934	21111014236	the	the	AT
601953	108643934	21111014237	issues	issue	NN2
601953	108643934	21111014238	surrounding	surround	VVG
601953	108643934	21111014239	the	the	AT
601953	108643934	21111014240	growing	growing	JJ
601953	108643934	21111014241	use	use	NN1
601953	108643934	21111014242	of	of	IO
601953	108643934	21111014243	data	data	NN
601953	108643934	21111014244	quality	quality	NN1
601953	108643934	21111014245	monitoring	monitor	VVG_NN1
601953	108643934	21111014246	in	in	II
601953	108643934	21111014247	CNS	cns	NP1
601953	108643934	21111014248	clinical	clinical	JJ
601953	108643934	21111014249	trials	trial	NN2
601953	108643934	21111014250	.	.	.
601953	108643934	21111014251	Drs	drs	NP1
601953	108643934	21111014252	.	.	.
601953	108643934	21111014253	David	david	NP1
601953	108643934	21111014254	Daniel	daniel	NP1
601953	108643934	21111014255	and	and	CC
601953	108643934	21111014256	Gary	gary	NP1
601953	108643934	21111014257	Sachs	sachs	NP1
601953	108643934	21111014258	from	from	II
601953	108643934	21111014259	Bracket	bracket	NN1
601953	108643934	21111014260	contributed	contribute	VVN_VVD
601953	108643934	21111014261	to	to	II
601953	108643934	21111014262	this	this	DD1
601953	108643934	21111014263	broad	broad	JJ
601953	108643934	21111014264	examination	examination	NN1
601953	108643934	21111014265	of	of	IO
601953	108643934	21111014266	the	the	AT
601953	108643934	21111014267	challenges	challenge	NN2
601953	108643934	21111014268	and	and	CC
601953	108643934	21111014269	benefits	benefit	NN2
601953	108643934	21111014270	of	of	IO
601953	108643934	21111014271	implementing	implement	VVG
601953	108643934	21111014272	this	this	DD1
601953	108643934	21111014273	monitoring	monitoring	NN1
601953	108643934	21111014274	.	.	.
601953	108643934	21111014275	<p>		NULL
601953	108643934	21111014276	The	the	AT
601953	108643934	21111014277	paper	paper	NN1
601953	108643934	21111014278	summarizes	summarize	VVZ
601953	108643934	21111014279	the	the	AT
601953	108643934	21111014280	results	result	NN2
601953	108643934	21111014281	of	of	IO
601953	108643934	21111014282	the	the	AT
601953	108643934	21111014283	CNS	cns	NP1
601953	108643934	21111014284	Summit	summit	NN1
601953	108643934	21111014285	Data	data	NN
601953	108643934	21111014286	Quality	quality	NN1
601953	108643934	21111014287	Monitoring	monitoring	NN1
601953	108643934	21111014288	Workgroup	workgroup	NN1
601953	108643934	21111014289	analysis	analysis	NN1
601953	108643934	21111014290	of	of	IO
601953	108643934	21111014291	current	current	JJ
601953	108643934	21111014292	data	data	NN
601953	108643934	21111014293	quality	quality	NN1
601953	108643934	21111014294	monitoring	monitoring	NN1_VVG
601953	108643934	21111014295	techniques	technique	NN2
601953	108643934	21111014296	used	use	VVN_VVD
601953	108643934	21111014297	in	in	II
601953	108643934	21111014298	central	central	JJ
601953	108643934	21111014299	nervous	nervous	JJ
601953	108643934	21111014300	system	system	NN1
601953	108643934	21111014301	(	(	(
601953	108643934	21111014302	CNS	cns	NP1
601953	108643934	21111014303	)	)	)
601953	108643934	21111014304	clinical	clinical	JJ
601953	108643934	21111014305	trials.		NNU
601953	108643934	21111014306	-	-	-
601953	108643934	21111014307	Based	base	VVN
601953	108643934	21111014308	on	on	II
601953	108643934	21111014309	audience	audience	NN1
601953	108643934	21111014310	polls	poll	NN2
601953	108643934	21111014311	conducted	conduct	VVN_VVD
601953	108643934	21111014312	at	at	II
601953	108643934	21111014313	the	the	AT
601953	108643934	21111014314	CNS	cns	NP1
601953	108643934	21111014315	Summit	summit	NN1
601953	108643934	21111014316	2014	2014	MC
601953	108643934	21111014317	,	,	,
601953	108643934	21111014318	the	the	AT
601953	108643934	21111014319	panel	panel	NN1
601953	108643934	21111014320	determined	determine	VVN_VVD@
601953	108643934	21111014321	that	that	CST_DD1
601953	108643934	21111014322	current	current	JJ
601953	108643934	21111014323	techniques	technique	NN2
601953	108643934	21111014324	used	use	VMK
601953	108643934	21111014325	to	to	TO
601953	108643934	21111014326	monitor	monitor	VVI
601953	108643934	21111014327	data	data	NN
601953	108643934	21111014328	and	and	CC
601953	108643934	21111014329	quality	quality	NN1
601953	108643934	21111014330	in	in	II
601953	108643934	21111014331	clinical	clinical	JJ
601953	108643934	21111014332	trials	trial	NN2
601953	108643934	21111014333	are	be	VBR
601953	108643934	21111014334	broad	broad	JJ
601953	108643934	21111014335	,	,	,
601953	108643934	21111014336	uncontrolled	uncontrolled	JJ
601953	108643934	21111014337	,	,	,
601953	108643934	21111014338	and	and	CC
601953	108643934	21111014339	lack	lack	VV0@_NN1
601953	108643934	21111014340	independent	independent	JJ
601953	108643934	21111014341	verification	verification	NN1
601953	108643934	21111014342	.	.	.
601953	108643934	21111014343	The	the	AT
601953	108643934	21111014344	majority	majority	NN1
601953	108643934	21111014345	of	of	IO
601953	108643934	21111014346	those	those	DD2
601953	108643934	21111014347	polled	poll	VVN
601953	108643934	21111014348	endorse	endorse	VV0
601953	108643934	21111014349	the	the	AT
601953	108643934	21111014350	value	value	NN1
601953	108643934	21111014351	of	of	IO
601953	108643934	21111014352	monitoring	monitor	VVG_NN1
601953	108643934	21111014353	data	data	NN
601953	108643934	21111014354	.	.	.
601953	108643934	21111014355	<p>		NULL
601953	108643934	21111014356	In	in	II
601953	108643934	21111014357	a	a	AT1
601953	108643934	21111014358	pre-competitive	precompetitive	JJ
601953	108643934	21111014359	session	session	NNT1
601953	108643934	21111014360	among	among	II
601953	108643934	21111014361	pharmaceutical	pharmaceutical	JJ
601953	108643934	21111014362	companies	company	NN2
601953	108643934	21111014363	,	,	,
601953	108643934	21111014364	clinical	clinical	JJ
601953	108643934	21111014365	service	service	NN1
601953	108643934	21111014366	companies	company	NN2
601953	108643934	21111014367	,	,	,
601953	108643934	21111014368	and	and	CC
601953	108643934	21111014369	clinical	clinical	JJ
601953	108643934	21111014370	trial	trial	NN1
601953	108643934	21111014371	sites	site	NN2
601953	108643934	21111014372	,	,	,
601953	108643934	21111014373	there	there	EX
601953	108643934	21111014374	was	be	VBDZ
601953	108643934	21111014375	an	a	AT1
601953	108643934	21111014376	overall	overall	JJ_RR
601953	108643934	21111014377	strong	strong	JJ
601953	108643934	21111014378	consensus	consensus	NN1
601953	108643934	21111014379	that	that	CST
601953	108643934	21111014380	data	data	NN
601953	108643934	21111014381	quality	quality	NN1
601953	108643934	21111014382	monitoring	monitoring	NN1_VVG
601953	108643934	21111014383	and	and	CC
601953	108643934	21111014384	remediation	remediation	NN1
601953	108643934	21111014385	has	have	VHZ
601953	108643934	21111014386	large	large	JJ
601953	108643934	21111014387	positive	positive	JJ
601953	108643934	21111014388	effects	effect	NN2
601953	108643934	21111014389	on	on	II
601953	108643934	21111014390	signal	signal	NN1
601953	108643934	21111014391	detection	detection	NN1
601953	108643934	21111014392	in	in	II
601953	108643934	21111014393	CNS	cns	NP1
601953	108643934	21111014394	trials	trial	NN2
601953	108643934	21111014395	.	.	.
601953	108643934	21111014396	<p>		NULL
601953	108643934	21111014397	The	the	AT
601953	108643934	21111014398	authors	author	NN2
601953	108643934	21111014399	also	also	RR
601953	108643934	21111014400	examined	examine	VVN_VVD
601953	108643934	21111014401	how	how	RRQ
601953	108643934	21111014402	this	this	DD1
601953	108643934	21111014403	data	data	NN
601953	108643934	21111014404	quality	quality	NN1
601953	108643934	21111014405	monitoring	monitoring	NN1
601953	108643934	21111014406	will	will	VM
601953	108643934	21111014407	evolve	evolve	VVI
601953	108643934	21111014408	in	in	II
601953	108643934	21111014409	the	the	AT
601953	108643934	21111014410	future	future	NN1_JJ
601953	108643934	21111014411	.	.	.
601953	108643934	21111014412	Increased	increased	JJ
601953	108643934	21111014413	utilization	utilization	NN1
601953	108643934	21111014414	@		II
601953	108643934	21111014415	@		II
601953	108643934	21111014416	@		II
601953	108643934	21111014417	@		II
601953	108643934	21111014418	@		II
601953	108643934	21111014419	@		II
601953	108643934	21111014420	@		II
601953	108643934	21111014421	@		II
601953	108643934	21111014422	@		II
601953	108643934	21111014423	@		II
601953	108643934	21111014424	be	be	VBI
601953	108643934	21111014425	used	use	VVN
601953	108643934	21111014426	as	as	CSA_RG@_II@
601953	108643934	21111014427	patient	patient	JJ
601953	108643934	21111014428	selection	selection	NN1
601953	108643934	21111014429	and	and	CC
601953	108643934	21111014430	outcomes	outcome	NN2
601953	108643934	21111014431	measures	measure	NN2_VVZ@
601953	108643934	21111014432	,	,	,
601953	108643934	21111014433	but	but	CCB
601953	108643934	21111014434	will	will	VM
601953	108643934	21111014435	require	require	VVI
601953	108643934	21111014436	careful	careful	JJ
601953	108643934	21111014437	validation	validation	NN1
601953	108643934	21111014438	against	against	II
601953	108643934	21111014439	current	current	JJ
601953	108643934	21111014440	measures	measure	NN2
601953	108643934	21111014441	.	.	.
601953	108643934	21111014442	<p>		NULL
601953	108643934	21111014443	Although	although	CS
601953	108643934	21111014444	,	,	,
601953	108643934	21111014445	there	there	EX
601953	108643934	21111014446	were	be	VBDR
601953	108643934	21111014447	a	a	AT1
601953	108643934	21111014448	number	number	NN1
601953	108643934	21111014449	of	of	IO
601953	108643934	21111014450	suggested	suggested	JJ@
601953	108643934	21111014451	new	new	JJ
601953	108643934	21111014452	approaches	approach	NN2
601953	108643934	21111014453	,	,	,
601953	108643934	21111014454	the	the	AT
601953	108643934	21111014455	creation	creation	NN1
601953	108643934	21111014456	of	of	IO
601953	108643934	21111014457	data	data	NN
601953	108643934	21111014458	banks	bank	NN2
601953	108643934	21111014459	of	of	IO
601953	108643934	21111014460	rater	rater	NN1
601953	108643934	21111014461	experience	experience	NN1
601953	108643934	21111014462	,	,	,
601953	108643934	21111014463	credentials	credential	NN2
601953	108643934	21111014464	,	,	,
601953	108643934	21111014465	and	and	CC
601953	108643934	21111014466	performance	performance	NN1
601953	108643934	21111014467	was	be	VBDZ
601953	108643934	21111014468	agreed	agree	VVN
601953	108643934	21111014469	upon	upon	II
601953	108643934	21111014470	as	as	RG@
601953	108643934	21111014471	high	high	JJ
601953	108643934	21111014472	priority	priority	NN1
601953	108643934	21111014473	achievable	achievable	JJ
601953	108643934	21111014474	pre-competitive	precompetitive	JJ
601953	108643934	21111014475	objectives	objective	NN2
601953	108643934	21111014476	.	.	.
601953	108643934	21111014477	Bracket	bracket	NN1
601953	108643934	21111014478	has	have	VHZ
601953	108643934	21111014479	been	be	VBN
601953	108643934	21111014480	a	a	AT1
601953	108643934	21111014481	leader	leader	NN1
601953	108643934	21111014482	in	in	II
601953	108643934	21111014483	this	this	DD1
601953	108643934	21111014484	area	area	NN1
601953	108643934	21111014485	,	,	,
601953	108643934	21111014486	both	both	RR_DB2
601953	108643934	21111014487	through	through	II
601953	108643934	21111014488	our	our	APPGE
601953	108643934	21111014489	own	own	DA
601953	108643934	21111014490	extensive	extensive	JJ
601953	108643934	21111014491	proprietary	proprietary	JJ
601953	108643934	21111014492	database	database	NN1
601953	108643934	21111014493	of	of	IO
601953	108643934	21111014494	investigator	investigator	NN1
601953	108643934	21111014495	and	and	CC
601953	108643934	21111014496	rater	rater	NN1
601953	108643934	21111014497	experience	experience	NN1_VV0
601953	108643934	21111014498	in	in	II
601953	108643934	21111014499	clinical	clinical	JJ
601953	108643934	21111014500	trials	trial	NN2
601953	108643934	21111014501	,	,	,
601953	108643934	21111014502	but	but	CCB
601953	108643934	21111014503	through	through	II
601953	108643934	21111014504	our	our	APPGE
601953	108643934	21111014505	support	support	NN1
601953	108643934	21111014506	of	of	IO
601953	108643934	21111014507	the	the	AT
601953	108643934	21111014508	CNS	cns	NP1
601953	108643934	21111014509	Summit	summit	NN1
601953	108643934	21111014510	Global	global	JJ
601953	108643934	21111014511	Rater		NP1_NN1%
601953	108643934	21111014512	Certificate	certificate	NN1
601953	108643934	21111014513	Database	database	NN1
601953	108643934	21111014514	.	.	.
601953	108643935	21111014534	@@##	----------	----------
601953	108643935	21111014535	@@108643935		FO
601953	108643935	21111014536	@4043935/		JJ_NN1_VV0
601953	108643935	21111014537	<h>		NULL
601953	108643935	21111014538	Bracket	bracket	NN1
601953	108643935	21111014539	Announces	announce	VVZ
601953	108643935	21111014540	Launch	launch	NN1
601953	108643935	21111014541	of	of	IO
601953	108643935	21111014542	Cloud-Based		JJ_NN1
601953	108643935	21111014543	Version	version	NN1
601953	108643935	21111014544	of	of	IO
601953	108643935	21111014545	SmartSupplies		NP1
601953	108643935	21111014546	<p>		NULL
601953	108643935	21111014547	May	may	NPM1
601953	108643935	21111014548	18	18	MC
601953	108643935	21111014549	,	,	,
601953	108643935	21111014550	2017	2017	MC
601953	108643935	21111014551	<p>		NULL
601953	108643935	21111014552	Wayne	wayne	NP1
601953	108643935	21111014553	,	,	,
601953	108643935	21111014554	Pa	pa	NP1
601953	108643935	21111014555	-	-	-
601953	108643935	21111014556	Bracket	bracket	NN1_VV0@
601953	108643935	21111014557	,	,	,
601953	108643935	21111014558	a	a	AT1
601953	108643935	21111014559	leading	leading	JJ
601953	108643935	21111014560	clinical	clinical	JJ
601953	108643935	21111014561	trial	trial	NN1
601953	108643935	21111014562	technology	technology	NN1
601953	108643935	21111014563	and	and	CC
601953	108643935	21111014564	specialty	specialty	NN1
601953	108643935	21111014565	services	service	NN2
601953	108643935	21111014566	provider	provider	NN1
601953	108643935	21111014567	,	,	,
601953	108643935	21111014568	today	today	RT
601953	108643935	21111014569	announced	announce	VVD_VVN
601953	108643935	21111014570	the	the	AT
601953	108643935	21111014571	launch	launch	NN1
601953	108643935	21111014572	of	of	IO
601953	108643935	21111014573	a	a	AT1
601953	108643935	21111014574	cloud-based		JJ_NN1
601953	108643935	21111014575	service	service	NN1
601953	108643935	21111014576	for	for	IF
601953	108643935	21111014577	SmartSupplies		NP1
601953	108643935	21111014578	,	,	,
601953	108643935	21111014579	its	its	APPGE
601953	108643935	21111014580	clinical	clinical	JJ
601953	108643935	21111014581	trial	trial	NN1
601953	108643935	21111014582	inventory	inventory	NN1
601953	108643935	21111014583	management	management	NN1
601953	108643935	21111014584	software	software	NN1
601953	108643935	21111014585	suite	suite	NN1
601953	108643935	21111014586	.	.	.
601953	108643935	21111014587	This	this	DD1
601953	108643935	21111014588	launch	launch	NN1
601953	108643935	21111014589	marks	mark	VVZ@_NN2
601953	108643935	21111014590	the	the	AT
601953	108643935	21111014591	first	first	MD
601953	108643935	21111014592	hosted	host	VVD_VVN
601953	108643935	21111014593	solution	solution	NN1
601953	108643935	21111014594	of	of	IO
601953	108643935	21111014595	SmartSupplies		NP1
601953	108643935	21111014596	since	since	CS_II@_RR@
601953	108643935	21111014597	Brackets	bracket	NN2_VVZ@
601953	108643935	21111014598	acquisition	acquisition	NN1
601953	108643935	21111014599	of	of	IO
601953	108643935	21111014600	CLINapps		NN2_NP1
601953	108643935	21111014601	in	in	II
601953	108643935	21111014602	2016	2016	MC
601953	108643935	21111014603	and	and	CC
601953	108643935	21111014604	is	be	VBZ
601953	108643935	21111014605	applicable	applicable	JJ
601953	108643935	21111014606	to	to	II
601953	108643935	21111014607	all	all	DB
601953	108643935	21111014608	modules	module	NN2
601953	108643935	21111014609	of	of	IO
601953	108643935	21111014610	the	the	AT
601953	108643935	21111014611	SmartSupplies		NP1
601953	108643935	21111014612	suite	suite	NN1
601953	108643935	21111014613	.	.	.
601953	108643935	21111014614	<p>		NULL
601953	108643935	21111014615	SmartSupplies		NP1
601953	108643935	21111014616	,	,	,
601953	108643935	21111014617	an	a	AT1
601953	108643935	21111014618	enterprise	enterprise	NN1
601953	108643935	21111014619	clinical	clinical	JJ
601953	108643935	21111014620	trial	trial	NN1
601953	108643935	21111014621	material	material	NN1
601953	108643935	21111014622	management	management	NN1
601953	108643935	21111014623	software	software	NN1
601953	108643935	21111014624	solution	solution	NN1
601953	108643935	21111014625	,	,	,
601953	108643935	21111014626	provides	provide	VVZ
601953	108643935	21111014627	end-to-end	end-to-end	JJ
601953	108643935	21111014628	clinical	clinical	JJ
601953	108643935	21111014629	inventory	inventory	NN1
601953	108643935	21111014630	management	management	NN1
601953	108643935	21111014631	for	for	IF
601953	108643935	21111014632	sponsors	sponsor	NN2
601953	108643935	21111014633	.	.	.
601953	108643935	21111014634	The	the	AT
601953	108643935	21111014635	release	release	NN1
601953	108643935	21111014636	of	of	IO
601953	108643935	21111014637	the	the	AT
601953	108643935	21111014638	cloud-based		JJ_NN1
601953	108643935	21111014639	offering	offering	NN1
601953	108643935	21111014640	will	will	VM
601953	108643935	21111014641	enable	enable	VVI
601953	108643935	21111014642	companies	company	NN2
601953	108643935	21111014643	without	without	IW
601953	108643935	21111014644	their	their	APPGE
601953	108643935	21111014645	own	own	DA
601953	108643935	21111014646	IT	it	NN1
601953	108643935	21111014647	infrastructure	infrastructure	NN1
601953	108643935	21111014648	and	and	CC
601953	108643935	21111014649	servers	server	NN2
601953	108643935	21111014650	to	to	II_TO
601953	108643935	21111014651	easily	easily	RR
601953	108643935	21111014652	and	and	CC
601953	108643935	21111014653	securely	securely	RR
601953	108643935	21111014654	run	run	VVN_VV0
601953	108643935	21111014655	and	and	CC
601953	108643935	21111014656	manage	manage	VV0
601953	108643935	21111014657	the	the	AT
601953	108643935	21111014658	application	application	NN1
601953	108643935	21111014659	.	.	.
601953	108643935	21111014660	Built	build	VVN_VVD
601953	108643935	21111014661	atop	atop	II
601953	108643935	21111014662	Oracle	oracle	NN1
601953	108643935	21111014663	Cloud	cloud	NN1
601953	108643935	21111014664	Services	service	NN2
601953	108643935	21111014665	,	,	,
601953	108643935	21111014666	the	the	AT
601953	108643935	21111014667	cloud-hosted		JJ_NN1
601953	108643935	21111014668	solution	solution	NN1
601953	108643935	21111014669	will	will	VM
601953	108643935	21111014670	facilitate	facilitate	VVI
601953	108643935	21111014671	enhanced	enhanced	JJ
601953	108643935	21111014672	integration	integration	NN1
601953	108643935	21111014673	with	with	IW
601953	108643935	21111014674	other	other	JJ
601953	108643935	21111014675	eClinical		JJ
601953	108643935	21111014676	systems	system	NN2
601953	108643935	21111014677	as	as	II31
601953	108643935	21111014678	well	well	II32
601953	108643935	21111014679	as	as	II33
601953	108643935	21111014680	allow	allow	VV0
601953	108643935	21111014681	end	end	NN1_VV0
601953	108643935	21111014682	users	user	NN2
601953	108643935	21111014683	and	and	CC
601953	108643935	21111014684	clinical	clinical	JJ
601953	108643935	21111014685	research	research	NN1
601953	108643935	21111014686	associates	associate	NN2
601953	108643935	21111014687	(	(	(
601953	108643935	21111014688	CRAs		NP2_NN2
601953	108643935	21111014689	)	)	)
601953	108643935	21111014690	to	to	TO
601953	108643935	21111014691	share	share	VVI
601953	108643935	21111014692	data	data	NN
601953	108643935	21111014693	seamlessly	seamlessly	RR
601953	108643935	21111014694	and	and	CC
601953	108643935	21111014695	instantaneously	instantaneously	RR
601953	108643935	21111014696	without	without	IW
601953	108643935	21111014697	geographic	geographic	JJ
601953	108643935	21111014698	constraints	constraint	NN2
601953	108643935	21111014699	.	.	.
601953	108643935	21111014700	<p>		NULL
601953	108643935	21111014701	"	"	"
601953	108643935	21111014702	We	we	PPIS2
601953	108643935	21111014703	are	be	VBR
601953	108643935	21111014704	pleased	pleased	JJ
601953	108643935	21111014705	to	to	TO
601953	108643935	21111014706	introduce	introduce	VVI
601953	108643935	21111014707	a	a	AT1
601953	108643935	21111014708	cloud-based		NN1_JJ
601953	108643935	21111014709	hosting	host	VVG_JJ%_NN1%
601953	108643935	21111014710	option	option	NN1
601953	108643935	21111014711	for	for	IF
601953	108643935	21111014712	SmartSupplies		NP1
601953	108643935	21111014713	to	to	II
601953	108643935	21111014714	our	our	APPGE
601953	108643935	21111014715	existing	existing	JJ
601953	108643935	21111014716	and	and	CC
601953	108643935	21111014717	new	new	JJ
601953	108643935	21111014718	customers	customer	NN2
601953	108643935	21111014719	,	,	,
601953	108643935	21111014720	"	"	"
601953	108643935	21111014721	said	say	VVD
601953	108643935	21111014722	Jeff	jeff	NP1
601953	108643935	21111014723	Kinell		NP1
601953	108643935	21111014724	,	,	,
601953	108643935	21111014725	CEO	ceo	NN1
601953	108643935	21111014726	@		II
601953	108643935	21111014727	@		II
601953	108643935	21111014728	@		II
601953	108643935	21111014729	@		II
601953	108643935	21111014730	@		II
601953	108643935	21111014731	@		II
601953	108643935	21111014732	@		II
601953	108643935	21111014733	@		II
601953	108643935	21111014734	@		II
601953	108643935	21111014735	@		II
601953	108643935	21111014736	to	to	TO
601953	108643935	21111014737	present	present	VVI
601953	108643935	21111014738	themselves	themselves	PPX2
601953	108643935	21111014739	,	,	,
601953	108643935	21111014740	especially	especially	RR
601953	108643935	21111014741	as	as	CSA_RG@
601953	108643935	21111014742	clinical	clinical	JJ
601953	108643935	21111014743	trials	trial	NN2
601953	108643935	21111014744	worldwide	worldwide	RL
601953	108643935	21111014745	rely	rely	VV0
601953	108643935	21111014746	more	more	RRR_DAR
601953	108643935	21111014747	on	on	II
601953	108643935	21111014748	immediate	immediate	JJ
601953	108643935	21111014749	collaboration	collaboration	NN1
601953	108643935	21111014750	across	across	II
601953	108643935	21111014751	sites	site	NN2
601953	108643935	21111014752	.	.	.
601953	108643935	21111014753	"	"	"
601953	108643935	21111014754	<p>		NULL
601953	108643935	21111014755	Enabling	enable	VVG_JJ@
601953	108643935	21111014756	proactive	proactive	JJ
601953	108643935	21111014757	support	support	NN1
601953	108643935	21111014758	and	and	CC
601953	108643935	21111014759	system	system	NN1
601953	108643935	21111014760	health-checks		NN2
601953	108643935	21111014761	from	from	II
601953	108643935	21111014762	Brackets	bracket	NN2
601953	108643935	21111014763	support	support	VV0
601953	108643935	21111014764	team	team	NN1
601953	108643935	21111014765	;	;	;
601953	108643935	21111014766	<p>		NULL
601953	108643935	21111014767	Facilitating	facilitate	VVG
601953	108643935	21111014768	better	better	JJR
601953	108643935	21111014769	integration	integration	NN1
601953	108643935	21111014770	with	with	IW
601953	108643935	21111014771	other	other	JJ
601953	108643935	21111014772	eClinical		JJ
601953	108643935	21111014773	systems	system	NN2
601953	108643935	21111014774	and	and	CC
601953	108643935	21111014775	collaboration	collaboration	NN1
601953	108643935	21111014776	across	across	II
601953	108643935	21111014777	sites	site	NN2
601953	108643935	21111014778	;	;	;
601953	108643935	21111014779	and	and	CC
601953	108643935	21111014780	<p>		NULL
601953	108643935	21111014781	Ensuring	ensure	VVG
601953	108643935	21111014782	a	a	AT1
601953	108643935	21111014783	well-maintained	well-maintained	JJ
601953	108643935	21111014784	regulatory	regulatory	JJ
601953	108643935	21111014785	environment	environment	NN1
601953	108643935	21111014786	and	and	CC
601953	108643935	21111014787	robust	robust	JJ
601953	108643935	21111014788	business	business	NN1
601953	108643935	21111014789	continuity	continuity	NN1
601953	108643935	21111014790	.	.	.
601953	108643935	21111014791	<p>		NULL
601953	108643935	21111014792	The	the	AT
601953	108643935	21111014793	transition	transition	NN1
601953	108643935	21111014794	of	of	IO
601953	108643935	21111014795	SmartSupplies		NP1
601953	108643935	21111014796	to	to	II
601953	108643935	21111014797	the	the	AT
601953	108643935	21111014798	cloud	cloud	NN1
601953	108643935	21111014799	is	be	VBZ
601953	108643935	21111014800	seamless	seamless	JJ
601953	108643935	21111014801	for	for	IF
601953	108643935	21111014802	existing	existing	JJ
601953	108643935	21111014803	customers	customer	NN2
601953	108643935	21111014804	,	,	,
601953	108643935	21111014805	causing	cause	VVG
601953	108643935	21111014806	no	no	AT
601953	108643935	21111014807	disruption	disruption	NN1
601953	108643935	21111014808	to	to	II
601953	108643935	21111014809	the	the	AT
601953	108643935	21111014810	end	end	NN1
601953	108643935	21111014811	user	user	NN1
601953	108643935	21111014812	.	.	.
601953	108643935	21111014813	<p>		NULL
601953	108643935	21111014814	"	"	"
601953	108643935	21111014815	Offering	offer	VVG_NN1
601953	108643935	21111014816	customers	customer	NN2
601953	108643935	21111014817	the	the	AT
601953	108643935	21111014818	option	option	NN1
601953	108643935	21111014819	of	of	IO
601953	108643935	21111014820	cloud	cloud	NN1
601953	108643935	21111014821	hosting	host	VVG
601953	108643935	21111014822	for	for	IF
601953	108643935	21111014823	SmartSupplies		NP1
601953	108643935	21111014824	was	be	VBDZ
601953	108643935	21111014825	born	born	VVN
601953	108643935	21111014826	out	out	II21
601953	108643935	21111014827	of	of	II22
601953	108643935	21111014828	necessity	necessity	NN1
601953	108643935	21111014829	,	,	,
601953	108643935	21111014830	"	"	"
601953	108643935	21111014831	said	say	VVD
601953	108643935	21111014832	Kinell		NP1
601953	108643935	21111014833	.	.	.
601953	108643935	21111014834	"	"	"
601953	108643935	21111014835	We	we	PPIS2
601953	108643935	21111014836	want	want	VV0
601953	108643935	21111014837	sponsors	sponsor	NN2
601953	108643935	21111014838	to	to	TO
601953	108643935	21111014839	focus	focus	VVI
601953	108643935	21111014840	their	their	APPGE
601953	108643935	21111014841	energy	energy	NN1
601953	108643935	21111014842	and	and	CC
601953	108643935	21111014843	efforts	effort	NN2
601953	108643935	21111014844	on	on	II
601953	108643935	21111014845	running	run	VVG_JJ
601953	108643935	21111014846	clinical	clinical	JJ
601953	108643935	21111014847	trials	trial	NN2
601953	108643935	21111014848	,	,	,
601953	108643935	21111014849	not	not	XX
601953	108643935	21111014850	on	on	II
601953	108643935	21111014851	managing	manage	VVG
601953	108643935	21111014852	their	their	APPGE
601953	108643935	21111014853	IT	it	NN1
601953	108643935	21111014854	infrastructure	infrastructure	NN1
601953	108643935	21111014855	"	"	"
601953	108643935	21111014856	and	and	CC
601953	108643935	21111014857	hosting	host	VVG
601953	108643935	21111014858	SmartSupplies		NP1
601953	108643935	21111014859	in	in	II
601953	108643935	21111014860	the	the	AT
601953	108643935	21111014861	cloud	cloud	NN1
601953	108643935	21111014862	will	will	VM
601953	108643935	21111014863	alleviate	alleviate	VVI
601953	108643935	21111014864	that	that	DD1
601953	108643935	21111014865	burden	burden	NN1
601953	108643935	21111014866	.	.	.
601953	108643935	21111014867	"	"	"
601953	108643935	21111014868	<p>		NULL
601953	108643935	21111014869	About	about	II
601953	108643935	21111014870	BracketBracket		NP1_NN1
601953	108643935	21111014871	,	,	,
601953	108643935	21111014872	with	with	IW
601953	108643935	21111014873	nine	nine	MC
601953	108643935	21111014874	offices	office	NN2
601953	108643935	21111014875	and	and	CC
601953	108643935	21111014876	more	more	DAR
601953	108643935	21111014877	than	than	CSN
601953	108643935	21111014878	700	700	MC
601953	108643935	21111014879	employees	employee	NN2
601953	108643935	21111014880	worldwide	worldwide	RL
601953	108643935	21111014881	,	,	,
601953	108643935	21111014882	is	be	VBZ
601953	108643935	21111014883	a	a	AT1
601953	108643935	21111014884	clinical	clinical	JJ
601953	108643935	21111014885	trial	trial	NN1
601953	108643935	21111014886	technology	technology	NN1
601953	108643935	21111014887	and	and	CC
601953	108643935	21111014888	specialty	specialty	NN1
601953	108643935	21111014889	services	service	NN2
601953	108643935	21111014890	provider	provider	NN1
601953	108643935	21111014891	dedicated	dedicate	VVN_VVD
601953	108643935	21111014892	to	to	II
601953	108643935	21111014893	helping	help	VVG
601953	108643935	21111014894	biopharmaceutical	biopharmaceutical	JJ
601953	108643935	21111014895	sponsors	sponsor	NN2
601953	108643935	21111014896	and	and	CC
601953	108643935	21111014897	contract	contract	NN1
601953	108643935	21111014898	research	research	NN1
601953	108643935	21111014899	organizations	organization	NN2
601953	108643935	21111014900	increase	increase	VV0
601953	108643935	21111014901	the	the	AT
601953	108643935	21111014902	power	power	NN1
601953	108643935	21111014903	of	of	IO
601953	108643935	21111014904	their	their	APPGE
601953	108643935	21111014905	clinical	clinical	JJ
601953	108643935	21111014906	research	research	NN1
601953	108643935	21111014907	data	data	NN
601953	108643935	21111014908	by	by	II
601953	108643935	21111014909	leveraging	leverage	VVG_JJ@
601953	108643935	21111014910	core	core	NN1
601953	108643935	21111014911	competencies	competency	NN2
601953	108643935	21111014912	in	in	II
601953	108643935	21111014913	Science	science	NN1
601953	108643935	21111014914	,	,	,
601953	108643935	21111014915	Technology	technology	NN1
601953	108643935	21111014916	,	,	,
601953	108643935	21111014917	and	and	CC
601953	108643935	21111014918	Service	service	NN1
601953	108643935	21111014919	.	.	.
601953	108643935	21111014920	Bracket	bracket	NN1_VV0@
601953	108643935	21111014921	eCOAG		NN1
601953	108643935	21111014922	is	be	VBZ
601953	108643935	21111014923	a	a	AT1
601953	108643935	21111014924	flexible	flexible	JJ
601953	108643935	21111014925	platform	platform	NN1
601953	108643935	21111014926	@		II
601953	108643935	21111014927	@		II
601953	108643935	21111014928	@		II
601953	108643935	21111014929	@		II
601953	108643935	21111014930	@		II
601953	108643935	21111014931	@		II
601953	108643935	21111014932	@		II
601953	108643935	21111014933	@		II
601953	108643935	21111014934	@		II
601953	108643935	21111014935	@		II
601953	108643935	21111014936	best-in-breed		NN1_JJ
601953	108643935	21111014937	,	,	,
601953	108643935	21111014938	scalable	scalable	JJ
601953	108643935	21111014939	and	and	CC
601953	108643935	21111014940	configurable	configurable	JJ
601953	108643935	21111014941	clinical	clinical	JJ
601953	108643935	21111014942	IRT	irt	NN1
601953	108643935	21111014943	solution	solution	NN1
601953	108643935	21111014944	for	for	IF
601953	108643935	21111014945	the	the	AT
601953	108643935	21111014946	life	life	NN1
601953	108643935	21111014947	sciences	science	NN2
601953	108643935	21111014948	industry	industry	NN1
601953	108643935	21111014949	.	.	.
601953	108643935	21111014950	Bracket	bracket	NN1_VV0@
601953	108643935	21111014951	SmartSuppliesG		NN1_NP1
601953	108643935	21111014952	is	be	VBZ
601953	108643935	21111014953	a	a	AT1
601953	108643935	21111014954	proven	proven	JJ
601953	108643935	21111014955	platform	platform	NN1
601953	108643935	21111014956	for	for	IF
601953	108643935	21111014957	improving	improve	VVG
601953	108643935	21111014958	a	a	AT1
601953	108643935	21111014959	clinical	clinical	JJ
601953	108643935	21111014960	supply	supply	NN1
601953	108643935	21111014961	chain	chain	NN1
601953	108643935	21111014962	.	.	.
601953	108643935	21111014963	Bracket	bracket	VV0@_NN1
601953	108643935	21111014964	Rater	rater	NP1
601953	108643935	21111014965	Training	training	NN1
601953	108643935	21111014966	and	and	CC
601953	108643935	21111014967	Quality	quality	NN1
601953	108643935	21111014968	Assurance	assurance	NN1
601953	108643935	21111014969	improve	improve	VV0
601953	108643935	21111014970	outcomes	outcome	NN2
601953	108643935	21111014971	through	through	II
601953	108643935	21111014972	customized	customized	JJ@
601953	108643935	21111014973	training	training	NN1
601953	108643935	21111014974	and	and	CC
601953	108643935	21111014975	quality	quality	NN1
601953	108643935	21111014976	assurance	assurance	NN1
601953	108643935	21111014977	programs	program	NN2
601953	108643935	21111014978	.	.	.
601953	108643937	21111014998	@@##	----------	----------
601953	108643937	21111014999	@@108643937		FO
601953	108643937	21111015000	@4043937/		NN1_VV0
601953	108643937	21111015001	<p>		NULL
601953	108643937	21111015002	The	the	AT
601953	108643937	21111015003	Vineland-II		MC
601953	108643937	21111015004	is	be	VBZ
601953	108643937	21111015005	a	a	AT1
601953	108643937	21111015006	complicated	complicated	JJ
601953	108643937	21111015007	assessment	assessment	NN1
601953	108643937	21111015008	that	that	CST_DD1
601953	108643937	21111015009	can	can	VM
601953	108643937	21111015010	be	be	VBI
601953	108643937	21111015011	difficult	difficult	JJ
601953	108643937	21111015012	for	for	IF
601953	108643937	21111015013	clinicians	clinician	NN2
601953	108643937	21111015014	to	to	TO
601953	108643937	21111015015	administer	administer	VVI
601953	108643937	21111015016	in	in	II_RP@
601953	108643937	21111015017	clinical	clinical	JJ
601953	108643937	21111015018	research	research	NN1
601953	108643937	21111015019	settings	setting	NN2
601953	108643937	21111015020	.	.	.
601953	108643937	21111015021	Utilized	utilize	VVN_VVD
601953	108643937	21111015022	nationwide	nationwide	RL
601953	108643937	21111015023	,	,	,
601953	108643937	21111015024	this	this	DD1
601953	108643937	21111015025	tool	tool	NN1
601953	108643937	21111015026	measures	measure	NN2_VVZ@
601953	108643937	21111015027	communication	communication	NN1
601953	108643937	21111015028	,	,	,
601953	108643937	21111015029	socialization	socialization	NN1
601953	108643937	21111015030	,	,	,
601953	108643937	21111015031	daily	daily	JJ_RR
601953	108643937	21111015032	living	living	NN1_JJ_VVG
601953	108643937	21111015033	and	and	CC
601953	108643937	21111015034	motor	motor	NN1_VV0@
601953	108643937	21111015035	skills	skill	NN2
601953	108643937	21111015036	and	and	CC
601953	108643937	21111015037	maladaptive	maladaptive	JJ
601953	108643937	21111015038	behavior	behavior	NN1
601953	108643937	21111015039	in	in	II
601953	108643937	21111015040	individuals	individual	NN2
601953	108643937	21111015041	from	from	II
601953	108643937	21111015042	birth	birth	NN1
601953	108643937	21111015043	to	to	II
601953	108643937	21111015044	adulthood	adulthood	NN1
601953	108643937	21111015045	.	.	.
601953	108643937	21111015046	Traditionally	traditionally	RR
601953	108643937	21111015047	,	,	,
601953	108643937	21111015048	the	the	AT
601953	108643937	21111015049	Vineland-II		MC
601953	108643937	21111015050	has	have	VHZ
601953	108643937	21111015051	been	be	VBN
601953	108643937	21111015052	administered	administer	VVN
601953	108643937	21111015053	in	in	II
601953	108643937	21111015054	a	a	AT1
601953	108643937	21111015055	semi-structured	semi-structured	JJ
601953	108643937	21111015056	interview	interview	NN1
601953	108643937	21111015057	,	,	,
601953	108643937	21111015058	via	via	II
601953	108643937	21111015059	paper-and-pencil	paper-and-pencil	NN1_JJ
601953	108643937	21111015060	,	,	,
601953	108643937	21111015061	in	in	II
601953	108643937	21111015062	the	the	AT
601953	108643937	21111015063	form	form	NN1
601953	108643937	21111015064	of	of	IO
601953	108643937	21111015065	a	a	AT1
601953	108643937	21111015066	questionnaire	questionnaire	NN1
601953	108643937	21111015067	.	.	.
601953	108643937	21111015068	<p>		NULL
601953	108643937	21111015069	Brackets	bracket	NN2_VVZ@
601953	108643937	21111015070	Rater	rater	NP1
601953	108643937	21111015071	Station	station	NN1
601953	108643937	21111015072	eCOA		NN1
601953	108643937	21111015073	solution	solution	NN1
601953	108643937	21111015074	for	for	IF
601953	108643937	21111015075	the	the	AT
601953	108643937	21111015076	Vineland-II		MC
601953	108643937	21111015077	is	be	VBZ
601953	108643937	21111015078	helping	help	VVG
601953	108643937	21111015079	to	to	TO
601953	108643937	21111015080	drive	drive	VVI
601953	108643937	21111015081	efficiencies	efficiency	NN2
601953	108643937	21111015082	,	,	,
601953	108643937	21111015083	productivity	productivity	NN1
601953	108643937	21111015084	and	and	CC
601953	108643937	21111015085	accuracy	accuracy	NN1
601953	108643937	21111015086	in	in	II
601953	108643937	21111015087	the	the	AT
601953	108643937	21111015088	identification	identification	NN1
601953	108643937	21111015089	of	of	IO
601953	108643937	21111015090	various	various	JJ
601953	108643937	21111015091	special	special	JJ
601953	108643937	21111015092	needs	need	NN2
601953	108643937	21111015093	by	by	II
601953	108643937	21111015094	offering	offer	VVG
601953	108643937	21111015095	an	a	AT1
601953	108643937	21111015096	electronic	electronic	JJ
601953	108643937	21111015097	version	version	NN1
601953	108643937	21111015098	of	of	IO
601953	108643937	21111015099	the	the	AT
601953	108643937	21111015100	clinical	clinical	JJ
601953	108643937	21111015101	assessment	assessment	NN1
601953	108643937	21111015102	.	.	.
601953	108643937	21111015103	Highly	highly	RR
601953	108643937	21111015104	interactive	interactive	JJ
601953	108643937	21111015105	,	,	,
601953	108643937	21111015106	the	the	AT
601953	108643937	21111015107	solution	solution	NN1
601953	108643937	21111015108	helps	help	NN2@_VVZ
601953	108643937	21111015109	make	make	VVI
601953	108643937	21111015110	a	a	AT1
601953	108643937	21111015111	clinicians	clinician	NN2
601953	108643937	21111015112	time	time	VV0%_NNT1
601953	108643937	21111015113	with	with	IW
601953	108643937	21111015114	a	a	AT1
601953	108643937	21111015115	patient	patient	NN1_JJ
601953	108643937	21111015116	more	more	RGR
601953	108643937	21111015117	effective	effective	JJ
601953	108643937	21111015118	.	.	.
601953	108643937	21111015119	<p>		NULL
601953	108643937	21111015120	"	"	"
601953	108643937	21111015121	Pearsons	pearson	NP2
601953	108643937	21111015122	Vineland	vineland	NP1
601953	108643937	21111015123	Adaptive	adaptive	NP1
601953	108643937	21111015124	Behavior	behavior	NP1_NN1
601953	108643937	21111015125	Scale	scale	NN1
601953	108643937	21111015126	helps	help	VVZ
601953	108643937	21111015127	clinicians	clinician	NN2
601953	108643937	21111015128	gain	gain	VVI
601953	108643937	21111015129	a	a	AT1
601953	108643937	21111015130	total	total	JJ
601953	108643937	21111015131	picture	picture	NN1
601953	108643937	21111015132	of	of	IO
601953	108643937	21111015133	an	a	AT1
601953	108643937	21111015134	individual	individual	JJ_NN1
601953	108643937	21111015135	and	and	CC
601953	108643937	21111015136	as	as	II
601953	108643937	21111015137	a	a	AT1
601953	108643937	21111015138	result	result	NN1
601953	108643937	21111015139	,	,	,
601953	108643937	21111015140	ensuring	ensure	VVG
601953	108643937	21111015141	its	its	APPGE
601953	108643937	21111015142	optimal	optimal	JJ
601953	108643937	21111015143	efficiency	efficiency	NN1
601953	108643937	21111015144	and	and	CC
601953	108643937	21111015145	accuracy	accuracy	NN1
601953	108643937	21111015146	is	be	VBZ
601953	108643937	21111015147	vital	vital	JJ
601953	108643937	21111015148	,	,	,
601953	108643937	21111015149	"	"	"
601953	108643937	21111015150	said	say	VVD
601953	108643937	21111015151	Jeff	jeff	NP1
601953	108643937	21111015152	Kinell		NP1
601953	108643937	21111015153	,	,	,
601953	108643937	21111015154	CEO	ceo	NN1
601953	108643937	21111015155	of	of	IO
601953	108643937	21111015156	Bracket	bracket	NN1
601953	108643937	21111015157	.	.	.
601953	108643937	21111015158	"	"	"
601953	108643937	21111015159	By	by	II
601953	108643937	21111015160	partnering	partner	VVG
601953	108643937	21111015161	with	with	IW
601953	108643937	21111015162	Pearson	pearson	NP1
601953	108643937	21111015163	to	to	TO
601953	108643937	21111015164	introduce	introduce	VVI
601953	108643937	21111015165	an	a	AT1
601953	108643937	21111015166	electronic	electronic	JJ
601953	108643937	21111015167	version	version	NN1
601953	108643937	21111015168	of	of	IO
601953	108643937	21111015169	the	the	AT
601953	108643937	21111015170	Vineland-II		MC
601953	108643937	21111015171	,	,	,
601953	108643937	21111015172	we	we	PPIS2
601953	108643937	21111015173	aim	aim	VV0
601953	108643937	21111015174	to	to	TO
601953	108643937	21111015175	provide	provide	VVI
601953	108643937	21111015176	clinicians	clinician	NN2
601953	108643937	21111015177	,	,	,
601953	108643937	21111015178	parents	parent	NN2
601953	108643937	21111015179	and	and	CC
601953	108643937	21111015180	caregivers	caregivers	VVZ_NN2
601953	108643937	21111015181	with	with	IW
601953	108643937	21111015182	a	a	AT1
601953	108643937	21111015183	precise	precise	JJ
601953	108643937	21111015184	and	and	CC
601953	108643937	21111015185	modernized	modernized	JJ@_VVD
601953	108643937	21111015186	method	method	NN1
601953	108643937	21111015187	for	for	IF
601953	108643937	21111015188	administering	administer	VVG
601953	108643937	21111015189	the	the	AT
601953	108643937	21111015190	@		II
601953	108643937	21111015191	@		II
601953	108643937	21111015192	@		II
601953	108643937	21111015193	@		II
601953	108643937	21111015194	@		II
601953	108643937	21111015195	@		II
601953	108643937	21111015196	@		II
601953	108643937	21111015197	@		II
601953	108643937	21111015198	@		II
601953	108643937	21111015199	@		II
601953	108643937	21111015200	clinical	clinical	JJ
601953	108643937	21111015201	trials	trial	NN2
601953	108643937	21111015202	,	,	,
601953	108643937	21111015203	Brackets	bracket	NN2_VVZ@
601953	108643937	21111015204	eCOA		NN1
601953	108643937	21111015205	version	version	NN1
601953	108643937	21111015206	of	of	IO
601953	108643937	21111015207	the	the	AT
601953	108643937	21111015208	Vineland-II		MC
601953	108643937	21111015209	is	be	VBZ
601953	108643937	21111015210	highly	highly	RR
601953	108643937	21111015211	customizable	customizable	JJ
601953	108643937	21111015212	and	and	CC
601953	108643937	21111015213	includes	include	VVZ
601953	108643937	21111015214	features	feature	NN2
601953	108643937	21111015215	that	that	CST
601953	108643937	21111015216	make	make	VV0
601953	108643937	21111015217	it	it	PPH1
601953	108643937	21111015218	more	more	RGR
601953	108643937	21111015219	powerful	powerful	JJ
601953	108643937	21111015220	than	than	CSN
601953	108643937	21111015221	the	the	AT
601953	108643937	21111015222	classic	classic	JJ_NN1
601953	108643937	21111015223	paper-and-pencil	paper-and-pencil	JJ_NN1
601953	108643937	21111015224	test	test	NN1
601953	108643937	21111015225	,	,	,
601953	108643937	21111015226	including	include	VVG@_II
601953	108643937	21111015227	:	:	:
601953	108643937	21111015228	<p>		NULL
601953	108643937	21111015229	Adaptive	adaptive	JJ_NP1
601953	108643937	21111015230	logic	logic	NN1
601953	108643937	21111015231	that	that	CST_DD1
601953	108643937	21111015232	allows	allow	VVZ
601953	108643937	21111015233	clinicians	clinician	NN2
601953	108643937	21111015234	to	to	II
601953	108643937	21111015235	only	only	JJ
601953	108643937	21111015236	administer		NN1
601953	108643937	21111015237	and	and	CC
601953	108643937	21111015238	score	score	VV0
601953	108643937	21111015239	patient-specific	patient-specific	JJ
601953	108643937	21111015240	items	item	NN2
601953	108643937	21111015241	;	;	;
601953	108643937	21111015242	<p>		NULL
601953	108643937	21111015243	A	a	AT1_ZZ1
601953	108643937	21111015244	prompted	prompted	JJ%_VVD_VVN
601953	108643937	21111015245	interview	interview	NN1
601953	108643937	21111015246	that	that	CST
601953	108643937	21111015247	guides	guide	NN2
601953	108643937	21111015248	a	a	AT1
601953	108643937	21111015249	clinician	clinician	NN1
601953	108643937	21111015250	through	through	II
601953	108643937	21111015251	the	the	AT
601953	108643937	21111015252	scale	scale	NN1
601953	108643937	21111015253	;	;	;
601953	108643937	21111015254	and	and	CC
601953	108643937	21111015255	<p>		NULL
601953	108643937	21111015256	Automated	automated	JJ
601953	108643937	21111015257	scoring	scoring	NN1_JJ@
601953	108643937	21111015258	algorithms	algorithm	NN2
601953	108643937	21111015259	that	that	CST
601953	108643937	21111015260	reduce	reduce	VV0
601953	108643937	21111015261	time	time	NNT1
601953	108643937	21111015262	and	and	CC
601953	108643937	21111015263	eliminate	eliminate	VV0
601953	108643937	21111015264	human	human	JJ_NN1
601953	108643937	21111015265	error	error	NN1
601953	108643937	21111015266	.	.	.
601953	108643937	21111015267	<p>		NULL
601953	108643937	21111015268	"	"	"
601953	108643937	21111015269	Pearson	pearson	NP1
601953	108643937	21111015270	Assessment	assessment	NN1
601953	108643937	21111015271	is	be	VBZ
601953	108643937	21111015272	pleased	pleased	JJ
601953	108643937	21111015273	to	to	TO
601953	108643937	21111015274	be	be	VBI
601953	108643937	21111015275	associated	associate	VVN
601953	108643937	21111015276	with	with	IW
601953	108643937	21111015277	the	the	AT
601953	108643937	21111015278	high	high	JJ
601953	108643937	21111015279	quality	quality	NN1
601953	108643937	21111015280	adaptation	adaptation	NN1
601953	108643937	21111015281	of	of	IO
601953	108643937	21111015282	one	one	MC1
601953	108643937	21111015283	of	of	IO
601953	108643937	21111015284	our	our	APPGE
601953	108643937	21111015285	key	key	JJ_NN1
601953	108643937	21111015286	products	product	NN2
601953	108643937	21111015287	,	,	,
601953	108643937	21111015288	now	now	RT
601953	108643937	21111015289	available	available	JJ
601953	108643937	21111015290	to	to	II
601953	108643937	21111015291	our	our	APPGE
601953	108643937	21111015292	Pharma	pharma	NN1@_NP1
601953	108643937	21111015293	partners	partner	NN2
601953	108643937	21111015294	,	,	,
601953	108643937	21111015295	"	"	"
601953	108643937	21111015296	said	say	VVD
601953	108643937	21111015297	Paul	paul	NP1
601953	108643937	21111015298	McKeown	mckeown	NP1
601953	108643937	21111015299	,	,	,
601953	108643937	21111015300	Director	director	NN1
601953	108643937	21111015301	Global	global	JJ
601953	108643937	21111015302	Licensing	licensing	NN1
601953	108643937	21111015303	and	and	CC
601953	108643937	21111015304	Strategic	strategic	JJ
601953	108643937	21111015305	Partnerships	partnership	NN2
601953	108643937	21111015306	at	at	II
601953	108643937	21111015307	Pearson	pearson	NP1
601953	108643937	21111015308	.	.	.
601953	108643937	21111015309	-	-	-
601953	108643937	21111015310	"	"	"
601953	108643937	21111015311	This	this	DD1
601953	108643937	21111015312	is	be	VBZ
601953	108643937	21111015313	a	a	AT1
601953	108643937	21111015314	great	great	JJ
601953	108643937	21111015315	example	example	NN1
601953	108643937	21111015316	of	of	IO
601953	108643937	21111015317	how	how	RRQ
601953	108643937	21111015318	we	we	PPIS2
601953	108643937	21111015319	,	,	,
601953	108643937	21111015320	as	as	CSA
601953	108643937	21111015321	IP	ip	NP1_NN1
601953	108643937	21111015322	owners	owner	NN2
601953	108643937	21111015323	,	,	,
601953	108643937	21111015324	can	can	VM
601953	108643937	21111015325	work	work	VVI
601953	108643937	21111015326	with	with	IW
601953	108643937	21111015327	a	a	AT1
601953	108643937	21111015328	leading	leading	JJ
601953	108643937	21111015329	CRO	cro	NN1
601953	108643937	21111015330	to	to	TO
601953	108643937	21111015331	produce	produce	VVI
601953	108643937	21111015332	a	a	AT1
601953	108643937	21111015333	quality	quality	NN1
601953	108643937	21111015334	outcome	outcome	NN1
601953	108643937	21111015335	for	for	IF
601953	108643937	21111015336	the	the	AT
601953	108643937	21111015337	sponsor	sponsor	NN1
601953	108643937	21111015338	and	and	CC
601953	108643937	21111015339	this	this	DD1
601953	108643937	21111015340	significant	significant	JJ
601953	108643937	21111015341	piece	piece	NN1
601953	108643937	21111015342	of	of	IO
601953	108643937	21111015343	pharma	pharma	NN1
601953	108643937	21111015344	research	research	NN1
601953	108643937	21111015345	.	.	.
601953	108643937	21111015346	Bracket	bracket	NN1
601953	108643937	21111015347	is	be	VBZ
601953	108643937	21111015348	a	a	AT1
601953	108643937	21111015349	very	very	RG
601953	108643937	21111015350	important	important	JJ
601953	108643937	21111015351	associate	associate	NN1_JJ
601953	108643937	21111015352	for	for	IF
601953	108643937	21111015353	us	us	PPIO2
601953	108643937	21111015354	in	in	II
601953	108643937	21111015355	this	this	DD1
601953	108643937	21111015356	market	market	NN1
601953	108643937	21111015357	and	and	CC
601953	108643937	21111015358	we	we	PPIS2
601953	108643937	21111015359	look	look	VV0
601953	108643937	21111015360	forward	forward	RL
601953	108643937	21111015361	to	to	II
601953	108643937	21111015362	building	building	NN1_VVG@
601953	108643937	21111015363	on	on	II
601953	108643937	21111015364	this	this	DD1
601953	108643937	21111015365	work	work	NN1
601953	108643937	21111015366	moving	move	VVG
601953	108643937	21111015367	forward	forward	RL
601953	108643937	21111015368	.	.	.
601953	108643937	21111015369	"	"	"
601953	108643937	21111015370	<p>		NULL
601953	108643937	21111015371	About	about	II
601953	108643937	21111015372	Bracket	bracket	NN1
601953	108643937	21111015373	<p>		NULL
601953	108643937	21111015374	Bracket	bracket	NN1_VV0@
601953	108643937	21111015375	,	,	,
601953	108643937	21111015376	with	with	IW
601953	108643937	21111015377	seven	seven	MC
601953	108643937	21111015378	offices	office	NN2
601953	108643937	21111015379	and	and	CC
601953	108643937	21111015380	more	more	DAR
601953	108643937	21111015381	than	than	CSN
601953	108643937	21111015382	500	500	MC
601953	108643937	21111015383	employees	employee	NN2
601953	108643937	21111015384	worldwide	worldwide	RL
601953	108643937	21111015385	,	,	,
601953	108643937	21111015386	is	be	VBZ
601953	108643937	21111015387	a	a	AT1
601953	108643937	21111015388	clinical	clinical	JJ
601953	108643937	21111015389	trial	trial	NN1
601953	108643937	21111015390	@		II
601953	108643937	21111015391	@		II
601953	108643937	21111015392	@		II
601953	108643937	21111015393	@		II
601953	108643937	21111015394	@		II
601953	108643937	21111015395	@		II
601953	108643937	21111015396	@		II
601953	108643937	21111015397	@		II
601953	108643937	21111015398	@		II
601953	108643937	21111015399	@		II
601953	108643937	21111015400	and	and	CC
601953	108643937	21111015401	contract	contract	NN1
601953	108643937	21111015402	research	research	NN1
601953	108643937	21111015403	organizations	organization	NN2
601953	108643937	21111015404	increase	increase	VV0
601953	108643937	21111015405	the	the	AT
601953	108643937	21111015406	power	power	NN1
601953	108643937	21111015407	of	of	IO
601953	108643937	21111015408	their	their	APPGE
601953	108643937	21111015409	clinical	clinical	JJ
601953	108643937	21111015410	research	research	NN1
601953	108643937	21111015411	data	data	NN
601953	108643937	21111015412	by	by	II
601953	108643937	21111015413	leveraging	leverage	VVG_JJ@
601953	108643937	21111015414	core	core	NN1
601953	108643937	21111015415	competencies	competency	NN2
601953	108643937	21111015416	in	in	II
601953	108643937	21111015417	Science	science	NN1
601953	108643937	21111015418	,	,	,
601953	108643937	21111015419	Technology	technology	NN1
601953	108643937	21111015420	,	,	,
601953	108643937	21111015421	and	and	CC
601953	108643937	21111015422	Service	service	NN1
601953	108643937	21111015423	.	.	.
601953	108643937	21111015424	Bracket	bracket	NN1_VV0@
601953	108643937	21111015425	eCOAG		NN1
601953	108643937	21111015426	is	be	VBZ
601953	108643937	21111015427	a	a	AT1
601953	108643937	21111015428	flexible	flexible	JJ
601953	108643937	21111015429	platform	platform	NN1
601953	108643937	21111015430	for	for	IF
601953	108643937	21111015431	electronic	electronic	JJ
601953	108643937	21111015432	clinical	clinical	JJ
601953	108643937	21111015433	outcomes	outcome	NN2
601953	108643937	21111015434	assessments	assessment	NN2
601953	108643937	21111015435	.	.	.
601953	108643937	21111015436	Bracket	bracket	VV0@_NN1
601953	108643937	21111015437	RTSMG		NP1
601953	108643937	21111015438	is	be	VBZ
601953	108643937	21111015439	a	a	AT1
601953	108643937	21111015440	best-in-breed		NN1_JJ
601953	108643937	21111015441	,	,	,
601953	108643937	21111015442	scalable	scalable	JJ
601953	108643937	21111015443	and	and	CC
601953	108643937	21111015444	configurable	configurable	JJ
601953	108643937	21111015445	clinical	clinical	JJ
601953	108643937	21111015446	IRT	irt	NN1
601953	108643937	21111015447	solution	solution	NN1
601953	108643937	21111015448	for	for	IF
601953	108643937	21111015449	the	the	AT
601953	108643937	21111015450	life	life	NN1
601953	108643937	21111015451	sciences	science	NN2
601953	108643937	21111015452	industry	industry	NN1
601953	108643937	21111015453	.	.	.
601953	108643937	21111015454	Bracket	bracket	VV0@_NN1
601953	108643937	21111015455	Rater	rater	NP1
601953	108643937	21111015456	Training	training	NN1
601953	108643937	21111015457	and	and	CC
601953	108643937	21111015458	Quality	quality	NN1
601953	108643937	21111015459	Assurance	assurance	NN1
601953	108643937	21111015460	improve	improve	VV0
601953	108643937	21111015461	outcomes	outcome	NN2
601953	108643937	21111015462	through	through	II
601953	108643937	21111015463	customized	customized	JJ@
601953	108643937	21111015464	training	training	NN1
601953	108643937	21111015465	and	and	CC
601953	108643937	21111015466	quality	quality	NN1
601953	108643937	21111015467	assurance	assurance	NN1
601953	108643937	21111015468	programs	program	NN2
601953	108643937	21111015469	.	.	.
601953	108643937	21111015470	Learn	learn	VV0
601953	108643937	21111015471	more	more	RRR_DAR
601953	108643937	21111015472	about	about	II
601953	108643937	21111015473	Bracket	bracket	NN1
601953	108643937	21111015474	atwww.bracketglobal.com.		NNU
601953	108643939	21111015494	@@##	----------	----------
601953	108643939	21111015495	@@108643939		FO
601953	108643939	21111015496	@4043939/		JJ_NN1_VV0
601953	108643939	21111015497	<h>		NULL
601953	108643939	21111015498	Site	site	NN1
601953	108643939	21111015499	Selection	selection	NN1
601953	108643939	21111015500	and	and	CC
601953	108643939	21111015501	Alzheimer	alzheimer	NP1
601953	108643939	21111015502	's	's	GE
601953	108643939	21111015503	Disease	disease	NN1
601953	108643939	21111015504	<p>		NULL
601953	108643939	21111015505	July	july	NPM1
601953	108643939	21111015506	14	14	MC
601953	108643939	21111015507	,	,	,
601953	108643939	21111015508	2016	2016	MC
601953	108643939	21111015509	<p>		NULL
601953	108643939	21111015510	Identify	identify	VV0
601953	108643939	21111015511	,	,	,
601953	108643939	21111015512	selecting	select	VVG
601953	108643939	21111015513	,	,	,
601953	108643939	21111015514	and	and	CC
601953	108643939	21111015515	preparing	prepare	VVG
601953	108643939	21111015516	clinical	clinical	JJ
601953	108643939	21111015517	trial	trial	NN1
601953	108643939	21111015518	sites	site	NN2
601953	108643939	21111015519	to	to	TO
601953	108643939	21111015520	conduct	conduct	VVI
601953	108643939	21111015521	a	a	AT1
601953	108643939	21111015522	clinical	clinical	JJ
601953	108643939	21111015523	trial	trial	NN1
601953	108643939	21111015524	is	be	VBZ
601953	108643939	21111015525	an	a	AT1
601953	108643939	21111015526	ongoing	ongoing	JJ
601953	108643939	21111015527	struggle	struggle	NN1
601953	108643939	21111015528	for	for	IF
601953	108643939	21111015529	sponsors	sponsor	NN2
601953	108643939	21111015530	looking	look	VVG
601953	108643939	21111015531	to	to	TO
601953	108643939	21111015532	run	run	VVI
601953	108643939	21111015533	bigger	big	JJR
601953	108643939	21111015534	and	and	CC
601953	108643939	21111015535	more	more	RGR
601953	108643939	21111015536	global	global	JJ
601953	108643939	21111015537	clinical	clinical	JJ
601953	108643939	21111015538	trials	trial	NN2
601953	108643939	21111015539	.	.	.
601953	108643939	21111015540	<p>		NULL
601953	108643939	21111015541	For	for	IF
601953	108643939	21111015542	some	some	DD
601953	108643939	21111015543	indications	indication	NN2
601953	108643939	21111015544	,	,	,
601953	108643939	21111015545	this	this	DD1
601953	108643939	21111015546	can	can	VM
601953	108643939	21111015547	be	be	VBI
601953	108643939	21111015548	an	a	AT1
601953	108643939	21111015549	especially	especially	RR
601953	108643939	21111015550	tricky	tricky	JJ
601953	108643939	21111015551	proposition	proposition	NN1
601953	108643939	21111015552	.	.	.
601953	108643939	21111015553	Increasingly	increasingly	RR
601953	108643939	21111015554	,	,	,
601953	108643939	21111015555	pivotal	pivotal	JJ
601953	108643939	21111015556	phase	phase	NN1
601953	108643939	21111015557	3	3	MC
601953	108643939	21111015558	trials	trial	NN2
601953	108643939	21111015559	in	in	II
601953	108643939	21111015560	Alzheimer	alzheimer	NP1
601953	108643939	21111015561	's	's	GE
601953	108643939	21111015562	disease	disease	NN1
601953	108643939	21111015563	are	be	VBR
601953	108643939	21111015564	required	require	VVN
601953	108643939	21111015565	to	to	TO
601953	108643939	21111015566	screen	screen	VVI
601953	108643939	21111015567	,	,	,
601953	108643939	21111015568	and	and	CC
601953	108643939	21111015569	eventually	eventually	RR
601953	108643939	21111015570	randomize	randomize	VVI
601953	108643939	21111015571	,	,	,
601953	108643939	21111015572	exceptionally	exceptionally	RR
601953	108643939	21111015573	large	large	JJ
601953	108643939	21111015574	numbers	number	NN2
601953	108643939	21111015575	of	of	IO
601953	108643939	21111015576	patients	patient	NN2
601953	108643939	21111015577	.	.	.
601953	108643939	21111015578	The	the	AT
601953	108643939	21111015579	result	result	NN1
601953	108643939	21111015580	has	have	VHZ
601953	108643939	21111015581	been	be	VBN
601953	108643939	21111015582	the	the	AT
601953	108643939	21111015583	requirement	requirement	NN1
601953	108643939	21111015584	for	for	IF
601953	108643939	21111015585	a	a	AT1
601953	108643939	21111015586	very	very	RG
601953	108643939	21111015587	large	large	JJ
601953	108643939	21111015588	number	number	NN1
601953	108643939	21111015589	of	of	IO
601953	108643939	21111015590	centers	center	NN2
601953	108643939	21111015591	to	to	TO
601953	108643939	21111015592	be	be	VBI
601953	108643939	21111015593	identified	identify	VVN
601953	108643939	21111015594	,	,	,
601953	108643939	21111015595	globally	globally	RR
601953	108643939	21111015596	,	,	,
601953	108643939	21111015597	for	for	IF
601953	108643939	21111015598	every	every	AT1
601953	108643939	21111015599	new	new	JJ
601953	108643939	21111015600	program	program	NN1
601953	108643939	21111015601	.	.	.
601953	108643939	21111015602	An	a	AT1
601953	108643939	21111015603	analysis	analysis	NN1
601953	108643939	21111015604	of	of	IO
601953	108643939	21111015605	currently	currently	RR
601953	108643939	21111015606	recruiting	recruit	VVG_NN1
601953	108643939	21111015607	,	,	,
601953	108643939	21111015608	industry-sponsored	industry-sponsored	JJ
601953	108643939	21111015609	,	,	,
601953	108643939	21111015610	phase	phase	NN1
601953	108643939	21111015611	3	3	MC
601953	108643939	21111015612	intervention	intervention	NN1
601953	108643939	21111015613	trials	trial	NN2
601953	108643939	21111015614	listed	list	VVN_VVD
601953	108643939	21111015615	in	in	II
601953	108643939	21111015616	ClinicalTrials.gov		NP1
601953	108643939	21111015617	shows	show	VVZ
601953	108643939	21111015618	an	a	AT1
601953	108643939	21111015619	average	average	NN1
601953	108643939	21111015620	of	of	IO
601953	108643939	21111015621	67	67	MC
601953	108643939	21111015622	centers	center	NN2
601953	108643939	21111015623	open	open	JJ
601953	108643939	21111015624	for	for	IF
601953	108643939	21111015625	each	each	DD1
601953	108643939	21111015626	trial	trial	NN1
601953	108643939	21111015627	,	,	,
601953	108643939	21111015628	and	and	CC
601953	108643939	21111015629	7	7	MC
601953	108643939	21111015630	studies	study	NN2
601953	108643939	21111015631	with	with	IW
601953	108643939	21111015632	more	more	DAR
601953	108643939	21111015633	than	than	CSN
601953	108643939	21111015634	100	100	MC
601953	108643939	21111015635	centers	center	NN2
601953	108643939	21111015636	.	.	.
601953	108643939	21111015637	<p>		NULL
601953	108643939	21111015638	Bracket	bracket	NN1
601953	108643939	21111015639	has	have	VHZ
601953	108643939	21111015640	traditionally	traditionally	RR
601953	108643939	21111015641	focused	focus	VVN
601953	108643939	21111015642	on	on	II
601953	108643939	21111015643	providing	provide	VVG
601953	108643939	21111015644	technology	technology	NN1
601953	108643939	21111015645	to	to	II
601953	108643939	21111015646	investigators	investigator	NN2
601953	108643939	21111015647	that	that	CST_DD1
601953	108643939	21111015648	will	will	VM
601953	108643939	21111015649	allow	allow	VVI
601953	108643939	21111015650	them	them	PPHO2
601953	108643939	21111015651	to	to	TO
601953	108643939	21111015652	better	better	RRR_JJR
601953	108643939	21111015653	collect	collect	VVI
601953	108643939	21111015654	outcomes	outcome	NN2
601953	108643939	21111015655	data	data	NN
601953	108643939	21111015656	in	in	II
601953	108643939	21111015657	these	these	DD2
601953	108643939	21111015658	trials	trial	NN2
601953	108643939	21111015659	.	.	.
601953	108643939	21111015660	And	and	CC
601953	108643939	21111015661	in	in	II
601953	108643939	21111015662	training	training	NN1
601953	108643939	21111015663	and	and	CC
601953	108643939	21111015664	certifying	certify	VVG
601953	108643939	21111015665	the	the	AT
601953	108643939	21111015666	sites	site	NN2
601953	108643939	21111015667	and	and	CC
601953	108643939	21111015668	site	site	NN1
601953	108643939	21111015669	personnel	personnel	NN2
601953	108643939	21111015670	who	who	PNQS
601953	108643939	21111015671	will	will	VM
601953	108643939	21111015672	execute	execute	VVI
601953	108643939	21111015673	a	a	AT1
601953	108643939	21111015674	trial	trial	NN1
601953	108643939	21111015675	.	.	.
601953	108643939	21111015676	However	however	RR
601953	108643939	21111015677	,	,	,
601953	108643939	21111015678	there	there	EX
601953	108643939	21111015679	are	be	VBR
601953	108643939	21111015680	things	thing	NN2
601953	108643939	21111015681	that	that	CST_DD1
601953	108643939	21111015682	can	can	VM
601953	108643939	21111015683	be	be	VBI
601953	108643939	21111015684	done	do	VDN
601953	108643939	21111015685	even	even	RR
601953	108643939	21111015686	@		II
601953	108643939	21111015687	@		II
601953	108643939	21111015688	@		II
601953	108643939	21111015689	@		II
601953	108643939	21111015690	@		II
601953	108643939	21111015691	@		II
601953	108643939	21111015692	@		II
601953	108643939	21111015693	@		II
601953	108643939	21111015694	@		II
601953	108643939	21111015695	@		II
601953	108643939	21111015696	detection	detection	NN1
601953	108643939	21111015697	in	in	II
601953	108643939	21111015698	your	your	APPGE
601953	108643939	21111015699	trial	trial	NN1
601953	108643939	21111015700	.	.	.
601953	108643939	21111015701	<p>		NULL
601953	108643939	21111015702	The	the	AT
601953	108643939	21111015703	selection	selection	NN1
601953	108643939	21111015704	of	of	IO
601953	108643939	21111015705	investigative	investigative	JJ
601953	108643939	21111015706	sites	site	NN2
601953	108643939	21111015707	to	to	TO
601953	108643939	21111015708	participate	participate	VVI
601953	108643939	21111015709	in	in	II_RP@
601953	108643939	21111015710	clinical	clinical	JJ
601953	108643939	21111015711	trials	trial	NN2
601953	108643939	21111015712	is	be	VBZ
601953	108643939	21111015713	often	often	RR
601953	108643939	21111015714	focused	focus	VVN_VVD
601953	108643939	21111015715	on	on	II
601953	108643939	21111015716	evaluation	evaluation	NN1
601953	108643939	21111015717	of	of	IO
601953	108643939	21111015718	historical	historical	JJ
601953	108643939	21111015719	therapeutic	therapeutic	JJ
601953	108643939	21111015720	experience	experience	NN1
601953	108643939	21111015721	,	,	,
601953	108643939	21111015722	past	past	JJ_II
601953	108643939	21111015723	subject	subject	NN1_JJ@
601953	108643939	21111015724	recruitment	recruitment	NN1
601953	108643939	21111015725	and	and	CC
601953	108643939	21111015726	regulatory	regulatory	JJ
601953	108643939	21111015727	compliance	compliance	NN1
601953	108643939	21111015728	records	record	NN2
601953	108643939	21111015729	.	.	.
601953	108643939	21111015730	However	however	RR
601953	108643939	21111015731	,	,	,
601953	108643939	21111015732	in	in	II
601953	108643939	21111015733	these	these	DD2
601953	108643939	21111015734	difficult	difficult	JJ
601953	108643939	21111015735	trials	trial	NN2
601953	108643939	21111015736	,	,	,
601953	108643939	21111015737	we	we	PPIS2
601953	108643939	21111015738	already	already	RR
601953	108643939	21111015739	know	know	VV0
601953	108643939	21111015740	the	the	AT
601953	108643939	21111015741	very	very	RG
601953	108643939	21111015742	subjective	subjective	JJ
601953	108643939	21111015743	Clinical	clinical	JJ
601953	108643939	21111015744	Outcomes	outcome	NN2
601953	108643939	21111015745	Assessments	assessment	NN2
601953	108643939	21111015746	can	can	VM
601953	108643939	21111015747	be	be	VBI
601953	108643939	21111015748	difficult	difficult	JJ
601953	108643939	21111015749	to	to	TO
601953	108643939	21111015750	administer	administer	VVI
601953	108643939	21111015751	,	,	,
601953	108643939	21111015752	and	and	CC
601953	108643939	21111015753	identifying	identify	VVG_JJ@
601953	108643939	21111015754	sites	site	NN2
601953	108643939	21111015755	,	,	,
601953	108643939	21111015756	investigators	investigator	NN2
601953	108643939	21111015757	,	,	,
601953	108643939	21111015758	raters	rater	NN2
601953	108643939	21111015759	who	who	PNQS
601953	108643939	21111015760	have	have	VH0
601953	108643939	21111015761	demonstrated	demonstrate	VVN
601953	108643939	21111015762	competency	competency	NN1
601953	108643939	21111015763	with	with	IW
601953	108643939	21111015764	these	these	DD2
601953	108643939	21111015765	instruments	instrument	NN2
601953	108643939	21111015766	in	in	II
601953	108643939	21111015767	past	past	JJ_NN1
601953	108643939	21111015768	studies	study	NN2
601953	108643939	21111015769	can	can	VM
601953	108643939	21111015770	be	be	VBI
601953	108643939	21111015771	a	a	AT1
601953	108643939	21111015772	meaningful	meaningful	JJ
601953	108643939	21111015773	strategy	strategy	NN1
601953	108643939	21111015774	.	.	.
601953	108643939	21111015775	<p>		NULL
601953	108643939	21111015776	At	at	II
601953	108643939	21111015777	Bracket	bracket	NN1
601953	108643939	21111015778	,	,	,
601953	108643939	21111015779	one	one	MC1
601953	108643939	21111015780	approach	approach	NN1
601953	108643939	21111015781	we	we	PPIS2
601953	108643939	21111015782	've	have	VH0
601953	108643939	21111015783	taken	take	VVN
601953	108643939	21111015784	is	be	VBZ
601953	108643939	21111015785	to	to	TO
601953	108643939	21111015786	bolster	bolster	VVI
601953	108643939	21111015787	traditional	traditional	JJ
601953	108643939	21111015788	site	site	NN1
601953	108643939	21111015789	feasibility	feasibility	NN1
601953	108643939	21111015790	data	data	NN
601953	108643939	21111015791	with	with	IW
601953	108643939	21111015792	additional	additional	JJ
601953	108643939	21111015793	metrics	metrics	NN2_NN1
601953	108643939	21111015794	utilizing	utilize	VVG
601953	108643939	21111015795	historical	historical	JJ
601953	108643939	21111015796	clinical	clinical	JJ
601953	108643939	21111015797	outcome	outcome	NN1
601953	108643939	21111015798	assessment	assessment	NN1
601953	108643939	21111015799	administration	administration	NN1
601953	108643939	21111015800	performance	performance	NN1
601953	108643939	21111015801	data	data	NN
601953	108643939	21111015802	.	.	.
601953	108643939	21111015803	In	in	II
601953	108643939	21111015804	research	research	NN1
601953	108643939	21111015805	that	that	CST_DD1
601953	108643939	21111015806	was	be	VBDZ
601953	108643939	21111015807	presented	present	VVN
601953	108643939	21111015808	at	at	II
601953	108643939	21111015809	the	the	AT
601953	108643939	21111015810	2015	2015	MC
601953	108643939	21111015811	Clinical	clinical	JJ
601953	108643939	21111015812	Trials	trial	NN2
601953	108643939	21111015813	on	on	II
601953	108643939	21111015814	Alzheimer	alzheimer	NP1
601953	108643939	21111015815	's	's	GE
601953	108643939	21111015816	Disease	disease	NN1
601953	108643939	21111015817	Conference	conference	NN1
601953	108643939	21111015818	(	(	(
601953	108643939	21111015819	CTAD		NP1
601953	108643939	21111015820	)	)	)
601953	108643939	21111015821	-	-	-
601953	108643939	21111015822	conference	conference	NN1
601953	108643939	21111015823	in	in	II
601953	108643939	21111015824	Barcelona	barcelona	NP1
601953	108643939	21111015825	,	,	,
601953	108643939	21111015826	sites	site	NN2
601953	108643939	21111015827	were	be	VBDR
601953	108643939	21111015828	able	able	JK
601953	108643939	21111015829	to	to	TO
601953	108643939	21111015830	be	be	VBI
601953	108643939	21111015831	stratified	stratify	VVN
601953	108643939	21111015832	using	use	VVG
601953	108643939	21111015833	this	this	DD1
601953	108643939	21111015834	performance	performance	NN1
601953	108643939	21111015835	data	data	NN
601953	108643939	21111015836	,	,	,
601953	108643939	21111015837	giving	give	VVG
601953	108643939	21111015838	sponsors	sponsor	NN2_VVZ@
601953	108643939	21111015839	an	a	AT1
601953	108643939	21111015840	additional	additional	JJ
601953	108643939	21111015841	criteria	criteria	NN2
601953	108643939	21111015842	to	to	TO
601953	108643939	21111015843	assist	assist	VVI
601953	108643939	21111015844	in	in	II_RP@
601953	108643939	21111015845	their	their	APPGE
601953	108643939	21111015846	evaluation	evaluation	NN1
601953	108643939	21111015847	.	.	.
601953	108643939	21111015848	<p>		NULL
601953	108643939	21111015849	Since	since	CS
601953	108643939	21111015850	potential	potential	JJ
601953	108643939	21111015851	recruitment	recruitment	NN1
601953	108643939	21111015852	numbers	number	NN2
601953	108643939	21111015853	,	,	,
601953	108643939	21111015854	and	and	CC
601953	108643939	21111015855	past	past	JJ_NN1
601953	108643939	21111015856	recruitment	recruitment	NN1
601953	108643939	21111015857	experience	experience	NN1
601953	108643939	21111015858	,	,	,
601953	108643939	21111015859	is	be	VBZ
601953	108643939	21111015860	so	so	RG_RR
601953	108643939	21111015861	important	important	JJ
601953	108643939	21111015862	to	to	II
601953	108643939	21111015863	the	the	AT
601953	108643939	21111015864	feasibility	feasibility	NN1
601953	108643939	21111015865	process	process	NN1_VV0
601953	108643939	21111015866	,	,	,
601953	108643939	21111015867	it	it	PPH1
601953	108643939	21111015868	's	be	VBZ
601953	108643939	21111015869	important	important	JJ
601953	108643939	21111015870	to	to	TO
601953	108643939	21111015871	evaluate	evaluate	VVI
601953	108643939	21111015872	recruitment	recruitment	NN1
601953	108643939	21111015873	in	in	II
601953	108643939	21111015874	the	the	AT
601953	108643939	21111015875	context	context	NN1
601953	108643939	21111015876	of	of	IO
601953	108643939	21111015877	these	these	DD2
601953	108643939	21111015878	performance	performance	NN1
601953	108643939	21111015879	data	data	NN
601953	108643939	21111015880	as	as	RR21_RG
601953	108643939	21111015881	well	well	RR22_RR
601953	108643939	21111015882	.	.	.
601953	108643939	21111015883	<p>		NULL
601953	108643939	21111015884	The	the	AT
601953	108643939	21111015885	evaluation	evaluation	NN1
601953	108643939	21111015886	@		II
601953	108643939	21111015887	@		II
601953	108643939	21111015888	@		II
601953	108643939	21111015889	@		II
601953	108643939	21111015890	@		II
601953	108643939	21111015891	@		II
601953	108643939	21111015892	@		II
601953	108643939	21111015893	@		II
601953	108643939	21111015894	@		II
601953	108643939	21111015895	@		II
601953	108643939	21111015896	of	of	IO
601953	108643939	21111015897	improving	improving	JJ_VVG
601953	108643939	21111015898	study	study	NN1
601953	108643939	21111015899	execution	execution	NN1
601953	108643939	21111015900	.	.	.
601953	108643939	21111015901	In	in	II
601953	108643939	21111015902	this	this	DD1
601953	108643939	21111015903	study	study	NN1
601953	108643939	21111015904	,	,	,
601953	108643939	21111015905	a	a	AT1
601953	108643939	21111015906	methodology	methodology	NN1
601953	108643939	21111015907	was	be	VBDZ
601953	108643939	21111015908	developed	develop	VVN
601953	108643939	21111015909	to	to	TO
601953	108643939	21111015910	evaluate	evaluate	VVI
601953	108643939	21111015911	historical	historical	JJ
601953	108643939	21111015912	experience	experience	NN1
601953	108643939	21111015913	and	and	CC
601953	108643939	21111015914	clinical	clinical	JJ
601953	108643939	21111015915	outcome	outcome	NN1
601953	108643939	21111015916	administration	administration	NN1
601953	108643939	21111015917	performance	performance	NN1
601953	108643939	21111015918	data	data	NN
601953	108643939	21111015919	as	as	II_CSA
601953	108643939	21111015920	a	a	AT1
601953	108643939	21111015921	mechanism	mechanism	NN1
601953	108643939	21111015922	to	to	TO
601953	108643939	21111015923	enhance	enhance	VVI
601953	108643939	21111015924	site	site	NN1
601953	108643939	21111015925	and	and	CC
601953	108643939	21111015926	rater	rater	NN1
601953	108643939	21111015927	selection	selection	NN1
601953	108643939	21111015928	.	.	.
601953	108643939	21111015929	Historical	historical	JJ
601953	108643939	21111015930	data	data	NN
601953	108643939	21111015931	shows	show	VVZ
601953	108643939	21111015932	only	only	JJ
601953	108643939	21111015933	a	a-i	AT1
601953	108643939	21111015934	limited	limited	JJ_VVN
601953	108643939	21111015935	correlation	correlation	NN1
601953	108643939	21111015936	between	between	II
601953	108643939	21111015937	sites	site	NN2
601953	108643939	21111015938	with	with	IW
601953	108643939	21111015939	high	high	JJ
601953	108643939	21111015940	or	or	CC
601953	108643939	21111015941	low	low	JJ
601953	108643939	21111015942	performance	performance	NN1
601953	108643939	21111015943	quality	quality	NN1
601953	108643939	21111015944	,	,	,
601953	108643939	21111015945	and	and	CC
601953	108643939	21111015946	sites	site	NN2
601953	108643939	21111015947	with	with	IW
601953	108643939	21111015948	high	high	JJ
601953	108643939	21111015949	or	or	CC
601953	108643939	21111015950	low	low	JJ
601953	108643939	21111015951	recruitment	recruitment	NN1
601953	108643939	21111015952	rates	rate	NN2
601953	108643939	21111015953	.	.	.
601953	108643939	21111015954	So	so	RR
601953	108643939	21111015955	combining	combine	VVG
601953	108643939	21111015956	both	both	DB2
601953	108643939	21111015957	factors	factor	NN2
601953	108643939	21111015958	in	in	II
601953	108643939	21111015959	your	your	APPGE
601953	108643939	21111015960	feasibility	feasibility	NN1
601953	108643939	21111015961	process	process	NN1
601953	108643939	21111015962	is	be	VBZ
601953	108643939	21111015963	essential	essential	JJ
601953	108643939	21111015964	.	.	.
601953	108643939	21111015965	And	and	CC
601953	108643939	21111015966	in	in	II
601953	108643939	21111015967	some	some	DD
601953	108643939	21111015968	cases	case	NN2
601953	108643939	21111015969	,	,	,
601953	108643939	21111015970	it	it	PPH1
601953	108643939	21111015971	can	can	VM
601953	108643939	21111015972	still	still	RR
601953	108643939	21111015973	be	be	VBI
601953	108643939	21111015974	valuable	valuable	JJ
601953	108643939	21111015975	to	to	TO
601953	108643939	21111015976	invest	invest	VVI
601953	108643939	21111015977	the	the	AT
601953	108643939	21111015978	time	time	NNT1
601953	108643939	21111015979	in	in	II
601953	108643939	21111015980	initiating	initiate	VVG
601953	108643939	21111015981	a	a	AT1
601953	108643939	21111015982	site	site	NN1
601953	108643939	21111015983	that	that	CST_DD1
601953	108643939	21111015984	may	may	VM
601953	108643939	21111015985	have	have	VHI
601953	108643939	21111015986	very	very	RG
601953	108643939	21111015987	limited	limited	JJ
601953	108643939	21111015988	recruitment	recruitment	NN1
601953	108643939	21111015989	,	,	,
601953	108643939	21111015990	if	if	CS
601953	108643939	21111015991	you	you	PPY
601953	108643939	21111015992	can	can	VM
601953	108643939	21111015993	have	have	VHI
601953	108643939	21111015994	greater	great	JJR
601953	108643939	21111015995	confidence	confidence	NN1
601953	108643939	21111015996	that	that	CST
601953	108643939	21111015997	they	they	PPHS2
601953	108643939	21111015998	will	will	VM
601953	108643939	21111015999	enroll	enroll	VVI
601953	108643939	21111016000	good	good	JJ
601953	108643939	21111016001	patients	patient	NN2
601953	108643939	21111016002	,	,	,
601953	108643939	21111016003	and	and	CC
601953	108643939	21111016004	provide	provide	VVI
601953	108643939	21111016005	high	high	JJ
601953	108643939	21111016006	quality	quality	NN1
601953	108643939	21111016007	data	data	NN
601953	108643939	21111016008	.	.	.
601953	108643940	21111016028	@@##	----------	----------
601953	108643940	21111016029	@@108643940		FO
601953	108643940	21111016030	@4043940/		VV0_JJ_NN1
601953	108643940	21111016031	<h>		NULL
601953	108643940	21111016032	ISCTM		NP1_NN1@_JJ@
601953	108643940	21111016033	9th	9th	MD
601953	108643940	21111016034	Annual	annual	JJ
601953	108643940	21111016035	Scientific	scientific	JJ
601953	108643940	21111016036	Meeting	meeting	NN1
601953	108643940	21111016037	<p>		NULL
601953	108643940	21111016038	February	february	NPM1
601953	108643940	21111016039	26	26	MC
601953	108643940	21111016040	,	,	,
601953	108643940	21111016041	2013	2013	MC
601953	108643940	21111016042	157705		MC
601953	108643940	21111016043	@qwx1017705		FO
601953	108643940	21111016044	<p>		NULL
601953	108643940	21111016045	The	the	AT
601953	108643940	21111016046	ISCTM		NP1_NN1@_JJ@
601953	108643940	21111016047	9th	9th	MD
601953	108643940	21111016048	Annual	annual	JJ
601953	108643940	21111016049	Scientific	scientific	JJ
601953	108643940	21111016050	Meeting	meeting	NN1
601953	108643940	21111016051	took	take	VVD
601953	108643940	21111016052	place	place	NN1
601953	108643940	21111016053	in	in	II
601953	108643940	21111016054	Washington	washington	NP1
601953	108643940	21111016055	,	,	,
601953	108643940	21111016056	D.C	d.c	NP1
601953	108643940	21111016057	on	on	II
601953	108643940	21111016058	19	19	MC
601953	108643940	21111016059	"	"	"
601953	108643940	21111016060	21	21	MC
601953	108643940	21111016061	February	february	NPM1
601953	108643940	21111016062	.	.	.
601953	108643940	21111016063	The	the	AT
601953	108643940	21111016064	International	international	JJ
601953	108643940	21111016065	Society	society	NN1
601953	108643940	21111016066	for	for	IF
601953	108643940	21111016067	CNS	cns	NP1
601953	108643940	21111016068	Clinical	clinical	JJ
601953	108643940	21111016069	Trials	trial	NN2
601953	108643940	21111016070	and	and	CC
601953	108643940	21111016071	Methodology	methodology	NN1
601953	108643940	21111016072	(	(	(
601953	108643940	21111016073	ISCTM		NP1
601953	108643940	21111016074	)	)	)
601953	108643940	21111016075	is	be	VBZ
601953	108643940	21111016076	a	a	AT1
601953	108643940	21111016077	multi-disciplinary	multidisciplinary	JJ
601953	108643940	21111016078	independent	independent	JJ
601953	108643940	21111016079	organization	organization	NN1
601953	108643940	21111016080	,	,	,
601953	108643940	21111016081	devoted	devote	VVD@_JJ
601953	108643940	21111016082	to	to	II
601953	108643940	21111016083	promoting	promote	VVG_JJ@
601953	108643940	21111016084	advances	advance	NN2_VVZ
601953	108643940	21111016085	that	that	CST_DD1
601953	108643940	21111016086	address	address	VV0@_NN1
601953	108643940	21111016087	strategic	strategic	JJ
601953	108643940	21111016088	clinical	clinical	JJ
601953	108643940	21111016089	,	,	,
601953	108643940	21111016090	regulatory	regulatory	JJ
601953	108643940	21111016091	,	,	,
601953	108643940	21111016092	methodological	methodological	JJ
601953	108643940	21111016093	and	and	CC
601953	108643940	21111016094	policy	policy	NN1
601953	108643940	21111016095	challenges	challenge	VVZ@_NN2
601953	108643940	21111016096	that	that	CST
601953	108643940	21111016097	arise	arise	VV0
601953	108643940	21111016098	in	in	II_RP@
601953	108643940	21111016099	the	the	AT
601953	108643940	21111016100	development	development	NN1
601953	108643940	21111016101	and	and	CC
601953	108643940	21111016102	use	use	NN1
601953	108643940	21111016103	of	of	IO
601953	108643940	21111016104	CNS	cns	NP1
601953	108643940	21111016105	therapeutic	therapeutic	JJ
601953	108643940	21111016106	agents	agent	NN2
601953	108643940	21111016107	.	.	.
601953	108643940	21111016108	<p>		NULL
601953	108643940	21111016109	The	the	AT
601953	108643940	21111016110	Annual	annual	JJ
601953	108643940	21111016111	Meeting	meeting	NN1
601953	108643940	21111016112	provided	provide	VVD_CS_VVN
601953	108643940	21111016113	an	a	AT1
601953	108643940	21111016114	impressive	impressive	JJ
601953	108643940	21111016115	agenda	agenda	NN1
601953	108643940	21111016116	addressing	address	VVG
601953	108643940	21111016117	the	the	AT
601953	108643940	21111016118	methodological	methodological	JJ
601953	108643940	21111016119	and	and	CC
601953	108643940	21111016120	regulatory	regulatory	JJ
601953	108643940	21111016121	issues	issue	NN2
601953	108643940	21111016122	that	that	CST
601953	108643940	21111016123	confound	confound	VV0_NN1
601953	108643940	21111016124	CNS	cns	NP1
601953	108643940	21111016125	drug	drug	NN1
601953	108643940	21111016126	development	development	NN1
601953	108643940	21111016127	.	.	.
601953	108643940	21111016128	Bracket	bracket	NN1
601953	108643940	21111016129	's	's	GE_VBZ
601953	108643940	21111016130	Adam	adam	NP1
601953	108643940	21111016131	Butler	butler	NP1
601953	108643940	21111016132	chaired	chair	VVD
601953	108643940	21111016133	the	the	AT
601953	108643940	21111016134	session	session	NNT1
601953	108643940	21111016135	,	,	,
601953	108643940	21111016136	-	-	-
601953	108643940	21111016137	Suicidal	suicidal	JJ
601953	108643940	21111016138	Ideation	ideation	NN1
601953	108643940	21111016139	and	and	CC
601953	108643940	21111016140	Behavior	behavior	NP1_NN1
601953	108643940	21111016141	:	:	:
601953	108643940	21111016142	Methodological	methodological	JJ
601953	108643940	21111016143	and	and	CC
601953	108643940	21111016144	Technical	technical	JJ
601953	108643940	21111016145	Challenges	challenge	NN2
601953	108643940	21111016146	,	,	,
601953	108643940	21111016147	along	along	II21
601953	108643940	21111016148	with	with	II22
601953	108643940	21111016149	Michelle	michelle	NP1
601953	108643940	21111016150	Stewart	stewart	NP1
601953	108643940	21111016151	,	,	,
601953	108643940	21111016152	PhD	phd	NNA
601953	108643940	21111016153	and	and	CC
601953	108643940	21111016154	Roger	roger	NP1
601953	108643940	21111016155	Meyer	meyer	NP1
601953	108643940	21111016156	,	,	,
601953	108643940	21111016157	MD	md	NNA
601953	108643940	21111016158	.	.	.
601953	108643940	21111016159	The	the	AT
601953	108643940	21111016160	symposium	symposium	NN1
601953	108643940	21111016161	tackled	tackle	VVN_VVD
601953	108643940	21111016162	such	such	DA
601953	108643940	21111016163	topics	topic	NN2
601953	108643940	21111016164	as	as	CSA
601953	108643940	21111016165	the-		JJ
601953	108643940	21111016166	Use	use	NN1
601953	108643940	21111016167	of	of	IO
601953	108643940	21111016168	the	the	AT
601953	108643940	21111016169	C-SSRS		NN2
601953	108643940	21111016170	in	in	II
601953	108643940	21111016171	Clinical	clinical	JJ
601953	108643940	21111016172	Trials	trial	NN2
601953	108643940	21111016173	:	:	:
601953	108643940	21111016174	Predicting	predict	VVG
601953	108643940	21111016175	Short-Term	short-term	JJ
601953	108643940	21111016176	Risk-		JJ_NN1
601953	108643940	21111016177	and-	and--	NN1
601953	108643940	21111016178	Detecting	detect	VVG
601953	108643940	21111016179	Clinical	clinical	JJ
601953	108643940	21111016180	Change	change	NN1
601953	108643940	21111016181	and	and	CC
601953	108643940	21111016182	Methodological	methodological	JJ
601953	108643940	21111016183	Approach	approach	NN1
601953	108643940	21111016184	to	to	II
601953	108643940	21111016185	the	the	AT
601953	108643940	21111016186	Use	use	NN1
601953	108643940	21111016187	and	and	CC
601953	108643940	21111016188	Interpretation	interpretation	NN1
601953	108643940	21111016189	of	of	IO
601953	108643940	21111016190	Baseline	baseline	NN1
601953	108643940	21111016191	History	history	NN1
601953	108643940	21111016192	of	of	IO
601953	108643940	21111016193	Suicidal	suicidal	JJ
601953	108643940	21111016194	Ideation	ideation	NN1
601953	108643940	21111016195	and	and	CC
601953	108643940	21111016196	Behavior	behavior	NP1_NN1
601953	108643940	21111016197	.	.	.
601953	108643940	21111016198	<p>		NULL
601953	108643940	21111016199	Bracket	bracket	NN1_VV0@
601953	108643940	21111016200	Subject	subject	NN1_JJ@
601953	108643940	21111016201	Matter	matter	NN1_VV0
601953	108643940	21111016202	Experts	expert	NN2
601953	108643940	21111016203	presented	present	VVD_VVN
601953	108643940	21111016204	a	a	AT1
601953	108643940	21111016205	total	total	NN1_JJ
601953	108643940	21111016206	of	of	IO
601953	108643940	21111016207	four	four	MC
601953	108643940	21111016208	scientific	scientific	JJ
601953	108643940	21111016209	posters	poster	NN2
601953	108643940	21111016210	at	at	II
601953	108643940	21111016211	the	the	AT
601953	108643940	21111016212	Meeting	meeting	NN1
601953	108643940	21111016213	as	as	RR21_RG
601953	108643940	21111016214	well	well	RR22_RR
601953	108643940	21111016215	:	:	:
601953	108643941	21111016235	@@##	----------	----------
601953	108643941	21111016236	@@108643941		FO
601953	108643941	21111016237	@4043941/		JJ_NN1_VV0
601953	108643941	21111016238	<h>		NULL
601953	108643941	21111016239	eBook	e-book	NN1
601953	108643941	21111016240	:	:	:
601953	108643941	21111016241	Improving	improve	VVG_JJ
601953	108643941	21111016242	Alzheimer	alzheimer	NP1
601953	108643941	21111016243	's	's	GE
601953	108643941	21111016244	Disease	disease	NN1
601953	108643941	21111016245	Clinical	clinical	JJ
601953	108643941	21111016246	Research	research	NN1
601953	108643941	21111016247	with	with	IW
601953	108643941	21111016248	Bracket	bracket	NN1
601953	108643941	21111016249	<h>		NULL
601953	108643941	21111016250	You	you	PPY
601953	108643941	21111016251	're	be	VBR
601953	108643941	21111016252	just	just	RR
601953	108643941	21111016253	a	a	AT1
601953	108643941	21111016254	click	click	NN1
601953	108643941	21111016255	away	away	II21
601953	108643941	21111016256	from	from	II22
601953	108643941	21111016257	new	new	JJ
601953	108643941	21111016258	information	information	NN1
601953	108643941	21111016259	on	on	II
601953	108643941	21111016260	the	the	AT
601953	108643941	21111016261	state	state	NN1
601953	108643941	21111016262	of	of	IO
601953	108643941	21111016263	Alzheimer	alzheimer	NP1
601953	108643941	21111016264	's	's	GE
601953	108643941	21111016265	disease	disease	NN1
601953	108643941	21111016266	clinical	clinical	JJ
601953	108643941	21111016267	trials	trial	NN2
601953	108643941	21111016268	.	.	.
601953	108643941	21111016269	<p>		NULL
601953	108643941	21111016270	Understanding	understand	VVG
601953	108643941	21111016271	the	the	AT
601953	108643941	21111016272	scope	scope	NN1
601953	108643941	21111016273	of	of	IO
601953	108643941	21111016274	how	how	RRQ
601953	108643941	21111016275	Alzheimer	alzheimer	NP1
601953	108643941	21111016276	's	's	GE
601953	108643941	21111016277	disease	disease	NN1
601953	108643941	21111016278	affects	affect	VVZ
601953	108643941	21111016279	people	people	NN
601953	108643941	21111016280	is	be	VBZ
601953	108643941	21111016281	difficult	difficult	JJ
601953	108643941	21111016282	.	.	.
601953	108643941	21111016283	Overall	overall	RR_NN1
601953	108643941	21111016284	,	,	,
601953	108643941	21111016285	its	its	APPGE
601953	108643941	21111016286	prevalence	prevalence	NN1
601953	108643941	21111016287	is	be	VBZ
601953	108643941	21111016288	increasing	increasing	JJ_VVG
601953	108643941	21111016289	and	and	CC
601953	108643941	21111016290	there	there	EX
601953	108643941	21111016291	is	be	VBZ
601953	108643941	21111016292	a	a	AT1
601953	108643941	21111016293	huge	huge	JJ
601953	108643941	21111016294	unmet	unmet	JJ
601953	108643941	21111016295	need	need	NN1
601953	108643941	21111016296	for	for	IF
601953	108643941	21111016297	successful	successful	JJ
601953	108643941	21111016298	trials	trial	NN2
601953	108643941	21111016299	and	and	CC
601953	108643941	21111016300	new	new	JJ
601953	108643941	21111016301	therapies	therapy	NN2
601953	108643941	21111016302	.	.	.
601953	108643941	21111016303	With	with	IW
601953	108643941	21111016304	the	the	AT
601953	108643941	21111016305	highest	high	JJT
601953	108643941	21111016306	trial	trial	NN1
601953	108643941	21111016307	failure	failure	NN1
601953	108643941	21111016308	rate	rate	NN1
601953	108643941	21111016309	of	of	IO
601953	108643941	21111016310	any	any	DD
601953	108643941	21111016311	therapeutic	therapeutic	JJ
601953	108643941	21111016312	area	area	NN1
601953	108643941	21111016313	at	at	II
601953	108643941	21111016314	99.6%	99.6%	FO
601953	108643941	21111016315	,	,	,
601953	108643941	21111016316	this	this	DD1
601953	108643941	21111016317	eBook	e-book	NN1
601953	108643941	21111016318	discusses	discuss	VVZ
601953	108643941	21111016319	the	the	AT
601953	108643941	21111016320	challenges	challenge	NN2
601953	108643941	21111016321	and	and	CC
601953	108643941	21111016322	how	how	RRQ
601953	108643941	21111016323	the	the	AT
601953	108643941	21111016324	emergence	emergence	NN1
601953	108643941	21111016325	of	of	IO
601953	108643941	21111016326	new	new	JJ
601953	108643941	21111016327	approaches	approach	NN2
601953	108643941	21111016328	and	and	CC
601953	108643941	21111016329	investments	investment	NN2
601953	108643941	21111016330	in	in	II
601953	108643941	21111016331	technology	technology	NN1
601953	108643941	21111016332	and	and	CC
601953	108643941	21111016333	research	research	NN1
601953	108643941	21111016334	are	be	VBR
601953	108643941	21111016335	paving	pave	VVG
601953	108643941	21111016336	a	a	AT1
601953	108643941	21111016337	path	path	NN1
601953	108643941	21111016338	forward	forward	RL
601953	108643941	21111016339	.	.	.
601953	108643944	21111016359	@@##	----------	----------
601953	108643944	21111016360	@@108643944		FO
601953	108643944	21111016361	@4043944/		NN1_VV0
601953	108643944	21111016362	<p>		NULL
601953	108643944	21111016363	Bracket	bracket	NN1_VV0@
601953	108643944	21111016364	,	,	,
601953	108643944	21111016365	a	a	AT1
601953	108643944	21111016366	leading	leading	JJ
601953	108643944	21111016367	clinical	clinical	JJ
601953	108643944	21111016368	trial	trial	NN1
601953	108643944	21111016369	specialty	specialty	NN1
601953	108643944	21111016370	services	service	NN2
601953	108643944	21111016371	provider	provider	NN1
601953	108643944	21111016372	,	,	,
601953	108643944	21111016373	today	today	RT
601953	108643944	21111016374	announced	announce	VVD_VVN
601953	108643944	21111016375	the	the	AT
601953	108643944	21111016376	addition	addition	NN1
601953	108643944	21111016377	of	of	IO
601953	108643944	21111016378	J.		NP1
601953	108643944	21111016379	Matthew	matthew	NP1
601953	108643944	21111016380	Bond	bond	NP1
601953	108643944	21111016381	as	as	CSA_RG@_II@
601953	108643944	21111016382	Chief	chief	JJ
601953	108643944	21111016383	Financial	financial	JJ
601953	108643944	21111016384	Officer	officer	NN1
601953	108643944	21111016385	and	and	CC
601953	108643944	21111016386	as	as	II_CSA
601953	108643944	21111016387	a	a	AT1
601953	108643944	21111016388	member	member	NN1
601953	108643944	21111016389	of	of	IO
601953	108643944	21111016390	the	the	AT
601953	108643944	21111016391	companys	company	NN2
601953	108643944	21111016392	leadership	leadership	NN1
601953	108643944	21111016393	team	team	NN1
601953	108643944	21111016394	.	.	.
601953	108643944	21111016395	<p>		NULL
601953	108643944	21111016396	Matt	matt	NP1
601953	108643944	21111016397	brings	bring	VVZ
601953	108643944	21111016398	more	more	DAR
601953	108643944	21111016399	than	than	CSN
601953	108643944	21111016400	25	25	MC
601953	108643944	21111016401	years	year	NNT2
601953	108643944	21111016402	of	of	IO
601953	108643944	21111016403	experience	experience	NN1
601953	108643944	21111016404	to	to	II
601953	108643944	21111016405	Bracket	bracket	NN1
601953	108643944	21111016406	,	,	,
601953	108643944	21111016407	primarily	primarily	RR
601953	108643944	21111016408	through	through	II
601953	108643944	21111016409	leadership	leadership	NN1
601953	108643944	21111016410	positions	position	NN2_VVZ@
601953	108643944	21111016411	in	in	II
601953	108643944	21111016412	growth	growth	NN1
601953	108643944	21111016413	oriented	orient	VVD
601953	108643944	21111016414	,	,	,
601953	108643944	21111016415	pharmaceutical	pharmaceutical	JJ
601953	108643944	21111016416	outsourcing	outsourcing	JJ@_NN1@
601953	108643944	21111016417	firms	firm	NN2
601953	108643944	21111016418	.	.	.
601953	108643944	21111016419	Most	most	RGT
601953	108643944	21111016420	recently	recently	RR
601953	108643944	21111016421	,	,	,
601953	108643944	21111016422	Matt	matt	NP1
601953	108643944	21111016423	co-founded	co-found	VVD
601953	108643944	21111016424	and	and	CC
601953	108643944	21111016425	served	serve	VVD_VVN
601953	108643944	21111016426	as	as	II_CSA
601953	108643944	21111016427	the	the	AT
601953	108643944	21111016428	CFO	cfo	NN1
601953	108643944	21111016429	of	of	IO
601953	108643944	21111016430	Aptiv		NN1_NP1
601953	108643944	21111016431	Solutions	solution	NN2
601953	108643944	21111016432	,	,	,
601953	108643944	21111016433	a	a	AT1
601953	108643944	21111016434	mid-size	mid-size	NN1_JJ
601953	108643944	21111016435	,	,	,
601953	108643944	21111016436	specialized	specialized	JJ_VVD
601953	108643944	21111016437	contract	contract	NN1
601953	108643944	21111016438	research	research	NN1
601953	108643944	21111016439	organization	organization	NN1
601953	108643944	21111016440	focused	focus	VVN_VVD
601953	108643944	21111016441	on	on	II
601953	108643944	21111016442	adaptive	adaptive	JJ
601953	108643944	21111016443	methods	method	NN2
601953	108643944	21111016444	for	for	IF
601953	108643944	21111016445	biopharmaceutical	biopharmaceutical	JJ
601953	108643944	21111016446	clinical	clinical	JJ
601953	108643944	21111016447	development	development	NN1
601953	108643944	21111016448	and	and	CC
601953	108643944	21111016449	in	in	II
601953	108643944	21111016450	the	the	AT
601953	108643944	21111016451	medical	medical	JJ
601953	108643944	21111016452	device	device	NN1
601953	108643944	21111016453	approval	approval	NN1
601953	108643944	21111016454	market	market	NN1
601953	108643944	21111016455	.	.	.
601953	108643944	21111016456	During	during	II
601953	108643944	21111016457	his	his	APPGE
601953	108643944	21111016458	tenure	tenure	NN1
601953	108643944	21111016459	,	,	,
601953	108643944	21111016460	he	he	PPHS1
601953	108643944	21111016461	grew	grow	VVD
601953	108643944	21111016462	the	the	AT
601953	108643944	21111016463	business	business	NN1
601953	108643944	21111016464	from	from	II
601953	108643944	21111016465	its	its	APPGE
601953	108643944	21111016466	startup	start-up	NN1
601953	108643944	21111016467	phase	phase	NN1
601953	108643944	21111016468	to	to	II
601953	108643944	21111016469	a	a	AT1
601953	108643944	21111016470	large	large	JJ
601953	108643944	21111016471	multi-national	multinational	JJ
601953	108643944	21111016472	organization	organization	NN1
601953	108643944	21111016473	primarily	primarily	RR
601953	108643944	21111016474	through	through	II
601953	108643944	21111016475	a	a	AT1
601953	108643944	21111016476	series	series	NN
601953	108643944	21111016477	of	of	IO
601953	108643944	21111016478	strategic	strategic	JJ
601953	108643944	21111016479	acquisitions	acquisition	NN2
601953	108643944	21111016480	,	,	,
601953	108643944	21111016481	and	and	CC
601953	108643944	21111016482	was	be	VBDZ
601953	108643944	21111016483	the	the	AT
601953	108643944	21111016484	recognized	recognized	JJ@
601953	108643944	21111016485	leader	leader	NN1
601953	108643944	21111016486	in	in	II
601953	108643944	21111016487	the	the	AT
601953	108643944	21111016488	development	development	NN1
601953	108643944	21111016489	and	and	CC
601953	108643944	21111016490	execution	execution	NN1
601953	108643944	21111016491	of	of	IO
601953	108643944	21111016492	adaptive	adaptive	JJ
601953	108643944	21111016493	clinical	clinical	JJ
601953	108643944	21111016494	trials	trial	NN2
601953	108643944	21111016495	until	until	CS_II@
601953	108643944	21111016496	its	its	APPGE
601953	108643944	21111016497	acquisition	acquisition	NN1
601953	108643944	21111016498	in	in	II
601953	108643944	21111016499	2014	2014	MC
601953	108643944	21111016500	.	.	.
601953	108643944	21111016501	Previously	previously	RR
601953	108643944	21111016502	,	,	,
601953	108643944	21111016503	Matt	matt	NP1
601953	108643944	21111016504	was	be	VBDZ
601953	108643944	21111016505	Executive	executive	JJ@_NN1
601953	108643944	21111016506	Vice	vice	JJ_NN1_II
601953	108643944	21111016507	President	president	NN1
601953	108643944	21111016508	and	and	CC
601953	108643944	21111016509	CFO	cfo	NN1
601953	108643944	21111016510	of	of	IO
601953	108643944	21111016511	a	a	AT1
601953	108643944	21111016512	global	global	JJ
601953	108643944	21111016513	,	,	,
601953	108643944	21111016514	growth	growth	NN1
601953	108643944	21111016515	oriented	orient	VVD
601953	108643944	21111016516	CRO	cro	NP1_NN1
601953	108643944	21111016517	,	,	,
601953	108643944	21111016518	where	where	CS_RRQ
601953	108643944	21111016519	over	over	RG
601953	108643944	21111016520	6	6	MC
601953	108643944	21111016521	years	year	NNT2
601953	108643944	21111016522	he	he	PPHS1
601953	108643944	21111016523	led	lead	VVD
601953	108643944	21111016524	a	a	AT1
601953	108643944	21111016525	very	very	RG
601953	108643944	21111016526	successful	successful	JJ
601953	108643944	21111016527	initial	initial	JJ_NN1
601953	108643944	21111016528	public	public	JJ_NN1
601953	108643944	21111016529	offering	offering	NN1_VVG
601953	108643944	21111016530	and	and	CC
601953	108643944	21111016531	created	create	VVD_VVN
601953	108643944	21111016532	significant	significant	JJ
601953	108643944	21111016533	value	value	NN1
601953	108643944	21111016534	for	for	IF
601953	108643944	21111016535	the	the	AT
601953	108643944	21111016536	various	various	JJ
601953	108643944	21111016537	stakeholders	stakeholder	NN2
601953	108643944	21111016538	.	.	.
601953	108643944	21111016539	<p>		NULL
601953	108643944	21111016540	"	"	"
601953	108643944	21111016541	I	i	PPIS1_MC1%
601953	108643944	21111016542	could n't		VV0_NN1
601953	108643944	21111016543	be	be	VBI
601953	108643944	21111016544	more	more	RGR_RRR
601953	108643944	21111016545	thrilled	thrilled	JJ_VVN_VVD
601953	108643944	21111016546	to	to	TO
601953	108643944	21111016547	welcome	welcome	VVI
601953	108643944	21111016548	Matt	matt	NP1
601953	108643944	21111016549	to	to	II
601953	108643944	21111016550	Bracket	bracket	NN1
601953	108643944	21111016551	@		II
601953	108643944	21111016552	@		II
601953	108643944	21111016553	@		II
601953	108643944	21111016554	@		II
601953	108643944	21111016555	@		II
601953	108643944	21111016556	@		II
601953	108643944	21111016557	@		II
601953	108643944	21111016558	@		II
601953	108643944	21111016559	@		II
601953	108643944	21111016560	@		II
601953	108643944	21111016561	said	say	VVD
601953	108643944	21111016562	Jeff	jeff	NP1
601953	108643944	21111016563	Kinell		NP1
601953	108643944	21111016564	,	,	,
601953	108643944	21111016565	president	president	NN1
601953	108643944	21111016566	and	and	CC
601953	108643944	21111016567	CEO	ceo	NN1
601953	108643944	21111016568	of	of	IO
601953	108643944	21111016569	Bracket	bracket	NN1
601953	108643944	21111016570	.	.	.
601953	108643944	21111016571	"	"	"
601953	108643944	21111016572	I	i	PPIS1
601953	108643944	21111016573	am	be	VBM
601953	108643944	21111016574	particularly	particularly	RR
601953	108643944	21111016575	impressed	impress	VVN_VVD
601953	108643944	21111016576	with	with	IW
601953	108643944	21111016577	Matts	matt	NP2
601953	108643944	21111016578	ability	ability	NN1
601953	108643944	21111016579	to	to	TO
601953	108643944	21111016580	lead	lead	VVI
601953	108643944	21111016581	a	a	AT1
601953	108643944	21111016582	financial	financial	JJ
601953	108643944	21111016583	function	function	NN1
601953	108643944	21111016584	in	in	II
601953	108643944	21111016585	a	a	AT1
601953	108643944	21111016586	complex	complex	JJ_NN1
601953	108643944	21111016587	,	,	,
601953	108643944	21111016588	industry-leading	industry-leading	JJ_NN1
601953	108643944	21111016589	business	business	NN1
601953	108643944	21111016590	,	,	,
601953	108643944	21111016591	while	while	CS
601953	108643944	21111016592	maintaining	maintain	VVG
601953	108643944	21111016593	an	a	AT1
601953	108643944	21111016594	unrelenting	unrelenting	JJ
601953	108643944	21111016595	focus	focus	NN1
601953	108643944	21111016596	on	on	II
601953	108643944	21111016597	serving	serve	VVG
601953	108643944	21111016598	and	and	CC
601953	108643944	21111016599	advocating	advocate	VVG
601953	108643944	21111016600	for	for	IF
601953	108643944	21111016601	his	his	APPGE
601953	108643944	21111016602	companys	company	NN2
601953	108643944	21111016603	customers	customer	NN2
601953	108643944	21111016604	.	.	.
601953	108643944	21111016605	"	"	"
601953	108643944	21111016606	<p>		NULL
601953	108643944	21111016607	"	"	"
601953	108643944	21111016608	I	i	MC1%_PPIS1
601953	108643944	21111016609	cant	cant	NN1_JJ
601953	108643944	21111016610	imagine	imagine	VV0
601953	108643944	21111016611	a	a	AT1
601953	108643944	21111016612	more	more	RGR
601953	108643944	21111016613	exciting	exciting	JJ
601953	108643944	21111016614	time	time	NNT1
601953	108643944	21111016615	to	to	TO
601953	108643944	21111016616	join	join	VVI
601953	108643944	21111016617	Bracket	bracket	NN1
601953	108643944	21111016618	,	,	,
601953	108643944	21111016619	"	"	"
601953	108643944	21111016620	Mr.		NNB
601953	108643944	21111016621	Bond	bond	NP1
601953	108643944	21111016622	said	say	VVD
601953	108643944	21111016623	.	.	.
601953	108643944	21111016624	"	"	"
601953	108643944	21111016625	Bracket	bracket	NN1
601953	108643944	21111016626	is	be	VBZ
601953	108643944	21111016627	leading	lead	VVG
601953	108643944	21111016628	the	the	AT
601953	108643944	21111016629	transformation	transformation	NN1
601953	108643944	21111016630	of	of	IO
601953	108643944	21111016631	eCOA		NN1
601953	108643944	21111016632	,	,	,
601953	108643944	21111016633	RTSM		NP1
601953	108643944	21111016634	and	and	CC
601953	108643944	21111016635	Rater	rater	NP1
601953	108643944	21111016636	Training	training	NN1
601953	108643944	21111016637	.	.	.
601953	108643944	21111016638	Jeff	jeff	NP1
601953	108643944	21111016639	and	and	CC
601953	108643944	21111016640	the	the	AT
601953	108643944	21111016641	leadership	leadership	NN1
601953	108643944	21111016642	team	team	NN1
601953	108643944	21111016643	recognize	recognize	VV0
601953	108643944	21111016644	and	and	CC
601953	108643944	21111016645	appreciate	appreciate	VV0
601953	108643944	21111016646	that	that	DD1_CST
601953	108643944	21111016647	they 're		NN1
601953	108643944	21111016648	making	make	VVG_NN1@
601953	108643944	21111016649	history	history	NN1
601953	108643944	21111016650	,	,	,
601953	108643944	21111016651	and	and	CC
601953	108643944	21111016652	I 'm		VV0_NP1
601953	108643944	21111016653	delighted	delighted	JJ
601953	108643944	21111016654	to	to	TO
601953	108643944	21111016655	be	be	VBI
601953	108643944	21111016656	a	a	AT1
601953	108643944	21111016657	part	part	NN1
601953	108643944	21111016658	of	of	IO
601953	108643944	21111016659	it	it	PPH1
601953	108643944	21111016660	.	.	.
601953	108643944	21111016661	"	"	"
601953	108643944	21111016662	<p>		NULL
601953	108643944	21111016663	"	"	"
601953	108643944	21111016664	Matt	matt	NP1
601953	108643944	21111016665	is	be	VBZ
601953	108643944	21111016666	extremely	extremely	RR
601953	108643944	21111016667	well	well	RR
601953	108643944	21111016668	qualified	qualify	VVN_JJ
601953	108643944	21111016669	to	to	TO
601953	108643944	21111016670	serve	serve	VVI
601953	108643944	21111016671	as	as	CSA_II@
601953	108643944	21111016672	CFO	cfo	NP1_NN1
601953	108643944	21111016673	,	,	,
601953	108643944	21111016674	"	"	"
601953	108643944	21111016675	said	say	VVD
601953	108643944	21111016676	Dave	dave	NP1
601953	108643944	21111016677	Ament	ament	NP1
601953	108643944	21111016678	,	,	,
601953	108643944	21111016679	Managing	managing	JJ_VVG
601953	108643944	21111016680	Partner	partner	NN1
601953	108643944	21111016681	,	,	,
601953	108643944	21111016682	Boston	boston	NP1
601953	108643944	21111016683	office	office	NN1
601953	108643944	21111016684	head	head	NN1
601953	108643944	21111016685	,	,	,
601953	108643944	21111016686	Parthenon	parthenon	NP1_NN1
601953	108643944	21111016687	Capital	capital	NN1_JJ@
601953	108643944	21111016688	Partners	partner	NN2
601953	108643944	21111016689	and	and	CC
601953	108643944	21111016690	lead	lead	VV0_NN1
601953	108643944	21111016691	director	director	NN1
601953	108643944	21111016692	of	of	IO
601953	108643944	21111016693	Bracket	bracket	NN1
601953	108643944	21111016694	.	.	.
601953	108643944	21111016695	"	"	"
601953	108643944	21111016696	His	his	APPGE
601953	108643944	21111016697	deep	deep	JJ
601953	108643944	21111016698	leadership	leadership	NN1
601953	108643944	21111016699	experience	experience	NN1
601953	108643944	21111016700	will	will	VM
601953	108643944	21111016701	be	be	VBI
601953	108643944	21111016702	a	a	AT1
601953	108643944	21111016703	strong	strong	JJ
601953	108643944	21111016704	complement	complement	NN1
601953	108643944	21111016705	to	to	II
601953	108643944	21111016706	our	our	APPGE
601953	108643944	21111016707	leadership	leadership	NN1
601953	108643944	21111016708	team	team	NN1
601953	108643944	21111016709	and	and	CC
601953	108643944	21111016710	will	will	VM
601953	108643944	21111016711	be	be	VBI
601953	108643944	21111016712	invaluable	invaluable	JJ
601953	108643944	21111016713	as	as	CSA
601953	108643944	21111016714	we	we	PPIS2
601953	108643944	21111016715	continue	continue	VV0
601953	108643944	21111016716	to	to	TO
601953	108643944	21111016717	drive	drive	VVI
601953	108643944	21111016718	our	our	APPGE
601953	108643944	21111016719	strategic	strategic	JJ
601953	108643944	21111016720	and	and	CC
601953	108643944	21111016721	financial	financial	JJ
601953	108643944	21111016722	business	business	NN1
601953	108643944	21111016723	transformation	transformation	NN1
601953	108643944	21111016724	.	.	.
601953	108643944	21111016725	"	"	"
601953	108643944	21111016726	<h>		NULL
601953	108643944	21111016727	About	about	II
601953	108643944	21111016728	Bracket	bracket	NN1
601953	108643944	21111016729	<p>		NULL
601953	108643944	21111016730	Bracket	bracket	NN1_VV0@
601953	108643944	21111016731	,	,	,
601953	108643944	21111016732	with	with	IW
601953	108643944	21111016733	seven	seven	MC
601953	108643944	21111016734	offices	office	NN2
601953	108643944	21111016735	and	and	CC
601953	108643944	21111016736	more	more	DAR
601953	108643944	21111016737	than	than	CSN
601953	108643944	21111016738	500	500	MC
601953	108643944	21111016739	employees	employee	NN2
601953	108643944	21111016740	worldwide	worldwide	RL
601953	108643944	21111016741	,	,	,
601953	108643944	21111016742	is	be	VBZ
601953	108643944	21111016743	a	a	AT1
601953	108643944	21111016744	specialty	specialty	NN1
601953	108643944	21111016745	services	service	NN2
601953	108643944	21111016746	provider	provider	NN1
601953	108643944	21111016747	dedicated	dedicate	VVN_VVD
601953	108643944	21111016748	to	to	II
601953	108643944	21111016749	helping	help	VVG
601953	108643944	21111016750	biopharmaceutical	biopharmaceutical	JJ
601953	108643944	21111016751	@		II
601953	108643944	21111016752	@		II
601953	108643944	21111016753	@		II
601953	108643944	21111016754	@		II
601953	108643944	21111016755	@		II
601953	108643944	21111016756	@		II
601953	108643944	21111016757	@		II
601953	108643944	21111016758	@		II
601953	108643944	21111016759	@		II
601953	108643944	21111016760	@		II
601953	108643944	21111016761	clinical	clinical	JJ
601953	108643944	21111016762	research	research	NN1
601953	108643944	21111016763	data	data	NN
601953	108643944	21111016764	by	by	II
601953	108643944	21111016765	leveraging	leverage	VVG_JJ@
601953	108643944	21111016766	core	core	NN1
601953	108643944	21111016767	competencies	competency	NN2
601953	108643944	21111016768	in	in	II
601953	108643944	21111016769	Science	science	NN1
601953	108643944	21111016770	,	,	,
601953	108643944	21111016771	Technology	technology	NN1
601953	108643944	21111016772	,	,	,
601953	108643944	21111016773	and	and	CC
601953	108643944	21111016774	Service	service	NN1
601953	108643944	21111016775	.	.	.
601953	108643944	21111016776	Bracket	bracket	NN1_VV0@
601953	108643944	21111016777	eCOAG		NN1
601953	108643944	21111016778	is	be	VBZ
601953	108643944	21111016779	a	a	AT1
601953	108643944	21111016780	flexible	flexible	JJ
601953	108643944	21111016781	platform	platform	NN1
601953	108643944	21111016782	for	for	IF
601953	108643944	21111016783	electronic	electronic	JJ
601953	108643944	21111016784	clinical	clinical	JJ
601953	108643944	21111016785	outcomes	outcome	NN2
601953	108643944	21111016786	assessments	assessment	NN2
601953	108643944	21111016787	.	.	.
601953	108643944	21111016788	Bracket	bracket	VV0@_NN1
601953	108643944	21111016789	RTSMG		NP1
601953	108643944	21111016790	is	be	VBZ
601953	108643944	21111016791	a	a	AT1
601953	108643944	21111016792	best-in-breed		NN1_JJ
601953	108643944	21111016793	,	,	,
601953	108643944	21111016794	scalable	scalable	JJ
601953	108643944	21111016795	and	and	CC
601953	108643944	21111016796	configurable	configurable	JJ
601953	108643944	21111016797	clinical	clinical	JJ
601953	108643944	21111016798	IRT	irt	NN1
601953	108643944	21111016799	solution	solution	NN1
601953	108643944	21111016800	for	for	IF
601953	108643944	21111016801	the	the	AT
601953	108643944	21111016802	life	life	NN1
601953	108643944	21111016803	sciences	science	NN2
601953	108643944	21111016804	industry	industry	NN1
601953	108643944	21111016805	.	.	.
601953	108643944	21111016806	Bracket	bracket	VV0@_NN1
601953	108643944	21111016807	Rater	rater	NP1
601953	108643944	21111016808	Training	training	NN1
601953	108643944	21111016809	and	and	CC
601953	108643944	21111016810	Quality	quality	NN1
601953	108643944	21111016811	Assurance	assurance	NN1
601953	108643944	21111016812	improve	improve	VV0
601953	108643944	21111016813	outcomes	outcome	NN2
601953	108643944	21111016814	through	through	II
601953	108643944	21111016815	customized	customized	JJ@
601953	108643944	21111016816	training	training	NN1
601953	108643944	21111016817	and	and	CC
601953	108643944	21111016818	quality	quality	NN1
601953	108643944	21111016819	assurance	assurance	NN1
601953	108643944	21111016820	programs	program	NN2
601953	108643944	21111016821	.	.	.
601953	108643949	21111016841	@@##	----------	----------
601953	108643949	21111016842	@@108643949		FO
601953	108643949	21111016843	@4043949/		JJ_NN1_VV0
601953	108643949	21111016844	<h>		NULL
601953	108643949	21111016845	eBook	e-book	NN1
601953	108643949	21111016846	:	:	:
601953	108643949	21111016847	Bracket	bracket	NN1_VV0@
601953	108643949	21111016848	eCOAG		NN1
601953	108643949	21111016849	and	and	CC
601953	108643949	21111016850	Bracket	bracket	NN1_VV0@
601953	108643949	21111016851	RTSMG		NP1
601953	108643949	21111016852	<h>		NULL
601953	108643949	21111016853	You	you	PPY
601953	108643949	21111016854	're	be	VBR
601953	108643949	21111016855	just	just	RR
601953	108643949	21111016856	a	a	AT1
601953	108643949	21111016857	click	click	NN1
601953	108643949	21111016858	away	away	II21
601953	108643949	21111016859	from	from	II22
601953	108643949	21111016860	new	new	JJ
601953	108643949	21111016861	information	information	NN1
601953	108643949	21111016862	on	on	II
601953	108643949	21111016863	the	the	AT
601953	108643949	21111016864	exceptional	exceptional	JJ
601953	108643949	21111016865	integration	integration	NN1
601953	108643949	21111016866	of	of	IO
601953	108643949	21111016867	Bracket	bracket	NN1
601953	108643949	21111016868	's	's	GE
601953	108643949	21111016869	eCOA		NN1
601953	108643949	21111016870	and	and	CC
601953	108643949	21111016871	RTSM		NP1
601953	108643949	21111016872	solutions	solution	NN2
601953	108643949	21111016873	.	.	.
601953	108643949	21111016874	<p>		NULL
601953	108643949	21111016875	Bracket	bracket	NN1
601953	108643949	21111016876	is	be	VBZ
601953	108643949	21111016877	the	the	AT
601953	108643949	21111016878	first	first	MD
601953	108643949	21111016879	clinical	clinical	JJ
601953	108643949	21111016880	trial	trial	NN1
601953	108643949	21111016881	specialty	specialty	NN1
601953	108643949	21111016882	services	service	NN2
601953	108643949	21111016883	provider	provider	NN1
601953	108643949	21111016884	to	to	TO
601953	108643949	21111016885	offer	offer	VVI
601953	108643949	21111016886	the	the	AT
601953	108643949	21111016887	unique	unique	JJ
601953	108643949	21111016888	integration	integration	NN1
601953	108643949	21111016889	of	of	IO
601953	108643949	21111016890	electronic	electronic	JJ
601953	108643949	21111016891	clinical	clinical	JJ
601953	108643949	21111016892	outcomes	outcome	NN2
601953	108643949	21111016893	assessments	assessment	NN2
601953	108643949	21111016894	,	,	,
601953	108643949	21111016895	Bracket	bracket	NN1_VV0@
601953	108643949	21111016896	eCOAG		NN1_VV0
601953	108643949	21111016897	,	,	,
601953	108643949	21111016898	and	and	CC
601953	108643949	21111016899	randomization	randomization	NN1
601953	108643949	21111016900	and	and	CC
601953	108643949	21111016901	trial	trial	NN1
601953	108643949	21111016902	supply	supply	NN1_VV0
601953	108643949	21111016903	management	management	NN1
601953	108643949	21111016904	,	,	,
601953	108643949	21111016905	Bracket	bracket	NN1_VV0@
601953	108643949	21111016906	RTSMG		NP1
601953	108643949	21111016907	.	.	.
601953	108643949	21111016908	Their	their	APPGE
601953	108643949	21111016909	seamless	seamless	JJ
601953	108643949	21111016910	integration	integration	NN1
601953	108643949	21111016911	is	be	VBZ
601953	108643949	21111016912	further	far	RRR
601953	108643949	21111016913	supported	support	VVN
601953	108643949	21111016914	by	by	II
601953	108643949	21111016915	Bracket	bracket	NN1
601953	108643949	21111016916	's	's	GE
601953	108643949	21111016917	development	development	NN1
601953	108643949	21111016918	of	of	IO
601953	108643949	21111016919	the	the	AT
601953	108643949	21111016920	first	first	MD
601953	108643949	21111016921	native	native	JJ_NN1@
601953	108643949	21111016922	RTSM		NP1
601953	108643949	21111016923	mobile	mobile	JJ_NN1
601953	108643949	21111016924	application	application	NN1
601953	108643949	21111016925	for	for	IF
601953	108643949	21111016926	Android	android	NN1
601953	108643949	21111016927	and	and	CC
601953	108643949	21111016928	iOS		NN2
601953	108643949	21111016929	devices	device	NN2
601953	108643949	21111016930	.	.	.
601953	108643949	21111016931	<p>		NULL
601953	108643949	21111016932	This	this	DD1
601953	108643949	21111016933	eBook	e-book	NN1
601953	108643949	21111016934	discusses	discuss	VVZ
601953	108643949	21111016935	Bracket	bracket	NN1
601953	108643949	21111016936	's	's	GE
601953	108643949	21111016937	eCOA		NN1
601953	108643949	21111016938	and	and	CC
601953	108643949	21111016939	RTSM		NP1
601953	108643949	21111016940	as	as	II_CSA
601953	108643949	21111016941	a	a	AT1
601953	108643949	21111016942	single	single	JJ
601953	108643949	21111016943	platform	platform	NN1
601953	108643949	21111016944	that	that	CST_DD1
601953	108643949	21111016945	can	can	VM
601953	108643949	21111016946	support	support	VVI
601953	108643949	21111016947	the	the	AT
601953	108643949	21111016948	logistics	logistics	NN1
601953	108643949	21111016949	and	and	CC
601953	108643949	21111016950	supply	supply	VVI
601953	108643949	21111016951	chain	chain	NN1
601953	108643949	21111016952	management	management	NN1
601953	108643949	21111016953	of	of	IO
601953	108643949	21111016954	clinical	clinical	JJ
601953	108643949	21111016955	trials	trial	NN2
601953	108643949	21111016956	and	and	CC
601953	108643949	21111016957	ensure	ensure	VV0
601953	108643949	21111016958	the	the	AT
601953	108643949	21111016959	interconnectivity	interconnectivity	NN1
601953	108643949	21111016960	of	of	IO
601953	108643949	21111016961	tech-enabled		JJ
601953	108643949	21111016962	clinical	clinical	JJ
601953	108643949	21111016963	trials	trial	NN2
601953	108643949	21111016964	.	.	.
601953	108643950	21111016984	@@##	----------	----------
601953	108643950	21111016985	@@108643950		FO
601953	108643950	21111016986	@4043950/		NN1_VV0
601953	108643950	21111016987	<p>		NULL
601953	108643950	21111016988	Wayne	wayne	NP1
601953	108643950	21111016989	,	,	,
601953	108643950	21111016990	PA.		NN1
601953	108643950	21111016991	,	,	,
601953	108643950	21111016992	-	-	-
601953	108643950	21111016993	-	-	-
601953	108643950	21111016994	Bracket	bracket	NN1_VV0@
601953	108643950	21111016995	,	,	,
601953	108643950	21111016996	a	a	AT1
601953	108643950	21111016997	leading	leading	JJ
601953	108643950	21111016998	clinical	clinical	JJ
601953	108643950	21111016999	trial	trial	NN1
601953	108643950	21111017000	technology	technology	NN1
601953	108643950	21111017001	and	and	CC
601953	108643950	21111017002	specialty	specialty	NN1
601953	108643950	21111017003	services	service	NN2
601953	108643950	21111017004	provider	provider	NN1
601953	108643950	21111017005	,	,	,
601953	108643950	21111017006	today	today	RT
601953	108643950	21111017007	announced	announce	VVD_VVN
601953	108643950	21111017008	an	a	AT1
601953	108643950	21111017009	agreement	agreement	NN1
601953	108643950	21111017010	with	with	IW
601953	108643950	21111017011	the	the	AT
601953	108643950	21111017012	International	international	JJ
601953	108643950	21111017013	Parkinson	parkinson	NP1
601953	108643950	21111017014	and	and	CC
601953	108643950	21111017015	Movement	movement	NN1
601953	108643950	21111017016	Disorder	disorder	NN1
601953	108643950	21111017017	Society	society	NN1
601953	108643950	21111017018	(	(	(
601953	108643950	21111017019	MDS	md	NN2_NP2@
601953	108643950	21111017020	)	)	)
601953	108643950	21111017021	,	,	,
601953	108643950	21111017022	to	to	TO
601953	108643950	21111017023	develop	develop	VVI
601953	108643950	21111017024	electronic	electronic	JJ
601953	108643950	21111017025	versions	version	NN2
601953	108643950	21111017026	of	of	IO
601953	108643950	21111017027	the	the	AT
601953	108643950	21111017028	MDS-Unified		JJ
601953	108643950	21111017029	Parkinsons	parkinson	NP2
601953	108643950	21111017030	disease	disease	NN1
601953	108643950	21111017031	Rating	rating	NN1
601953	108643950	21111017032	Scale	scale	NN1
601953	108643950	21111017033	(	(	(
601953	108643950	21111017034	MDS-UPDRS		NN2
601953	108643950	21111017035	)	)	)
601953	108643950	21111017036	and	and	CC
601953	108643950	21111017037	the	the	AT
601953	108643950	21111017038	Unified	unified	JJ
601953	108643950	21111017039	Dyskinesia		NN1@_NP1
601953	108643950	21111017040	Rating	rating	NN1
601953	108643950	21111017041	Scale	scale	NN1
601953	108643950	21111017042	(	(	(
601953	108643950	21111017043	UDysRS		NP1_VVZ
601953	108643950	21111017044	)	)	)
601953	108643950	21111017045	.	.	.
601953	108643950	21111017046	The	the	AT
601953	108643950	21111017047	migration	migration	NN1
601953	108643950	21111017048	of	of	IO
601953	108643950	21111017049	these	these	DD2
601953	108643950	21111017050	complex	complex	JJ
601953	108643950	21111017051	scales	scale	NN2
601953	108643950	21111017052	to	to	II
601953	108643950	21111017053	an	a	AT1
601953	108643950	21111017054	electronic	electronic	JJ
601953	108643950	21111017055	clinical	clinical	JJ
601953	108643950	21111017056	outcome	outcome	NN1
601953	108643950	21111017057	assessment	assessment	NN1
601953	108643950	21111017058	(	(	(
601953	108643950	21111017059	eCOA		NN1
601953	108643950	21111017060	)	)	)
601953	108643950	21111017061	format	format	NN1_VV0
601953	108643950	21111017062	aims	aim	VVZ_NN2
601953	108643950	21111017063	to	to	TO
601953	108643950	21111017064	improve	improve	VVI
601953	108643950	21111017065	trial	trial	NN1
601953	108643950	21111017066	conduct	conduct	NN1
601953	108643950	21111017067	and	and	CC
601953	108643950	21111017068	data	data	NN
601953	108643950	21111017069	quality	quality	NN1
601953	108643950	21111017070	for	for	IF
601953	108643950	21111017071	Parkinsons	parkinson	NP2
601953	108643950	21111017072	disease	disease	NN1
601953	108643950	21111017073	(	(	(
601953	108643950	21111017074	PD	pd	NP1
601953	108643950	21111017075	)	)	)
601953	108643950	21111017076	studies	study	NN2
601953	108643950	21111017077	.	.	.
601953	108643950	21111017078	<p>		NULL
601953	108643950	21111017079	The	the	AT
601953	108643950	21111017080	increasing	increasing	JJ
601953	108643950	21111017081	prominence	prominence	NN1
601953	108643950	21111017082	of	of	IO
601953	108643950	21111017083	PD	pd	NP1
601953	108643950	21111017084	,	,	,
601953	108643950	21111017085	a	a	AT1
601953	108643950	21111017086	progressive	progressive	JJ
601953	108643950	21111017087	disorder	disorder	NN1
601953	108643950	21111017088	of	of	IO
601953	108643950	21111017089	the	the	AT
601953	108643950	21111017090	nervous	nervous	JJ
601953	108643950	21111017091	system	system	NN1
601953	108643950	21111017092	that	that	CST_DD1
601953	108643950	21111017093	affects	affect	VVZ
601953	108643950	21111017094	movement	movement	NN1
601953	108643950	21111017095	,	,	,
601953	108643950	21111017096	drove	drive	VVD
601953	108643950	21111017097	MDS	md	NN2
601953	108643950	21111017098	to	to	TO
601953	108643950	21111017099	prioritize	prioritize	VVI
601953	108643950	21111017100	the	the	AT
601953	108643950	21111017101	update	update	NN1
601953	108643950	21111017102	of	of	IO
601953	108643950	21111017103	its	its	APPGE
601953	108643950	21111017104	scales	scale	NN2
601953	108643950	21111017105	.	.	.
601953	108643950	21111017106	Today	today	RT
601953	108643950	21111017107	more	more	DAR
601953	108643950	21111017108	than	than	CSN
601953	108643950	21111017109	10	10	MC
601953	108643950	21111017110	million	million	NNO
601953	108643950	21111017111	people	people	NN
601953	108643950	21111017112	worldwide	worldwide	RL
601953	108643950	21111017113	are	be	VBR
601953	108643950	21111017114	living	live	VVG
601953	108643950	21111017115	with	with	IW
601953	108643950	21111017116	the	the	AT
601953	108643950	21111017117	condition	condition	NN1
601953	108643950	21111017118	,	,	,
601953	108643950	21111017119	and	and	CC
601953	108643950	21111017120	each	each	DD1
601953	108643950	21111017121	year	year	NNT1
601953	108643950	21111017122	60,000	60,000	MC
601953	108643950	21111017123	people	people	NN
601953	108643950	21111017124	are	be	VBR
601953	108643950	21111017125	newly	newly	RR
601953	108643950	21111017126	diagnosed	diagnose	VVN_VVD
601953	108643950	21111017127	in	in	II
601953	108643950	21111017128	the	the	AT
601953	108643950	21111017129	United	united	NP1
601953	108643950	21111017130	States	state	NP1
601953	108643950	21111017131	alone	alone	RR_JJ
601953	108643950	21111017132	.	.	.
601953	108643950	21111017133	<p>		NULL
601953	108643950	21111017134	Bracket	bracket	NN1
601953	108643950	21111017135	has	have	VHZ
601953	108643950	21111017136	extensive	extensive	JJ
601953	108643950	21111017137	experience	experience	NN1
601953	108643950	21111017138	working	work	VVG
601953	108643950	21111017139	with	with	IW
601953	108643950	21111017140	paper-and-pencil	paper-and-pencil	JJ
601953	108643950	21111017141	clinical	clinical	JJ
601953	108643950	21111017142	outcomes	outcome	NN2
601953	108643950	21111017143	in	in	II
601953	108643950	21111017144	Parkinsons	parkinson	NP2
601953	108643950	21111017145	disease	disease	NN1
601953	108643950	21111017146	and	and	CC
601953	108643950	21111017147	other	other	JJ
601953	108643950	21111017148	movement	movement	NN1
601953	108643950	21111017149	disorders	disorder	NN2
601953	108643950	21111017150	.	.	.
601953	108643950	21111017151	Bracket	bracket	NN1
601953	108643950	21111017152	is	be	VBZ
601953	108643950	21111017153	creating	create	VVG
601953	108643950	21111017154	eCOA		NN1
601953	108643950	21111017155	versions	version	NN2
601953	108643950	21111017156	of	of	IO
601953	108643950	21111017157	the	the	AT
601953	108643950	21111017158	MDS-UPDRS		NN2
601953	108643950	21111017159	and	and	CC
601953	108643950	21111017160	UDysRS		VVZ_NN2
601953	108643950	21111017161	to	to	TO
601953	108643950	21111017162	support	support	VVI
601953	108643950	21111017163	efforts	effort	NN2
601953	108643950	21111017164	to	to	TO
601953	108643950	21111017165	improve	improve	VVI
601953	108643950	21111017166	data	data	NN
601953	108643950	21111017167	quality	quality	NN1
601953	108643950	21111017168	in	in	II
601953	108643950	21111017169	these	these	DD2
601953	108643950	21111017170	studies	study	NN2
601953	108643950	21111017171	.	.	.
601953	108643950	21111017172	Both	both	DB2
601953	108643950	21111017173	scales	scale	NN2
601953	108643950	21111017174	require	require	VV0
601953	108643950	21111017175	careful	careful	JJ
601953	108643950	21111017176	@		II
601953	108643950	21111017177	@		II
601953	108643950	21111017178	@		II
601953	108643950	21111017179	@		II
601953	108643950	21111017180	@		II
601953	108643950	21111017181	@		II
601953	108643950	21111017182	@		II
601953	108643950	21111017183	@		II
601953	108643950	21111017184	@		II
601953	108643950	21111017185	@		II
601953	108643950	21111017186	from	from	II
601953	108643950	21111017187	paper	paper	NN1
601953	108643950	21111017188	records	record	NN2_VVZ@
601953	108643950	21111017189	to	to	II
601953	108643950	21111017190	eCOA		NN1
601953	108643950	21111017191	platforms	platform	NN2
601953	108643950	21111017192	,	,	,
601953	108643950	21111017193	investigators	investigator	NN2
601953	108643950	21111017194	and	and	CC
601953	108643950	21111017195	pharmaceutical	pharmaceutical	JJ
601953	108643950	21111017196	sponsors	sponsor	NN2
601953	108643950	21111017197	will	will	VM
601953	108643950	21111017198	be	be	VBI
601953	108643950	21111017199	equipped	equip	VVN
601953	108643950	21111017200	with	with	IW
601953	108643950	21111017201	a	a	AT1
601953	108643950	21111017202	more	more	RGR
601953	108643950	21111017203	effective	effective	JJ
601953	108643950	21111017204	method	method	NN1
601953	108643950	21111017205	for	for	IF
601953	108643950	21111017206	using	use	VVG
601953	108643950	21111017207	these	these	DD2
601953	108643950	21111017208	outcomes	outcome	NN2
601953	108643950	21111017209	in	in	II
601953	108643950	21111017210	clinical	clinical	JJ
601953	108643950	21111017211	trials	trial	NN2
601953	108643950	21111017212	.	.	.
601953	108643950	21111017213	<p>		NULL
601953	108643950	21111017214	"	"	"
601953	108643950	21111017215	Clinical	clinical	JJ
601953	108643950	21111017216	trials	trial	NN2
601953	108643950	21111017217	in	in	II
601953	108643950	21111017218	Parkinsons	parkinson	NP2
601953	108643950	21111017219	disease	disease	NN1
601953	108643950	21111017220	and	and	CC
601953	108643950	21111017221	other	other	JJ
601953	108643950	21111017222	movement	movement	NN1
601953	108643950	21111017223	disorders	disorder	NN2
601953	108643950	21111017224	are	be	VBR
601953	108643950	21111017225	extremely	extremely	RR
601953	108643950	21111017226	complex	complex	JJ
601953	108643950	21111017227	and	and	CC
601953	108643950	21111017228	have	have	VH0
601953	108643950	21111017229	a	a	AT1
601953	108643950	21111017230	high	high	JJ
601953	108643950	21111017231	failure	failure	NN1
601953	108643950	21111017232	rate	rate	NN1
601953	108643950	21111017233	,	,	,
601953	108643950	21111017234	"	"	"
601953	108643950	21111017235	said	say	VVD
601953	108643950	21111017236	Jeff	jeff	NP1
601953	108643950	21111017237	Kinell		NP1
601953	108643950	21111017238	,	,	,
601953	108643950	21111017239	CEO	ceo	NN1
601953	108643950	21111017240	of	of	IO
601953	108643950	21111017241	Bracket	bracket	NN1
601953	108643950	21111017242	.	.	.
601953	108643950	21111017243	"	"	"
601953	108643950	21111017244	Fortunately	fortunately	RR
601953	108643950	21111017245	,	,	,
601953	108643950	21111017246	digitization	digitization	NN1
601953	108643950	21111017247	in	in	II
601953	108643950	21111017248	clinical	clinical	JJ
601953	108643950	21111017249	trials	trial	NN2
601953	108643950	21111017250	is	be	VBZ
601953	108643950	21111017251	improving	improving	JJ_VVG
601953	108643950	21111017252	results	result	NN2
601953	108643950	21111017253	,	,	,
601953	108643950	21111017254	as	as	CSA_II
601953	108643950	21111017255	the	the	AT
601953	108643950	21111017256	logic	logic	NN1
601953	108643950	21111017257	of	of	IO
601953	108643950	21111017258	eCOA		NN1
601953	108643950	21111017259	streamlines	streamline	VVZ
601953	108643950	21111017260	scoring	score	VVG_JJ@_NN1
601953	108643950	21111017261	protocols	protocol	NN2
601953	108643950	21111017262	and	and	CC
601953	108643950	21111017263	compliance	compliance	NN1
601953	108643950	21111017264	.	.	.
601953	108643950	21111017265	Were	be	VBDR
601953	108643950	21111017266	proud	proud	JJ
601953	108643950	21111017267	to	to	TO
601953	108643950	21111017268	partner	partner	VVI
601953	108643950	21111017269	with	with	IW
601953	108643950	21111017270	MDS	md	NN2
601953	108643950	21111017271	to	to	TO
601953	108643950	21111017272	advance	advance	VVI
601953	108643950	21111017273	PD	pd	NP1
601953	108643950	21111017274	trials	trial	NN2
601953	108643950	21111017275	and	and	CC
601953	108643950	21111017276	help	help	VVI
601953	108643950	21111017277	address	address	VV0@_NN1
601953	108643950	21111017278	the	the	AT
601953	108643950	21111017279	growing	growing	JJ
601953	108643950	21111017280	prevalence	prevalence	NN1
601953	108643950	21111017281	of	of	IO
601953	108643950	21111017282	the	the	AT
601953	108643950	21111017283	disease	disease	NN1
601953	108643950	21111017284	at	at	II
601953	108643950	21111017285	the	the	AT
601953	108643950	21111017286	ground	ground	NN1
601953	108643950	21111017287	level	level	NN1
601953	108643950	21111017288	.	.	.
601953	108643950	21111017289	"	"	"
601953	108643950	21111017290	<p>		NULL
601953	108643950	21111017291	The	the	AT
601953	108643950	21111017292	UPDRS		NP2
601953	108643950	21111017293	was	be	VBDZ
601953	108643950	21111017294	developed	develop	VVN
601953	108643950	21111017295	in	in	II
601953	108643950	21111017296	the	the	AT
601953	108643950	21111017297	1980s	1980s	MC2
601953	108643950	21111017298	and	and	CC
601953	108643950	21111017299	is	be	VBZ
601953	108643950	21111017300	the	the	AT
601953	108643950	21111017301	most	most	RGT
601953	108643950	21111017302	widely	widely	RR
601953	108643950	21111017303	used	used	JJ_VVN_VVD
601953	108643950	21111017304	rating	rating	NN1_VVG
601953	108643950	21111017305	scale	scale	NN1
601953	108643950	21111017306	for	for	IF
601953	108643950	21111017307	PD	pd	NP1
601953	108643950	21111017308	in	in	II
601953	108643950	21111017309	clinical	clinical	JJ
601953	108643950	21111017310	trials	trial	NN2
601953	108643950	21111017311	.	.	.
601953	108643950	21111017312	The	the	AT
601953	108643950	21111017313	revision	revision	NN1
601953	108643950	21111017314	,	,	,
601953	108643950	21111017315	known	know	VVN
601953	108643950	21111017316	as	as	II
601953	108643950	21111017317	the	the	AT
601953	108643950	21111017318	MDS-UPDRS		NN2
601953	108643950	21111017319	,	,	,
601953	108643950	21111017320	was	be	VBDZ
601953	108643950	21111017321	released	release	VVN
601953	108643950	21111017322	in	in	II
601953	108643950	21111017323	2008	2008	MC
601953	108643950	21111017324	and	and	CC
601953	108643950	21111017325	measures	measure	NN2_VVZ@
601953	108643950	21111017326	mentation	mentation	NN1
601953	108643950	21111017327	,	,	,
601953	108643950	21111017328	behavior	behavior	NN1
601953	108643950	21111017329	and	and	CC
601953	108643950	21111017330	mood	mood	NN1
601953	108643950	21111017331	,	,	,
601953	108643950	21111017332	activities	activity	NN2
601953	108643950	21111017333	of	of	IO
601953	108643950	21111017334	daily	daily	JJ
601953	108643950	21111017335	living	living	NN1_JJ
601953	108643950	21111017336	and	and	CC
601953	108643950	21111017337	motor	motor	NN1_VV0@
601953	108643950	21111017338	functions	function	NN2
601953	108643950	21111017339	.	.	.
601953	108643950	21111017340	The	the	AT
601953	108643950	21111017341	UDysRS		NP1_NN2
601953	108643950	21111017342	evaluates	evaluate	VVZ
601953	108643950	21111017343	involuntary	involuntary	JJ
601953	108643950	21111017344	movements	movement	NN2
601953	108643950	21111017345	associated	associate	VVN
601953	108643950	21111017346	with	with	IW
601953	108643950	21111017347	treated	treated	JJ@
601953	108643950	21111017348	PD	pd	NP1
601953	108643950	21111017349	,	,	,
601953	108643950	21111017350	measuring	measure	VVG
601953	108643950	21111017351	on-dyskinesia		NN1_JJ
601953	108643950	21111017352	,	,	,
601953	108643950	21111017353	off-dystonia		NN1_JJ
601953	108643950	21111017354	,	,	,
601953	108643950	21111017355	impairment	impairment	NN1
601953	108643950	21111017356	and	and	CC
601953	108643950	21111017357	disability	disability	NN1
601953	108643950	21111017358	.	.	.
601953	108643950	21111017359	<p>		NULL
601953	108643950	21111017360	The	the	AT
601953	108643950	21111017361	MDS-UPDRS		NN2
601953	108643950	21111017362	and	and	CC
601953	108643950	21111017363	UDysRS		VVZ_NP1
601953	108643950	21111017364	scales	scale	NN2
601953	108643950	21111017365	are	be	VBR
601953	108643950	21111017366	prime	prime	JJ
601953	108643950	21111017367	candidates	candidate	NN2
601953	108643950	21111017368	for	for	IF
601953	108643950	21111017369	digitization	digitization	NN1
601953	108643950	21111017370	as	as	CSA_II@
601953	108643950	21111017371	eCOA		NN1
601953	108643950	21111017372	will	will	VM
601953	108643950	21111017373	streamline	streamline	VVI
601953	108643950	21111017374	specific	specific	JJ
601953	108643950	21111017375	trial	trial	NN1
601953	108643950	21111017376	@		II
601953	108643950	21111017377	@		II
601953	108643950	21111017378	@		II
601953	108643950	21111017379	@		II
601953	108643950	21111017380	@		II
601953	108643950	21111017381	@		II
601953	108643950	21111017382	@		II
601953	108643950	21111017383	@		II
601953	108643950	21111017384	@		II
601953	108643950	21111017385	@		II
601953	108643950	21111017386	administration	administration	NN1
601953	108643950	21111017387	to	to	TO
601953	108643950	21111017388	ensure	ensure	VVI
601953	108643950	21111017389	scales	scale	NN2
601953	108643950	21111017390	are	be	VBR
601953	108643950	21111017391	administered	administer	VVN
601953	108643950	21111017392	appropriately	appropriately	RR
601953	108643950	21111017393	.	.	.
601953	108643950	21111017394	Additionally	additionally	RR
601953	108643950	21111017395	,	,	,
601953	108643950	21111017396	eCOA		NN1
601953	108643950	21111017397	will	will	VM
601953	108643950	21111017398	simplify	simplify	VVI
601953	108643950	21111017399	calculations	calculation	NN2
601953	108643950	21111017400	on	on	II
601953	108643950	21111017401	how	how	RGQ@
601953	108643950	21111017402	much	much	DA1
601953	108643950	21111017403	time	time	NNT1
601953	108643950	21111017404	subjects	subject	NN2
601953	108643950	21111017405	report	report	VV0@_NN1
601953	108643950	21111017406	experiencing	experience	VVG
601953	108643950	21111017407	dyskinesia	dyskinesia	NN1
601953	108643950	21111017408	,	,	,
601953	108643950	21111017409	dystonia	dystonia	NN1
601953	108643950	21111017410	and	and	CC
601953	108643950	21111017411	an	a	AT1
601953	108643950	21111017412	"	"	"
601953	108643950	21111017413	off	off	JJ%
601953	108643950	21111017414	"	"	"
601953	108643950	21111017415	state	state	NN1
601953	108643950	21111017416	.	.	.
601953	108643950	21111017417	<p>		NULL
601953	108643950	21111017418	About	about	II
601953	108643950	21111017419	BracketBracket		NP1_NN1
601953	108643950	21111017420	,	,	,
601953	108643950	21111017421	with	with	IW
601953	108643950	21111017422	nine	nine	MC
601953	108643950	21111017423	offices	office	NN2
601953	108643950	21111017424	and	and	CC
601953	108643950	21111017425	more	more	DAR
601953	108643950	21111017426	than	than	CSN
601953	108643950	21111017427	700	700	MC
601953	108643950	21111017428	employees	employee	NN2
601953	108643950	21111017429	worldwide	worldwide	RL
601953	108643950	21111017430	,	,	,
601953	108643950	21111017431	is	be	VBZ
601953	108643950	21111017432	a	a	AT1
601953	108643950	21111017433	clinical	clinical	JJ
601953	108643950	21111017434	trial	trial	NN1
601953	108643950	21111017435	technology	technology	NN1
601953	108643950	21111017436	and	and	CC
601953	108643950	21111017437	specialty	specialty	NN1
601953	108643950	21111017438	services	service	NN2
601953	108643950	21111017439	provider	provider	NN1
601953	108643950	21111017440	dedicated	dedicate	VVN_VVD
601953	108643950	21111017441	to	to	II
601953	108643950	21111017442	helping	help	VVG
601953	108643950	21111017443	biopharmaceutical	biopharmaceutical	JJ
601953	108643950	21111017444	sponsors	sponsor	NN2
601953	108643950	21111017445	and	and	CC
601953	108643950	21111017446	contract	contract	NN1
601953	108643950	21111017447	research	research	NN1
601953	108643950	21111017448	organizations	organization	NN2
601953	108643950	21111017449	increase	increase	VV0
601953	108643950	21111017450	the	the	AT
601953	108643950	21111017451	power	power	NN1
601953	108643950	21111017452	of	of	IO
601953	108643950	21111017453	their	their	APPGE
601953	108643950	21111017454	clinical	clinical	JJ
601953	108643950	21111017455	research	research	NN1
601953	108643950	21111017456	data	data	NN
601953	108643950	21111017457	by	by	II
601953	108643950	21111017458	leveraging	leverage	VVG_JJ@
601953	108643950	21111017459	core	core	NN1
601953	108643950	21111017460	competencies	competency	NN2
601953	108643950	21111017461	in	in	II
601953	108643950	21111017462	Science	science	NN1
601953	108643950	21111017463	,	,	,
601953	108643950	21111017464	Technology	technology	NN1
601953	108643950	21111017465	,	,	,
601953	108643950	21111017466	and	and	CC
601953	108643950	21111017467	Service	service	NN1
601953	108643950	21111017468	.	.	.
601953	108643950	21111017469	Bracket	bracket	NN1_VV0@
601953	108643950	21111017470	eCOAG		NN1
601953	108643950	21111017471	is	be	VBZ
601953	108643950	21111017472	a	a	AT1
601953	108643950	21111017473	flexible	flexible	JJ
601953	108643950	21111017474	platform	platform	NN1
601953	108643950	21111017475	for	for	IF
601953	108643950	21111017476	electronic	electronic	JJ
601953	108643950	21111017477	clinical	clinical	JJ
601953	108643950	21111017478	outcomes	outcome	NN2
601953	108643950	21111017479	assessments	assessment	NN2
601953	108643950	21111017480	.	.	.
601953	108643950	21111017481	Bracket	bracket	VV0@_NN1
601953	108643950	21111017482	RTSMG		NP1
601953	108643950	21111017483	is	be	VBZ
601953	108643950	21111017484	a	a	AT1
601953	108643950	21111017485	best-in-breed		NN1_JJ
601953	108643950	21111017486	,	,	,
601953	108643950	21111017487	scalable	scalable	JJ
601953	108643950	21111017488	and	and	CC
601953	108643950	21111017489	configurable	configurable	JJ
601953	108643950	21111017490	clinical	clinical	JJ
601953	108643950	21111017491	IRT	irt	NN1
601953	108643950	21111017492	solution	solution	NN1
601953	108643950	21111017493	for	for	IF
601953	108643950	21111017494	the	the	AT
601953	108643950	21111017495	life	life	NN1
601953	108643950	21111017496	sciences	science	NN2
601953	108643950	21111017497	industry	industry	NN1
601953	108643950	21111017498	.	.	.
601953	108643950	21111017499	Bracket	bracket	NN1_VV0@
601953	108643950	21111017500	SmartSuppliesG		NN1_NP1
601953	108643950	21111017501	is	be	VBZ
601953	108643950	21111017502	a	a	AT1
601953	108643950	21111017503	proven	proven	JJ
601953	108643950	21111017504	platform	platform	NN1
601953	108643950	21111017505	for	for	IF
601953	108643950	21111017506	improving	improve	VVG
601953	108643950	21111017507	a	a	AT1
601953	108643950	21111017508	clinical	clinical	JJ
601953	108643950	21111017509	supply	supply	NN1
601953	108643950	21111017510	chain	chain	NN1
601953	108643950	21111017511	.	.	.
601953	108643950	21111017512	Bracket	bracket	VV0@_NN1
601953	108643950	21111017513	Rater	rater	NP1
601953	108643950	21111017514	Training	training	NN1
601953	108643950	21111017515	and	and	CC
601953	108643950	21111017516	Quality	quality	NN1
601953	108643950	21111017517	Assurance	assurance	NN1
601953	108643950	21111017518	improve	improve	VV0
601953	108643950	21111017519	outcomes	outcome	NN2
601953	108643950	21111017520	through	through	II
601953	108643950	21111017521	customized	customized	JJ@
601953	108643950	21111017522	training	training	NN1
601953	108643950	21111017523	and	and	CC
601953	108643950	21111017524	quality	quality	NN1
601953	108643950	21111017525	assurance	assurance	NN1
601953	108643950	21111017526	programs	program	NN2
601953	108643950	21111017527	.	.	.
601953	108643951	21111017547	@@##	----------	----------
601953	108643951	21111017548	@@108643951		FO
601953	108643951	21111017549	@4043951/		VV0_NN1
601953	108643951	21111017550	<h>		NULL
601953	108643951	21111017551	Why	why	RRQ
601953	108643951	21111017552	Cloud	cloud	NN1
601953	108643951	21111017553	Hosting	host	VVG
601953	108643951	21111017554	can	can	VM
601953	108643951	21111017555	be	be	VBI
601953	108643951	21111017556	the	the	AT
601953	108643951	21111017557	right	right	JJ_NN1
601953	108643951	21111017558	choice	choice	NN1
601953	108643951	21111017559	for	for	IF
601953	108643951	21111017560	Clinical	clinical	JJ
601953	108643951	21111017561	Trial	trial	NN1
601953	108643951	21111017562	Inventory	inventory	NN1
601953	108643951	21111017563	Management	management	NN1
601953	108643951	21111017564	Solutions	solution	NN2
601953	108643951	21111017565	<p>		NULL
601953	108643951	21111017566	May	may	NPM1
601953	108643951	21111017567	18	18	MC
601953	108643951	21111017568	,	,	,
601953	108643951	21111017569	2017	2017	MC
601953	108643951	21111017570	<h>		NULL
601953	108643951	21111017571	By-		NP1
601953	108643951	21111017572	Jim	jim	NP1
601953	108643951	21111017573	Primerano		NP1
601953	108643951	21111017574	,	,	,
601953	108643951	21111017575	Sr.		NNA
601953	108643951	21111017576	Vice	vice	NP1
601953	108643951	21111017577	President	president	NN1
601953	108643951	21111017578	and	and	CC
601953	108643951	21111017579	General	general	JJ_NN1
601953	108643951	21111017580	Manager	manager	NN1
601953	108643951	21111017581	,	,	,
601953	108643951	21111017582	eClinical-		NN1_JJ
601953	108643951	21111017583	at	at	II
601953	108643951	21111017584	Bracket	bracket	NN1
601953	108643951	21111017585	<p>		NULL
601953	108643951	21111017586	As	as	CSA
601953	108643951	21111017587	sites	site	NN2
601953	108643951	21111017588	,	,	,
601953	108643951	21111017589	sponsors	sponsor	NN2
601953	108643951	21111017590	and	and	CC
601953	108643951	21111017591	clinical	clinical	JJ
601953	108643951	21111017592	research	research	NN1
601953	108643951	21111017593	organizations	organization	NN2
601953	108643951	21111017594	(	(	(
601953	108643951	21111017595	CROs	cro	NP2_NN2
601953	108643951	21111017596	)	)	)
601953	108643951	21111017597	continue	continue	VV0
601953	108643951	21111017598	to	to	TO
601953	108643951	21111017599	manage	manage	VVI
601953	108643951	21111017600	more	more	RGR_DAR
601953	108643951	21111017601	complex	complex	JJ
601953	108643951	21111017602	trial	trial	NN1
601953	108643951	21111017603	inventory	inventory	NN1
601953	108643951	21111017604	,	,	,
601953	108643951	21111017605	frequently	frequently	RR
601953	108643951	21111017606	on	on	II
601953	108643951	21111017607	an	a	AT1
601953	108643951	21111017608	international	international	JJ
601953	108643951	21111017609	level	level	NN1_JJ
601953	108643951	21111017610	,	,	,
601953	108643951	21111017611	the	the	AT
601953	108643951	21111017612	need	need	NN1
601953	108643951	21111017613	for	for	IF
601953	108643951	21111017614	an	a	AT1
601953	108643951	21111017615	end-to-end	end-to-end	JJ
601953	108643951	21111017616	clinical	clinical	JJ
601953	108643951	21111017617	trial	trial	NN1
601953	108643951	21111017618	management	management	NN1
601953	108643951	21111017619	solution	solution	NN1
601953	108643951	21111017620	that	that	CST_DD1
601953	108643951	21111017621	will	will	VM
601953	108643951	21111017622	ensure	ensure	VVI
601953	108643951	21111017623	inventory	inventory	NN1
601953	108643951	21111017624	is	be	VBZ
601953	108643951	21111017625	regulated	regulate	VVN
601953	108643951	21111017626	in	in	II
601953	108643951	21111017627	an	a	AT1
601953	108643951	21111017628	FDA	fda	NN1_NP1
601953	108643951	21111017629	compliant	compliant	JJ
601953	108643951	21111017630	manner	manner	NN1
601953	108643951	21111017631	is	be	VBZ
601953	108643951	21111017632	critical	critical	JJ
601953	108643951	21111017633	.	.	.
601953	108643951	21111017634	Small	small	NP1_JJ
601953	108643951	21111017635	to	to	II
601953	108643951	21111017636	mid-sized	mid-sized	JJ@
601953	108643951	21111017637	companies	company	NN2
601953	108643951	21111017638	often	often	RR
601953	108643951	21111017639	face	face	VV0
601953	108643951	21111017640	challenges	challenge	NN2
601953	108643951	21111017641	implementing	implement	VVG
601953	108643951	21111017642	these	these	DD2
601953	108643951	21111017643	solutions	solution	NN2
601953	108643951	21111017644	,	,	,
601953	108643951	21111017645	due	due	II21
601953	108643951	21111017646	to	to	II22
601953	108643951	21111017647	the	the	AT
601953	108643951	21111017648	complex	complex	JJ_NN1
601953	108643951	21111017649	IT	it	NN1
601953	108643951	21111017650	infrastructure	infrastructure	NN1
601953	108643951	21111017651	requirements	requirement	NN2
601953	108643951	21111017652	,	,	,
601953	108643951	21111017653	associated	associated	JJ_VVN
601953	108643951	21111017654	third-party	third-party	JJ
601953	108643951	21111017655	costs	cost	NN2
601953	108643951	21111017656	and	and	CC
601953	108643951	21111017657	lack	lack	NN1
601953	108643951	21111017658	of	of	IO
601953	108643951	21111017659	in-house	in-house	JJ
601953	108643951	21111017660	resources	resource	NN2
601953	108643951	21111017661	to	to	TO
601953	108643951	21111017662	maintain	maintain	VVI
601953	108643951	21111017663	and	and	CC
601953	108643951	21111017664	manage	manage	VVI
601953	108643951	21111017665	the	the	AT
601953	108643951	21111017666	solution	solution	NN1
601953	108643951	21111017667	.	.	.
601953	108643951	21111017668	These	these	DD2
601953	108643951	21111017669	roadblocks	roadblock	NN2
601953	108643951	21111017670	highlight	highlight	VV0
601953	108643951	21111017671	the	the	AT
601953	108643951	21111017672	advantages	advantage	NN2
601953	108643951	21111017673	of	of	IO
601953	108643951	21111017674	a	a	AT1
601953	108643951	21111017675	cloud-based		JJ_NN1
601953	108643951	21111017676	solution	solution	NN1
601953	108643951	21111017677	,	,	,
601953	108643951	21111017678	which	which	DDQ
601953	108643951	21111017679	is	be	VBZ
601953	108643951	21111017680	what	what	DDQ
601953	108643951	21111017681	Bracket	bracket	NN1_VV0@
601953	108643951	21111017682	is	be	VBZ
601953	108643951	21111017683	now	now	RT
601953	108643951	21111017684	offering	offer	VVG
601953	108643951	21111017685	for	for	IF
601953	108643951	21111017686	our	our	APPGE
601953	108643951	21111017687	SmartSupplies		NP1
601953	108643951	21111017688	suite	suite	NN1
601953	108643951	21111017689	.	.	.
601953	108643951	21111017690	<p>		NULL
601953	108643951	21111017691	If	if	CS
601953	108643951	21111017692	you	you	PPY
601953	108643951	21111017693	are	be	VBR
601953	108643951	21111017694	considering	considering	II_RR@_VVG
601953	108643951	21111017695	upgrading	upgrade	VVG
601953	108643951	21111017696	from	from	II
601953	108643951	21111017697	static	static	JJ_NN1@
601953	108643951	21111017698	Excel	excel	VV0
601953	108643951	21111017699	spreadsheets	spreadsheet	NN2
601953	108643951	21111017700	to	to	II
601953	108643951	21111017701	intelligent	intelligent	JJ
601953	108643951	21111017702	inventory	inventory	NN1
601953	108643951	21111017703	management	management	NN1
601953	108643951	21111017704	software	software	NN1
601953	108643951	21111017705	,	,	,
601953	108643951	21111017706	consider	consider	VV0
601953	108643951	21111017707	how	how	RRQ
601953	108643951	21111017708	a	a	AT1
601953	108643951	21111017709	cloud-based		JJ_NN1
601953	108643951	21111017710	solution	solution	NN1
601953	108643951	21111017711	will	will	VM
601953	108643951	21111017712	benefit	benefit	VVI
601953	108643951	21111017713	your	your	APPGE
601953	108643951	21111017714	organization	organization	NN1
601953	108643951	21111017715	almost	almost	RR
601953	108643951	21111017716	immediately	immediately	RR
601953	108643951	21111017717	.	.	.
601953	108643951	21111017718	<p>		NULL
601953	108643951	21111017719	In	in	II31
601953	108643951	21111017720	addition	addition	II32
601953	108643951	21111017721	to	to	II33
601953	108643951	21111017722	being	be	VBG
601953	108643951	21111017723	competitively	competitively	RR
601953	108643951	21111017724	priced	price	VVN
601953	108643951	21111017725	and	and	CC
601953	108643951	21111017726	with	with	IW
601953	108643951	21111017727	reports	report	NN2
601953	108643951	21111017728	demonstrating	demonstrate	VVG
601953	108643951	21111017729	cloud-based		JJ_NN1
601953	108643951	21111017730	services	service	NN2
601953	108643951	21111017731	to	to	TO
601953	108643951	21111017732	reduce	reduce	VVI
601953	108643951	21111017733	expenses	expense	NN2
601953	108643951	21111017734	by	by	II
601953	108643951	21111017735	50%		NNU
601953	108643951	21111017736	,	,	,
601953	108643951	21111017737	a	a	AT1
601953	108643951	21111017738	solution	solution	NN1
601953	108643951	21111017739	@		II
601953	108643951	21111017740	@		II
601953	108643951	21111017741	@		II
601953	108643951	21111017742	@		II
601953	108643951	21111017743	@		II
601953	108643951	21111017744	@		II
601953	108643951	21111017745	@		II
601953	108643951	21111017746	@		II
601953	108643951	21111017747	@		II
601953	108643951	21111017748	@		II
601953	108643951	21111017749	Cloud	cloud	NN1_VV0@
601953	108643951	21111017750	hosting	host	VVG_NN1%
601953	108643951	21111017751	eliminates	eliminate	VVZ
601953	108643951	21111017752	the	the	AT
601953	108643951	21111017753	need	need	NN1
601953	108643951	21111017754	for	for	IF
601953	108643951	21111017755	hardware	hardware	NN1
601953	108643951	21111017756	maintenance	maintenance	NN1
601953	108643951	21111017757	and	and	CC
601953	108643951	21111017758	management	management	NN1
601953	108643951	21111017759	,	,	,
601953	108643951	21111017760	thereby	thereby	RR
601953	108643951	21111017761	reducing	reduce	VVG
601953	108643951	21111017762	the	the	AT
601953	108643951	21111017763	need	need	NN1
601953	108643951	21111017764	for	for	IF
601953	108643951	21111017765	costly	costly	JJ
601953	108643951	21111017766	off-shore	offshore	JJ
601953	108643951	21111017767	contractors	contractor	NN2
601953	108643951	21111017768	and	and	CC
601953	108643951	21111017769	vendors	vendor	NN2
601953	108643951	21111017770	.	.	.
601953	108643951	21111017771	For	for	IF
601953	108643951	21111017772	companies	company	NN2
601953	108643951	21111017773	without	without	IW
601953	108643951	21111017774	their	their	APPGE
601953	108643951	21111017775	own	own	DA
601953	108643951	21111017776	IT	it	NN1
601953	108643951	21111017777	infrastructure	infrastructure	NN1
601953	108643951	21111017778	and	and	CC
601953	108643951	21111017779	servers	server	NN2
601953	108643951	21111017780	in	in	II
601953	108643951	21111017781	place	place	NN1
601953	108643951	21111017782	,	,	,
601953	108643951	21111017783	a	a	AT1
601953	108643951	21111017784	cloud-based		JJ_NN1
601953	108643951	21111017785	solution	solution	NN1
601953	108643951	21111017786	eliminates	eliminate	VVZ
601953	108643951	21111017787	the	the	AT
601953	108643951	21111017788	need	need	NN1
601953	108643951	21111017789	to	to	TO
601953	108643951	21111017790	configure	configure	VVI
601953	108643951	21111017791	that	that	DD1_CST
601953	108643951	21111017792	framework	framework	NN1
601953	108643951	21111017793	"	"	"
601953	108643951	21111017794	and	and	CC
601953	108643951	21111017795	instead	instead	RR
601953	108643951	21111017796	,	,	,
601953	108643951	21111017797	allows	allow	VVZ
601953	108643951	21111017798	the	the	AT
601953	108643951	21111017799	company	company	NN1
601953	108643951	21111017800	to	to	TO
601953	108643951	21111017801	focus	focus	VVI
601953	108643951	21111017802	on	on	II_RP@
601953	108643951	21111017803	benefitting	benefit	VVG
601953	108643951	21111017804	from	from	II
601953	108643951	21111017805	the	the	AT
601953	108643951	21111017806	application	application	NN1
601953	108643951	21111017807	itself	itself	PPX1
601953	108643951	21111017808	.	.	.
601953	108643951	21111017809	<p>		NULL
601953	108643951	21111017810	The	the	AT
601953	108643951	21111017811	transparency	transparency	NN1
601953	108643951	21111017812	provided	provide	VVN
601953	108643951	21111017813	by	by	II
601953	108643951	21111017814	cloud-hosted		JJ_NN1
601953	108643951	21111017815	solutions	solution	NN2
601953	108643951	21111017816	allows	allow	VVZ
601953	108643951	21111017817	your	your	APPGE
601953	108643951	21111017818	vendor	vendor	NN1
601953	108643951	21111017819	to	to	TO
601953	108643951	21111017820	proactively	proactively	RR
601953	108643951	21111017821	monitor	monitor	VVI
601953	108643951	21111017822	the	the	AT
601953	108643951	21111017823	software	software	NN1
601953	108643951	21111017824	,	,	,
601953	108643951	21111017825	push	push	VV0
601953	108643951	21111017826	out	out	RP
601953	108643951	21111017827	updates	update	NN2
601953	108643951	21111017828	and	and	CC
601953	108643951	21111017829	ensure	ensure	VV0
601953	108643951	21111017830	all	all	DB
601953	108643951	21111017831	components	component	NN2
601953	108643951	21111017832	are	be	VBR
601953	108643951	21111017833	compliant	compliant	JJ
601953	108643951	21111017834	with	with	IW
601953	108643951	21111017835	the	the	AT
601953	108643951	21111017836	latest	late	JJT
601953	108643951	21111017837	FDA	fda	NN1
601953	108643951	21111017838	regulations	regulation	NN2
601953	108643951	21111017839	.	.	.
601953	108643951	21111017840	For	for	REX21
601953	108643951	21111017841	example	example	REX22
601953	108643951	21111017842	,	,	,
601953	108643951	21111017843	your	your	APPGE
601953	108643951	21111017844	software	software	NN1
601953	108643951	21111017845	provider	provider	NN1
601953	108643951	21111017846	can	can	VM
601953	108643951	21111017847	see	see	VVI
601953	108643951	21111017848	if	if	CSW@_CS
601953	108643951	21111017849	your	your	APPGE
601953	108643951	21111017850	organization	organization	NN1
601953	108643951	21111017851	is	be	VBZ
601953	108643951	21111017852	properly	properly	RR
601953	108643951	21111017853	allocating	allocate	VVG
601953	108643951	21111017854	memory	memory	NN1
601953	108643951	21111017855	space	space	NN1
601953	108643951	21111017856	,	,	,
601953	108643951	21111017857	if	if	CS
601953	108643951	21111017858	and	and	CC
601953	108643951	21111017859	when	when	CS_RRQ
601953	108643951	21111017860	the	the	AT
601953	108643951	21111017861	infrastructure	infrastructure	NN1
601953	108643951	21111017862	is	be	VBZ
601953	108643951	21111017863	aging	aging	JJ_VVG
601953	108643951	21111017864	and	and	CC
601953	108643951	21111017865	work	work	VV0_NN1
601953	108643951	21111017866	to	to	TO
601953	108643951	21111017867	proactively	proactively	RR
601953	108643951	21111017868	mitigate	mitigate	VVI
601953	108643951	21111017869	the	the	AT
601953	108643951	21111017870	issues	issue	NN2
601953	108643951	21111017871	.	.	.
601953	108643951	21111017872	Ultimately	ultimately	RR
601953	108643951	21111017873	,	,	,
601953	108643951	21111017874	the	the	AT
601953	108643951	21111017875	transparency	transparency	NN1
601953	108643951	21111017876	of	of	IO
601953	108643951	21111017877	the	the	AT
601953	108643951	21111017878	cloud	cloud	NN1
601953	108643951	21111017879	will	will	VM
601953	108643951	21111017880	allow	allow	VVI
601953	108643951	21111017881	your	your	APPGE
601953	108643951	21111017882	organization	organization	NN1
601953	108643951	21111017883	to	to	TO
601953	108643951	21111017884	focus	focus	VVI
601953	108643951	21111017885	first	first	MD
601953	108643951	21111017886	and	and	CC
601953	108643951	21111017887	foremost	foremost	JJT
601953	108643951	21111017888	on	on	II
601953	108643951	21111017889	running	run	VVG
601953	108643951	21111017890	your	your	APPGE
601953	108643951	21111017891	clinical	clinical	JJ
601953	108643951	21111017892	trial	trial	NN1
601953	108643951	21111017893	smoothly	smoothly	RR
601953	108643951	21111017894	,	,	,
601953	108643951	21111017895	rather	rather	CS21@_II21
601953	108643951	21111017896	than	than	CS22@_II22
601953	108643951	21111017897	on	on	II
601953	108643951	21111017898	incessant	incessant	JJ
601953	108643951	21111017899	maintenance	maintenance	NN1
601953	108643951	21111017900	of	of	IO
601953	108643951	21111017901	your	your	APPGE
601953	108643951	21111017902	IT	it	NN1
601953	108643951	21111017903	infrastructure	infrastructure	NN1
601953	108643951	21111017904	.	.	.
601953	108643951	21111017905	<p>		NULL
601953	108643951	21111017906	Enables	enable	VVZ
601953	108643951	21111017907	better	better	JJR
601953	108643951	21111017908	collaboration	collaboration	NN1
601953	108643951	21111017909	across	across	II
601953	108643951	21111017910	sites	site	NN2
601953	108643951	21111017911	and	and	CC
601953	108643951	21111017912	easier	easy	JJR
601953	108643951	21111017913	integration	integration	NN1
601953	108643951	21111017914	with	with	IW
601953	108643951	21111017915	other	other	JJ
601953	108643951	21111017916	eClinical		JJ
601953	108643951	21111017917	systems	system	NN2
601953	108643951	21111017918	<p>		NULL
601953	108643951	21111017919	The	the	AT
601953	108643951	21111017920	smartest	smart	JJT
601953	108643951	21111017921	clinical	clinical	JJ
601953	108643951	21111017922	trial	trial	NN1
601953	108643951	21111017923	inventory	inventory	NN1
601953	108643951	21111017924	management	management	NN1
601953	108643951	21111017925	software	software	NN1
601953	108643951	21111017926	solutions	solution	NN2
601953	108643951	21111017927	are	be	VBR
601953	108643951	21111017928	designed	design	VVN
601953	108643951	21111017929	to	to	TO
601953	108643951	21111017930	facilitate	facilitate	VVI
601953	108643951	21111017931	end-to-end	end-to-end	JJ
601953	108643951	21111017932	materials	material	NN2
601953	108643951	21111017933	management	management	NN1
601953	108643951	21111017934	for	for	IF
601953	108643951	21111017935	sponsors	sponsor	NN2
601953	108643951	21111017936	and	and	CC
601953	108643951	21111017937	enable	enable	VV0
601953	108643951	21111017938	greater	great	JJR
601953	108643951	21111017939	@		II
601953	108643951	21111017940	@		II
601953	108643951	21111017941	@		II
601953	108643951	21111017942	@		II
601953	108643951	21111017943	@		II
601953	108643951	21111017944	@		II
601953	108643951	21111017945	@		II
601953	108643951	21111017946	@		II
601953	108643951	21111017947	@		II
601953	108643951	21111017948	@		II
601953	108643951	21111017949	parties	party	NN2
601953	108643951	21111017950	"	"	"
601953	108643951	21111017951	from	from	II
601953	108643951	21111017952	clinical	clinical	JJ
601953	108643951	21111017953	research	research	NN1
601953	108643951	21111017954	associates	associate	NN2_VVZ@
601953	108643951	21111017955	to	to	II
601953	108643951	21111017956	end-users	end-user	NN2
601953	108643951	21111017957	"	"	"
601953	108643951	21111017958	can	can	VM
601953	108643951	21111017959	seamlessly	seamlessly	RR
601953	108643951	21111017960	and	and	CC
601953	108643951	21111017961	instantaneously	instantaneously	RR
601953	108643951	21111017962	share	share	VV0
601953	108643951	21111017963	data	data	NN
601953	108643951	21111017964	,	,	,
601953	108643951	21111017965	regardless	regardless	RR
601953	108643951	21111017966	of	of	IO
601953	108643951	21111017967	geography	geography	NN1
601953	108643951	21111017968	.	.	.
601953	108643951	21111017969	For	for	IF
601953	108643951	21111017970	clinical	clinical	JJ
601953	108643951	21111017971	research	research	NN1
601953	108643951	21111017972	associates	associate	NN2
601953	108643951	21111017973	who	who	PNQS
601953	108643951	21111017974	are	be	VBR
601953	108643951	21111017975	running	running	JJ_VVG
601953	108643951	21111017976	study	study	NN1
601953	108643951	21111017977	management	management	NN1
601953	108643951	21111017978	around	around	II
601953	108643951	21111017979	the	the	AT
601953	108643951	21111017980	globe	globe	NN1
601953	108643951	21111017981	or	or	CC
601953	108643951	21111017982	for	for	IF
601953	108643951	21111017983	organizations	organization	NN2
601953	108643951	21111017984	who	who	PNQS
601953	108643951	21111017985	have	have	VH0
601953	108643951	21111017986	thousands	thousand	NNO2
601953	108643951	21111017987	of	of	IO
601953	108643951	21111017988	end-users	end-user	NN2
601953	108643951	21111017989	managing	manage	VVG_JJ
601953	108643951	21111017990	inventory	inventory	NN1
601953	108643951	21111017991	at	at	II
601953	108643951	21111017992	a	a	AT1
601953	108643951	21111017993	site	site	NN1
601953	108643951	21111017994	,	,	,
601953	108643951	21111017995	it	it	PPH1
601953	108643951	21111017996	's	be	VBZ
601953	108643951	21111017997	important	important	JJ
601953	108643951	21111017998	to	to	TO
601953	108643951	21111017999	have	have	VHI
601953	108643951	21111018000	easy	easy	JJ
601953	108643951	21111018001	and	and	CC
601953	108643951	21111018002	instant	instant	JJ
601953	108643951	21111018003	access	access	NN1
601953	108643951	21111018004	to	to	II
601953	108643951	21111018005	a	a	AT1
601953	108643951	21111018006	shared	shared	JJ
601953	108643951	21111018007	database	database	NN1
601953	108643951	21111018008	.	.	.
601953	108643951	21111018009	<p>		NULL
601953	108643951	21111018010	For	for	IF
601953	108643951	21111018011	more	more	DAR
601953	108643951	21111018012	information	information	NN1
601953	108643951	21111018013	on	on	II
601953	108643951	21111018014	cloud-hosted		JJ_NN1
601953	108643951	21111018015	inventory	inventory	NN1
601953	108643951	21111018016	management	management	NN1
601953	108643951	21111018017	solutions	solution	NN2
601953	108643951	21111018018	,	,	,
601953	108643951	21111018019	click	click	VV0
601953	108643951	21111018020	here	here	RL
601953	108643951	21111018021	.	.	.
601953	108643956	21111018071	@@##	----------	----------
601953	108643956	21111018072	@@108643956		FO
601953	108643956	21111018073	@4043956/		VV0
601953	108643956	21111018074	<h>		NULL
601953	108643956	21111018075	A	a	AT1@_ZZ1
601953	108643956	21111018076	Comparison	comparison	NN1
601953	108643956	21111018077	of	of	IO
601953	108643956	21111018078	Techniques	technique	NN2
601953	108643956	21111018079	for	for	IF
601953	108643956	21111018080	Creating	create	VVG
601953	108643956	21111018081	Permuted		JJ@_VVN
601953	108643956	21111018082	Blocked	blocked	JJ@
601953	108643956	21111018083	Randomization	randomization	NN1
601953	108643956	21111018084	Lists	list	NN2_VVZ
601953	108643956	21111018085	<p>		NULL
601953	108643956	21111018086	February	february	NPM1
601953	108643956	21111018087	16	16	MC
601953	108643956	21111018088	,	,	,
601953	108643956	21111018089	2016	2016	MC
601953	108643956	21111018090	<p>		NULL
601953	108643956	21111018091	Randomization	randomization	NN1_NP1@
601953	108643956	21111018092	is	be	VBZ
601953	108643956	21111018093	a	a	AT1
601953	108643956	21111018094	core	core	NN1
601953	108643956	21111018095	component	component	NN1
601953	108643956	21111018096	in	in	II
601953	108643956	21111018097	the	the	AT
601953	108643956	21111018098	design	design	NN1
601953	108643956	21111018099	and	and	CC
601953	108643956	21111018100	implementation	implementation	NN1
601953	108643956	21111018101	of	of	IO
601953	108643956	21111018102	RTSM		NP1
601953	108643956	21111018103	in	in	II
601953	108643956	21111018104	clinical	clinical	JJ
601953	108643956	21111018105	trials	trial	NN2
601953	108643956	21111018106	.	.	.
601953	108643956	21111018107	Two	two	MC
601953	108643956	21111018108	of	of	IO
601953	108643956	21111018109	the	the	AT
601953	108643956	21111018110	most	most	RGT
601953	108643956	21111018111	important	important	JJ
601953	108643956	21111018112	elements	element	NN2
601953	108643956	21111018113	to	to	II
601953	108643956	21111018114	the	the	AT
601953	108643956	21111018115	integrity	integrity	NN1
601953	108643956	21111018116	of	of	IO
601953	108643956	21111018117	a	a	AT1
601953	108643956	21111018118	controlled	controlled	JJ@
601953	108643956	21111018119	clinical	clinical	JJ
601953	108643956	21111018120	study	study	NN1
601953	108643956	21111018121	are	be	VBR
601953	108643956	21111018122	the	the	AT
601953	108643956	21111018123	patient	patient	JJ_NN1
601953	108643956	21111018124	randomization	randomization	NN1
601953	108643956	21111018125	and	and	CC
601953	108643956	21111018126	the	the	AT
601953	108643956	21111018127	treatment	treatment	NN1
601953	108643956	21111018128	blinding	blinding	JJ_VVG@_NN1%
601953	108643956	21111018129	,	,	,
601953	108643956	21111018130	and	and	CC
601953	108643956	21111018131	the	the	AT
601953	108643956	21111018132	RTSM		NP1
601953	108643956	21111018133	system	system	NN1
601953	108643956	21111018134	is	be	VBZ
601953	108643956	21111018135	the	the	AT
601953	108643956	21111018136	backbone	backbone	NN1
601953	108643956	21111018137	supporting	support	VVG
601953	108643956	21111018138	these	these	DD2
601953	108643956	21111018139	controls	control	NN2
601953	108643956	21111018140	.	.	.
601953	108643956	21111018141	In	in	II
601953	108643956	21111018142	the	the	AT
601953	108643956	21111018143	February	february	NPM1
601953	108643956	21111018144	issue	issue	NN1
601953	108643956	21111018145	of	of	IO
601953	108643956	21111018146	Applied	applied	JJ
601953	108643956	21111018147	Clinical	clinical	JJ
601953	108643956	21111018148	Trials	trial	NN2
601953	108643956	21111018149	,	,	,
601953	108643956	21111018150	Bracket	bracket	NN1
601953	108643956	21111018151	's	's	GE
601953	108643956	21111018152	Dr.		NNB
601953	108643956	21111018153	Scott	scott	NP1
601953	108643956	21111018154	Hamilton	hamilton	NP1
601953	108643956	21111018155	contributes	contribute	VVZ
601953	108643956	21111018156	to	to	II
601953	108643956	21111018157	an	a	AT1
601953	108643956	21111018158	article	article	NN1
601953	108643956	21111018159	describing	describe	VVG
601953	108643956	21111018160	the	the	AT
601953	108643956	21111018161	results	result	NN2
601953	108643956	21111018162	of	of	IO
601953	108643956	21111018163	a	a	AT1
601953	108643956	21111018164	simulation	simulation	NN1
601953	108643956	21111018165	study	study	NN1
601953	108643956	21111018166	comparing	compare	VVG
601953	108643956	21111018167	a	a	AT1
601953	108643956	21111018168	novel	novel	JJ_NN1
601953	108643956	21111018169	randomization	randomization	NN1
601953	108643956	21111018170	procedure	procedure	NN1
601953	108643956	21111018171	with	with	IW
601953	108643956	21111018172	a	a	AT1
601953	108643956	21111018173	more	more	RGR
601953	108643956	21111018174	traditional	traditional	JJ
601953	108643956	21111018175	procedure	procedure	NN1
601953	108643956	21111018176	.	.	.
601953	108643956	21111018177	In	in	II
601953	108643956	21111018178	this	this	DD1
601953	108643956	21111018179	case	case	NN1
601953	108643956	21111018180	,	,	,
601953	108643956	21111018181	the	the	AT
601953	108643956	21111018182	authors	author	NN2
601953	108643956	21111018183	compared	compare	VVD_VVN
601953	108643956	21111018184	two	two	MC
601953	108643956	21111018185	forms	form	NN2
601953	108643956	21111018186	of	of	IO
601953	108643956	21111018187	utilizing	utilize	VVG_JJ@
601953	108643956	21111018188	block	block	NN1
601953	108643956	21111018189	pattern	pattern	NN1
601953	108643956	21111018190	distribution	distribution	NN1
601953	108643956	21111018191	,	,	,
601953	108643956	21111018192	which	which	DDQ
601953	108643956	21111018193	can	can	VM
601953	108643956	21111018194	minimize	minimize	VVI
601953	108643956	21111018195	selection	selection	NN1
601953	108643956	21111018196	bias	bias	NN1
601953	108643956	21111018197	in	in	II
601953	108643956	21111018198	a	a	AT1
601953	108643956	21111018199	randomization	randomization	NN1
601953	108643956	21111018200	scheme	scheme	NN1
601953	108643956	21111018201	.	.	.
601953	108643956	21111018202	<p>		NULL
601953	108643956	21111018203	Bracket	bracket	VV0@_NN1
601953	108643956	21111018204	developed	developed	JJ_VVD_VVN
601953	108643956	21111018205	Precision	precision	NN1
601953	108643956	21111018206	Block	block	NN1
601953	108643956	21111018207	DesignG		NN1_VV0
601953	108643956	21111018208	for	for	IF
601953	108643956	21111018209	sponsors	sponsor	NN2
601953	108643956	21111018210	who	who	PNQS
601953	108643956	21111018211	want	want	VV0
601953	108643956	21111018212	or	or	CC
601953	108643956	21111018213	need	need	VV0_NN1
601953	108643956	21111018214	to	to	TO
601953	108643956	21111018215	utilize	utilize	VVI
601953	108643956	21111018216	block	block	NN1
601953	108643956	21111018217	pattern	pattern	NN1
601953	108643956	21111018218	distribution	distribution	NN1
601953	108643956	21111018219	in	in	II
601953	108643956	21111018220	their	their	APPGE
601953	108643956	21111018221	randomization	randomization	NN1
601953	108643956	21111018222	lists	list	NN2_VVZ
601953	108643956	21111018223	when	when	CS
601953	108643956	21111018224	using	use	VVG
601953	108643956	21111018225	Bracket	bracket	NN1
601953	108643956	21111018226	RTSMG		NP1
601953	108643956	21111018227	.	.	.
601953	108643956	21111018228	The	the	AT
601953	108643956	21111018229	use	use	NN1
601953	108643956	21111018230	of	of	IO
601953	108643956	21111018231	Precision	precision	NN1
601953	108643956	21111018232	Block	block	NN1
601953	108643956	21111018233	DesignG		NN1_NP1
601953	108643956	21111018234	does	do	VDZ
601953	108643956	21111018235	not	not	XX
601953	108643956	21111018236	add	add	VVI
601953	108643956	21111018237	additional	additional	JJ
601953	108643956	21111018238	time	time	NNT1
601953	108643956	21111018239	nor	nor	CC
601953	108643956	21111018240	cost	cost	NN1_VV0_VVD@
601953	108643956	21111018241	to	to	II
601953	108643956	21111018242	the	the	AT
601953	108643956	21111018243	creation	creation	NN1
601953	108643956	21111018244	of	of	IO
601953	108643956	21111018245	the	the	AT
601953	108643956	21111018246	randomization	randomization	NN1
601953	108643956	21111018247	list	list	NN1
601953	108643956	21111018248	.	.	.
601953	108643956	21111018249	For	for	IF
601953	108643956	21111018250	more	more	DAR
601953	108643956	21111018251	information	information	NN1
601953	108643956	21111018252	about	about	II
601953	108643956	21111018253	selection	selection	NN1
601953	108643956	21111018254	bias	bias	NN1
601953	108643956	21111018255	and/or	and/or	CC
601953	108643956	21111018256	Precision	precision	NN1
601953	108643956	21111018257	Block	block	NN1
601953	108643956	21111018258	DesignG		VV0
601953	108643956	21111018259	you	you	PPY
601953	108643956	21111018260	can	can	VM
601953	108643956	21111018261	download	download	VVI
601953	108643956	21111018262	our	our	APPGE
601953	108643956	21111018263	@		II
601953	108643956	21111018264	@		II
601953	108643956	21111018265	@		II
601953	108643956	21111018266	@		II
601953	108643956	21111018267	@		II
601953	108643956	21111018268	@		II
601953	108643956	21111018269	@		II
601953	108643956	21111018270	@		II
601953	108643956	21111018271	@		II
601953	108643956	21111018272	@		II
601953	108643956	21111018273	for	for	IF
601953	108643956	21111018274	more	more	DAR
601953	108643956	21111018275	details	detail	NN2
601953	108643956	21111018276	.	.	.
601953	108643958	21111018296	@@##	----------	----------
601953	108643958	21111018297	@@108643958		FO
601953	108643958	21111018298	@4043958/		VV0_NN1_JJ
601953	108643958	21111018299	<h>		NULL
601953	108643958	21111018300	11th	11th	MD
601953	108643958	21111018301	International	international	JJ
601953	108643958	21111018302	Conference	conference	NN1
601953	108643958	21111018303	on	on	II
601953	108643958	21111018304	Alzheimer	alzheimer	NP1
601953	108643958	21111018305	's	's	GE
601953	108643958	21111018306	and	and	CC
601953	108643958	21111018307	Parkinson	parkinson	NP1
601953	108643958	21111018308	's	's	GE
601953	108643958	21111018309	Disease	disease	NN1
601953	108643958	21111018310	<p>		NULL
601953	108643958	21111018311	March	march	NPM1
601953	108643958	21111018312	8	8	MC
601953	108643958	21111018313	,	,	,
601953	108643958	21111018314	2013	2013	MC
601953	108643958	21111018315	157705		MC
601953	108643958	21111018316	@qwx1017705		FO
601953	108643958	21111018317	<p>		NULL
601953	108643958	21111018318	The	the	AT
601953	108643958	21111018319	11th	11th	MD
601953	108643958	21111018320	International	international	JJ
601953	108643958	21111018321	Conference	conference	NN1
601953	108643958	21111018322	on	on	II
601953	108643958	21111018323	Alzheimer	alzheimer	NP1
601953	108643958	21111018324	's	's	GE
601953	108643958	21111018325	&amp;		CC
601953	108643958	21111018326	Parkinson	parkinson	NP1
601953	108643958	21111018327	's	's	GE
601953	108643958	21111018328	Disease	disease	NN1
601953	108643958	21111018329	(	(	(
601953	108643958	21111018330	AD/PD		FU
601953	108643958	21111018331	)	)	)
601953	108643958	21111018332	is	be	VBZ
601953	108643958	21111018333	taking	take	VVG
601953	108643958	21111018334	place	place	NN1
601953	108643958	21111018335	in	in	II
601953	108643958	21111018336	Florence	florence	NP1
601953	108643958	21111018337	,	,	,
601953	108643958	21111018338	Italy	italy	NP1
601953	108643958	21111018339	.	.	.
601953	108643958	21111018340	Medical	medical	JJ
601953	108643958	21111018341	professionals	professional	NN2
601953	108643958	21111018342	from	from	II
601953	108643958	21111018343	around	around	II
601953	108643958	21111018344	the	the	AT
601953	108643958	21111018345	world	world	NN1
601953	108643958	21111018346	are	be	VBR
601953	108643958	21111018347	gathering	gather	VVG
601953	108643958	21111018348	to	to	TO
601953	108643958	21111018349	discuss	discuss	VVI
601953	108643958	21111018350	cutting-edge	cutting-edge	JJ
601953	108643958	21111018351	research	research	NN1
601953	108643958	21111018352	and	and	CC
601953	108643958	21111018353	new	new	JJ
601953	108643958	21111018354	discoveries	discovery	NN2
601953	108643958	21111018355	in	in	II
601953	108643958	21111018356	neurodegenerative	neurodegenerative	JJ
601953	108643958	21111018357	diseases.		NNU
601953	108643958	21111018358	-	-	-
601953	108643958	21111018359	Review	review	VV0@
601953	108643958	21111018360	the	the	AT
601953	108643958	21111018361	full	full	JJ
601953	108643958	21111018362	scientific	scientific	JJ
601953	108643958	21111018363	program	program	NN1
601953	108643958	21111018364	.	.	.
601953	108643958	21111018365	<p>		NULL
601953	108643958	21111018366	Bracket	bracket	NN1_VV0@
601953	108643958	21111018367	subject	subject	NN1_JJ@
601953	108643958	21111018368	matter	matter	NN1
601953	108643958	21111018369	experts	expert	NN2
601953	108643958	21111018370	presented	present	VVD_VVN
601953	108643958	21111018371	a	a	AT1
601953	108643958	21111018372	total	total	NN1_JJ
601953	108643958	21111018373	of	of	IO
601953	108643958	21111018374	three	three	MC
601953	108643958	21111018375	scientific	scientific	JJ
601953	108643958	21111018376	posters	poster	NN2
601953	108643958	21111018377	at	at	II
601953	108643958	21111018378	the	the	AT
601953	108643958	21111018379	Conference	conference	NN1
601953	108643958	21111018380	on	on	II
601953	108643958	21111018381	Thursday	thursday	NPD1
601953	108643958	21111018382	,	,	,
601953	108643958	21111018383	March	march	NPM1
601953	108643958	21111018384	7	7	MC
601953	108643958	21111018385	.	.	.
601953	108643958	21111018386	Click	click	VV0_NN1
601953	108643958	21111018387	on	on	II
601953	108643958	21111018388	the	the	AT
601953	108643958	21111018389	links	link	NN2
601953	108643958	21111018390	below	below	RL
601953	108643958	21111018391	to	to	TO
601953	108643958	21111018392	review	review	VVI
601953	108643958	21111018393	the	the	AT
601953	108643958	21111018394	posters	poster	NN2
601953	108643958	21111018395	.	.	.
601953	108643960	21111018415	@@##	----------	----------
601953	108643960	21111018416	@@108643960		FO
601953	108643960	21111018417	@4043960/		NN1_VV0
601953	108643960	21111018418	<p>		NULL
601953	108643960	21111018419	WAYNE	wayne	NP1
601953	108643960	21111018420	,	,	,
601953	108643960	21111018421	PA-		JJ_NN1
601953	108643960	21111018422	Bracket	bracket	NN1
601953	108643960	21111018423	,	,	,
601953	108643960	21111018424	a	a	AT1
601953	108643960	21111018425	leading	leading	JJ
601953	108643960	21111018426	clinical	clinical	JJ
601953	108643960	21111018427	trial	trial	NN1
601953	108643960	21111018428	technology	technology	NN1
601953	108643960	21111018429	and	and	CC
601953	108643960	21111018430	specialty	specialty	NN1
601953	108643960	21111018431	services	service	NN2
601953	108643960	21111018432	provider	provider	NN1
601953	108643960	21111018433	with	with	IW
601953	108643960	21111018434	expertise	expertise	NN1
601953	108643960	21111018435	in	in	II
601953	108643960	21111018436	Alzheimers	alzheimers	NP1
601953	108643960	21111018437	disease	disease	NN1
601953	108643960	21111018438	(	(	(
601953	108643960	21111018439	AD	ad	RA
601953	108643960	21111018440	)	)	)
601953	108643960	21111018441	,	,	,
601953	108643960	21111018442	announced	announce	VVD_VVN
601953	108643960	21111018443	that	that	CST
601953	108643960	21111018444	its	its	APPGE
601953	108643960	21111018445	Scientific	scientific	JJ
601953	108643960	21111018446	Advisory	advisory	JJ
601953	108643960	21111018447	Board	board	NN1
601953	108643960	21111018448	(	(	(
601953	108643960	21111018449	SAB	sab	NP1
601953	108643960	21111018450	)	)	)
601953	108643960	21111018451	has	have	VHZ
601953	108643960	21111018452	formed	form	VVN
601953	108643960	21111018453	an	a	AT1
601953	108643960	21111018454	AD	ad	NN1%
601953	108643960	21111018455	sub-committee	subcommittee	NN1
601953	108643960	21111018456	that	that	CST_DD1
601953	108643960	21111018457	will	will	VM
601953	108643960	21111018458	hold	hold	VVI
601953	108643960	21111018459	its	its	APPGE
601953	108643960	21111018460	inaugural	inaugural	JJ
601953	108643960	21111018461	meeting	meeting	NN1
601953	108643960	21111018462	at	at	II
601953	108643960	21111018463	the	the	AT
601953	108643960	21111018464	9th	9th	MD
601953	108643960	21111018465	Annual	annual	JJ
601953	108643960	21111018466	Clinical	clinical	JJ
601953	108643960	21111018467	Trials	trial	NN2
601953	108643960	21111018468	on	on	II
601953	108643960	21111018469	Alzheimers	alzheimers	NP1
601953	108643960	21111018470	Disease	disease	NN1
601953	108643960	21111018471	(	(	(
601953	108643960	21111018472	CTAD		NP1
601953	108643960	21111018473	)	)	)
601953	108643960	21111018474	conference	conference	NN1
601953	108643960	21111018475	on	on	II
601953	108643960	21111018476	December	december	NPM1
601953	108643960	21111018477	8	8	MC
601953	108643960	21111018478	"	"	"
601953	108643960	21111018479	10	10	MC
601953	108643960	21111018480	,	,	,
601953	108643960	21111018481	2016	2016	MC
601953	108643960	21111018482	in	in	II
601953	108643960	21111018483	San	san	NP1
601953	108643960	21111018484	Diego	diego	NP1
601953	108643960	21111018485	,	,	,
601953	108643960	21111018486	California	california	NP1
601953	108643960	21111018487	.	.	.
601953	108643960	21111018488	<p>		NULL
601953	108643960	21111018489	The	the	AT
601953	108643960	21111018490	sub-committee	subcommittee	NN1
601953	108643960	21111018491	,	,	,
601953	108643960	21111018492	chaired	chair	VVN
601953	108643960	21111018493	by	by	II_RP%
601953	108643960	21111018494	and	and	CC
601953	108643960	21111018495	established	establish	VVN_VVD
601953	108643960	21111018496	in	in	II
601953	108643960	21111018497	collaboration	collaboration	NN1
601953	108643960	21111018498	with	with	IW
601953	108643960	21111018499	Jeffrey	jeffrey	NP1
601953	108643960	21111018500	Cummings	cummings	NP1
601953	108643960	21111018501	,	,	,
601953	108643960	21111018502	M.D.	m.d	NNA
601953	108643960	21111018503	,	,	,
601953	108643960	21111018504	Sc.D.		NP1
601953	108643960	21111018505	,	,	,
601953	108643960	21111018506	Director	director	NN1
601953	108643960	21111018507	of	of	IO
601953	108643960	21111018508	Cleveland	cleveland	NP1
601953	108643960	21111018509	Clinics	clinic	NN2
601953	108643960	21111018510	Lou	lou	NP1
601953	108643960	21111018511	Ruvo		NP1_NN1
601953	108643960	21111018512	Center	center	NN1
601953	108643960	21111018513	for	for	IF
601953	108643960	21111018514	Brain	brain	NN1
601953	108643960	21111018515	Health	health	NN1
601953	108643960	21111018516	and	and	CC
601953	108643960	21111018517	Camille	camille	NP1
601953	108643960	21111018518	and	and	CC
601953	108643960	21111018519	Larry	larry	NP1
601953	108643960	21111018520	Ruvo		NP1_NN1
601953	108643960	21111018521	Chair	chair	NN1
601953	108643960	21111018522	of	of	IO
601953	108643960	21111018523	the	the	AT
601953	108643960	21111018524	Neurological	neurological	JJ
601953	108643960	21111018525	Institute	institute	NN1
601953	108643960	21111018526	of	of	IO
601953	108643960	21111018527	Cleveland	cleveland	NP1
601953	108643960	21111018528	Clinic	clinic	NN1
601953	108643960	21111018529	,	,	,
601953	108643960	21111018530	will	will	VM
601953	108643960	21111018531	focus	focus	VVI
601953	108643960	21111018532	exclusively	exclusively	RR
601953	108643960	21111018533	on	on	II
601953	108643960	21111018534	maintaining	maintain	VVG
601953	108643960	21111018535	Brackets	bracket	NN2
601953	108643960	21111018536	awareness	awareness	NN1
601953	108643960	21111018537	and	and	CC
601953	108643960	21111018538	involvement	involvement	NN1
601953	108643960	21111018539	in	in	II
601953	108643960	21111018540	AD	ad	RA_NN1%
601953	108643960	21111018541	research	research	NN1_VV0@
601953	108643960	21111018542	advancement	advancement	NN1
601953	108643960	21111018543	,	,	,
601953	108643960	21111018544	field	field	NN1_VV0@
601953	108643960	21111018545	changes	change	NN2
601953	108643960	21111018546	,	,	,
601953	108643960	21111018547	emerging	emerge	VVG_JJ
601953	108643960	21111018548	technologies	technology	NN2
601953	108643960	21111018549	and	and	CC
601953	108643960	21111018550	competitive	competitive	JJ
601953	108643960	21111018551	landscape	landscape	NN1
601953	108643960	21111018552	.	.	.
601953	108643960	21111018553	<p>		NULL
601953	108643960	21111018554	As	as	II_CSA
601953	108643960	21111018555	a	a	AT1
601953	108643960	21111018556	specialty	specialty	NN1
601953	108643960	21111018557	services	service	NN2
601953	108643960	21111018558	provider	provider	NN1
601953	108643960	21111018559	with	with	IW
601953	108643960	21111018560	specific	specific	JJ
601953	108643960	21111018561	expertise	expertise	NN1
601953	108643960	21111018562	in	in	II
601953	108643960	21111018563	AD	ad	RA_NN1%
601953	108643960	21111018564	trial	trial	NN1
601953	108643960	21111018565	technology	technology	NN1
601953	108643960	21111018566	,	,	,
601953	108643960	21111018567	including	including	II_VVG@
601953	108643960	21111018568	the	the	AT
601953	108643960	21111018569	development	development	NN1
601953	108643960	21111018570	and	and	CC
601953	108643960	21111018571	launch	launch	NN1
601953	108643960	21111018572	of	of	IO
601953	108643960	21111018573	Bracket	bracket	NN1
601953	108643960	21111018574	eCOASM		NN1
601953	108643960	21111018575	,	,	,
601953	108643960	21111018576	Brackets	bracket	NN2_VVZ@
601953	108643960	21111018577	sub-committee	subcommittee	NN1
601953	108643960	21111018578	will	will	VM
601953	108643960	21111018579	build	build	VVI
601953	108643960	21111018580	upon	upon	II
601953	108643960	21111018581	the	the	AT
601953	108643960	21111018582	Companys	company	NN2
601953	108643960	21111018583	strategic	strategic	JJ
601953	108643960	21111018584	agenda	agenda	NN1
601953	108643960	21111018585	to	to	TO
601953	108643960	21111018586	capture	capture	VVI
601953	108643960	21111018587	data	data	NN
601953	108643960	21111018588	using	use	VVG
601953	108643960	21111018589	technology	technology	NN1
601953	108643960	21111018590	,	,	,
601953	108643960	21111018591	finding	find	VVG
601953	108643960	21111018592	innovative	innovative	JJ
601953	108643960	21111018593	ways	way	NN2
601953	108643960	21111018594	to	to	TO
601953	108643960	21111018595	minimize	minimize	VVI
601953	108643960	21111018596	error-prone	error-prone	JJ
601953	108643960	21111018597	human	human	JJ_NN1
601953	108643960	21111018598	factors	factor	NN2
601953	108643960	21111018599	in	in	II
601953	108643960	21111018600	clinical	clinical	JJ
601953	108643960	21111018601	trials	trial	NN2
601953	108643960	21111018602	.	.	.
601953	108643960	21111018603	The	the	AT
601953	108643960	21111018604	committee	committee	NN1
601953	108643960	21111018605	will	will	VM
601953	108643960	21111018606	be	be	VBI
601953	108643960	21111018607	@		II
601953	108643960	21111018608	@		II
601953	108643960	21111018609	@		II
601953	108643960	21111018610	@		II
601953	108643960	21111018611	@		II
601953	108643960	21111018612	@		II
601953	108643960	21111018613	@		II
601953	108643960	21111018614	@		II
601953	108643960	21111018615	@		II
601953	108643960	21111018616	@		II
601953	108643960	21111018617	.	.	.
601953	108643960	21111018618	<p>		NULL
601953	108643960	21111018619	"	"	"
601953	108643960	21111018620	Brackets	bracket	NN2
601953	108643960	21111018621	SAB		VV0_NN1_NP1
601953	108643960	21111018622	is	be	VBZ
601953	108643960	21111018623	well-represented	well-represented	JJ_NN1
601953	108643960	21111018624	across	across	II
601953	108643960	21111018625	various	various	JJ
601953	108643960	21111018626	therapeutic	therapeutic	JJ
601953	108643960	21111018627	areas	area	NN2
601953	108643960	21111018628	,	,	,
601953	108643960	21111018629	but	but	CCB
601953	108643960	21111018630	we	we	PPIS2
601953	108643960	21111018631	maintain	maintain	VV0
601953	108643960	21111018632	a	a	AT1
601953	108643960	21111018633	specialized	specialized	JJ
601953	108643960	21111018634	focus	focus	NN1
601953	108643960	21111018635	on	on	II
601953	108643960	21111018636	AD	ad	RA
601953	108643960	21111018637	in	in	II
601953	108643960	21111018638	effort	effort	NN1
601953	108643960	21111018639	to	to	TO
601953	108643960	21111018640	combat	combat	VVI
601953	108643960	21111018641	the	the	AT
601953	108643960	21111018642	many	many	DA2
601953	108643960	21111018643	challenges	challenge	NN2
601953	108643960	21111018644	facing	face	VVG
601953	108643960	21111018645	its	its	APPGE
601953	108643960	21111018646	clinical	clinical	JJ
601953	108643960	21111018647	trials	trial	NN2
601953	108643960	21111018648	today	today	RT
601953	108643960	21111018649	,	,	,
601953	108643960	21111018650	"	"	"
601953	108643960	21111018651	said	say	VVD
601953	108643960	21111018652	Jeff	jeff	NP1
601953	108643960	21111018653	Kinell		NP1
601953	108643960	21111018654	,	,	,
601953	108643960	21111018655	CEO	ceo	NN1
601953	108643960	21111018656	of	of	IO
601953	108643960	21111018657	Bracket	bracket	NN1
601953	108643960	21111018658	.	.	.
601953	108643960	21111018659	"	"	"
601953	108643960	21111018660	Weve		NP1@_NN1_VV0
601953	108643960	21111018661	invested	invest	VVD_VVN
601953	108643960	21111018662	tremendously	tremendously	RR
601953	108643960	21111018663	on	on	II
601953	108643960	21111018664	improving	improving	JJ_VVG
601953	108643960	21111018665	outcomes	outcome	NN2
601953	108643960	21111018666	in	in	II
601953	108643960	21111018667	the	the	AT
601953	108643960	21111018668	area	area	NN1
601953	108643960	21111018669	and	and	CC
601953	108643960	21111018670	were	be	VBDR
601953	108643960	21111018671	hopeful	hopeful	JJ
601953	108643960	21111018672	that	that	CST
601953	108643960	21111018673	this	this	DD1
601953	108643960	21111018674	focused	focused	JJ@_VVD
601953	108643960	21111018675	sub-committee	subcommittee	NN1
601953	108643960	21111018676	will	will	VM
601953	108643960	21111018677	connect	connect	VVI
601953	108643960	21111018678	the	the	AT
601953	108643960	21111018679	right	right	JJ_NN1
601953	108643960	21111018680	data	data	NN
601953	108643960	21111018681	,	,	,
601953	108643960	21111018682	minds	mind	NN2
601953	108643960	21111018683	and	and	CC
601953	108643960	21111018684	initiatives	initiative	NN2
601953	108643960	21111018685	to	to	TO
601953	108643960	21111018686	move	move	VVI
601953	108643960	21111018687	AD	ad	NN1%
601953	108643960	21111018688	trials	trial	NN2
601953	108643960	21111018689	forward	forward	RL
601953	108643960	21111018690	.	.	.
601953	108643960	21111018691	"	"	"
601953	108643960	21111018692	<p>		NULL
601953	108643960	21111018693	With	with	IW
601953	108643960	21111018694	plans	plan	NN2
601953	108643960	21111018695	to	to	TO
601953	108643960	21111018696	meet	meet	VVI
601953	108643960	21111018697	several	several	DA2
601953	108643960	21111018698	times	time	NNT2
601953	108643960	21111018699	per	per	II
601953	108643960	21111018700	year	year	NNT1
601953	108643960	21111018701	at	at	II
601953	108643960	21111018702	relevant	relevant	JJ
601953	108643960	21111018703	meetings	meeting	NN2
601953	108643960	21111018704	such	such	II21
601953	108643960	21111018705	as	as	II22
601953	108643960	21111018706	American	american	JJ
601953	108643960	21111018707	Academy	academy	NN1
601953	108643960	21111018708	of	of	IO
601953	108643960	21111018709	Neurology	neurology	NP1_NN1
601953	108643960	21111018710	Annual	annual	JJ
601953	108643960	21111018711	Meeting	meeting	NN1
601953	108643960	21111018712	and	and	CC
601953	108643960	21111018713	Alzheimers	alzheimers	NP1
601953	108643960	21111018714	Association	association	NN1
601953	108643960	21111018715	International	international	JJ
601953	108643960	21111018716	Conference	conference	NN1
601953	108643960	21111018717	,	,	,
601953	108643960	21111018718	the	the	AT
601953	108643960	21111018719	committee	committee	NN1
601953	108643960	21111018720	will	will	VM
601953	108643960	21111018721	share	share	VVI
601953	108643960	21111018722	meeting	meet	VVG_NN1
601953	108643960	21111018723	notes	note	NN2
601953	108643960	21111018724	and	and	CC
601953	108643960	21111018725	coordinate	coordinate	VVI
601953	108643960	21111018726	on	on	II_RP@
601953	108643960	21111018727	common	common	JJ
601953	108643960	21111018728	projects	project	NN2
601953	108643960	21111018729	with	with	IW
601953	108643960	21111018730	Brackets	bracket	NN2
601953	108643960	21111018731	SAB		VV0
601953	108643960	21111018732	,	,	,
601953	108643960	21111018733	while	while	CS
601953	108643960	21111018734	operating	operate	VVG
601953	108643960	21111018735	independently	independently	RR
601953	108643960	21111018736	.	.	.
601953	108643960	21111018737	The	the	AT
601953	108643960	21111018738	SAB	sab	NN1_NP1
601953	108643960	21111018739	is	be	VBZ
601953	108643960	21111018740	currently	currently	RR
601953	108643960	21111018741	chaired	chair	VVN
601953	108643960	21111018742	by	by	II
601953	108643960	21111018743	Dr.		NNB
601953	108643960	21111018744	Charles	charles	NP1
601953	108643960	21111018745	Nemeroff	nemeroff	NP1
601953	108643960	21111018746	,	,	,
601953	108643960	21111018747	M.D.	m.d	NNA
601953	108643960	21111018748	,	,	,
601953	108643960	21111018749	Ph.D	phd	NP1
601953	108643960	21111018750	.	.	.
601953	108643960	21111018751	and	and	CC
601953	108643960	21111018752	Dr.		NNB
601953	108643960	21111018753	Jeffrey	jeffrey	NP1
601953	108643960	21111018754	A.Lieberman		NP1
601953	108643960	21111018755	,	,	,
601953	108643960	21111018756	M.D.	m.d	NNA
601953	108643960	21111018757	<p>		NULL
601953	108643960	21111018758	About	about	II
601953	108643960	21111018759	Bracket	bracket	NN1
601953	108643960	21111018760	Bracket	bracket	NN1
601953	108643960	21111018761	,	,	,
601953	108643960	21111018762	with	with	IW
601953	108643960	21111018763	nine	nine	MC
601953	108643960	21111018764	offices	office	NN2
601953	108643960	21111018765	and	and	CC
601953	108643960	21111018766	more	more	DAR
601953	108643960	21111018767	than	than	CSN
601953	108643960	21111018768	700	700	MC
601953	108643960	21111018769	employees	employee	NN2
601953	108643960	21111018770	worldwide	worldwide	RL
601953	108643960	21111018771	,	,	,
601953	108643960	21111018772	is	be	VBZ
601953	108643960	21111018773	a	a	AT1
601953	108643960	21111018774	clinical	clinical	JJ
601953	108643960	21111018775	trial	trial	NN1
601953	108643960	21111018776	technology	technology	NN1
601953	108643960	21111018777	and	and	CC
601953	108643960	21111018778	specialty	specialty	NN1
601953	108643960	21111018779	services	service	NN2
601953	108643960	21111018780	provider	provider	NN1
601953	108643960	21111018781	dedicated	dedicate	VVN_VVD
601953	108643960	21111018782	to	to	II
601953	108643960	21111018783	helping	help	VVG
601953	108643960	21111018784	biopharmaceutical	biopharmaceutical	JJ
601953	108643960	21111018785	sponsors	sponsor	NN2
601953	108643960	21111018786	and	and	CC
601953	108643960	21111018787	contract	contract	NN1
601953	108643960	21111018788	research	research	NN1
601953	108643960	21111018789	organizations	organization	NN2
601953	108643960	21111018790	increase	increase	VV0
601953	108643960	21111018791	the	the	AT
601953	108643960	21111018792	power	power	NN1
601953	108643960	21111018793	of	of	IO
601953	108643960	21111018794	their	their	APPGE
601953	108643960	21111018795	clinical	clinical	JJ
601953	108643960	21111018796	research	research	NN1
601953	108643960	21111018797	data	data	NN
601953	108643960	21111018798	by	by	II
601953	108643960	21111018799	leveraging	leverage	VVG_JJ@
601953	108643960	21111018800	core	core	NN1
601953	108643960	21111018801	competencies	competency	NN2
601953	108643960	21111018802	in	in	II
601953	108643960	21111018803	Science	science	NN1
601953	108643960	21111018804	,	,	,
601953	108643960	21111018805	Technology	technology	NN1
601953	108643960	21111018806	,	,	,
601953	108643960	21111018807	@		II
601953	108643960	21111018808	@		II
601953	108643960	21111018809	@		II
601953	108643960	21111018810	@		II
601953	108643960	21111018811	@		II
601953	108643960	21111018812	@		II
601953	108643960	21111018813	@		II
601953	108643960	21111018814	@		II
601953	108643960	21111018815	@		II
601953	108643960	21111018816	@		II
601953	108643960	21111018817	electronic	electronic	JJ
601953	108643960	21111018818	clinical	clinical	JJ
601953	108643960	21111018819	outcomes	outcome	NN2
601953	108643960	21111018820	assessments	assessment	NN2
601953	108643960	21111018821	.	.	.
601953	108643960	21111018822	Bracket	bracket	VV0@_NN1
601953	108643960	21111018823	RTSMG		NP1
601953	108643960	21111018824	is	be	VBZ
601953	108643960	21111018825	a	a	AT1
601953	108643960	21111018826	best-in-breed		NN1_JJ
601953	108643960	21111018827	,	,	,
601953	108643960	21111018828	scalable	scalable	JJ
601953	108643960	21111018829	and	and	CC
601953	108643960	21111018830	configurable	configurable	JJ
601953	108643960	21111018831	clinical	clinical	JJ
601953	108643960	21111018832	IRT	irt	NN1
601953	108643960	21111018833	solution	solution	NN1
601953	108643960	21111018834	for	for	IF
601953	108643960	21111018835	the	the	AT
601953	108643960	21111018836	life	life	NN1
601953	108643960	21111018837	sciences	science	NN2
601953	108643960	21111018838	industry	industry	NN1
601953	108643960	21111018839	.	.	.
601953	108643960	21111018840	Bracket	bracket	VV0@_NN1
601953	108643960	21111018841	Rater	rater	NP1
601953	108643960	21111018842	Training	training	NN1
601953	108643960	21111018843	and	and	CC
601953	108643960	21111018844	Quality	quality	NN1
601953	108643960	21111018845	Assurance	assurance	NN1
601953	108643960	21111018846	improve	improve	VV0
601953	108643960	21111018847	outcomes	outcome	NN2
601953	108643960	21111018848	through	through	II
601953	108643960	21111018849	customized	customized	JJ@
601953	108643960	21111018850	training	training	NN1
601953	108643960	21111018851	and	and	CC
601953	108643960	21111018852	quality	quality	NN1
601953	108643960	21111018853	assurance	assurance	NN1
601953	108643960	21111018854	programs	program	NN2
601953	108643960	21111018855	.	.	.
601953	108643964	21111018950	@@##	----------	----------
601953	108643964	21111018951	@@108643964		FO
601953	108643964	21111018952	@4043964/		NN1_VV0
601953	108643964	21111018953	<p>		NULL
601953	108643964	21111018954	This	this	DD1
601953	108643964	21111018955	is	be	VBZ
601953	108643964	21111018956	an	a	AT1
601953	108643964	21111018957	exciting	exciting	JJ
601953	108643964	21111018958	and	and	CC
601953	108643964	21111018959	challenging	challenging	JJ_VVG
601953	108643964	21111018960	time	time	NNT1
601953	108643964	21111018961	to	to	TO
601953	108643964	21111018962	be	be	VBI
601953	108643964	21111018963	working	work	VVG
601953	108643964	21111018964	in	in	II_RP@
601953	108643964	21111018965	pharmaceutical	pharmaceutical	JJ
601953	108643964	21111018966	R&amp;D	r&amp;d	NN1
601953	108643964	21111018967	.	.	.
601953	108643964	21111018968	The	the	AT
601953	108643964	21111018969	evolution	evolution	NN1
601953	108643964	21111018970	of	of	IO
601953	108643964	21111018971	research	research	NN1
601953	108643964	21111018972	practices	practice	NN2_VVZ@
601953	108643964	21111018973	to	to	TO
601953	108643964	21111018974	focus	focus	VVI
601953	108643964	21111018975	more	more	RRR_DAR
601953	108643964	21111018976	on	on	II
601953	108643964	21111018977	technology	technology	NN1
601953	108643964	21111018978	and	and	CC
601953	108643964	21111018979	innovative	innovative	JJ
601953	108643964	21111018980	approaches	approach	NN2
601953	108643964	21111018981	requires	require	VVZ
601953	108643964	21111018982	investment	investment	NN1
601953	108643964	21111018983	,	,	,
601953	108643964	21111018984	a	a	AT1
601953	108643964	21111018985	careful	careful	JJ
601953	108643964	21111018986	consideration	consideration	NN1
601953	108643964	21111018987	of	of	IO
601953	108643964	21111018988	the	the	AT
601953	108643964	21111018989	results	result	NN2
601953	108643964	21111018990	,	,	,
601953	108643964	21111018991	and	and	CC
601953	108643964	21111018992	a	a	AT1
601953	108643964	21111018993	commitment	commitment	NN1
601953	108643964	21111018994	on	on	II
601953	108643964	21111018995	combining	combine	VVG
601953	108643964	21111018996	the	the	AT
601953	108643964	21111018997	best	best	JJT
601953	108643964	21111018998	science	science	NN1
601953	108643964	21111018999	with	with	IW
601953	108643964	21111019000	the	the	AT
601953	108643964	21111019001	most	most	RGT
601953	108643964	21111019002	effective	effective	JJ
601953	108643964	21111019003	tools	tool	NN2
601953	108643964	21111019004	.	.	.
601953	108643964	21111019005	Bracket	bracket	NN1
601953	108643964	21111019006	's	's	GE
601953	108643964	21111019007	mission	mission	NN1
601953	108643964	21111019008	is	be	VBZ
601953	108643964	21111019009	to	to	TO
601953	108643964	21111019010	deploy	deploy	VVI
601953	108643964	21111019011	superior	superior	JJ
601953	108643964	21111019012	data	data	NN
601953	108643964	21111019013	and	and	CC
601953	108643964	21111019014	technology	technology	NN1
601953	108643964	21111019015	insight	insight	NN1
601953	108643964	21111019016	and	and	CC
601953	108643964	21111019017	knowledge	knowledge	NN1
601953	108643964	21111019018	,	,	,
601953	108643964	21111019019	ensuring	ensure	VVG
601953	108643964	21111019020	accuracy	accuracy	NN1
601953	108643964	21111019021	,	,	,
601953	108643964	21111019022	visibility	visibility	NN1
601953	108643964	21111019023	and	and	CC
601953	108643964	21111019024	efficiencies	efficiency	NN2
601953	108643964	21111019025	in	in	II
601953	108643964	21111019026	our	our	APPGE
601953	108643964	21111019027	clients	client	NN2
601953	108643964	21111019028	'	'	GE
601953	108643964	21111019029	clinical	clinical	JJ
601953	108643964	21111019030	trial	trial	NN1
601953	108643964	21111019031	studies	study	NN2
601953	108643964	21111019032	.	.	.
601953	108643964	21111019033	The	the	AT
601953	108643964	21111019034	investment	investment	NN1
601953	108643964	21111019035	that	that	CST_DD1
601953	108643964	21111019036	Parthenon	parthenon	NP1_NN1
601953	108643964	21111019037	is	be	VBZ
601953	108643964	21111019038	making	make	VVG
601953	108643964	21111019039	in	in	II
601953	108643964	21111019040	Bracket	bracket	NN1
601953	108643964	21111019041	will	will	VM
601953	108643964	21111019042	allow	allow	VVI
601953	108643964	21111019043	us	us	PPIO2
601953	108643964	21111019044	to	to	TO
601953	108643964	21111019045	continue	continue	VVI
601953	108643964	21111019046	to	to	TO
601953	108643964	21111019047	serve	serve	VVI
601953	108643964	21111019048	that	that	DD1_CST
601953	108643964	21111019049	mission	mission	NN1
601953	108643964	21111019050	,	,	,
601953	108643964	21111019051	and	and	CC
601953	108643964	21111019052	in	in	II
601953	108643964	21111019053	the	the	AT
601953	108643964	21111019054	process	process	NN1
601953	108643964	21111019055	help	help	VV0
601953	108643964	21111019056	our	our	APPGE
601953	108643964	21111019057	pharmaceutical	pharmaceutical	JJ
601953	108643964	21111019058	and	and	CC
601953	108643964	21111019059	CRO	cro	NN1_NP1
601953	108643964	21111019060	partners	partner	NN2
601953	108643964	21111019061	be	be	VBI
601953	108643964	21111019062	more	more	RGR
601953	108643964	21111019063	successful	successful	JJ
601953	108643964	21111019064	in	in	II
601953	108643964	21111019065	our	our	APPGE
601953	108643964	21111019066	combined	combined	JJ
601953	108643964	21111019067	efforts	effort	NN2
601953	108643964	21111019068	.	.	.
601953	108643964	21111019069	<p>		NULL
601953	108643964	21111019070	If	if	CS
601953	108643964	21111019071	you	you	PPY
601953	108643964	21111019072	are	be	VBR
601953	108643964	21111019073	an	a	AT1
601953	108643964	21111019074	existing	existing	JJ
601953	108643964	21111019075	Bracket	bracket	NN1
601953	108643964	21111019076	partner	partner	NN1
601953	108643964	21111019077	,	,	,
601953	108643964	21111019078	it	it	PPH1
601953	108643964	21111019079	is	be	VBZ
601953	108643964	21111019080	our	our	APPGE
601953	108643964	21111019081	hope	hope	NN1
601953	108643964	21111019082	that	that	CST
601953	108643964	21111019083	this	this	DD1
601953	108643964	21111019084	transition	transition	NN1
601953	108643964	21111019085	is	be	VBZ
601953	108643964	21111019086	a	a	AT1
601953	108643964	21111019087	seamless	seamless	JJ
601953	108643964	21111019088	one	one	PN1
601953	108643964	21111019089	.	.	.
601953	108643964	21111019090	There	there	EX
601953	108643964	21111019091	are	be	VBR
601953	108643964	21111019092	no	no	AT_RR%
601953	108643964	21111019093	planned	planned	JJ@
601953	108643964	21111019094	changes	change	NN2
601953	108643964	21111019095	in	in	II
601953	108643964	21111019096	how	how	RRQ
601953	108643964	21111019097	we	we	PPIS2
601953	108643964	21111019098	staff	staff	VV0@
601953	108643964	21111019099	our	our	APPGE
601953	108643964	21111019100	projects	project	NN2
601953	108643964	21111019101	or	or	CC
601953	108643964	21111019102	serve	serve	VV0
601953	108643964	21111019103	our	our	APPGE
601953	108643964	21111019104	existing	existing	JJ
601953	108643964	21111019105	clients	client	NN2
601953	108643964	21111019106	.	.	.
601953	108643964	21111019107	And	and	CC
601953	108643964	21111019108	our	our	APPGE
601953	108643964	21111019109	new	new	JJ
601953	108643964	21111019110	independence	independence	NN1
601953	108643964	21111019111	will	will	VM
601953	108643964	21111019112	give	give	VVI
601953	108643964	21111019113	us	us	PPIO2
601953	108643964	21111019114	new	new	JJ
601953	108643964	21111019115	tools	tool	NN2
601953	108643964	21111019116	to	to	TO
601953	108643964	21111019117	continue	continue	VVI
601953	108643964	21111019118	to	to	TO
601953	108643964	21111019119	invest	invest	VVI
601953	108643964	21111019120	in	in	II
601953	108643964	21111019121	being	be	VBG
601953	108643964	21111019122	the	the	AT
601953	108643964	21111019123	right	right	JJ_NN1
601953	108643964	21111019124	choice	choice	NN1
601953	108643964	21111019125	for	for	IF
601953	108643964	21111019126	both	both	DB2
601953	108643964	21111019127	our	our	APPGE
601953	108643964	21111019128	existing	existing	JJ
601953	108643964	21111019129	partners	partner	NN2
601953	108643964	21111019130	,	,	,
601953	108643964	21111019131	and	and	CC
601953	108643964	21111019132	our	our	APPGE
601953	108643964	21111019133	new	new	JJ
601953	108643964	21111019134	ones	one	NN2
601953	108643964	21111019135	in	in	II
601953	108643964	21111019136	the	the	AT
601953	108643964	21111019137	future	future	NN1_JJ
601953	108643964	21111019138	.	.	.
601953	108643965	21111019158	@@##	----------	----------
601953	108643965	21111019159	@@108643965		FO
601953	108643965	21111019160	@4043965/		JJ_VV0_NN1
601953	108643965	21111019161	<h>		NULL
601953	108643965	21111019162	Terms	term	NN2
601953	108643965	21111019163	of	of	IO
601953	108643965	21111019164	Service	service	NN1
601953	108643965	21111019165	<p>		NULL
601953	108643965	21111019166	This	this	DD1
601953	108643965	21111019167	website	website	NN1
601953	108643965	21111019168	is	be	VBZ
601953	108643965	21111019169	a	a	AT1
601953	108643965	21111019170	resource	resource	NN1
601953	108643965	21111019171	which	which	DDQ
601953	108643965	21111019172	is	be	VBZ
601953	108643965	21111019173	intended	intend	VVN
601953	108643965	21111019174	,	,	,
601953	108643965	21111019175	but	but	CCB
601953	108643965	21111019176	not	not	XX
601953	108643965	21111019177	promised	promise	VVN
601953	108643965	21111019178	or	or	CC
601953	108643965	21111019179	guaranteed	guarantee	VVD_JJ_VVN
601953	108643965	21111019180	,	,	,
601953	108643965	21111019181	to	to	TO
601953	108643965	21111019182	be	be	VBI
601953	108643965	21111019183	correct	correct	JJ
601953	108643965	21111019184	,	,	,
601953	108643965	21111019185	complete	complete	JJ_VV0
601953	108643965	21111019186	and	and	CC
601953	108643965	21111019187	current	current	JJ_NN1@
601953	108643965	21111019188	.	.	.
601953	108643965	21111019189	All	all	DB
601953	108643965	21111019190	information	information	NN1
601953	108643965	21111019191	on	on	II
601953	108643965	21111019192	this	this	DD1
601953	108643965	21111019193	website	website	NN1
601953	108643965	21111019194	is	be	VBZ
601953	108643965	21111019195	subject	subject	II21
601953	108643965	21111019196	to	to	II22
601953	108643965	21111019197	change	change	NN1
601953	108643965	21111019198	without	without	IW
601953	108643965	21111019199	notice	notice	NN1
601953	108643965	21111019200	.	.	.
601953	108643965	21111019201	The	the	AT
601953	108643965	21111019202	information	information	NN1
601953	108643965	21111019203	that	that	CST_DD1
601953	108643965	21111019204	appears	appear	VVZ
601953	108643965	21111019205	on	on	II
601953	108643965	21111019206	this	this	DD1
601953	108643965	21111019207	website	website	NN1
601953	108643965	21111019208	has	have	VHZ
601953	108643965	21111019209	been	be	VBN
601953	108643965	21111019210	compiled	compile	VVN
601953	108643965	21111019211	in	in	II
601953	108643965	21111019212	good	good	JJ
601953	108643965	21111019213	faith	faith	NN1
601953	108643965	21111019214	by	by	II
601953	108643965	21111019215	Bracket	bracket	NN1
601953	108643965	21111019216	solely	solely	RR
601953	108643965	21111019217	for	for	IF
601953	108643965	21111019218	the	the	AT
601953	108643965	21111019219	purpose	purpose	NN1
601953	108643965	21111019220	of	of	IO
601953	108643965	21111019221	providing	provide	VVG
601953	108643965	21111019222	information	information	NN1
601953	108643965	21111019223	about	about	II
601953	108643965	21111019224	the	the	AT
601953	108643965	21111019225	company	company	NN1
601953	108643965	21111019226	and	and	CC
601953	108643965	21111019227	the	the	AT
601953	108643965	21111019228	products	product	NN2
601953	108643965	21111019229	and	and	CC
601953	108643965	21111019230	services	service	NN2
601953	108643965	21111019231	that	that	CST
601953	108643965	21111019232	it	it	PPH1
601953	108643965	21111019233	offers	offer	VVZ@
601953	108643965	21111019234	.	.	.
601953	108643965	21111019235	Bracket	bracket	NN1_VV0@
601953	108643965	21111019236	,	,	,
601953	108643965	21111019237	Brackets	bracket	VVZ@_NN2
601953	108643965	21111019238	subsidiaries	subsidiary	NN2
601953	108643965	21111019239	and/or	and/or	CC
601953	108643965	21111019240	their	their	APPGE
601953	108643965	21111019241	suppliers	supplier	NN2
601953	108643965	21111019242	may	may	VM
601953	108643965	21111019243	make	make	VVI
601953	108643965	21111019244	improvements	improvement	NN2
601953	108643965	21111019245	and/or	and/or	CC
601953	108643965	21111019246	changes	change	NN2_VVZ@
601953	108643965	21111019247	to	to	II
601953	108643965	21111019248	the	the	AT
601953	108643965	21111019249	information	information	NN1
601953	108643965	21111019250	,	,	,
601953	108643965	21111019251	products	product	NN2
601953	108643965	21111019252	,	,	,
601953	108643965	21111019253	services	service	NN2
601953	108643965	21111019254	,	,	,
601953	108643965	21111019255	graphics	graphic	NN
601953	108643965	21111019256	,	,	,
601953	108643965	21111019257	video	video	NN1_VV0@
601953	108643965	21111019258	,	,	,
601953	108643965	21111019259	sound	sound	NN1_VV0@
601953	108643965	21111019260	,	,	,
601953	108643965	21111019261	images	image	NN2
601953	108643965	21111019262	,	,	,
601953	108643965	21111019263	and/or	and/or	CC
601953	108643965	21111019264	programs	program	NN2
601953	108643965	21111019265	on	on	II
601953	108643965	21111019266	this	this	DD1
601953	108643965	21111019267	website	website	NN1
601953	108643965	21111019268	(	(	(
601953	108643965	21111019269	collectively	collectively	RR
601953	108643965	21111019270	,	,	,
601953	108643965	21111019271	"	"	"
601953	108643965	21111019272	Information	information	NN1
601953	108643965	21111019273	"	"	"
601953	108643965	21111019274	)	)	)
601953	108643965	21111019275	at	at	II
601953	108643965	21111019276	any	any	DD
601953	108643965	21111019277	time	time	NNT1
601953	108643965	21111019278	.	.	.
601953	108643965	21111019279	Bracket	bracket	NN1
601953	108643965	21111019280	makes	make	VVZ
601953	108643965	21111019281	no	no	AT
601953	108643965	21111019282	commitment	commitment	NN1
601953	108643965	21111019283	and	and	CC
601953	108643965	21111019284	disclaims	disclaim	VVZ
601953	108643965	21111019285	any	any	DD
601953	108643965	21111019286	duty	duty	NN1
601953	108643965	21111019287	to	to	TO
601953	108643965	21111019288	have	have	VHI
601953	108643965	21111019289	these	these	DD2
601953	108643965	21111019290	materials	material	NN2
601953	108643965	21111019291	updated	update	VVN_VVD
601953	108643965	21111019292	at	at	II
601953	108643965	21111019293	all	all	DB
601953	108643965	21111019294	times	time	NNT2
601953	108643965	21111019295	.	.	.
601953	108643965	21111019296	<p>		NULL
601953	108643965	21111019297	Permission	permission	NN1
601953	108643965	21111019298	to	to	TO
601953	108643965	21111019299	use	use	VVI
601953	108643965	21111019300	documents	document	NN2
601953	108643965	21111019301	such	such	II21
601953	108643965	21111019302	as	as	II22
601953	108643965	21111019303	white	white	JJ
601953	108643965	21111019304	papers	paper	NN2
601953	108643965	21111019305	,	,	,
601953	108643965	21111019306	press	press	VV0_NN1
601953	108643965	21111019307	releases	release	NN2_VVZ
601953	108643965	21111019308	,	,	,
601953	108643965	21111019309	data	data	NN
601953	108643965	21111019310	sheets	sheet	NN2
601953	108643965	21111019311	,	,	,
601953	108643965	21111019312	etc.		RA
601953	108643965	21111019313	from	from	II
601953	108643965	21111019314	this	this	DD1
601953	108643965	21111019315	website	website	NN1
601953	108643965	21111019316	is	be	VBZ
601953	108643965	21111019317	granted	grant	VVN
601953	108643965	21111019318	,	,	,
601953	108643965	21111019319	provided	provided	CS21
601953	108643965	21111019320	that	that	CS22
601953	108643965	21111019321	(	(	(
601953	108643965	21111019322	i	i	ZZ1
601953	108643965	21111019323	)	)	)
601953	108643965	21111019324	the	the	AT
601953	108643965	21111019325	copyright	copyright	NN1
601953	108643965	21111019326	notice	notice	VV0_NN1
601953	108643965	21111019327	below	below	RL
601953	108643965	21111019328	and	and	CC
601953	108643965	21111019329	this	this	DD1
601953	108643965	21111019330	permission	permission	NN1
601953	108643965	21111019331	notice	notice	NN1_VV0
601953	108643965	21111019332	appear	appear	VV0
601953	108643965	21111019333	on	on	II_RP@
601953	108643965	21111019334	each	each	DD1
601953	108643965	21111019335	use	use	NN1
601953	108643965	21111019336	of	of	IO
601953	108643965	21111019337	such	such	DA
601953	108643965	21111019338	documents	document	NN2
601953	108643965	21111019339	;	;	;
601953	108643965	21111019340	(	(	(
601953	108643965	21111019341	ii	ii	MC
601953	108643965	21111019342	)	)	)
601953	108643965	21111019343	such	such	DA
601953	108643965	21111019344	use	use	NN1
601953	108643965	21111019345	is	be	VBZ
601953	108643965	21111019346	for	for	IF
601953	108643965	21111019347	informational	informational	JJ
601953	108643965	21111019348	and	and	CC
601953	108643965	21111019349	non-commercial	noncommercial	JJ
601953	108643965	21111019350	@		II
601953	108643965	21111019351	@		II
601953	108643965	21111019352	@		II
601953	108643965	21111019353	@		II
601953	108643965	21111019354	@		II
601953	108643965	21111019355	@		II
601953	108643965	21111019356	@		II
601953	108643965	21111019357	@		II
601953	108643965	21111019358	@		II
601953	108643965	21111019359	@		II
601953	108643965	21111019360	are	be	VBR
601953	108643965	21111019361	not	not	XX
601953	108643965	21111019362	copied	copy	VVN
601953	108643965	21111019363	or	or	CC
601953	108643965	21111019364	posted	post	VVN_VVD
601953	108643965	21111019365	on	on	II_RP@
601953	108643965	21111019366	any	any	DD
601953	108643965	21111019367	network	network	NN1
601953	108643965	21111019368	computer	computer	NN1
601953	108643965	21111019369	or	or	CC
601953	108643965	21111019370	broadcast	broadcast	VVN_VV0_NN1
601953	108643965	21111019371	in	in	II_RP@
601953	108643965	21111019372	any	any	DD
601953	108643965	21111019373	media	media	NN
601953	108643965	21111019374	.	.	.
601953	108643965	21111019375	No	no	AT
601953	108643965	21111019376	modifications	modification	NN2
601953	108643965	21111019377	of	of	IO
601953	108643965	21111019378	any	any	DD
601953	108643965	21111019379	Information	information	NN1
601953	108643965	21111019380	is	be	VBZ
601953	108643965	21111019381	permitted	permit	VVN
601953	108643965	21111019382	.	.	.
601953	108643965	21111019383	Use	use	VV0_NN1
601953	108643965	21111019384	for	for	IF
601953	108643965	21111019385	any	any	DD
601953	108643965	21111019386	other	other	JJ
601953	108643965	21111019387	purpose	purpose	NN1
601953	108643965	21111019388	is	be	VBZ
601953	108643965	21111019389	expressly	expressly	RR
601953	108643965	21111019390	prohibited	prohibit	VVN
601953	108643965	21111019391	by	by	II
601953	108643965	21111019392	law	law	NN1
601953	108643965	21111019393	.	.	.
601953	108643965	21111019394	Documents	document	NN2
601953	108643965	21111019395	specified	specify	VVN_VVD
601953	108643965	21111019396	above	above	RL
601953	108643965	21111019397	do	do	VD0
601953	108643965	21111019398	not	not	XX
601953	108643965	21111019399	include	include	VVI
601953	108643965	21111019400	the	the	AT
601953	108643965	21111019401	design	design	NN1
601953	108643965	21111019402	or	or	CC
601953	108643965	21111019403	layout	layout	NN1
601953	108643965	21111019404	of	of	IO
601953	108643965	21111019405	the	the	AT
601953	108643965	21111019406	www.bracket.com		NNU
601953	108643965	21111019407	website	website	NN1
601953	108643965	21111019408	or	or	CC
601953	108643965	21111019409	any	any	DD
601953	108643965	21111019410	other	other	JJ
601953	108643965	21111019411	Bracket	bracket	NN1
601953	108643965	21111019412	owned	own	VVD_VVN
601953	108643965	21111019413	,	,	,
601953	108643965	21111019414	operated	operate	VVN_VVD@
601953	108643965	21111019415	,	,	,
601953	108643965	21111019416	licensed	licensed	JJ_VVN
601953	108643965	21111019417	or	or	CC
601953	108643965	21111019418	controlled	controlled	JJ@_VVD_VVN
601953	108643965	21111019419	site	site	NN1
601953	108643965	21111019451	sound	sound	NN1
601953	108643965	21111019452	or	or	CC
601953	108643965	21111019453	image	image	NN1
601953	108643965	21111019454	from	from	II
601953	108643965	21111019455	any	any	DD
601953	108643965	21111019456	Bracket	bracket	NN1
601953	108643965	21111019457	website	website	NN1
601953	108643965	21111019458	may	may	VM
601953	108643965	21111019459	be	be	VBI
601953	108643965	21111019460	copied	copy	VVN
601953	108643965	21111019461	or	or	CC
601953	108643965	21111019462	retransmitted		VVD
601953	108643965	21111019463	unless	unless	CS
601953	108643965	21111019464	expressly	expressly	RR
601953	108643965	21111019465	permitted	permit	VVN
601953	108643965	21111019466	by	by	II
601953	108643965	21111019467	Bracket	bracket	NN1
601953	108643965	21111019468	.	.	.
601953	108643965	21111019469	<p>		NULL
601953	108643965	21111019470	Bracket	bracket	NN1
601953	108643965	21111019471	does	do	VDZ
601953	108643965	21111019472	not	not	XX
601953	108643965	21111019473	accept	accept	VVI
601953	108643965	21111019474	responsibility	responsibility	NN1
601953	108643965	21111019475	for	for	IF
601953	108643965	21111019476	other	other	JJ
601953	108643965	21111019477	organizations	organization	NN2
601953	108643965	21111019478	,	,	,
601953	108643965	21111019479	businesses	business	NN2
601953	108643965	21111019480	,	,	,
601953	108643965	21111019481	and	and	CC
601953	108643965	21111019482	private	private	JJ
601953	108643965	21111019483	persons	person	NN2
601953	108643965	21111019484	that	that	CST_DD1
601953	108643965	21111019485	may	may	VM
601953	108643965	21111019486	provide	provide	VVI
601953	108643965	21111019487	information	information	NN1
601953	108643965	21111019488	on	on	II
601953	108643965	21111019489	this	this	DD1
601953	108643965	21111019490	website	website	NN1
601953	108643965	21111019491	.	.	.
601953	108643965	21111019492	Any	any	DD
601953	108643965	21111019493	links	link	NN2
601953	108643965	21111019494	on	on	II
601953	108643965	21111019495	this	this	DD1
601953	108643965	21111019496	website	website	NN1
601953	108643965	21111019497	may	may	VM
601953	108643965	21111019498	let	let	VVI
601953	108643965	21111019499	you	you	PPY
601953	108643965	21111019500	leave	leave	VVI
601953	108643965	21111019501	the	the	AT
601953	108643965	21111019502	Bracket	bracket	NN1
601953	108643965	21111019503	website	website	NN1
601953	108643965	21111019504	.	.	.
601953	108643965	21111019505	The	the	AT
601953	108643965	21111019506	linked	linked	JJ
601953	108643965	21111019507	sites	site	NN2
601953	108643965	21111019508	are	be	VBR
601953	108643965	21111019509	not	not	XX
601953	108643965	21111019510	under	under	II
601953	108643965	21111019511	the	the	AT
601953	108643965	21111019563	does	do	VDZ
601953	108643965	21111019564	not	not	XX
601953	108643965	21111019565	imply	imply	VVI
601953	108643965	21111019566	endorsement	endorsement	NN1
601953	108643965	21111019567	by	by	II
601953	108643965	21111019568	Bracket	bracket	NN1
601953	108643965	21111019569	of	of	IO
601953	108643965	21111019570	the	the	AT
601953	108643965	21111019571	site	site	NN1
601953	108643965	21111019572	.	.	.
601953	108643965	21111019573	Bracket	bracket	NN1
601953	108643965	21111019574	is	be	VBZ
601953	108643965	21111019575	not	not	XX
601953	108643965	21111019576	responsible	responsible	JJ
601953	108643965	21111019577	and	and	CC
601953	108643965	21111019578	assumes	assume	VVZ
601953	108643965	21111019579	no	no	AT
601953	108643965	21111019580	legal	legal	JJ
601953	108643965	21111019581	liability	liability	NN1
601953	108643965	21111019582	for	for	IF
601953	108643965	21111019583	the	the	AT
601953	108643965	21111019584	accuracy	accuracy	NN1
601953	108643965	21111019585	of	of	IO
601953	108643965	21111019586	the	the	AT
601953	108643965	21111019587	contents	content	NN2
601953	108643965	21111019588	or	or	CC
601953	108643965	21111019589	any	any	DD
601953	108643965	21111019590	other	other	JJ
601953	108643965	21111019591	aspect	aspect	NN1
601953	108643965	21111019592	of	of	IO
601953	108643965	21111019593	any	any	DD
601953	108643965	21111019594	external	external	JJ
601953	108643965	21111019595	website	website	NN1
601953	108643965	21111019596	to	to	II
601953	108643965	21111019597	which	which	DDQ
601953	108643965	21111019598	a	a	AT1
601953	108643965	21111019599	link	link	NN1
601953	108643965	21111019600	or	or	CC
601953	108643965	21111019601	other	other	JJ
601953	108643965	21111019602	reference	reference	NN1
601953	108643965	21111019603	has	have	VHZ
601953	108643965	21111019604	been	be	VBN
601953	108643965	21111019605	provided	provide	VVN
601953	108643965	21111019606	in	in	II
601953	108643965	21111019607	this	this	DD1
601953	108643965	21111019608	website	website	NN1
601953	108643965	21111019609	.	.	.
601953	108643965	21111019610	<p>		NULL
601953	108643965	21111019611	All	all	DB
601953	108643965	21111019612	brand	brand	NN1_VV0@
601953	108643965	21111019613	,	,	,
601953	108643965	21111019614	product	product	NN1
601953	108643965	21111019615	,	,	,
601953	108643965	21111019616	service	service	NN1_VV0@
601953	108643965	21111019617	,	,	,
601953	108643965	21111019618	and	and	CC
601953	108643965	21111019619	process	process	VV0_NN1
601953	108643965	21111019620	names	name	NN2
601953	108643965	21111019621	appearing	appear	VVG
601953	108643965	21111019622	on	on	II
601953	108643965	21111019623	this	this	DD1
601953	108643965	21111019624	website	website	NN1
601953	108643965	21111019625	are	be	VBR
601953	108643965	21111019626	trademarks	trademark	NN2
601953	108643965	21111019627	of	of	IO
601953	108643965	21111019628	their	their	APPGE
601953	108643965	21111019629	respective	respective	JJ
601953	108643965	21111019630	holders	holder	NN2
601953	108643965	21111019631	.	.	.
601953	108643965	21111019632	Reference	reference	NN1_VV0@
601953	108643965	21111019633	to	to	II
601953	108643965	21111019634	or	or	CC
601953	108643965	21111019635	use	use	NN1
601953	108643965	21111019636	of	of	IO
601953	108643965	21111019637	a	a	AT1
601953	108643965	21111019638	product	product	NN1
601953	108643965	21111019639	,	,	,
601953	108643965	21111019640	service	service	NN1_VV0@
601953	108643965	21111019641	,	,	,
601953	108643965	21111019642	or	or	CC
601953	108643965	21111019643	process	process	NN1_VV0
601953	108643965	21111019644	does	do	VDZ
601953	108643965	21111019645	not	not	XX
601953	108643965	21111019646	imply	imply	VVI
601953	108643965	21111019647	recommendation	recommendation	NN1
601953	108643965	21111019648	,	,	,
601953	108643965	21111019649	approval	approval	NN1
601953	108643965	21111019650	,	,	,
601953	108643965	21111019651	affiliation	affiliation	NN1
601953	108643965	21111019652	,	,	,
601953	108643965	21111019653	or	or	CC
601953	108643965	21111019654	sponsorship	sponsorship	NN1
601953	108643965	21111019655	of	of	IO
601953	108643965	21111019656	that	that	DD1
601953	108643965	21111019657	product	product	NN1
601953	108643965	21111019658	,	,	,
601953	108643965	21111019659	service	service	NN1_VV0@
601953	108643965	21111019688	,	,	,
601953	108643965	21111019689	copyright	copyright	NN1
601953	108643965	21111019690	,	,	,
601953	108643965	21111019691	trademark	trademark	NN1
601953	108643965	21111019692	,	,	,
601953	108643965	21111019693	or	or	CC
601953	108643965	21111019694	other	other	JJ
601953	108643965	21111019695	intellectual	intellectual	JJ_NN1
601953	108643965	21111019696	property	property	NN1
601953	108643965	21111019697	right	right	NN1
601953	108643965	21111019698	of	of	IO
601953	108643965	21111019699	Bracket	bracket	NN1
601953	108643965	21111019700	or	or	CC
601953	108643965	21111019701	any	any	RR%
601953	108643965	21111019702	third	third	MD
601953	108643965	21111019703	party	party	NN1
601953	108643965	21111019704	,	,	,
601953	108643965	21111019705	except	except	CS_II
601953	108643965	21111019706	as	as	CSA_RG@
601953	108643965	21111019707	expressly	expressly	RR
601953	108643965	21111019708	granted	grant	VVN_VVD
601953	108643965	21111019709	herein	herein	RR
601953	108643965	21111019710	.	.	.
601953	108643965	21111019711	<p>		NULL
601953	108643965	21111019712	In	in	II
601953	108643965	21111019713	the	the	AT
601953	108643965	21111019714	event	event	NN1
601953	108643965	21111019715	any	any	DD
601953	108643965	21111019716	user	user	NN1
601953	108643965	21111019717	of	of	IO
601953	108643965	21111019718	the	the	AT
601953	108643965	21111019719	Bracket	bracket	NN1
601953	108643965	21111019720	website	website	NN1
601953	108643965	21111019721	provides	provide	VVZ
601953	108643965	21111019722	any	any	DD
601953	108643965	21111019723	information	information	NN1
601953	108643965	21111019724	,	,	,
601953	108643965	21111019725	including	include	VVG@_II
601953	108643965	21111019726	,	,	,
601953	108643965	21111019727	but	but	CCB
601953	108643965	21111019728	not	not	XX
601953	108643965	21111019729	limited	limit	VVN
601953	108643965	21111019730	to	to	II_TO
601953	108643965	21111019731	,	,	,
601953	108643965	21111019732	questions	question	NN2
601953	108643965	21111019733	,	,	,
601953	108643965	21111019734	comments	comment	NN2
601953	108643965	21111019735	,	,	,
601953	108643965	21111019736	or	or	CC
601953	108643965	21111019737	ideas	idea	NN2
601953	108643965	21111019738	,	,	,
601953	108643965	21111019739	through	through	II
601953	108643965	21111019740	any	any	DD
601953	108643965	21111019741	interactive	interactive	JJ
601953	108643965	21111019768	disclose	disclose	VV0
601953	108643965	21111019769	,	,	,
601953	108643965	21111019770	and	and	CC
601953	108643965	21111019771	distribute	distribute	VV0
601953	108643965	21111019772	such	such	DA
601953	108643965	21111019773	information	information	NN1
601953	108643965	21111019774	to	to	II
601953	108643965	21111019775	others	others	NN2
601953	108643965	21111019776	without	without	IW
601953	108643965	21111019777	limitation	limitation	NN1
601953	108643965	21111019778	.	.	.
601953	108643965	21111019779	<h>		NULL
601953	108643965	21111019780	Why	why	RRQ
601953	108643965	21111019781	Wait	wait	VV0
601953	108643965	21111019782	?	?	?
601953	108643965	21111019783	<p>		NULL
601953	108643965	21111019784	Sign	sign	VV0
601953	108643965	21111019785	up	up	RP
601953	108643965	21111019786	now	now	RT
601953	108643965	21111019787	to	to	TO
601953	108643965	21111019788	have	have	VHI
601953	108643965	21111019789	someone	someone	PN1
601953	108643965	21111019790	from	from	II
601953	108643965	21111019791	Bracket	bracket	NN1
601953	108643965	21111019792	contact	contact	VV0_NN1
601953	108643965	21111019793	you	you	PPY
601953	108643965	21111019794	.	.	.
601953	108643965	21111019795	Let	let	VV0
601953	108643965	21111019796	us	us	PPIO2
601953	108643965	21111019797	show	show	VVI
601953	108643965	21111019798	you	you	PPY
601953	108643965	21111019799	how	how	RRQ
601953	108643965	21111019800	Bracket	bracket	NN1
601953	108643965	21111019801	eclipses	eclipse	VVZ@_NN2
601953	108643965	21111019802	the	the	AT
601953	108643965	21111019803	industry	industry	NN1
601953	108643965	21111019804	through	through	II
601953	108643965	21111019805	Science	science	NN1
601953	108643965	21111019806	,	,	,
601953	108643965	21111019807	Technology	technology	NN1
601953	108643965	21111019808	,	,	,
601953	108643965	21111019809	and	and	CC
601953	108643965	21111019810	Service	service	NN1
601953	108643965	21111019811	.	.	.
601953	108643967	21111019831	@@##	----------	----------
601953	108643967	21111019832	@@108643967		FO
601953	108643967	21111019833	@4043967/		JJ_NN1_VV0
601953	108643967	21111019834	<h>		NULL
601953	108643967	21111019835	Bracket	bracket	NN1
601953	108643967	21111019836	Encourages	encourage	VVZ
601953	108643967	21111019837	Its	its	APPGE
601953	108643967	21111019838	Employees	employee	NN2
601953	108643967	21111019839	To	to	TO_II
601953	108643967	21111019840	Get	get	VV0
601953	108643967	21111019841	Involved	involve	VVN
601953	108643967	21111019842	<p>		NULL
601953	108643967	21111019843	Bracket	bracket	NN1
601953	108643967	21111019844	is	be	VBZ
601953	108643967	21111019845	proud	proud	JJ
601953	108643967	21111019846	to	to	TO
601953	108643967	21111019847	encourage	encourage	VVI
601953	108643967	21111019848	and	and	CC
601953	108643967	21111019849	support	support	VVI
601953	108643967	21111019850	its	its	APPGE
601953	108643967	21111019851	employees	employee	NN2
601953	108643967	21111019852	to	to	TO
601953	108643967	21111019853	get	get	VVI
601953	108643967	21111019854	involved	involved	JJ
601953	108643967	21111019855	in	in	II
601953	108643967	21111019856	fundraising	fund-raising	NN1_VVG@
601953	108643967	21111019857	events	event	NN2
601953	108643967	21111019858	that	that	CST
601953	108643967	21111019859	benefit	benefit	VV0
601953	108643967	21111019860	their	their	APPGE
601953	108643967	21111019861	local	local	JJ
601953	108643967	21111019862	or	or	CC
601953	108643967	21111019863	national	national	JJ
601953	108643967	21111019864	charities	charity	NN2
601953	108643967	21111019865	.	.	.
601953	108643967	21111019866	Bracket	bracket	NN1
601953	108643967	21111019867	provides	provide	VVZ
601953	108643967	21111019868	each	each	DD1
601953	108643967	21111019869	of	of	IO
601953	108643967	21111019870	our	our	APPGE
601953	108643967	21111019871	global	global	JJ
601953	108643967	21111019872	offices	office	NN2
601953	108643967	21111019873	with	with	IW
601953	108643967	21111019874	a	a	AT1
601953	108643967	21111019875	donation	donation	NN1
601953	108643967	21111019876	to	to	TO
601953	108643967	21111019877	be	be	VBI
601953	108643967	21111019878	contributed	contribute	VVN
601953	108643967	21111019879	to	to	II
601953	108643967	21111019880	a	a	AT1
601953	108643967	21111019881	charitable	charitable	JJ
601953	108643967	21111019882	organization	organization	NN1
601953	108643967	21111019883	of	of	IO
601953	108643967	21111019884	their	their	APPGE
601953	108643967	21111019885	choosing	choosing	NN1
601953	108643967	21111019886	.	.	.
601953	108643967	21111019887	Bracket	bracket	VV0@_NN1
601953	108643967	21111019888	UK	uk	NP1
601953	108643967	21111019889	have	have	VH0
601953	108643967	21111019890	set	set	VVN
601953	108643967	21111019891	themselves	themselves	PPX2
601953	108643967	21111019892	two	two	MC
601953	108643967	21111019893	grueling	grueling	JJ@_VVG
601953	108643967	21111019894	challenges	challenge	NN2
601953	108643967	21111019895	in	in	II
601953	108643967	21111019896	aid	aid	NN1
601953	108643967	21111019897	of-	of--	JJ_NN1
601953	108643967	21111019898	British	british	JJ
601953	108643967	21111019899	Heart	heart	NN1
601953	108643967	21111019900	Foundation-		JJ_NN1
601953	108643967	21111019901	and-	and--	JJ_NN1
601953	108643967	21111019902	Cancer	cancer	NN1
601953	108643967	21111019903	Research	research	NN1
601953	108643967	21111019904	UK-		NN1
601953	108643967	21111019905	.	.	.
601953	108643967	21111019906	<p>		NULL
601953	108643967	21111019907	A	a	AT1
601953	108643967	21111019908	group	group	NN1
601953	108643967	21111019909	of	of	IO
601953	108643967	21111019910	employees	employee	NN2
601953	108643967	21111019911	from	from	II
601953	108643967	21111019912	both	both	DB2
601953	108643967	21111019913	the	the	AT
601953	108643967	21111019914	Goring		NP1_NN1@_JJ@
601953	108643967	21111019915	and	and	CC
601953	108643967	21111019916	Hammersmith	hammersmith	NP1
601953	108643967	21111019917	office	office	NN1
601953	108643967	21111019918	embarked	embark	VVN_VVD
601953	108643967	21111019919	on	on	II
601953	108643967	21111019920	the	the	AT
601953	108643967	21111019921	first	first	MD
601953	108643967	21111019922	of	of	IO
601953	108643967	21111019923	two	two	MC
601953	108643967	21111019924	planned	plan	VVD_JJ@_VVN
601953	108643967	21111019925	charitable	charitable	JJ
601953	108643967	21111019926	events	event	NN2
601953	108643967	21111019927	this	this	DD1
601953	108643967	21111019928	year	year	NNT1
601953	108643967	21111019929	,	,	,
601953	108643967	21111019930	the	the	AT
601953	108643967	21111019931	London	london	NP1
601953	108643967	21111019932	to	to	II
601953	108643967	21111019933	Reading	reading	NP1
601953	108643967	21111019934	Bike	bike	NN1
601953	108643967	21111019935	Ride	ride	NN1
601953	108643967	21111019936	.	.	.
601953	108643967	21111019937	The	the	AT
601953	108643967	21111019938	event	event	NN1
601953	108643967	21111019939	,	,	,
601953	108643967	21111019940	which	which	DDQ
601953	108643967	21111019941	aided	aid	VVD
601953	108643967	21111019942	the	the	AT
601953	108643967	21111019943	British	british	JJ
601953	108643967	21111019944	Heart	heart	NN1
601953	108643967	21111019945	Foundation	foundation	NN1
601953	108643967	21111019946	,	,	,
601953	108643967	21111019947	took	take	VVD
601953	108643967	21111019948	place	place	NN1
601953	108643967	21111019949	on	on	II
601953	108643967	21111019950	April	april	NPM1
601953	108643967	21111019951	28th	28th	MD
601953	108643967	21111019952	,	,	,
601953	108643967	21111019953	2013	2013	MC
601953	108643967	21111019954	and	and	CC
601953	108643967	21111019955	involved	involve	VVD_JJ@_VVN
601953	108643967	21111019956	cycling	cycle	VVG_NN1
601953	108643967	21111019957	40	40	MC
601953	108643967	21111019958	miles	mile	NNU2
601953	108643967	21111019959	from	from	II
601953	108643967	21111019960	London	london	NP1
601953	108643967	21111019961	to	to	II
601953	108643967	21111019962	Reading	reading	NP1
601953	108643967	21111019963	.	.	.
601953	108643967	21111019964	The	the	AT
601953	108643967	21111019965	British	british	JJ
601953	108643967	21111019966	Heart	heart	NN1
601953	108643967	21111019967	Foundation	foundation	NN1
601953	108643967	21111019968	funds	fund	NN2
601953	108643967	21111019969	research	research	VV0@_NN1
601953	108643967	21111019970	into	into	II
601953	108643967	21111019971	the	the	AT
601953	108643967	21111019972	causes	cause	NN2
601953	108643967	21111019973	,	,	,
601953	108643967	21111019974	diagnosis	diagnosis	NN1
601953	108643967	21111019975	,	,	,
601953	108643967	21111019976	treatment	treatment	NN1
601953	108643967	21111019977	and	and	CC
601953	108643967	21111019978	prevention	prevention	NN1
601953	108643967	21111019979	of	of	IO
601953	108643967	21111019980	heart	heart	NN1
601953	108643967	21111019981	and	and	CC
601953	108643967	21111019982	circulatory	circulatory	JJ
601953	108643967	21111019983	disease	disease	NN1
601953	108643967	21111019984	.	.	.
601953	108643967	21111019985	<p>		NULL
601953	108643967	21111019986	Not	not	XX
601953	108643967	21111019987	satisfied	satisfy	VVN@_JJ
601953	108643967	21111019988	with	with	IW
601953	108643967	21111019989	just	just	RR_JJ@
601953	108643967	21111019990	cycling	cycle	VVG_NN1
601953	108643967	21111019991	40	40	MC
601953	108643967	21111019992	miles	mile	NNU2
601953	108643967	21111019993	,	,	,
601953	108643967	21111019994	the	the	AT
601953	108643967	21111019995	team	team	NN1
601953	108643967	21111019996	will	will	VM
601953	108643967	21111019997	set	set	VVI
601953	108643967	21111019998	out	out	RP
601953	108643967	21111019999	to	to	TO
601953	108643967	21111020000	conquer	conquer	VVI
601953	108643967	21111020001	Mount	mount	NNL1
601953	108643967	21111020002	Snowdon	snowdon	NP1
601953	108643967	21111020003	on	on	II
601953	108643967	21111020004	July	july	NPM1
601953	108643967	21111020005	27th	27th	MD
601953	108643967	21111020006	,	,	,
601953	108643967	21111020007	2013	2013	MC
601953	108643967	21111020008	in	in	II31
601953	108643967	21111020009	aid	aid	II32
601953	108643967	21111020010	of	of	II33
601953	108643967	21111020011	Cancer	cancer	NN1
601953	108643967	21111020012	Research	research	NN1
601953	108643967	21111020013	UK	uk	NP1
601953	108643967	21111020014	.	.	.
601953	108643967	21111020015	Snowdon		NN1_NP1@
601953	108643967	21111020016	is	be	VBZ
601953	108643967	21111020017	the	the	AT
601953	108643967	21111020018	largest	large	JJT
601953	108643967	21111020019	mountain	mountain	NN1
601953	108643967	21111020020	in	in	II
601953	108643967	21111020021	Wales	wales	NP1
601953	108643967	21111020022	,	,	,
601953	108643967	21111020023	@		II
601953	108643967	21111020024	@		II
601953	108643967	21111020025	@		II
601953	108643967	21111020026	@		II
601953	108643967	21111020027	@		II
601953	108643967	21111020028	@		II
601953	108643967	21111020029	@		II
601953	108643967	21111020030	@		II
601953	108643967	21111020031	@		II
601953	108643967	21111020032	@		II
601953	108643967	21111020033	the	the	AT
601953	108643967	21111020034	team	team	NN1
601953	108643967	21111020035	between	between	II
601953	108643967	21111020036	6-8	6-8	MCMC
601953	108643967	21111020037	hours	hour	NNT2
601953	108643967	21111020038	to	to	TO
601953	108643967	21111020039	complete	complete	VVI
601953	108643967	21111020040	the	the	AT
601953	108643967	21111020041	climb	climb	NN1
601953	108643967	21111020042	.	.	.
601953	108643967	21111020043	Cancer	cancer	NN1
601953	108643967	21111020044	Research	research	NN1
601953	108643967	21111020045	UK	uk	NP1
601953	108643967	21111020046	is	be	VBZ
601953	108643967	21111020047	the	the	AT
601953	108643967	21111020048	leading	leading	JJ
601953	108643967	21111020049	cancer	cancer	NN1
601953	108643967	21111020050	research	research	NN1
601953	108643967	21111020051	and	and	CC
601953	108643967	21111020052	awareness	awareness	NN1
601953	108643967	21111020053	charity	charity	NN1
601953	108643967	21111020054	in	in	II
601953	108643967	21111020055	the	the	AT
601953	108643967	21111020056	United	united	NP1
601953	108643967	21111020057	Kingdom	kingdom	NP1
601953	108643967	21111020058	.	.	.
601953	108643967	21111020059	As	as	II_CSA
601953	108643967	21111020060	the	the	AT
601953	108643967	21111020061	worlds	world	NN2
601953	108643967	21111020062	largest	large	JJT
601953	108643967	21111020063	independent	independent	JJ
601953	108643967	21111020064	cancer	cancer	NN1
601953	108643967	21111020065	research	research	NN1
601953	108643967	21111020066	charity	charity	NN1
601953	108643967	21111020067	it	it	PPH1
601953	108643967	21111020068	conducts	conduct	VVZ
601953	108643967	21111020069	research	research	NN1
601953	108643967	21111020070	into	into	II
601953	108643967	21111020071	the	the	AT
601953	108643967	21111020072	prevention	prevention	NN1
601953	108643967	21111020073	,	,	,
601953	108643967	21111020074	diagnosis	diagnosis	NN1
601953	108643967	21111020075	and	and	CC
601953	108643967	21111020076	treatment	treatment	NN1
601953	108643967	21111020077	of	of	IO
601953	108643967	21111020078	the	the	AT
601953	108643967	21111020079	disease	disease	NN1
601953	108643967	21111020080	.	.	.
601953	108643967	21111020081	<p>		NULL
601953	108643967	21111020082	We	we	PPIS2
601953	108643967	21111020083	have	have	VH0
601953	108643967	21111020084	chosen	choose	VVN
601953	108643967	21111020085	Cancer	cancer	NN1
601953	108643967	21111020086	Research	research	NN1
601953	108643967	21111020087	in	in	II
601953	108643967	21111020088	memory	memory	NN1
601953	108643967	21111020089	of	of	IO
601953	108643967	21111020090	a	a	AT1
601953	108643967	21111020091	former	former	DA
601953	108643967	21111020092	employee	employee	NN1
601953	108643967	21111020093	and	and	CC
601953	108643967	21111020094	dear	dear	JJ_NN1
601953	108643967	21111020095	friend	friend	NN1
601953	108643967	21111020096	,	,	,
601953	108643967	21111020097	Gretchen	gretchen	NP1
601953	108643967	21111020098	Amorim	amorim	NP1_NN1
601953	108643967	21111020099	who	who	PNQS
601953	108643967	21111020100	passed	pass	VVD
601953	108643967	21111020101	away	away	RL
601953	108643967	21111020102	last	last	MD
601953	108643967	21111020103	year	year	NNT1
601953	108643967	21111020104	.	.	.
601953	108643967	21111020105	Gretchen	gretchen	NP1@_NN1
601953	108643967	21111020106	had	have	VHD
601953	108643967	21111020107	worked	work	VVN
601953	108643967	21111020108	in	in	II
601953	108643967	21111020109	the	the	AT
601953	108643967	21111020110	Goring		JJ@_NP1_NN1@
601953	108643967	21111020111	office	office	NN1
601953	108643967	21111020112	for	for	IF
601953	108643967	21111020113	over	over	RG
601953	108643967	21111020114	3	3	MC
601953	108643967	21111020115	years	year	NNT2
601953	108643967	21111020116	but	but	CCB
601953	108643967	21111020117	had	have	VHD
601953	108643967	21111020118	made	make	VVN
601953	108643967	21111020119	many	many	DA2
601953	108643967	21111020120	friends	friend	NN2
601953	108643967	21111020121	all	all	RR
601953	108643967	21111020122	over	over	II
601953	108643967	21111020123	Bracket	bracket	NN1
601953	108643967	21111020124	.	.	.
601953	108643967	21111020125	Gretchen	gretchen	NP1@_NN1
601953	108643967	21111020126	battled	battle	VVD
601953	108643967	21111020127	with	with	IW
601953	108643967	21111020128	cancer	cancer	NN1
601953	108643967	21111020129	a	a	AT1
601953	108643967	21111020130	number	number	NN1
601953	108643967	21111020131	of	of	IO
601953	108643967	21111020132	times	time	NNT2
601953	108643967	21111020133	before	before	CS
601953	108643967	21111020134	she	she	PPHS1
601953	108643967	21111020135	sadly	sadly	RR
601953	108643967	21111020136	passed	pass	VVN_VVD
601953	108643967	21111020137	away	away	RL
601953	108643967	21111020138	,	,	,
601953	108643967	21111020139	her	her	APPGE
601953	108643967	21111020140	bravery	bravery	NN1
601953	108643967	21111020141	was	be	VBDZ
601953	108643967	21111020142	an	a	AT1
601953	108643967	21111020143	inspiration	inspiration	NN1
601953	108643967	21111020144	to	to	II
601953	108643967	21111020145	everyone	everyone	PN1
601953	108643967	21111020146	.	.	.
601953	108643968	21111020166	@@##	----------	----------
601953	108643968	21111020167	@@108643968		FO
601953	108643968	21111020168	@4043968/		NN1_VV0
601953	108643968	21111020169	<p>		NULL
601953	108643968	21111020170	The	the	AT
601953	108643968	21111020171	proportion	proportion	NN1
601953	108643968	21111020172	of	of	IO
601953	108643968	21111020173	identical	identical	JJ
601953	108643968	21111020174	scorings		NN2
601953	108643968	21111020175	(	(	(
601953	108643968	21111020176	all	all	DB_RR@
601953	108643968	21111020177	30	30	MC
601953	108643968	21111020178	PANSS		NN1_NP1_VV0
601953	108643968	21111020179	items	item	NN2
601953	108643968	21111020180	identical	identical	JJ
601953	108643968	21111020181	)	)	)
601953	108643968	21111020182	across	across	II
601953	108643968	21111020183	consecutive	consecutive	JJ
601953	108643968	21111020184	visits	visit	NN2
601953	108643968	21111020185	has	have	VHZ
601953	108643968	21111020186	been	be	VBN
601953	108643968	21111020187	estimated	estimate	VVN
601953	108643968	21111020188	to	to	TO
601953	108643968	21111020189	be	be	VBI
601953	108643968	21111020190	approximately	approximately	RR
601953	108643968	21111020191	5%		NNU
601953	108643968	21111020192	in	in	II
601953	108643968	21111020193	schizophrenia	schizophrenia	NN1
601953	108643968	21111020194	clinical	clinical	JJ
601953	108643968	21111020195	trials	trial	NN2
601953	108643968	21111020196	(	(	(
601953	108643968	21111020197	Daniel	daniel	NP1
601953	108643968	21111020198	and	and	CC
601953	108643968	21111020199	Kott	kott	NN1
601953	108643968	21111020200	,	,	,
601953	108643968	21111020201	2014	2014	MC
601953	108643968	21111020202	)	)	)
601953	108643968	21111020203	.	.	.
601953	108643968	21111020204	In	in	II
601953	108643968	21111020205	the	the	AT
601953	108643968	21111020206	current	current	JJ
601953	108643968	21111020207	analysis	analysis	NN1
601953	108643968	21111020208	,	,	,
601953	108643968	21111020209	Dr.		NNB
601953	108643968	21111020210	Kott	kott	NP1
601953	108643968	21111020211	and	and	CC
601953	108643968	21111020212	Dr.		NNB
601953	108643968	21111020213	Daniel	daniel	NP1
601953	108643968	21111020214	estimated	estimate	VVD
601953	108643968	21111020215	the	the	AT
601953	108643968	21111020216	likelihood	likelihood	NN1
601953	108643968	21111020217	two	two	MC
601953	108643968	21111020218	random	random	JJ
601953	108643968	21111020219	raters	rater	NN2
601953	108643968	21111020220	would	would	VM
601953	108643968	21111020221	agree	agree	VVI
601953	108643968	21111020222	on	on	II_RP@
601953	108643968	21111020223	all	all	DB
601953	108643968	21111020224	30	30	MC
601953	108643968	21111020225	PANSS		NN1_NP1_VV0
601953	108643968	21111020226	items	item	NN2
601953	108643968	21111020227	rating	rate	VVG
601953	108643968	21111020228	the	the	AT
601953	108643968	21111020229	same	same	DA
601953	108643968	21111020230	subject	subject	NN1
601953	108643968	21111020231	from	from	II
601953	108643968	21111020232	73	73	MC
601953	108643968	21111020233	datasets	dataset	NN2
601953	108643968	21111020234	of	of	IO
601953	108643968	21111020235	raters	rater	NN2
601953	108643968	21111020236	rating	rate	VVG
601953	108643968	21111020237	the	the	AT
601953	108643968	21111020238	same	same	DA
601953	108643968	21111020239	videotaped	videotaped	JJ@_VVD
601953	108643968	21111020240	subjects	subject	NN2
601953	108643968	21111020241	used	use	VVN_VVD
601953	108643968	21111020242	for	for	IF
601953	108643968	21111020243	certification	certification	NN1
601953	108643968	21111020244	purposes	purpose	NN2
601953	108643968	21111020245	.	.	.
601953	108643968	21111020246	The	the	AT
601953	108643968	21111020247	results	result	NN2
601953	108643968	21111020248	indicate	indicate	VV0
601953	108643968	21111020249	that	that	CST
601953	108643968	21111020250	it	it	PPH1
601953	108643968	21111020251	is	be	VBZ
601953	108643968	21111020252	extremely	extremely	RR
601953	108643968	21111020253	unlikely	unlikely	JJ
601953	108643968	21111020254	for	for	IF
601953	108643968	21111020255	two	two	MC
601953	108643968	21111020256	raters	rater	NN2
601953	108643968	21111020257	to	to	TO
601953	108643968	21111020258	agree	agree	VVI
601953	108643968	21111020259	exactly	exactly	RR
601953	108643968	21111020260	on	on	II
601953	108643968	21111020261	all	all	DB
601953	108643968	21111020262	30	30	MC
601953	108643968	21111020263	PANSS		NN1_NP1_VV0
601953	108643968	21111020264	items	item	NN2
601953	108643968	21111020265	even	even	CS21
601953	108643968	21111020266	when	when	CS22
601953	108643968	21111020267	rating	rate	VVG
601953	108643968	21111020268	the	the	AT
601953	108643968	21111020269	same	same	DA
601953	108643968	21111020270	videotaped	videotaped	JJ@
601953	108643968	21111020271	subject	subject	NN1
601953	108643968	21111020272	and	and	CC
601953	108643968	21111020273	the	the	AT
601953	108643968	21111020274	authors	author	NN2
601953	108643968	21111020275	conclude	conclude	VV0
601953	108643968	21111020276	that	that	CST_DD1
601953	108643968	21111020277	identical	identical	JJ
601953	108643968	21111020278	scorings		NN2
601953	108643968	21111020279	should	should	VM
601953	108643968	21111020280	be	be	VBI
601953	108643968	21111020281	considered	consider	VVN
601953	108643968	21111020282	as	as	II
601953	108643968	21111020283	a	a	AT1
601953	108643968	21111020284	marker	marker	NN1
601953	108643968	21111020285	of	of	IO
601953	108643968	21111020286	poor	poor	JJ
601953	108643968	21111020287	data	data	NN
601953	108643968	21111020288	quality	quality	NN1
601953	108643968	21111020289	and	and	CC
601953	108643968	21111020290	investigated	investigate	VVD_VVN
601953	108643968	21111020291	further	far	RRR
601953	108643968	21111020292	.	.	.
601953	108643968	21111020293	<p>		NULL
601953	108643968	21111020294	Blinded		JJ@_VVN_VVD
601953	108643968	21111020295	data	data	NN
601953	108643968	21111020296	analytics	analytics	NN1_NN2
601953	108643968	21111020297	seeks	seek	VVZ
601953	108643968	21111020298	to	to	TO
601953	108643968	21111020299	unobtrusively	unobtrusively	RR
601953	108643968	21111020300	identify	identify	VVI
601953	108643968	21111020301	patterns	pattern	NN2
601953	108643968	21111020302	of	of	IO
601953	108643968	21111020303	clinical	clinical	JJ
601953	108643968	21111020304	trials	trial	NN2
601953	108643968	21111020305	ratings	rating	NN2
601953	108643968	21111020306	associated	associate	VVN
601953	108643968	21111020307	with	with	IW
601953	108643968	21111020308	poor	poor	JJ
601953	108643968	21111020309	quality	quality	NN1
601953	108643968	21111020310	data	data	NN
601953	108643968	21111020311	.	.	.
601953	108643968	21111020312	Measures	measure	NN2
601953	108643968	21111020313	of	of	IO
601953	108643968	21111020314	function	function	NN1
601953	108643968	21111020315	,	,	,
601953	108643968	21111020316	such	such	II21
601953	108643968	21111020317	as	as	II22
601953	108643968	21111020318	the	the	AT
601953	108643968	21111020319	CGI	cgi	NP1
601953	108643968	21111020320	,	,	,
601953	108643968	21111020321	are	be	VBR
601953	108643968	21111020322	particularly	particularly	RR
601953	108643968	21111020323	vulnerable	vulnerable	JJ
601953	108643968	21111020324	to	to	II
601953	108643968	21111020325	error	error	NN1
601953	108643968	21111020326	.	.	.
601953	108643968	21111020327	The	the	AT
601953	108643968	21111020328	problem	problem	NN1
601953	108643968	21111020329	is	be	VBZ
601953	108643968	21111020330	compounded	compound	VVN
601953	108643968	21111020331	in	in	II
601953	108643968	21111020332	schizophrenia	schizophrenia	NN1
601953	108643968	21111020333	trials	trial	NN2
601953	108643968	21111020334	by	by	II
601953	108643968	21111020335	the	the	AT
601953	108643968	21111020336	multidimensional	multidimensional	JJ
601953	108643968	21111020337	nature	nature	NN1
601953	108643968	21111020338	of	of	IO
601953	108643968	21111020339	schizophrenia	schizophrenia	NN1
601953	108643968	21111020340	symptoms	symptom	NN2
601953	108643968	21111020341	.	.	.
601953	108643968	21111020342	The	the	AT
601953	108643968	21111020343	analysis	analysis	NN1
601953	108643968	21111020344	of	of	IO
601953	108643968	21111020345	this	this	DD1
601953	108643968	21111020346	poster	poster	NN1
601953	108643968	21111020347	sought	seek	VVD_VVN
601953	108643968	21111020348	to	to	TO
601953	108643968	21111020349	determine	determine	VVI
601953	108643968	21111020350	the	the	AT
601953	108643968	21111020351	frequency	frequency	NN1
601953	108643968	21111020352	and	and	CC
601953	108643968	21111020353	regional	regional	JJ
601953	108643968	21111020354	distribution	distribution	NN1
601953	108643968	21111020355	of	of	IO
601953	108643968	21111020356	errors	error	NN2
601953	108643968	21111020357	in	in	II
601953	108643968	21111020358	@		II
601953	108643968	21111020359	@		II
601953	108643968	21111020360	@		II
601953	108643968	21111020361	@		II
601953	108643968	21111020362	@		II
601953	108643968	21111020363	@		II
601953	108643968	21111020364	@		II
601953	108643968	21111020365	@		II
601953	108643968	21111020366	@		II
601953	108643968	21111020367	@		II
601953	108643968	21111020368	10	10	MC
601953	108643968	21111020369	global	global	JJ
601953	108643968	21111020370	schizophrenia	schizophrenia	NN1
601953	108643968	21111020371	studies	study	NN2
601953	108643968	21111020372	.	.	.
601953	108643969	21111020392	@@##	----------	----------
601953	108643969	21111020393	@@108643969		FO
601953	108643969	21111020394	@4043969/		NN1_VV0
601953	108643969	21111020395	<p>		NULL
601953	108643969	21111020396	Bracket	bracket	NN1
601953	108643969	21111020397	will	will	VM
601953	108643969	21111020398	be	be	VBI
601953	108643969	21111020399	presenting	present	VVG
601953	108643969	21111020400	several	several	DA2
601953	108643969	21111020401	new	new	JJ
601953	108643969	21111020402	research	research	NN1
601953	108643969	21111020403	papers	paper	NN2
601953	108643969	21111020404	at	at	II
601953	108643969	21111020405	this	this	DD1
601953	108643969	21111020406	year	year	NNT1
601953	108643969	21111020407	's	's	GE_VBZ
601953	108643969	21111020408	NCDEU-ASCP		JJ_NN1
601953	108643969	21111020409	Annual	annual	JJ
601953	108643969	21111020410	Meeting	meeting	NN1
601953	108643969	21111020411	in	in	II
601953	108643969	21111020412	Miami	miami	NP1
601953	108643969	21111020413	,	,	,
601953	108643969	21111020414	FL	fl	NNU_FW@
601953	108643969	21111020415	.	.	.
601953	108643969	21111020416	Bracket	bracket	NN1
601953	108643969	21111020417	is	be	VBZ
601953	108643969	21111020418	committed	commit	VVN
601953	108643969	21111020419	to	to	II
601953	108643969	21111020420	methodological	methodological	JJ
601953	108643969	21111020421	research	research	NN1
601953	108643969	21111020422	and	and	CC
601953	108643969	21111020423	a	a	AT1
601953	108643969	21111020424	continuous	continuous	JJ
601953	108643969	21111020425	examination	examination	NN1
601953	108643969	21111020426	of	of	IO
601953	108643969	21111020427	the	the	AT
601953	108643969	21111020428	best	best	JJT_RRT
601953	108643969	21111020429	approaches	approach	NN2_VVZ
601953	108643969	21111020430	to	to	II
601953	108643969	21111020431	improving	improving	JJ_VVG
601953	108643969	21111020432	outcomes	outcome	NN2
601953	108643969	21111020433	in	in	II
601953	108643969	21111020434	CNS	cns	NP1
601953	108643969	21111020435	clinical	clinical	JJ
601953	108643969	21111020436	trials	trial	NN2
601953	108643969	21111020437	.	.	.
601953	108643969	21111020438	<p>		NULL
601953	108643969	21111020439	-	-	-
601953	108643969	21111020440	-	-	-
601953	108643969	21111020441	Regional	regional	JJ
601953	108643969	21111020442	Distribution	distribution	NN1
601953	108643969	21111020443	of	of	IO
601953	108643969	21111020444	Scoring	score	VVG_NN1_JJ@
601953	108643969	21111020445	Errors	error	NN2
601953	108643969	21111020446	in	in	II
601953	108643969	21111020447	Rating		VVG@
601953	108643969	21111020448	the	the	AT
601953	108643969	21111020449	Clinical	clinical	JJ
601953	108643969	21111020450	Global	global	JJ
601953	108643969	21111020451	Impression	impression	NN1
601953	108643969	21111020452	Scale	scale	NN1
601953	108643969	21111020453	in	in	II
601953	108643969	21111020454	Global	global	JJ
601953	108643969	21111020455	Schizophrenia	schizophrenia	NN1
601953	108643969	21111020456	Clinical	clinical	JJ
601953	108643969	21111020457	Trials	trial	NN2
601953	108643969	21111020458	shows	show	VVZ
601953	108643969	21111020459	that	that	CST
601953	108643969	21111020460	Errors	error	NN2
601953	108643969	21111020461	in	in	II
601953	108643969	21111020462	scoring	score	VVG
601953	108643969	21111020463	the	the	AT
601953	108643969	21111020464	CGI	cgi	NP1
601953	108643969	21111020465	are	be	VBR
601953	108643969	21111020466	relatively	relatively	RR
601953	108643969	21111020467	common	common	JJ
601953	108643969	21111020468	and	and	CC
601953	108643969	21111020469	vary	vary	VV0
601953	108643969	21111020470	in	in	II_RP@
601953	108643969	21111020471	frequency	frequency	NN1
601953	108643969	21111020472	by	by	II
601953	108643969	21111020473	geographical	geographical	JJ
601953	108643969	21111020474	region	region	NN1
601953	108643969	21111020475	.	.	.
601953	108643970	21111020495	@@##	----------	----------
601953	108643970	21111020496	@@108643970		FO
601953	108643970	21111020497	@4043970/		VV0_JJ_NN1
601953	108643970	21111020498	<h>		NULL
601953	108643970	21111020499	CNS	cns	NP1
601953	108643970	21111020500	Summit	summit	NN1
601953	108643970	21111020501	2014	2014	MC
601953	108643970	21111020502	<p>		NULL
601953	108643970	21111020503	November	november	NPM1
601953	108643970	21111020504	6	6	MC
601953	108643970	21111020505	,	,	,
601953	108643970	21111020506	2014	2014	MC
601953	108643970	21111020507	<p>		NULL
601953	108643970	21111020508	CNS	cns	NP1
601953	108643970	21111020509	Summit	summit	NN1
601953	108643970	21111020510	2014-		NN1
601953	108643970	21111020511	will	will	VM
601953	108643970	21111020512	begin	begin	VVI
601953	108643970	21111020513	on	on	II
601953	108643970	21111020514	Thursday	thursday	NPD1
601953	108643970	21111020515	,	,	,
601953	108643970	21111020516	November	november	NPM1
601953	108643970	21111020517	13	13	MC
601953	108643970	21111020518	in	in	II
601953	108643970	21111020519	Boca	boca	NP1
601953	108643970	21111020520	Raton	raton	NP1
601953	108643970	21111020521	,	,	,
601953	108643970	21111020522	Florida	florida	NP1
601953	108643970	21111020523	.	.	.
601953	108643970	21111020524	The	the	AT
601953	108643970	21111020525	Summit	summit	NN1
601953	108643970	21111020526	offers	offer	VVZ@_NN2
601953	108643970	21111020527	a	a	AT1
601953	108643970	21111020528	pre-competitive	precompetitive	JJ
601953	108643970	21111020529	environment	environment	NN1
601953	108643970	21111020530	in	in	II
601953	108643970	21111020531	which	which	DDQ
601953	108643970	21111020532	industry	industry	NN1
601953	108643970	21111020533	leaders	leader	NN2
601953	108643970	21111020534	can	can	VM
601953	108643970	21111020535	discuss	discuss	VVI
601953	108643970	21111020536	the	the	AT
601953	108643970	21111020537	challenges	challenge	NN2
601953	108643970	21111020538	being	be	VBG
601953	108643970	21111020539	faced	face	VVN
601953	108643970	21111020540	in	in	II
601953	108643970	21111020541	CNS	cns	NP1
601953	108643970	21111020542	research	research	NN1
601953	108643970	21111020543	and	and	CC
601953	108643970	21111020544	work	work	VV0
601953	108643970	21111020545	together	together	RL
601953	108643970	21111020546	to	to	TO
601953	108643970	21111020547	find	find	VVI
601953	108643970	21111020548	practical	practical	JJ
601953	108643970	21111020549	solutions	solution	NN2
601953	108643970	21111020550	.	.	.
601953	108643970	21111020551	<p>		NULL
601953	108643970	21111020552	Bracket	bracket	NN1
601953	108643970	21111020553	's	's	GE
601953	108643970	21111020554	subject	subject	NN1_JJ@
601953	108643970	21111020555	matter	matter	NN1
601953	108643970	21111020556	experts	expert	NN2
601953	108643970	21111020557	will	will	VM
601953	108643970	21111020558	be	be	VBI
601953	108643970	21111020559	participating	participate	VVG_JJ
601953	108643970	21111020560	in	in	II_RP@
601953	108643970	21111020561	a	a	AT1
601953	108643970	21111020562	variety	variety	NN1
601953	108643970	21111020563	of	of	IO
601953	108643970	21111020564	activities	activity	NN2
601953	108643970	21111020565	at	at	II
601953	108643970	21111020566	the	the	AT
601953	108643970	21111020567	Summit	summit	NN1
601953	108643970	21111020568	.	.	.
601953	108643970	21111020569	In	in	RR21
601953	108643970	21111020570	addition	addition	RR22
601953	108643970	21111020571	,	,	,
601953	108643970	21111020572	we	we	PPIS2
601953	108643970	21111020573	will	will	VM
601953	108643970	21111020574	be	be	VBI
601953	108643970	21111020575	exhibiting	exhibit	VVG
601953	108643970	21111020576	during	during	II
601953	108643970	21111020577	the	the	AT
601953	108643970	21111020578	Evening	evening	NNT1
601953	108643970	21111020579	Receptions	reception	NN2
601953	108643970	21111020580	and	and	CC
601953	108643970	21111020581	will	will	VM
601953	108643970	21111020582	have	have	VHI
601953	108643970	21111020583	demos	demo	NN2
601953	108643970	21111020584	of	of	IO
601953	108643970	21111020585	our	our	APPGE
601953	108643970	21111020586	Endpoint	endpoint	NN1
601953	108643970	21111020587	Reliability	reliability	NN1
601953	108643970	21111020588	services	service	NN2
601953	108643970	21111020589	on	on	II
601953	108643970	21111020590	Bracket	bracket	NN1
601953	108643970	21111020591	's	be	VBZ
601953	108643970	21111020592	newly	newly	RR
601953	108643970	21111020593	released	release	VVN_VVD@
601953	108643970	21111020594	Rater	rater	NP1
601953	108643970	21111020595	Station	station	NN1
601953	108643970	21111020596	3.5	3.5	MC
601953	108643970	21111020597	.	.	.
601953	108643970	21111020598	We	we	PPIS2
601953	108643970	21111020599	will	will	VM
601953	108643970	21111020600	be	be	VBI
601953	108643970	21111020601	located	locate	VVN
601953	108643970	21111020602	at	at	II
601953	108643970	21111020603	booth	booth	NN1
601953	108643970	21111020604	#1.		NNU
601953	108643979	21111020624	@@##	----------	----------
601953	108643979	21111020625	@@108643979		FO
601953	108643979	21111020626	@4043979/		VV0
601953	108643979	21111020627	<h>		NULL
601953	108643979	21111020628	You	you	PPY
601953	108643979	21111020629	're	be	VBR
601953	108643979	21111020630	just	just	RR
601953	108643979	21111020631	a	a	AT1
601953	108643979	21111020632	click	click	NN1
601953	108643979	21111020633	away	away	II21
601953	108643979	21111020634	from	from	II22
601953	108643979	21111020635	downloading	download	VVG
601953	108643979	21111020636	our	our	APPGE
601953	108643979	21111020637	case	case	NN1
601953	108643979	21111020638	study	study	NN1
601953	108643979	21111020639	!	!	!
601953	108643979	21111020640	<p>		NULL
601953	108643979	21111020641	The	the	AT
601953	108643979	21111020642	Vineland	vineland	NP1
601953	108643979	21111020643	Adaptive	adaptive	NP1
601953	108643979	21111020644	Behavior	behavior	NP1_NN1
601953	108643979	21111020645	Scale	scale	NN1
601953	108643979	21111020646	,	,	,
601953	108643979	21111020647	Second	second	MD
601953	108643979	21111020648	Edition	edition	NN1
601953	108643979	21111020649	(	(	(
601953	108643979	21111020650	VinelandG-II		MC
601953	108643979	21111020651	)	)	)
601953	108643979	21111020652	,	,	,
601953	108643979	21111020653	published	publish	VVN
601953	108643979	21111020654	by	by	II
601953	108643979	21111020655	Pearson	pearson	NP1
601953	108643979	21111020656	,	,	,
601953	108643979	21111020657	is	be	VBZ
601953	108643979	21111020658	a	a	AT1
601953	108643979	21111020659	gold	gold	JJ@_NN1
601953	108643979	21111020660	standard	standard	JJ_NN1
601953	108643979	21111020661	measure	measure	NN1
601953	108643979	21111020662	of	of	IO
601953	108643979	21111020663	adaptive	adaptive	JJ
601953	108643979	21111020664	functioning	functioning	NN1@_VVG
601953	108643979	21111020665	in	in	II
601953	108643979	21111020666	clinical	clinical	JJ
601953	108643979	21111020667	trials	trial	NN2
601953	108643979	21111020668	of	of	IO
601953	108643979	21111020669	children	child	NN2
601953	108643979	21111020670	and	and	CC
601953	108643979	21111020671	special	special	JJ_NN1%
601953	108643979	21111020672	needs	need	VVZ
601953	108643979	21111020673	adults	adult	NN2
601953	108643979	21111020674	.	.	.
601953	108643979	21111020675	Used	use	VVN_JJ_VVD
601953	108643979	21111020676	internationally	internationally	RR
601953	108643979	21111020677	,	,	,
601953	108643979	21111020678	this	this	DD1
601953	108643979	21111020679	tool	tool	NN1
601953	108643979	21111020680	measures	measure	NN2_VVZ@
601953	108643979	21111020681	function	function	VV0@_NN1
601953	108643979	21111020682	in	in	II
601953	108643979	21111020683	communication	communication	NN1
601953	108643979	21111020684	,	,	,
601953	108643979	21111020685	socialization	socialization	NN1
601953	108643979	21111020686	,	,	,
601953	108643979	21111020687	daily	daily	JJ_RR
601953	108643979	21111020688	living	living	NN1_JJ_VVG
601953	108643979	21111020689	,	,	,
601953	108643979	21111020690	and	and	CC
601953	108643979	21111020691	motor	motor	NN1_VV0@
601953	108643979	21111020692	skills	skill	NN2
601953	108643979	21111020693	,	,	,
601953	108643979	21111020694	and	and	CC
601953	108643979	21111020695	also	also	RR
601953	108643979	21111020696	measures	measure	VVZ@
601953	108643979	21111020697	aspects	aspect	NN2
601953	108643979	21111020698	of	of	IO
601953	108643979	21111020699	maladaptive	maladaptive	JJ
601953	108643979	21111020700	behavior	behavior	NN1
601953	108643979	21111020701	.	.	.
601953	108643979	21111020702	Traditionally	traditionally	RR
601953	108643979	21111020703	,	,	,
601953	108643979	21111020704	Vineland-II		MC
601953	108643979	21111020705	administration	administration	NN1
601953	108643979	21111020706	has	have	VHZ
601953	108643979	21111020707	been	be	VBN
601953	108643979	21111020708	limited	limit	VVN
601953	108643979	21111020709	to	to	II
601953	108643979	21111020710	paper-and-pencil	paper-and-pencil	NN1_JJ
601953	108643979	21111020711	until	until	II
601953	108643979	21111020712	recently	recently	RR
601953	108643979	21111020713	,	,	,
601953	108643979	21111020714	when	when	CS_RRQ
601953	108643979	21111020715	Bracket	bracket	NN1
601953	108643979	21111020716	introduced	introduce	VVD_VVN
601953	108643979	21111020717	an	a	AT1
601953	108643979	21111020718	advanced	advanced	JJ
601953	108643979	21111020719	eCOA		NN1
601953	108643979	21111020720	solution	solution	NN1
601953	108643979	21111020721	that	that	CST_DD1
601953	108643979	21111020722	aims	aim	VVZ
601953	108643979	21111020723	to	to	TO
601953	108643979	21111020724	bring	bring	VVI
601953	108643979	21111020725	better	better	JJR
601953	108643979	21111020726	treatments	treatment	NN2
601953	108643979	21111020727	to	to	II
601953	108643979	21111020728	the	the	AT
601953	108643979	21111020729	market	market	NN1
601953	108643979	21111020730	by	by	II
601953	108643979	21111020731	reliably	reliably	RR
601953	108643979	21111020732	measuring	measure	VVG
601953	108643979	21111020733	their	their	APPGE
601953	108643979	21111020734	effectiveness	effectiveness	NN1
601953	108643979	21111020735	in	in	II
601953	108643979	21111020736	clinical	clinical	JJ
601953	108643979	21111020737	research	research	NN1
601953	108643979	21111020738	trials	trial	NN2
601953	108643979	21111020739	.	.	.
601953	108643979	21111020740	<p>		NULL
601953	108643979	21111020741	This	this	DD1
601953	108643979	21111020742	Case	case	NN1
601953	108643979	21111020743	Study	study	NN1
601953	108643979	21111020744	describes	describe	VVZ
601953	108643979	21111020745	how	how	RRQ
601953	108643979	21111020746	Bracket	bracket	NN1
601953	108643979	21111020747	worked	work	VVN_VVD
601953	108643979	21111020748	in	in	II
601953	108643979	21111020749	partnership	partnership	NN1
601953	108643979	21111020750	with	with	IW
601953	108643979	21111020751	the	the	AT
601953	108643979	21111020752	scale	scale	NN1
601953	108643979	21111020753	publisher	publisher	NN1
601953	108643979	21111020754	to	to	TO
601953	108643979	21111020755	create	create	VVI
601953	108643979	21111020756	an	a	AT1
601953	108643979	21111020757	electronic	electronic	JJ
601953	108643979	21111020758	version	version	NN1
601953	108643979	21111020759	suitable	suitable	JJ
601953	108643979	21111020760	for	for	IF
601953	108643979	21111020761	use	use	NN1
601953	108643979	21111020762	in	in	II
601953	108643979	21111020763	clinical	clinical	JJ
601953	108643979	21111020764	trials	trial	NN2
601953	108643979	21111020765	.	.	.
601953	108643979	21111020766	Want	want	VV0
601953	108643979	21111020767	to	to	TO
601953	108643979	21111020768	speak	speak	VVI
601953	108643979	21111020769	to	to	II
601953	108643979	21111020770	someone	someone	PN1
601953	108643979	21111020771	at	at	II
601953	108643979	21111020772	Bracket	bracket	NN1
601953	108643979	21111020773	about	about	II
601953	108643979	21111020774	this	this	DD1
601953	108643979	21111020775	project	project	NN1
601953	108643979	21111020776	?	?	?
601953	108643979	21111020777	Contact	contact	VV0
601953	108643979	21111020778	us	us	PPIO2
601953	108643979	21111020779	to	to	II
601953	108643979	21111020780	setup	setup	NN1
601953	108643979	21111020781	time	time	NNT1
601953	108643979	21111020782	to	to	TO
601953	108643979	21111020783	talk	talk	VVI
601953	108643979	21111020784	.	.	.
601953	108643981	21111020804	@@##	----------	----------
601953	108643981	21111020805	@@108643981		FO
601953	108643981	21111020806	@4043981/		NN1_VV0
601953	108643981	21111020807	<p>		NULL
601953	108643981	21111020808	Bracket	bracket	NN1
601953	108643981	21111020809	is	be	VBZ
601953	108643981	21111020810	pleased	pleased	JJ
601953	108643981	21111020811	to	to	TO
601953	108643981	21111020812	announce	announce	VVI
601953	108643981	21111020813	that	that	CST
601953	108643981	21111020814	the	the	AT
601953	108643981	21111020815	company	company	NN1
601953	108643981	21111020816	will	will	VM
601953	108643981	21111020817	be	be	VBI
601953	108643981	21111020818	participating	participate	VVG_JJ
601953	108643981	21111020819	in	in	II
601953	108643981	21111020820	two	two	MC
601953	108643981	21111020821	conferences	conference	NN2
601953	108643981	21111020822	this	this	DD1
601953	108643981	21111020823	February	february	NPM1
601953	108643981	21111020824	"	"	"
601953	108643981	21111020825	Dpharm		NP1_VV0
601953	108643981	21111020826	Europe	europe	NP1
601953	108643981	21111020827	in	in	II
601953	108643981	21111020828	London	london	NP1
601953	108643981	21111020829	and	and	CC
601953	108643981	21111020830	Outsourcing	outsource	VVG_NP1
601953	108643981	21111020831	in	in	II
601953	108643981	21111020832	Clinical	clinical	JJ
601953	108643981	21111020833	Trials	trial	NN2
601953	108643981	21111020834	West	west	ND1
601953	108643981	21111020835	Coast	coast	NN1
601953	108643981	21111020836	in	in	II
601953	108643981	21111020837	California.		NP1
601953	108643981	21111020838	-	-	-
601953	108643981	21111020839	Information	information	NN1
601953	108643981	21111020840	regarding	regarding	II_VVG
601953	108643981	21111020841	both	both	DB2
601953	108643981	21111020842	conferences	conference	NN2
601953	108643981	21111020843	can	can	VM
601953	108643981	21111020844	be	be	VBI
601953	108643981	21111020845	found	find	VVN
601953	108643981	21111020846	by	by	II
601953	108643981	21111020847	clicking	click	VVG
601953	108643981	21111020848	on	on	II
601953	108643981	21111020849	the	the	AT
601953	108643981	21111020850	links	link	NN2
601953	108643981	21111020851	below	below	RL
601953	108643981	21111020852	.	.	.
601953	108643981	21111020853	<p>		NULL
601953	108643981	21111020854	The	the	AT
601953	108643981	21111020855	2nd	2nd	MD
601953	108643981	21111020856	annual	annual	JJ_NN1@
601953	108643981	21111020857	DPharm		NP1_NN1
601953	108643981	21111020858	Europe	europe	NP1
601953	108643981	21111020859	:	:	:
601953	108643981	21111020860	Disruptive	disruptive	JJ
601953	108643981	21111020861	Innovations	innovation	NN2
601953	108643981	21111020862	to	to	II
601953	108643981	21111020863	Advance	advance	JJ@_NN1
601953	108643981	21111020864	Clinical	clinical	JJ
601953	108643981	21111020865	Trials	trial	NN2
601953	108643981	21111020866	will	will	VM
601953	108643981	21111020867	be	be	VBI
601953	108643981	21111020868	taking	take	VVG
601953	108643981	21111020869	place	place	NN1
601953	108643981	21111020870	the	the	AT
601953	108643981	21111020871	9th	9th	MD
601953	108643981	21111020872	of	of	IO
601953	108643981	21111020873	February	february	NPM1
601953	108643981	21111020874	to	to	II
601953	108643981	21111020875	the	the	AT
601953	108643981	21111020876	10th	10th	MD
601953	108643981	21111020877	at	at	II
601953	108643981	21111020878	the	the	AT
601953	108643981	21111020879	St.		NP1
601953	108643981	21111020880	Pancras	pancras	NP1
601953	108643981	21111020881	Renaissance	renaissance	NN1
601953	108643981	21111020882	Hotel	hotel	NN1
601953	108643981	21111020883	in	in	II
601953	108643981	21111020884	London	london	NP1
601953	108643981	21111020885	,	,	,
601953	108643981	21111020886	United	united	NP1
601953	108643981	21111020887	Kingdom.		NP1
601953	108643981	21111020888	-	-	-
601953	108643981	21111020889	This	this	DD1
601953	108643981	21111020890	conference	conference	NN1
601953	108643981	21111020891	will	will	VM
601953	108643981	21111020892	cover	cover	VVI
601953	108643981	21111020893	many	many	DA2
601953	108643981	21111020894	topics	topic	NN2
601953	108643981	21111020895	that	that	CST_DD1
601953	108643981	21111020896	will	will	VM
601953	108643981	21111020897	ultimately	ultimately	RR
601953	108643981	21111020898	transform	transform	VVI
601953	108643981	21111020899	drug	drug	NN1
601953	108643981	21111020900	development	development	NN1
601953	108643981	21111020901	and	and	CC
601953	108643981	21111020902	the	the	AT
601953	108643981	21111020903	industry.		NNU
601953	108643981	21111020904	-	-	-
601953	108643981	21111020905	On	on	II
601953	108643981	21111020906	the	the	AT
601953	108643981	21111020907	first	first	MD
601953	108643981	21111020908	day	day	NNT1
601953	108643981	21111020909	of	of	IO
601953	108643981	21111020910	this	this	DD1
601953	108643981	21111020911	conference	conference	NN1
601953	108643981	21111020912	,	,	,
601953	108643981	21111020913	Adam	adam	NP1
601953	108643981	21111020914	Butler	butler	NP1
601953	108643981	21111020915	,	,	,
601953	108643981	21111020916	will	will	VM
601953	108643981	21111020917	present	present	VVI
601953	108643981	21111020918	a	a	AT1
601953	108643981	21111020919	brief	brief	JJ
601953	108643981	21111020920	case	case	NN1
601953	108643981	21111020921	study	study	NN1
601953	108643981	21111020922	on	on	II
601953	108643981	21111020923	utilizing	utilize	VVG
601953	108643981	21111020924	a	a	AT1
601953	108643981	21111020925	BYOD		NN1
601953	108643981	21111020926	mobile	mobile	NN1_JJ
601953	108643981	21111020927	app	app	NN1_VV0
601953	108643981	21111020928	to	to	TO
601953	108643981	21111020929	ensure	ensure	VVI
601953	108643981	21111020930	patient	patient	JJ_NN1
601953	108643981	21111020931	safety	safety	NN1
601953	108643981	21111020932	,	,	,
601953	108643981	21111020933	improve	improve	VV0
601953	108643981	21111020934	site	site	NN1
601953	108643981	21111020935	efficiency	efficiency	NN1
601953	108643981	21111020936	,	,	,
601953	108643981	21111020937	and	and	CC
601953	108643981	21111020938	give	give	VV0
601953	108643981	21111020939	patients	patient	NN2
601953	108643981	21111020940	the	the	AT
601953	108643981	21111020941	flexibility	flexibility	NN1
601953	108643981	21111020942	to	to	TO
601953	108643981	21111020943	report	report	VVI
601953	108643981	21111020944	data	data	NN
601953	108643981	21111020945	using	use	VVG
601953	108643981	21111020946	their	their	APPGE
601953	108643981	21111020947	own	own	DA
601953	108643981	21111020948	smart	smart	JJ
601953	108643981	21111020949	phones	phone	NN2
601953	108643981	21111020950	.	.	.
601953	108643981	21111020951	<p>		NULL
601953	108643981	21111020952	If	if	CS
601953	108643981	21111020953	you	you	PPY
601953	108643981	21111020954	are	be	VBR
601953	108643981	21111020955	interested	interested	JJ
601953	108643981	21111020956	in	in	II
601953	108643981	21111020957	attending	attend	VVG
601953	108643981	21111020958	,	,	,
601953	108643981	21111020959	our	our	APPGE
601953	108643981	21111020960	referral	referral	NN1
601953	108643981	21111020961	code	code	NN1
601953	108643981	21111020962	for	for	IF
601953	108643981	21111020963	registration	registration	NN1
601953	108643981	21111020964	is-		NN1
601953	108643981	21111020965	BRKT25.		FO
601953	108643981	21111020966	-	-	-
601953	108643981	21111020967	Please	please	RR
601953	108643981	21111020968	be	be	VBI
601953	108643981	21111020969	sure	sure	JJ
601953	108643981	21111020970	to	to	TO
601953	108643981	21111020971	come	come	VVI
601953	108643981	21111020972	see	see	VV0
601953	108643981	21111020973	us	us	PPIO2
601953	108643981	21111020974	at	at	II
601953	108643981	21111020975	booth	booth	NN1
601953	108643981	21111020976	9	9	MC
601953	108643981	21111020977	!	!	!
601953	108643981	21111020978	More	more	DAR
601953	108643981	21111020979	details	detail	NN2
601953	108643981	21111020980	on	on	II
601953	108643981	21111020981	the	the	AT
601953	108643981	21111020982	conference	conference	NN1
601953	108643981	21111020983	here	here	RL
601953	108643981	21111020984	.	.	.
601953	108643981	21111020985	<p>		NULL
601953	108643981	21111020986	Outsourcing	outsource	VVG
601953	108643981	21111020987	in	in	II_RP@
601953	108643981	21111020988	Clinical	clinical	JJ
601953	108643981	21111020989	Trials	trial	NN2
601953	108643981	21111020990	"	"	"
601953	108643981	21111020991	West	west	ND1
601953	108643981	21111020992	Coast	coast	NN1
601953	108643981	21111020993	in	in	II
601953	108643981	21111020994	San	san	NP1
601953	108643981	21111020995	Mateo	mateo	NP1
601953	108643981	21111020996	@		II
601953	108643981	21111020997	@		II
601953	108643981	21111020998	@		II
601953	108643981	21111020999	@		II
601953	108643981	21111021000	@		II
601953	108643981	21111021001	@		II
601953	108643981	21111021002	@		II
601953	108643981	21111021003	@		II
601953	108643981	21111021004	@		II
601953	108643981	21111021005	@		II
601953	108643981	21111021006	Clinical	clinical	JJ
601953	108643981	21111021007	Trials	trial	NN2
601953	108643981	21111021008	"	"	"
601953	108643981	21111021009	West	west	ND1
601953	108643981	21111021010	Coast	coast	NN1
601953	108643981	21111021011	event	event	NN1
601953	108643981	21111021012	in	in	II
601953	108643981	21111021013	San	san	NP1
601953	108643981	21111021014	Mateo	mateo	NP1
601953	108643981	21111021015	,	,	,
601953	108643981	21111021016	California	california	NP1
601953	108643981	21111021017	on	on	II
601953	108643981	21111021018	the	the	AT
601953	108643981	21111021019	10th	10th	MD
601953	108643981	21111021020	of	of	IO
601953	108643981	21111021021	February	february	NPM1
601953	108643981	21111021022	to	to	II
601953	108643981	21111021023	the	the	AT
601953	108643981	21111021024	11th	11th	MD
601953	108643981	21111021025	.	.	.
601953	108643981	21111021026	This	this	DD1
601953	108643981	21111021027	two-day	two-day	JJ
601953	108643981	21111021028	conference	conference	NN1
601953	108643981	21111021029	will	will	VM
601953	108643981	21111021030	be	be	VBI
601953	108643981	21111021031	held	hold	VVN
601953	108643981	21111021032	at	at	II
601953	108643981	21111021033	the	the	AT
601953	108643981	21111021034	San	san	NP1
601953	108643981	21111021035	Mateo	mateo	NP1
601953	108643981	21111021036	Event	event	NN1
601953	108643981	21111021037	Center	center	NN1
601953	108643981	21111021038	and	and	CC
601953	108643981	21111021039	will	will	VM
601953	108643981	21111021040	cover	cover	VVI
601953	108643981	21111021041	the	the	AT
601953	108643981	21111021042	latest	late	JJT
601953	108643981	21111021043	challenges	challenge	NN2
601953	108643981	21111021044	,	,	,
601953	108643981	21111021045	trends	trend	NN2
601953	108643981	21111021046	and	and	CC
601953	108643981	21111021047	innovation	innovation	NN1
601953	108643981	21111021048	in	in	II
601953	108643981	21111021049	clinical	clinical	JJ
601953	108643981	21111021050	operations	operation	NN2
601953	108643981	21111021051	,	,	,
601953	108643981	21111021052	outsourcing	outsource	VVG
601953	108643981	21111021053	and	and	CC
601953	108643981	21111021054	development	development	NN1
601953	108643981	21111021055	.	.	.
601953	108643981	21111021056	If	if	CS
601953	108643981	21111021057	you	you	PPY
601953	108643981	21111021058	plan	plan	VV0
601953	108643981	21111021059	on	on	II_RP@
601953	108643981	21111021060	attending	attend	VVG
601953	108643981	21111021061	,	,	,
601953	108643981	21111021062	stop	stop	VV0_NN1
601953	108643981	21111021063	by	by	II
601953	108643981	21111021064	booth	booth	NN1
601953	108643981	21111021065	84	84	MC
601953	108643981	21111021066	to	to	TO
601953	108643981	21111021067	see	see	VVI
601953	108643981	21111021068	what	what	DDQ
601953	108643981	21111021069	we	we	PPIS2
601953	108643981	21111021070	are	be	VBR
601953	108643981	21111021071	offering	offer	VVG
601953	108643981	21111021072	!	!	!
601953	108643982	21111021092	@@##	----------	----------
601953	108643982	21111021093	@@108643982		FO
601953	108643982	21111021094	@4043982/		JJ_NN1_VV0
601953	108643982	21111021095	<h>		NULL
601953	108643982	21111021096	Bracket	bracket	NN1
601953	108643982	21111021097	and	and	CC
601953	108643982	21111021098	ePRO		NN1
601953	108643982	21111021099	Consortium	consortium	NN1
601953	108643982	21111021100	Members	member	NN2
601953	108643982	21111021101	Present	present	VV0@_NN1_JJ
601953	108643982	21111021102	at	at	II
601953	108643982	21111021103	ISOQOL		NP1_NN1
601953	108643982	21111021104	2013	2013	MC
601953	108643982	21111021105	<p>		NULL
601953	108643982	21111021106	October	october	NPM1
601953	108643982	21111021107	25	25	MC
601953	108643982	21111021108	,	,	,
601953	108643982	21111021109	2013	2013	MC
601953	108643982	21111021110	<p>		NULL
601953	108643982	21111021111	The-		JJ
601953	108643982	21111021112	International	international	JJ
601953	108643982	21111021113	Society	society	NN1
601953	108643982	21111021114	for	for	IF
601953	108643982	21111021115	Quality	quality	NN1
601953	108643982	21111021116	of	of	IO
601953	108643982	21111021117	Life	life	NN1
601953	108643982	21111021118	Research	research	NN1
601953	108643982	21111021119	(	(	(
601953	108643982	21111021120	ISOQOL		NP1
601953	108643982	21111021121	)	)	)
601953	108643982	21111021122	20th	20th	MD
601953	108643982	21111021123	Annual	annual	JJ
601953	108643982	21111021124	Conference-		NN1
601953	108643982	21111021125	was	be	VBDZ
601953	108643982	21111021126	held	hold	VVN
601953	108643982	21111021127	on	on	II
601953	108643982	21111021128	October	october	NPM1
601953	108643982	21111021129	9-12	9-12	MCMC
601953	108643982	21111021130	in	in	II
601953	108643982	21111021131	Miami	miami	NP1
601953	108643982	21111021132	,	,	,
601953	108643982	21111021133	Florida	florida	NP1
601953	108643982	21111021134	.	.	.
601953	108643982	21111021135	The	the	AT
601953	108643982	21111021136	conference	conference	NN1
601953	108643982	21111021137	offers	offer	NN2
601953	108643982	21111021138	ISOQOL		VV0
601953	108643982	21111021139	members	member	NN2
601953	108643982	21111021140	an	a	AT1
601953	108643982	21111021141	opportunity	opportunity	NN1
601953	108643982	21111021142	to	to	TO
601953	108643982	21111021143	present	present	VVI
601953	108643982	21111021144	their	their	APPGE
601953	108643982	21111021145	research	research	NN1
601953	108643982	21111021146	on	on	II
601953	108643982	21111021147	important	important	JJ
601953	108643982	21111021148	topics	topic	NN2
601953	108643982	21111021149	and	and	CC
601953	108643982	21111021150	advances	advance	VVZ_NN2
601953	108643982	21111021151	in	in	II
601953	108643982	21111021152	health-related	health-related	JJ_NN1
601953	108643982	21111021153	quality	quality	NN1
601953	108643982	21111021154	of	of	IO
601953	108643982	21111021155	life	life	NN1
601953	108643982	21111021156	research	research	NN1
601953	108643982	21111021157	.	.	.
601953	108643982	21111021158	In	in	RR21
601953	108643982	21111021159	addition	addition	RR22
601953	108643982	21111021160	,	,	,
601953	108643982	21111021161	plenary	plenary	JJ
601953	108643982	21111021162	sessions	session	NNT2
601953	108643982	21111021163	and	and	CC
601953	108643982	21111021164	in-depth	in-depth	JJ
601953	108643982	21111021165	workshops	workshop	NN2
601953	108643982	21111021166	are	be	VBR
601953	108643982	21111021167	available	available	JJ
601953	108643982	21111021168	for	for	IF
601953	108643982	21111021169	attendees	attendee	NN2
601953	108643982	21111021170	to	to	TO
601953	108643982	21111021171	learn	learn	VVI
601953	108643982	21111021172	more	more	RRR_DAR
601953	108643982	21111021173	about	about	II
601953	108643982	21111021174	new	new	JJ
601953	108643982	21111021175	innovations	innovation	NN2
601953	108643982	21111021176	in	in	II
601953	108643982	21111021177	the	the	AT
601953	108643982	21111021178	industry	industry	NN1
601953	108643982	21111021179	.	.	.
601953	108643982	21111021180	<p>		NULL
601953	108643982	21111021181	Bracket	bracket	NN1
601953	108643982	21111021182	's	's	GE
601953	108643982	21111021183	ePRO		NN1
601953	108643982	21111021184	Solutions	solution	NN2
601953	108643982	21111021185	Principal	principal	NN1_JJ
601953	108643982	21111021186	,	,	,
601953	108643982	21111021187	Cindy	cindy	NP1
601953	108643982	21111021188	Howry	howry	NP1
601953	108643982	21111021189	,	,	,
601953	108643982	21111021190	was	be	VBDZ
601953	108643982	21111021191	a	a	AT1
601953	108643982	21111021192	presenter	presenter	NN1
601953	108643982	21111021193	at	at	II
601953	108643982	21111021194	this	this	DD1
601953	108643982	21111021195	year	year	NNT1
601953	108643982	21111021196	's	's	GE
601953	108643982	21111021197	conference	conference	NN1
601953	108643982	21111021198	.	.	.
601953	108643982	21111021199	Cindy	cindy	NP1
601953	108643982	21111021200	,	,	,
601953	108643982	21111021201	along	along	II21
601953	108643982	21111021202	with	with	II22
601953	108643982	21111021203	other	other	JJ
601953	108643982	21111021204	members	member	NN2
601953	108643982	21111021205	of	of	IO
601953	108643982	21111021206	the	the	AT
601953	108643982	21111021207	Critical	critical	JJ
601953	108643982	21111021208	Path	path	NN1
601953	108643982	21111021209	Institute	institute	NN1
601953	108643982	21111021210	's	's	GE
601953	108643982	21111021211	(	(	(
601953	108643982	21111021212	C-Path		NP1
601953	108643982	21111021213	)	)	)
601953	108643982	21111021214	ePRO		NN1
601953	108643982	21111021215	Consortium	consortium	NN1
601953	108643982	21111021216	,	,	,
601953	108643982	21111021217	presented	present	VVD_VVN
601953	108643982	21111021218	their	their	APPGE
601953	108643982	21111021219	research	research	NN1
601953	108643982	21111021220	poster	poster	NN1
601953	108643982	21111021221	:	:	:
601953	108643982	21111021222	-	-	-
601953	108643982	21111021223	Implementing	implement	VVG
601953	108643982	21111021224	New	new	JJ
601953	108643982	21111021225	Clinical	clinical	JJ
601953	108643982	21111021226	Outcome	outcome	NN1
601953	108643982	21111021227	Assessment	assessment	NN1
601953	108643982	21111021228	Instruments	instrument	NN2
601953	108643982	21111021229	on	on	II
601953	108643982	21111021230	Alternative	alternative	JJ_NN1
601953	108643982	21111021231	Date	date	NN1
601953	108643982	21111021232	Collection	collection	NN1
601953	108643982	21111021233	Modes	mode	NN2
601953	108643982	21111021234	:	:	:
601953	108643982	21111021235	The	the	AT
601953	108643982	21111021236	Electronic	electronic	JJ
601953	108643982	21111021237	Implementation	implementation	NN1
601953	108643982	21111021238	Assessment	assessment	NN1
601953	108643982	21111021239	and	and	CC
601953	108643982	21111021240	Migration	migration	NN1
601953	108643982	21111021241	Process	process	NN1
601953	108643982	21111021242	.	.	.
601953	108643982	21111021243	The	the	AT
601953	108643982	21111021244	research	research	NN1
601953	108643982	21111021245	presents	present	VVZ
601953	108643982	21111021246	the	the	AT
601953	108643982	21111021247	electronic	electronic	JJ
601953	108643982	21111021248	implementation	implementation	NN1
601953	108643982	21111021249	assessment	assessment	NN1
601953	108643982	21111021250	process	process	NN1
601953	108643982	21111021251	and	and	CC
601953	108643982	21111021252	discusses	discuss	VVZ
601953	108643982	21111021253	subsequent	subsequent	JJ
601953	108643982	21111021254	migration	migration	NN1
601953	108643982	21111021255	to	to	TO
601953	108643982	21111021256	illustrate	illustrate	VVI
601953	108643982	21111021257	the	the	AT
601953	108643982	21111021258	issues	issue	NN2
601953	108643982	21111021259	that	that	CST_DD1
601953	108643982	21111021260	may	may	VM
601953	108643982	21111021261	arise	arise	VVI
601953	108643982	21111021262	during	during	II
601953	108643982	21111021263	the	the	AT
601953	108643982	21111021264	migration	migration	NN1
601953	108643982	21111021265	from	from	II
601953	108643982	21111021266	a	a	AT1
601953	108643982	21111021267	paper-based	paper-based	JJ_NN1
601953	108643982	21111021268	instrument	instrument	NN1
601953	108643982	21111021269	to	to	II
601953	108643982	21111021270	an	a	AT1
601953	108643982	21111021271	electronic	electronic	JJ
601953	108643982	21111021272	platform	platform	NN1
601953	108643982	21111021273	.	.	.
601953	108643982	21111021274	<p>		NULL
601953	108643982	21111021275	The	the	AT
601953	108643982	21111021276	ePRO		NN1
601953	108643982	21111021277	Consortium	consortium	NN1
601953	108643982	21111021278	was	be	VBDZ
601953	108643982	21111021279	established	establish	VVN
601953	108643982	21111021280	within	within	II
601953	108643982	21111021281	C-Path		NP1
601953	108643982	21111021282	on	on	II
601953	108643982	21111021283	April	april	NPM1
601953	108643982	21111021284	@		II
601953	108643982	21111021285	@		II
601953	108643982	21111021286	@		II
601953	108643982	21111021287	@		II
601953	108643982	21111021288	@		II
601953	108643982	21111021289	@		II
601953	108643982	21111021290	@		II
601953	108643982	21111021291	@		II
601953	108643982	21111021292	@		II
601953	108643982	21111021293	@		II
601953	108643982	21111021294	firms	firm	NN2
601953	108643982	21111021295	that	that	CST
601953	108643982	21111021296	provide	provide	VV0
601953	108643982	21111021297	electronic	electronic	JJ
601953	108643982	21111021298	data	data	NN
601953	108643982	21111021299	collection	collection	NN1
601953	108643982	21111021300	technologies	technology	NN2
601953	108643982	21111021301	and	and	CC
601953	108643982	21111021302	services	service	NN2
601953	108643982	21111021303	to	to	II
601953	108643982	21111021304	the	the	AT
601953	108643982	21111021305	medical	medical	JJ
601953	108643982	21111021306	products	product	NN2
601953	108643982	21111021307	industry	industry	NN1
601953	108643982	21111021308	for	for	IF
601953	108643982	21111021309	capturing	capture	VVG
601953	108643982	21111021310	patient-reported	patient-reported	JJ_NN1
601953	108643982	21111021311	outcome	outcome	NN1
601953	108643982	21111021312	(	(	(
601953	108643982	21111021313	PRO	pro	NN1_JJ_RR@
601953	108643982	21111021314	)	)	)
601953	108643982	21111021315	endpoints	endpoint	NN2
601953	108643982	21111021316	in	in	II
601953	108643982	21111021317	clinical	clinical	JJ
601953	108643982	21111021318	trials	trial	NN2
601953	108643982	21111021319	.	.	.
601953	108643982	21111021320	The	the	AT
601953	108643982	21111021321	mission	mission	NN1
601953	108643982	21111021322	of	of	IO
601953	108643982	21111021323	the	the	AT
601953	108643982	21111021324	ePRO		NN1
601953	108643982	21111021325	Consortium	consortium	NN1
601953	108643982	21111021326	is	be	VBZ
601953	108643982	21111021327	to	to	TO
601953	108643982	21111021328	advance	advance	VVI
601953	108643982	21111021329	the	the	AT
601953	108643982	21111021330	quality	quality	NN1
601953	108643982	21111021331	,	,	,
601953	108643982	21111021332	practicality	practicality	NN1
601953	108643982	21111021333	,	,	,
601953	108643982	21111021334	and	and	CC
601953	108643982	21111021335	acceptability	acceptability	NN1
601953	108643982	21111021336	of	of	IO
601953	108643982	21111021337	electronic	electronic	JJ
601953	108643982	21111021338	data	data	NN
601953	108643982	21111021339	capture	capture	VV0_NN1
601953	108643982	21111021340	(	(	(
601953	108643982	21111021341	EDC	edc	NP1
601953	108643982	21111021342	)	)	)
601953	108643982	21111021343	methods	method	NN2
601953	108643982	21111021344	used	use	VVN_VVD
601953	108643982	21111021345	in	in	II
601953	108643982	21111021346	clinical	clinical	JJ
601953	108643982	21111021347	trials	trial	NN2
601953	108643982	21111021348	for	for	IF
601953	108643982	21111021349	PRO	pro	JJ_NN1
601953	108643982	21111021350	endpoint	endpoint	NN1
601953	108643982	21111021351	assessment	assessment	NN1
601953	108643982	21111021352	.	.	.
601953	108643989	21111021372	@@##	----------	----------
601953	108643989	21111021373	@@108643989		FO
601953	108643989	21111021374	@4043989/		JJ_NN1_VV0
601953	108643989	21111021375	<h>		NULL
601953	108643989	21111021376	Bracket	bracket	NN1
601953	108643989	21111021377	Community	community	NN1
601953	108643989	21111021378	Events	event	NN2
601953	108643989	21111021379	this	this	DD1
601953	108643989	21111021380	Spring	spring	NN1
601953	108643989	21111021381	<p>		NULL
601953	108643989	21111021382	May	may	NPM1
601953	108643989	21111021383	9	9	MC
601953	108643989	21111021384	,	,	,
601953	108643989	21111021385	2017	2017	MC
601953	108643989	21111021386	<p>		NULL
601953	108643989	21111021387	MS	ms	NNB
601953	108643989	21111021388	Walk	walk	NP1
601953	108643989	21111021389	(	(	(
601953	108643989	21111021390	Walk	walk	VV0_NN1
601953	108643989	21111021391	to	to	II
601953	108643989	21111021392	Fight	fight	NN1
601953	108643989	21111021393	MS	ms	NN1
601953	108643989	21111021394	)	)	)
601953	108643989	21111021395	<p>		NULL
601953	108643989	21111021396	This	this	DD1
601953	108643989	21111021397	walk	walk	NN1
601953	108643989	21111021398	was	be	VBDZ
601953	108643989	21111021399	hosted	host	VVN
601953	108643989	21111021400	on	on	II
601953	108643989	21111021401	Sunday	sunday	NPD1
601953	108643989	21111021402	,	,	,
601953	108643989	21111021403	April	april	NPM1
601953	108643989	21111021404	30th	30th	MD
601953	108643989	21111021405	-	-	-
601953	108643989	21111021406	in	in	II
601953	108643989	21111021407	Downtown	downtown	JJ_RL
601953	108643989	21111021408	Phoenixville.		NP1
601953	108643989	21111021409	-	-	-
601953	108643989	21111021410	Some	some	DD
601953	108643989	21111021411	of	of	IO
601953	108643989	21111021412	our	our	APPGE
601953	108643989	21111021413	Bracket	bracket	NN1
601953	108643989	21111021414	employees	employee	NN2
601953	108643989	21111021415	in	in	II
601953	108643989	21111021416	our	our	APPGE
601953	108643989	21111021417	Wayne	wayne	NP1
601953	108643989	21111021418	,	,	,
601953	108643989	21111021419	PA	pa	NN1_NP1@
601953	108643989	21111021420	office	office	NN1
601953	108643989	21111021421	participated	participate	VVD_VVN@
601953	108643989	21111021422	in	in	II
601953	108643989	21111021423	the	the	AT
601953	108643989	21111021424	MS	ms	NNB
601953	108643989	21111021425	Walk	walk	NP1
601953	108643989	21111021426	and	and	CC
601953	108643989	21111021427	wore	wear	VVD
601953	108643989	21111021428	orange	orange	JJ
601953	108643989	21111021429	shirts-		NN1
601953	108643989	21111021430	walking	walk	VVG
601953	108643989	21111021431	the	the	AT
601953	108643989	21111021432	trail	trail	NN1
601953	108643989	21111021433	for	for	IF
601953	108643989	21111021434	awareness	awareness	NN1
601953	108643989	21111021435	.	.	.
601953	108643989	21111021436	-	-	-
601953	108643989	21111021437	To	to	TO
601953	108643989	21111021438	find	find	VVI
601953	108643989	21111021439	out	out	RP
601953	108643989	21111021440	more	more	RRR_DAR
601953	108643989	21111021441	about	about	II
601953	108643989	21111021442	the	the	AT
601953	108643989	21111021443	MS	ms	NN1
601953	108643989	21111021444	walk	walk	NN1_VV0
601953	108643989	21111021445	,	,	,
601953	108643989	21111021446	please	please	RR
601953	108643989	21111021447	visit	visit	VV0
601953	108643989	21111021448	the	the	AT
601953	108643989	21111021449	website	website	NN1
601953	108643989	21111021450	here	here	RL
601953	108643989	21111021451	:	:	:
601953	108643989	21111021452	-	-	-
601953	108643989	21111021453	MS	ms	NNB
601953	108643989	21111021454	Walk	walk	NP1
601953	108643989	21111021455	.	.	.
601953	108643989	21111021456	<p>		NULL
601953	108643989	21111021457	Our	our	APPGE
601953	108643989	21111021458	next	next	MD
601953	108643989	21111021459	walk	walk	NN1
601953	108643989	21111021460	Bracket	bracket	NN1
601953	108643989	21111021461	will	will	VM
601953	108643989	21111021462	be	be	VBI
601953	108643989	21111021463	attending	attend	VVG
601953	108643989	21111021464	is	be	VBZ
601953	108643989	21111021465	the	the	AT
601953	108643989	21111021466	Anti-Defamation	anti-defamation	NP1
601953	108643989	21111021467	League	league	NN1
601953	108643989	21111021468	(	(	(
601953	108643989	21111021469	ADL	adl	NP1
601953	108643989	21111021470	)	)	)
601953	108643989	21111021471	-Walk		NN1_JJ
601953	108643989	21111021472	Against	against	II
601953	108643989	21111021473	Hate	hate	NN1
601953	108643989	21111021474	.	.	.
601953	108643989	21111021475	ADL	adl	NP1
601953	108643989	21111021476	's	's	GE
601953	108643989	21111021477	7th	7th	MD
601953	108643989	21111021478	annual	annual	JJ
601953	108643989	21111021479	WALK	walk	NN1
601953	108643989	21111021480	Against	against	II
601953	108643989	21111021481	Hate	hate	NN1
601953	108643989	21111021482	on	on	II
601953	108643989	21111021483	Sunday	sunday	NPD1
601953	108643989	21111021484	,	,	,
601953	108643989	21111021485	May	may	NPM1
601953	108643989	21111021486	21	21	MC
601953	108643989	21111021487	,	,	,
601953	108643989	21111021488	2017	2017	MC
601953	108643989	21111021489	from	from	II
601953	108643989	21111021490	9:00am-12:00pm		FO
601953	108643989	21111021491	to	to	TO
601953	108643989	21111021492	take	take	VVI
601953	108643989	21111021493	part	part	NN1
601953	108643989	21111021494	in	in	II
601953	108643989	21111021495	a	a	AT1
601953	108643989	21111021496	one	one	MC1
601953	108643989	21111021497	of	of	IO
601953	108643989	21111021498	a	a	AT1
601953	108643989	21111021499	kind	kind	NN1_JJ@
601953	108643989	21111021500	initiative	initiative	NN1
601953	108643989	21111021501	in	in	II
601953	108643989	21111021502	which	which	DDQ
601953	108643989	21111021503	people	people	NN
601953	108643989	21111021504	from	from	II
601953	108643989	21111021505	various	various	JJ
601953	108643989	21111021506	backgrounds	background	NN2
601953	108643989	21111021507	are	be	VBR
601953	108643989	21111021508	united	unite	VVN
601953	108643989	21111021509	to	to	TO
601953	108643989	21111021510	make	make	VVI
601953	108643989	21111021511	strides	stride	NN2
601953	108643989	21111021512	toward	toward	II
601953	108643989	21111021513	embracing	embrace	VVG
601953	108643989	21111021514	diversity	diversity	NN1
601953	108643989	21111021515	.	.	.
601953	108643989	21111021516	This	this	DD1
601953	108643989	21111021517	is	be	VBZ
601953	108643989	21111021518	an	a	AT1
601953	108643989	21111021519	opportunity	opportunity	NN1
601953	108643989	21111021520	for	for	IF
601953	108643989	21111021521	all	all	DB
601953	108643989	21111021522	of	of	IO
601953	108643989	21111021523	us	us	PPIO2
601953	108643989	21111021524	to	to	TO
601953	108643989	21111021525	stand	stand	VVI
601953	108643989	21111021526	together	together	RL
601953	108643989	21111021527	against	against	II
601953	108643989	21111021528	bigotry	bigotry	NN1
601953	108643989	21111021529	and	and	CC
601953	108643989	21111021530	hatred	hatred	NN1
601953	108643989	21111021531	in	in	II
601953	108643989	21111021532	our	our	APPGE
601953	108643989	21111021533	own	own	DA
601953	108643989	21111021534	community	community	NN1
601953	108643989	21111021535	and	and	CC
601953	108643989	21111021536	were	be	VBDR
601953	108643989	21111021537	inviting	invite	VVG
601953	108643989	21111021538	all	all	DB
601953	108643989	21111021539	of	of	IO
601953	108643989	21111021540	our	our	APPGE
601953	108643989	21111021541	friends	friend	NN2
601953	108643989	21111021542	,	,	,
601953	108643989	21111021543	family	family	NN1
601953	108643989	21111021544	,	,	,
601953	108643989	21111021545	and	and	CC
601953	108643989	21111021546	neighbors	neighbor	NN2
601953	108643989	21111021547	to	to	TO
601953	108643989	21111021548	join	join	VVI
601953	108643989	21111021549	us	us	PPIO2
601953	108643989	21111021550	when	when	RRQ_CS
601953	108643989	21111021551	we	we	PPIS2
601953	108643989	21111021552	lace	lace	VV0%
601953	108643989	21111021553	up	up	RP
601953	108643989	21111021554	our	our	APPGE
601953	108643989	21111021555	sneakers	sneakers	NN2
601953	108643989	21111021556	to	to	TO
601953	108643989	21111021557	WALK	walk	VVI
601953	108643989	21111021558	Against	against	II
601953	108643989	21111021559	Hate	hate	NN1
601953	108643989	21111021560	.	.	.
601953	108643989	21111021561	Learn	learn	VV0
601953	108643989	21111021562	more	more	RGR_DAR
601953	108643989	21111021563	on-		JJ_NN1
601953	108643989	21111021564	Anti-Defamation	anti-defamation	NP1
601953	108643989	21111021565	League	league	NN1
601953	108643989	21111021566	(	(	(
601953	108643989	21111021567	ADL	adl	NP1
601953	108643989	21111021568	)	)	)
601953	108643989	21111021569	-Walk		NN1_JJ
601953	108643989	21111021570	Against	against	II
601953	108643989	21111021571	Hate	hate	NN1
601953	108643989	21111021572	.	.	.
601953	108643993	21111021592	@@##	----------	----------
601953	108643993	21111021593	@@108643993		FO
601953	108643993	21111021594	@4043993/		JJ_NN1_VV0
601953	108643993	21111021595	<h>		NULL
601953	108643993	21111021596	Bracket	bracket	NN1
601953	108643993	21111021597	Continues	continue	VVZ
601953	108643993	21111021598	Support	support	NN1
601953	108643993	21111021599	for	for	IF
601953	108643993	21111021600	CNS	cns	NP1
601953	108643993	21111021601	Summit	summit	NN1
601953	108643993	21111021602	2015	2015	MC
601953	108643993	21111021603	<p>		NULL
601953	108643993	21111021604	September	september	NPM1
601953	108643993	21111021605	30	30	MC
601953	108643993	21111021606	,	,	,
601953	108643993	21111021607	2015	2015	MC
601953	108643993	21111021608	<p>		NULL
601953	108643993	21111021609	Bracket	bracket	NN1
601953	108643993	21111021610	is	be	VBZ
601953	108643993	21111021611	proud	proud	JJ
601953	108643993	21111021612	to	to	TO
601953	108643993	21111021613	continue	continue	VVI
601953	108643993	21111021614	our	our	APPGE
601953	108643993	21111021615	support	support	NN1
601953	108643993	21111021616	for	for	IF
601953	108643993	21111021617	the	the	AT
601953	108643993	21111021618	CNS	cns	NP1
601953	108643993	21111021619	Summit	summit	NN1
601953	108643993	21111021620	,	,	,
601953	108643993	21111021621	and	and	CC
601953	108643993	21111021622	annual	annual	JJ
601953	108643993	21111021623	gathering	gathering	NN1
601953	108643993	21111021624	of	of	IO
601953	108643993	21111021625	drug	drug	NN1
601953	108643993	21111021626	development	development	NN1
601953	108643993	21111021627	leaders	leader	NN2
601953	108643993	21111021628	from	from	II
601953	108643993	21111021629	pharma	pharma	NN1
601953	108643993	21111021630	,	,	,
601953	108643993	21111021631	sites	site	NN2
601953	108643993	21111021632	,	,	,
601953	108643993	21111021633	and	and	CC
601953	108643993	21111021634	service	service	NN1_VV0@
601953	108643993	21111021635	companies	company	NN2
601953	108643993	21111021636	.	.	.
601953	108643993	21111021637	CNS	cns	NP1
601953	108643993	21111021638	Summit	summit	NN1
601953	108643993	21111021639	occurs	occur	VVZ
601953	108643993	21111021640	from	from	II
601953	108643993	21111021641	October	october	NPM1
601953	108643993	21111021642	9-11	9-11	MCMC
601953	108643993	21111021643	in	in	II
601953	108643993	21111021644	Boca	boca	NP1
601953	108643993	21111021645	Raton	raton	NP1
601953	108643993	21111021646	,	,	,
601953	108643993	21111021647	Fl	fl	NNU_FW@
601953	108643993	21111021648	.	.	.
601953	108643993	21111021649	Bracket	bracket	NN1
601953	108643993	21111021650	's	's	GE_VBZ
601953	108643993	21111021651	scientific	scientific	JJ
601953	108643993	21111021652	and	and	CC
601953	108643993	21111021653	medical	medical	JJ
601953	108643993	21111021654	leadership	leadership	NN1
601953	108643993	21111021655	will	will	VM
601953	108643993	21111021656	be	be	VBI
601953	108643993	21111021657	presenting	present	VVG
601953	108643993	21111021658	new	new	JJ
601953	108643993	21111021659	research	research	NN1
601953	108643993	21111021660	at	at	II
601953	108643993	21111021661	this	this	DD1
601953	108643993	21111021662	years	year	NNT2
601953	108643993	21111021663	meeting	meet	VVG_NN1
601953	108643993	21111021664	,	,	,
601953	108643993	21111021665	and	and	CC
601953	108643993	21111021666	also	also	RR
601953	108643993	21111021667	showcasing	showcasing	NN1
601953	108643993	21111021668	new	new	JJ
601953	108643993	21111021669	developments	development	NN2
601953	108643993	21111021670	in	in	II
601953	108643993	21111021671	Bracket	bracket	NN1
601953	108643993	21111021672	's	's	GE_VBZ
601953	108643993	21111021673	industry-leading	industry-leading	JJ
601953	108643993	21111021674	Electronic	electronic	JJ
601953	108643993	21111021675	Clinician-Reported		JJ_NN1
601953	108643993	21111021676	Outcomes	outcome	NN2
601953	108643993	21111021677	tools	tool	NN2
601953	108643993	21111021678	.	.	.
601953	108643993	21111021679	These	these	DD2
601953	108643993	21111021680	include	include	VV0
601953	108643993	21111021681	the	the	AT
601953	108643993	21111021682	newest	new	JJT
601953	108643993	21111021683	features	feature	NN2
601953	108643993	21111021684	and	and	CC
601953	108643993	21111021685	tools	tool	NN2
601953	108643993	21111021686	included	include	VVN_VVD
601953	108643993	21111021687	in	in	II
601953	108643993	21111021688	Bracket	bracket	NN1
601953	108643993	21111021689	's	's	GE_VBZ
601953	108643993	21111021690	Rater	rater	NP1
601953	108643993	21111021691	Station	station	NN1
601953	108643993	21111021692	platform	platform	NN1
601953	108643993	21111021693	.	.	.
601953	108643993	21111021694	New	new	JJ
601953	108643993	21111021695	research	research	NN1
601953	108643993	21111021696	presented	present	VVN_VVD
601953	108643993	21111021697	at	at	II
601953	108643993	21111021698	the	the	AT
601953	108643993	21111021699	meeting	meeting	NN1
601953	108643993	21111021700	will	will	VM
601953	108643993	21111021701	include	include	VVI
601953	108643993	21111021702	:	:	:
601953	108643996	21111021722	@@##	----------	----------
601953	108643996	21111021723	@@108643996		FO
601953	108643996	21111021724	@4043996/		JJ_NN1_VV0
601953	108643996	21111021725	<h>		NULL
601953	108643996	21111021726	Bracket	bracket	NN1
601953	108643996	21111021727	Presents	present	VVZ
601953	108643996	21111021728	Recent	recent	JJ
601953	108643996	21111021729	Findings	finding	NN2
601953	108643996	21111021730	at	at	II
601953	108643996	21111021731	AAIC		NP1_JJ
601953	108643996	21111021732	2013	2013	MC
601953	108643996	21111021733	<p>		NULL
601953	108643996	21111021734	July	july	NPM1
601953	108643996	21111021735	22	22	MC
601953	108643996	21111021736	,	,	,
601953	108643996	21111021737	2013	2013	MC
601953	108643996	21111021738	157705		MC
601953	108643996	21111021739	@qwx1017705		FO
601953	108643996	21111021740	<p>		NULL
601953	108643996	21111021741	The	the	AT
601953	108643996	21111021742	latest	late	JJT
601953	108643996	21111021743	research	research	NN1
601953	108643996	21111021744	in	in	II
601953	108643996	21111021745	dementia	dementia	NN1
601953	108643996	21111021746	was	be	VBDZ
601953	108643996	21111021747	revealed	reveal	VVN
601953	108643996	21111021748	last	last	MD
601953	108643996	21111021749	week	week	NNT1
601953	108643996	21111021750	at	at	II
601953	108643996	21111021751	the-	the--	NN1_JJ
601953	108643996	21111021752	2013	2013	MC
601953	108643996	21111021753	Alzheimer	alzheimer	NP1
601953	108643996	21111021754	's	's	GE
601953	108643996	21111021755	Association	association	NN1
601953	108643996	21111021756	International	international	JJ
601953	108643996	21111021757	Conference-		NN1
601953	108643996	21111021758	in	in	II
601953	108643996	21111021759	Boston	boston	NP1
601953	108643996	21111021760	.	.	.
601953	108643996	21111021761	The	the	AT
601953	108643996	21111021762	conference	conference	NN1
601953	108643996	21111021763	brought	bring	VVD_VVN
601953	108643996	21111021764	together	together	RL
601953	108643996	21111021765	leading	leading	JJ_VVG
601953	108643996	21111021766	researchers	researcher	NN2
601953	108643996	21111021767	from	from	II
601953	108643996	21111021768	around	around	II
601953	108643996	21111021769	the	the	AT
601953	108643996	21111021770	globe	globe	NN1
601953	108643996	21111021771	to	to	TO
601953	108643996	21111021772	share	share	VVI
601953	108643996	21111021773	their	their	APPGE
601953	108643996	21111021774	discoveries	discovery	NN2
601953	108643996	21111021775	and	and	CC
601953	108643996	21111021776	study	study	NN1_VV0@
601953	108643996	21111021777	results	result	NN2
601953	108643996	21111021778	,	,	,
601953	108643996	21111021779	bringing	bring	VVG
601953	108643996	21111021780	the	the	AT
601953	108643996	21111021781	world	world	NN1
601953	108643996	21111021782	one	one	MC1
601953	108643996	21111021783	step	step	NN1_VV0
601953	108643996	21111021784	closer	close	RRR
601953	108643996	21111021785	to	to	II
601953	108643996	21111021786	finding	find	VVG
601953	108643996	21111021787	a	a	AT1
601953	108643996	21111021788	cure	cure	NN1
601953	108643996	21111021789	for	for	IF
601953	108643996	21111021790	Alzheimer	alzheimer	NP1
601953	108643996	21111021791	's	's	GE
601953	108643996	21111021792	disease	disease	NN1
601953	108643996	21111021793	.	.	.
601953	108643996	21111021794	Professor	professor	NNB
601953	108643996	21111021795	Keith	keith	NP1
601953	108643996	21111021796	Wesnes		NP2
601953	108643996	21111021797	,	,	,
601953	108643996	21111021798	Practice	practice	NN1
601953	108643996	21111021799	Leader	leader	NN1
601953	108643996	21111021800	for	for	IF
601953	108643996	21111021801	Cognition	cognition	NN1
601953	108643996	21111021802	,	,	,
601953	108643996	21111021803	and	and	CC
601953	108643996	21111021804	Dr.		NNB
601953	108643996	21111021805	David	david	NP1
601953	108643996	21111021806	Miller	miller	NP1
601953	108643996	21111021807	,	,	,
601953	108643996	21111021808	Therapeutic	therapeutic	JJ
601953	108643996	21111021809	Area	area	NN1
601953	108643996	21111021810	Leader	leader	NN1
601953	108643996	21111021811	for	for	IF
601953	108643996	21111021812	Dementia	dementia	NN1
601953	108643996	21111021813	,	,	,
601953	108643996	21111021814	presented	present	VVD_VVN
601953	108643996	21111021815	their	their	APPGE
601953	108643996	21111021816	recent	recent	JJ
601953	108643996	21111021817	findings	finding	NN2
601953	108643996	21111021818	.	.	.
601953	108643996	21111021819	To	to	TO
601953	108643996	21111021820	view	view	VVI
601953	108643996	21111021821	the	the	AT
601953	108643996	21111021822	posters	poster	NN2
601953	108643996	21111021823	,	,	,
601953	108643996	21111021824	click	click	VV0_NN1
601953	108643996	21111021825	on	on	II
601953	108643996	21111021826	the	the	AT
601953	108643996	21111021827	links	link	NN2
601953	108643996	21111021828	below	below	RL
601953	108643996	21111021829	.	.	.
601953	108643999	21111021895	@@##	----------	----------
601953	108643999	21111021896	@@108643999		FO
601953	108643999	21111021897	@4043999/		JJ_NN1_VV0
601953	108643999	21111021898	<h>		NULL
601953	108643999	21111021899	Bracket	bracket	NN1
601953	108643999	21111021900	to	to	II
601953	108643999	21111021901	Present	present	NN1_JJ
601953	108643999	21111021902	at	at	II
601953	108643999	21111021903	AAIC		NP1_JJ
601953	108643999	21111021904	2014	2014	MC
601953	108643999	21111021905	<p>		NULL
601953	108643999	21111021906	July	july	NPM1
601953	108643999	21111021907	8	8	MC
601953	108643999	21111021908	,	,	,
601953	108643999	21111021909	2014	2014	MC
601953	108643999	21111021910	<p>		NULL
601953	108643999	21111021911	The	the	AT
601953	108643999	21111021912	Alzheimer	alzheimer	NP1
601953	108643999	21111021913	's	's	GE
601953	108643999	21111021914	Association	association	NN1
601953	108643999	21111021915	International	international	JJ
601953	108643999	21111021916	Conference	conference	NN1
601953	108643999	21111021917	is	be	VBZ
601953	108643999	21111021918	right	right	JJ
601953	108643999	21111021919	around	around	II
601953	108643999	21111021920	the	the	AT
601953	108643999	21111021921	corner	corner	NN1
601953	108643999	21111021922	.	.	.
601953	108643999	21111021923	Taking	take	VVG
601953	108643999	21111021924	place	place	NN1
601953	108643999	21111021925	in	in	II
601953	108643999	21111021926	Copenhagen	copenhagen	NP1
601953	108643999	21111021927	,	,	,
601953	108643999	21111021928	Denmark	denmark	NP1
601953	108643999	21111021929	on	on	II
601953	108643999	21111021930	July	july	NPM1
601953	108643999	21111021931	11-17	11-17	MCMC
601953	108643999	21111021932	,	,	,
601953	108643999	21111021933	the	the	AT
601953	108643999	21111021934	conference	conference	NN1
601953	108643999	21111021935	will	will	VM
601953	108643999	21111021936	bring	bring	VVI
601953	108643999	21111021937	together	together	RL
601953	108643999	21111021938	thousands	thousand	NNO2
601953	108643999	21111021939	of	of	IO
601953	108643999	21111021940	researchers	researcher	NN2
601953	108643999	21111021941	to	to	TO
601953	108643999	21111021942	reveal	reveal	VVI
601953	108643999	21111021943	the	the	AT
601953	108643999	21111021944	latest	late	JJT
601953	108643999	21111021945	research	research	NN1
601953	108643999	21111021946	in	in	II
601953	108643999	21111021947	dementia	dementia	NN1
601953	108643999	21111021948	.	.	.
601953	108643999	21111021949	<p>		NULL
601953	108643999	21111021950	Bracket	bracket	NN1
601953	108643999	21111021951	's	's	GE
601953	108643999	21111021952	Dr.		NNB
601953	108643999	21111021953	David	david	NP1
601953	108643999	21111021954	Miller	miller	NP1
601953	108643999	21111021955	,	,	,
601953	108643999	21111021956	Therapeutic	therapeutic	JJ
601953	108643999	21111021957	Area	area	NN1
601953	108643999	21111021958	Leader	leader	NN1
601953	108643999	21111021959	for	for	IF
601953	108643999	21111021960	Dementia	dementia	NN1
601953	108643999	21111021961	and	and	CC
601953	108643999	21111021962	Geriatric	geriatric	NP1_JJ
601953	108643999	21111021963	Psychiatry	psychiatry	NP1_NN1
601953	108643999	21111021964	,	,	,
601953	108643999	21111021965	collaborated	collaborate	VVD_VVN@
601953	108643999	21111021966	on	on	II
601953	108643999	21111021967	four	four	MC
601953	108643999	21111021968	scientific	scientific	JJ
601953	108643999	21111021969	posters	poster	NN2
601953	108643999	21111021970	with	with	IW
601953	108643999	21111021971	his	his	APPGE
601953	108643999	21111021972	industry	industry	NN1
601953	108643999	21111021973	and	and	CC
601953	108643999	21111021974	academic	academic	JJ
601953	108643999	21111021975	colleagues	colleague	NN2
601953	108643999	21111021976	.	.	.
601953	108643999	21111021977	Below	below	RL
601953	108643999	21111021978	is	be	VBZ
601953	108643999	21111021979	a	a	AT1
601953	108643999	21111021980	list	list	NN1
601953	108643999	21111021981	of	of	IO
601953	108643999	21111021982	their	their	APPGE
601953	108643999	21111021983	posters	poster	NN2
601953	108643999	21111021984	.	.	.
601953	108643999	21111021985	Be	be	VB0
601953	108643999	21111021986	sure	sure	JJ
601953	108643999	21111021987	to	to	TO
601953	108643999	21111021988	check	check	VVI
601953	108643999	21111021989	back	back	RP
601953	108643999	21111021990	on	on	II
601953	108643999	21111021991	our	our	APPGE
601953	108643999	21111021992	website	website	NN1
601953	108643999	21111021993	after	after	II_CS
601953	108643999	21111021994	the	the	AT
601953	108643999	21111021995	conference	conference	NN1
601953	108643999	21111021996	for	for	IF
601953	108643999	21111021997	links	link	NN2
601953	108643999	21111021998	to	to	II
601953	108643999	21111021999	the	the	AT
601953	108643999	21111022000	posters	poster	NN2
601953	108643999	21111022001	.	.	.
601953	108643999	21111022002	<p>		NULL
601953	108643999	21111022003	Alzheimer	alzheimer	NP1
601953	108643999	21111022004	's	's	GE
601953	108643999	21111022005	disease	disease	NN1
601953	108643999	21111022006	(	(	(
601953	108643999	21111022007	AD	ad	RA
601953	108643999	21111022008	)	)	)
601953	108643999	21111022009	clinical	clinical	JJ
601953	108643999	21111022010	trials	trial	NN2
601953	108643999	21111022011	frequently	frequently	RR
601953	108643999	21111022012	struggle	struggle	VV0@
601953	108643999	21111022013	to	to	TO
601953	108643999	21111022014	enroll	enroll	VVI
601953	108643999	21111022015	.	.	.
601953	108643999	21111022016	To	to	TO
601953	108643999	21111022017	address	address	VVI
601953	108643999	21111022018	this	this	DD1
601953	108643999	21111022019	consistent	consistent	JJ
601953	108643999	21111022020	challenge	challenge	NN1
601953	108643999	21111022021	,	,	,
601953	108643999	21111022022	most	most	DAT_RGT
601953	108643999	21111022023	AD	ad	NN1%_RA
601953	108643999	21111022024	clinical	clinical	JJ
601953	108643999	21111022025	trials	trial	NN2
601953	108643999	21111022026	now	now	RT
601953	108643999	21111022027	recruit	recruit	VV0
601953	108643999	21111022028	multi	multi	JJ
601953	108643999	21111022029	nationally	nationally	RR
601953	108643999	21111022030	.	.	.
601953	108643999	21111022031	Demographic	demographic	JJ
601953	108643999	21111022032	and	and	CC
601953	108643999	21111022033	clinical	clinical	JJ
601953	108643999	21111022034	measures	measure	NN2
601953	108643999	21111022035	were	be	VBDR
601953	108643999	21111022036	compared	compare	VVN
601953	108643999	21111022037	for	for	IF
601953	108643999	21111022038	participants	participant	NN2
601953	108643999	21111022039	and	and	CC
601953	108643999	21111022040	their	their	APPGE
601953	108643999	21111022041	study	study	NN1
601953	108643999	21111022042	partners	partner	NN2
601953	108643999	21111022043	from	from	II
601953	108643999	21111022044	four	four	MC
601953	108643999	21111022045	similarly-designed		JJ_NN1
601953	108643999	21111022046	,	,	,
601953	108643999	21111022047	randomized	randomize	VVD
601953	108643999	21111022048	,	,	,
601953	108643999	21111022049	double-blind	double-blind	JJ_NN1@
601953	108643999	21111022050	,	,	,
601953	108643999	21111022051	placebo-controlled	placebo-controlled	JJ_NN1
601953	108643999	21111022052	trials	trial	NN2
601953	108643999	21111022053	.	.	.
601953	108643999	21111022054	For	for	IF
601953	108643999	21111022055	all	all	DB
601953	108643999	21111022056	outcomes	outcome	NN2
601953	108643999	21111022057	,	,	,
601953	108643999	21111022058	the	the	AT
601953	108643999	21111022059	hypothesis	hypothesis	NN1
601953	108643999	21111022060	that	that	CST_DD1
601953	108643999	21111022061	global	global	JJ
601953	108643999	21111022062	regions	region	NN2
601953	108643999	21111022063	do	do	VD0
601953	108643999	21111022064	not	not	XX
601953	108643999	21111022065	differ	differ	VVI
601953	108643999	21111022066	from	from	II
601953	108643999	21111022067	each	each	PPX221
601953	108643999	21111022068	other	other	PPX222
601953	108643999	21111022069	was	be	VBDZ
601953	108643999	21111022070	tested	test	VVN
601953	108643999	21111022071	.	.	.
601953	108643999	21111022072	<p>		NULL
601953	108643999	21111022073	The	the	AT
601953	108643999	21111022074	ADAS-Cog		NP1_NN1_JJ
601953	108643999	21111022075	(	(	(
601953	108643999	21111022076	Rosen	rosen	NP1
601953	108643999	21111022077	et	et	RA21
601953	108643999	21111022078	al.		RA22
601953	108643999	21111022079	,	,	,
601953	108643999	21111022080	1984	1984	MC
601953	108643999	21111022081	)	)	)
601953	108643999	21111022082	is	be	VBZ
601953	108643999	21111022083	widely	widely	RR
601953	108643999	21111022084	used	use	VVN_VVD
601953	108643999	21111022085	as	as	II_CSA
601953	108643999	21111022086	the	the	AT
601953	108643999	21111022087	@		II
601953	108643999	21111022088	@		II
601953	108643999	21111022089	@		II
601953	108643999	21111022090	@		II
601953	108643999	21111022091	@		II
601953	108643999	21111022092	@		II
601953	108643999	21111022093	@		II
601953	108643999	21111022094	@		II
601953	108643999	21111022095	@		II
601953	108643999	21111022096	@		II
601953	108643999	21111022097	administration	administration	NN1
601953	108643999	21111022098	manual	manual	NN1
601953	108643999	21111022099	for	for	IF
601953	108643999	21111022100	the	the	AT
601953	108643999	21111022101	ADAS-Cog		NN1_NP1
601953	108643999	21111022102	was	be	VBDZ
601953	108643999	21111022103	first	first	MD
601953	108643999	21111022104	prepared	prepare	VVN
601953	108643999	21111022105	in	in	II
601953	108643999	21111022106	1994	1994	MC
601953	108643999	21111022107	by	by	II
601953	108643999	21111022108	Richard	richard	NP1
601953	108643999	21111022109	Mohs	mohs	NP1
601953	108643999	21111022110	,	,	,
601953	108643999	21111022111	revised	revise	VVN_VVD
601953	108643999	21111022112	in	in	II
601953	108643999	21111022113	1998	1998	MC
601953	108643999	21111022114	,	,	,
601953	108643999	21111022115	and	and	CC
601953	108643999	21111022116	has	have	VHZ
601953	108643999	21111022117	been	be	VBN
601953	108643999	21111022118	broadly	broadly	RR
601953	108643999	21111022119	distributed	distribute	VVN
601953	108643999	21111022120	by	by	II
601953	108643999	21111022121	the	the	AT
601953	108643999	21111022122	Alzheimer	alzheimer	NP1
601953	108643999	21111022123	's	's	GE
601953	108643999	21111022124	Disease	disease	NN1
601953	108643999	21111022125	Cooperative	cooperative	JJ_NN1@
601953	108643999	21111022126	Study	study	NN1
601953	108643999	21111022127	Group	group	NN1
601953	108643999	21111022128	(	(	(
601953	108643999	21111022129	ADCS	adc	NP2
601953	108643999	21111022130	)	)	)
601953	108643999	21111022131	.	.	.
601953	108643999	21111022132	The	the	AT
601953	108643999	21111022133	manual	manual	NN1
601953	108643999	21111022134	needed	need	VVD_VVN
601953	108643999	21111022135	updating	update	VVG
601953	108643999	21111022136	and	and	CC
601953	108643999	21111022137	revision	revision	NN1
601953	108643999	21111022138	to	to	TO
601953	108643999	21111022139	reduce	reduce	VVI
601953	108643999	21111022140	inconsistent	inconsistent	JJ
601953	108643999	21111022141	interpretations	interpretation	NN2
601953	108643999	21111022142	of	of	IO
601953	108643999	21111022143	administration	administration	NN1
601953	108643999	21111022144	instructions	instruction	NN2
601953	108643999	21111022145	and	and	CC
601953	108643999	21111022146	scoring	scoring	NN1_VVG
601953	108643999	21111022147	.	.	.
601953	108643999	21111022148	The	the	AT
601953	108643999	21111022149	goal	goal	NN1
601953	108643999	21111022150	was	be	VBDZ
601953	108643999	21111022151	to	to	TO
601953	108643999	21111022152	revise	revise	VVI
601953	108643999	21111022153	the	the	AT
601953	108643999	21111022154	US	us	NP1
601953	108643999	21111022155	version	version	NN1
601953	108643999	21111022156	which	which	DDQ
601953	108643999	21111022157	could	could	VM
601953	108643999	21111022158	then	then	RT
601953	108643999	21111022159	serve	serve	VVI
601953	108643999	21111022160	as	as	II
601953	108643999	21111022161	a	a	AT1
601953	108643999	21111022162	primary	primary	JJ_NN1
601953	108643999	21111022163	reference	reference	NN1
601953	108643999	21111022164	for	for	IF
601953	108643999	21111022165	use	use	NN1
601953	108643999	21111022166	in	in	II
601953	108643999	21111022167	other	other	JJ
601953	108643999	21111022168	regions	region	NN2
601953	108643999	21111022169	and	and	CC
601953	108643999	21111022170	languages	language	NN2
601953	108643999	21111022171	.	.	.
601953	108643999	21111022172	<p>		NULL
601953	108643999	21111022173	Agitation	agitation	NN1
601953	108643999	21111022174	and	and	CC
601953	108643999	21111022175	Aggression	aggression	NN1
601953	108643999	21111022176	are	be	VBR
601953	108643999	21111022177	among	among	II
601953	108643999	21111022178	the	the	AT
601953	108643999	21111022179	most	most	RGT
601953	108643999	21111022180	disruptive	disruptive	JJ
601953	108643999	21111022181	neuropsychiatric	neuropsychiatric	JJ
601953	108643999	21111022182	symptoms	symptom	NN2
601953	108643999	21111022183	(	(	(
601953	108643999	21111022184	NPS	nps	NP1
601953	108643999	21111022185	)	)	)
601953	108643999	21111022186	in	in	II
601953	108643999	21111022187	Alzheimer	alzheimer	NP1
601953	108643999	21111022188	's	's	GE
601953	108643999	21111022189	disease	disease	NN1
601953	108643999	21111022190	(	(	(
601953	108643999	21111022191	AD	ad	RA
601953	108643999	21111022192	)	)	)
601953	108643999	21111022193	and	and	CC
601953	108643999	21111022194	occur	occur	VV0
601953	108643999	21111022195	in	in	RP@_II
601953	108643999	21111022196	up	up	RG21
601953	108643999	21111022197	to	to	RG22
601953	108643999	21111022198	50%		NNU
601953	108643999	21111022199	of	of	IO
601953	108643999	21111022200	AD	ad	NN1%
601953	108643999	21111022201	dementia	dementia	NN1
601953	108643999	21111022202	patients	patient	NN2
601953	108643999	21111022203	.	.	.
601953	108643999	21111022204	ELND005		FO
601953	108643999	21111022205	(	(	(
601953	108643999	21111022206	Scyllo-inositol		NN1_JJ
601953	108643999	21111022207	,	,	,
601953	108643999	21111022208	a	a	AT1
601953	108643999	21111022209	myo-inositol		JJ_NN1
601953	108643999	21111022210	isomer		JJR
601953	108643999	21111022211	)	)	)
601953	108643999	21111022212	is	be	VBZ
601953	108643999	21111022213	being	be	VBG
601953	108643999	21111022214	evaluated	evaluate	VVN
601953	108643999	21111022215	as	as	II
601953	108643999	21111022216	a	a	AT1
601953	108643999	21111022217	potential	potential	JJ_NN1
601953	108643999	21111022218	treatment	treatment	NN1
601953	108643999	21111022219	for	for	IF
601953	108643999	21111022220	Agitation	agitation	NN1
601953	108643999	21111022221	and	and	CC
601953	108643999	21111022222	Aggression	aggression	NN1
601953	108643999	21111022223	in	in	II
601953	108643999	21111022224	AD	ad	RA
601953	108643999	21111022225	(	(	(
601953	108643999	21111022226	clintrials		NN2
601953	108643999	21111022227	NCT01735630		FO
601953	108643999	21111022228	)	)	)
601953	108643999	21111022229	.	.	.
601953	108643999	21111022230	This	this	DD1
601953	108643999	21111022231	poster	poster	NN1
601953	108643999	21111022232	describes	describe	VVZ
601953	108643999	21111022233	the	the	AT
601953	108643999	21111022234	operational	operational	JJ
601953	108643999	21111022235	diagnostic	diagnostic	JJ
601953	108643999	21111022236	criteria	criteria	NN2
601953	108643999	21111022237	&amp;		CC
601953	108643999	21111022238	novel	novel	JJ_NN1
601953	108643999	21111022239	outcome	outcome	NN1
601953	108643999	21111022240	measures	measure	NN2
601953	108643999	21111022241	utilized	utilize	VVN_VVD
601953	108643999	21111022242	in	in	II
601953	108643999	21111022243	this	this	DD1
601953	108643999	21111022244	trial	trial	NN1
601953	108643999	21111022245	,	,	,
601953	108643999	21111022246	and	and	CC
601953	108643999	21111022247	baseline	baseline	NN1
601953	108643999	21111022248	characteristics	characteristic	NN2
601953	108643999	21111022249	of	of	IO
601953	108643999	21111022250	the	the	AT
601953	108643999	21111022251	population	population	NN1
601953	108643999	21111022252	.	.	.
601953	108643999	21111022253	<p>		NULL
601953	108643999	21111022254	Dr.		NNB
601953	108643999	21111022255	Miller	miller	NP1
601953	108643999	21111022256	will	will	VM
601953	108643999	21111022257	also	also	RR
601953	108643999	21111022258	be	be	VBI
601953	108643999	21111022259	participating	participate	VVG_JJ
601953	108643999	21111022260	in	in	II
601953	108643999	21111022261	the	the	AT
601953	108643999	21111022262	Neuropsychiatric	neuropsychiatric	JJ
601953	108643999	21111022263	Symptoms	symptom	NN2
601953	108643999	21111022264	Professional	professional	JJ
601953	108643999	21111022265	Interest	interest	NN1
601953	108643999	21111022266	Area	area	NN1
601953	108643999	21111022267	of	of	IO
601953	108643999	21111022268	the-	the--	JJ_NN1
601953	108643999	21111022269	PIA	pia	NP1
601953	108643999	21111022270	day	day	NNT1
601953	108643999	21111022271	program-		NN1
601953	108643999	21111022272	on	on	II
601953	108643999	21111022273	Saturday	saturday	NPD1
601953	108643999	21111022274	morning	morning	NNT1
601953	108643999	21111022275	,	,	,
601953	108643999	21111022276	July	july	NPM1
601953	108643999	21111022277	11	11	MC
601953	108643999	21111022278	,	,	,
601953	108643999	21111022279	at	at	II
601953	108643999	21111022280	the	the	AT
601953	108643999	21111022281	Bella	bella	NP1_NN1@
601953	108643999	21111022282	Sky	sky	NN1
601953	108643999	21111022283	Hotel	hotel	NN1
601953	108643999	21111022284	and	and	CC
601953	108643999	21111022285	Co-Chairing	co-chair	VVG
601953	108643999	21111022286	the	the	AT
601953	108643999	21111022287	NPS	nps	NP1
601953	108643999	21111022288	PIA	pia	NP1
601953	108643999	21111022289	Business	business	NN1
601953	108643999	21111022290	meeting	meet	VVG_NN1
601953	108643999	21111022291	later	later	RRR
601953	108643999	21111022292	that	that	DD1_CST
601953	108643999	21111022293	same	same	DA
601953	108643999	21111022294	morning	morning	NNT1
601953	108643999	21111022295	.	.	.
601953	108644002	21111022360	@@##	----------	----------
601953	108644002	21111022361	@@108644002		FO
601953	108644002	21111022362	@4044002/		VV0_NN1
601953	108644002	21111022363	157705		MC
601953	108644002	21111022364	@qwx1017705		FO
601953	108644002	21111022365	<p>		NULL
601953	108644002	21111022366	Adam	adam	NP1
601953	108644002	21111022367	Butler	butler	NP1
601953	108644002	21111022368	,	,	,
601953	108644002	21111022369	VP	vp	NP1
601953	108644002	21111022370	of	of	IO
601953	108644002	21111022371	Client	client	NN1
601953	108644002	21111022372	Services	service	NN2
601953	108644002	21111022373	at	at	II
601953	108644002	21111022374	Bracket	bracket	NN1
601953	108644002	21111022375	,	,	,
601953	108644002	21111022376	along	along	II21
601953	108644002	21111022377	with	with	II22
601953	108644002	21111022378	a	a	AT1
601953	108644002	21111022379	distinguished	distinguished	JJ
601953	108644002	21111022380	group	group	NN1
601953	108644002	21111022381	of	of	IO
601953	108644002	21111022382	industry	industry	NN1
601953	108644002	21111022383	colleagues	colleague	NN2
601953	108644002	21111022384	at	at	II
601953	108644002	21111022385	the	the	AT
601953	108644002	21111022386	International	international	JJ
601953	108644002	21111022387	Society	society	NN1
601953	108644002	21111022388	for	for	IF
601953	108644002	21111022389	CNS	cns	NP1
601953	108644002	21111022390	Clinical	clinical	JJ
601953	108644002	21111022391	Trials	trial	NN2
601953	108644002	21111022392	and	and	CC
601953	108644002	21111022393	Methodology	methodology	NN1
601953	108644002	21111022394	(	(	(
601953	108644002	21111022395	ISCTM		NP1
601953	108644002	21111022396	)	)	)
601953	108644002	21111022397	worked	work	VVD_VVN
601953	108644002	21111022398	together	together	RL
601953	108644002	21111022399	over	over	II
601953	108644002	21111022400	the	the	AT
601953	108644002	21111022401	past	past	JJ_NN1
601953	108644002	21111022402	few	few	DA2
601953	108644002	21111022403	years	year	NNT2
601953	108644002	21111022404	examining	examine	VVG
601953	108644002	21111022405	issues	issue	NN2
601953	108644002	21111022406	related	relate	VVN_VVD
601953	108644002	21111022407	to	to	II
601953	108644002	21111022408	the	the	AT
601953	108644002	21111022409	use	use	NN1
601953	108644002	21111022410	of	of	IO
601953	108644002	21111022411	Suicidality		NP1_NN1
601953	108644002	21111022412	Ideation	ideation	NN1
601953	108644002	21111022413	and	and	CC
601953	108644002	21111022414	Behavior	behavior	NP1_NN1
601953	108644002	21111022415	measurement	measurement	NN1
601953	108644002	21111022416	instruments	instrument	NN2
601953	108644002	21111022417	in	in	II
601953	108644002	21111022418	clinical	clinical	JJ
601953	108644002	21111022419	trials	trial	NN2
601953	108644002	21111022420	.	.	.
601953	108644002	21111022421	Their	their	APPGE
601953	108644002	21111022422	work	work	NN1
601953	108644002	21111022423	was	be	VBDZ
601953	108644002	21111022424	published	publish	VVN
601953	108644002	21111022425	in	in	II
601953	108644002	21111022426	the	the	AT
601953	108644002	21111022427	June	june	NPM1_NP1@
601953	108644002	21111022428	issue	issue	VV0_NN1
601953	108644002	21111022429	of-	of--	JJ_NN1
601953	108644002	21111022430	Innovations	innovation	NN2
601953	108644002	21111022431	in	in	II
601953	108644002	21111022432	Clinical	clinical	JJ
601953	108644002	21111022433	Neuroscience	neuroscience	NN1@_NP1
601953	108644002	21111022434	.	.	.
601953	108644002	21111022435	Click	click	VV0_NN1
601953	108644002	21111022436	on	on	II
601953	108644002	21111022437	the	the	AT
601953	108644002	21111022438	below	below	RL_RG
601953	108644002	21111022439	link	link	VV0
601953	108644002	21111022440	to	to	TO
601953	108644002	21111022441	read	read	VVI
601953	108644002	21111022442	the	the	AT
601953	108644002	21111022443	paper	paper	NN1
601953	108644002	21111022444	.	.	.
601953	108644003	21111022464	@@##	----------	----------
601953	108644003	21111022465	@@108644003		FO
601953	108644003	21111022466	@4044003/		NN1_VV0
601953	108644003	21111022467	<p>		NULL
601953	108644003	21111022468	WAYNE	wayne	NP1
601953	108644003	21111022469	,	,	,
601953	108644003	21111022470	Pa-		NN1_JJ
601953	108644003	21111022471	-	-	-
601953	108644003	21111022472	Bracket	bracket	NN1_VV0@
601953	108644003	21111022473	,	,	,
601953	108644003	21111022474	a	a	AT1
601953	108644003	21111022475	leading	leading	JJ
601953	108644003	21111022476	clinical	clinical	JJ
601953	108644003	21111022477	trial	trial	NN1
601953	108644003	21111022478	technology	technology	NN1
601953	108644003	21111022479	and	and	CC
601953	108644003	21111022480	specialty	specialty	NN1
601953	108644003	21111022481	services	service	NN2
601953	108644003	21111022482	provider	provider	NN1
601953	108644003	21111022483	,	,	,
601953	108644003	21111022484	announced	announce	VVD_VVN
601953	108644003	21111022485	today	today	RT
601953	108644003	21111022486	the	the	AT
601953	108644003	21111022487	release	release	NN1
601953	108644003	21111022488	of	of	IO
601953	108644003	21111022489	CUBETM		NP1
601953	108644003	21111022490	,	,	,
601953	108644003	21111022491	a	a	AT1
601953	108644003	21111022492	transformative	transformative	JJ
601953	108644003	21111022493	interactive	interactive	JJ
601953	108644003	21111022494	response	response	NN1
601953	108644003	21111022495	technology	technology	NN1
601953	108644003	21111022496	(	(	(
601953	108644003	21111022497	IRT	irt	NP1
601953	108644003	21111022498	)	)	)
601953	108644003	21111022499	solution	solution	NN1
601953	108644003	21111022500	for	for	IF
601953	108644003	21111022501	the	the	AT
601953	108644003	21111022502	life	life	NN1
601953	108644003	21111022503	sciences	science	NN2
601953	108644003	21111022504	industry	industry	NN1
601953	108644003	21111022505	.	.	.
601953	108644003	21111022506	Designed	design	VVN_VVD
601953	108644003	21111022507	through	through	II
601953	108644003	21111022508	an	a	AT1
601953	108644003	21111022509	iterative	iterative	JJ
601953	108644003	21111022510	user	user	NN1
601953	108644003	21111022511	acceptance	acceptance	NN1
601953	108644003	21111022512	build	build	VV0_NN1@
601953	108644003	21111022513	experience	experience	NN1
601953	108644003	21111022514	,	,	,
601953	108644003	21111022515	CUBE	cube	NN1
601953	108644003	21111022516	will	will	VM
601953	108644003	21111022517	be	be	VBI
601953	108644003	21111022518	immediately	immediately	RR
601953	108644003	21111022519	available	available	JJ
601953	108644003	21111022520	to	to	II
601953	108644003	21111022521	qualifying	qualifying	JJ_VVG_NN1
601953	108644003	21111022522	biotechnology	biotechnology	NN1
601953	108644003	21111022523	and	and	CC
601953	108644003	21111022524	pharmaceutical	pharmaceutical	JJ
601953	108644003	21111022525	trial	trial	NN1
601953	108644003	21111022526	sponsors	sponsor	NN2_VVZ@
601953	108644003	21111022527	through	through	II
601953	108644003	21111022528	Bracket	bracket	NN1
601953	108644003	21111022529	.	.	.
601953	108644003	21111022530	<p>		NULL
601953	108644003	21111022531	The	the	AT
601953	108644003	21111022532	solution	solution	NN1
601953	108644003	21111022533	will	will	VM
601953	108644003	21111022534	enable	enable	VVI
601953	108644003	21111022535	biotech	biotech	NN1
601953	108644003	21111022536	and	and	CC
601953	108644003	21111022537	pharma	pharma	NN1
601953	108644003	21111022538	sponsors	sponsor	NN2_VVZ@
601953	108644003	21111022539	to	to	TO
601953	108644003	21111022540	utilize	utilize	VVI
601953	108644003	21111022541	an	a	AT1
601953	108644003	21111022542	innovative	innovative	JJ
601953	108644003	21111022543	new	new	JJ
601953	108644003	21111022544	solution	solution	NN1
601953	108644003	21111022545	to	to	TO
601953	108644003	21111022546	deploy	deploy	VVI
601953	108644003	21111022547	studies	study	NN2
601953	108644003	21111022548	in	in	II
601953	108644003	21111022549	one	one	MC1
601953	108644003	21111022550	to	to	II
601953	108644003	21111022551	two	two	MC
601953	108644003	21111022552	weeks	week	NNT2
601953	108644003	21111022553	.	.	.
601953	108644003	21111022554	It	it	NN1%
601953	108644003	21111022555	leverages	leverage	NN2
601953	108644003	21111022556	an	a	AT1
601953	108644003	21111022557	iterative	iterative	JJ
601953	108644003	21111022558	user	user	NN1
601953	108644003	21111022559	acceptance	acceptance	NN1
601953	108644003	21111022560	build	build	VV0_NN1@
601953	108644003	21111022561	experience	experience	NN1_VV0
601953	108644003	21111022562	to	to	TO
601953	108644003	21111022563	provide	provide	VVI
601953	108644003	21111022564	a	a	AT1
601953	108644003	21111022565	rapid	rapid	JJ
601953	108644003	21111022566	and	and	CC
601953	108644003	21111022567	advanced	advanced	JJ
601953	108644003	21111022568	deployment	deployment	NN1
601953	108644003	21111022569	methodology	methodology	NN1
601953	108644003	21111022570	without	without	IW
601953	108644003	21111022571	the	the	AT
601953	108644003	21111022572	time	time	NNT1
601953	108644003	21111022573	and	and	CC
601953	108644003	21111022574	cost	cost	NN1_VV0
601953	108644003	21111022575	constraints	constraint	NN2
601953	108644003	21111022576	of	of	IO
601953	108644003	21111022577	traditional	traditional	JJ
601953	108644003	21111022578	IRT	irt	NN1
601953	108644003	21111022579	solutions	solution	NN2
601953	108644003	21111022580	.	.	.
601953	108644003	21111022581	Key	key	JJ_NN1
601953	108644003	21111022582	highlights	highlight	NN2
601953	108644003	21111022583	of	of	IO
601953	108644003	21111022584	CUBE	cube	NN1
601953	108644003	21111022585	for	for	IF
601953	108644003	21111022586	biotech	biotech	NN1
601953	108644003	21111022587	and	and	CC
601953	108644003	21111022588	pharma	pharma	NN1
601953	108644003	21111022589	sponsors	sponsor	NN2
601953	108644003	21111022590	of	of	IO
601953	108644003	21111022591	any	any	DD
601953	108644003	21111022592	size	size	NN1
601953	108644003	21111022593	include	include	VV0
601953	108644003	21111022594	:	:	:
601953	108644003	21111022595	<p>		NULL
601953	108644003	21111022596	Accelerate	accelerate	VV0
601953	108644003	21111022597	times	time	NNT2_VVZ%_II%
601953	108644003	21111022598	for	for	IF
601953	108644003	21111022599	sponsors	sponsor	NN2
601953	108644003	21111022600	and	and	CC
601953	108644003	21111022601	improves	improve	VVZ
601953	108644003	21111022602	efficiency	efficiency	NN1
601953	108644003	21111022603	for	for	IF
601953	108644003	21111022604	CROs	cro	NN2
601953	108644003	21111022605	<p>		NULL
601953	108644003	21111022606	Leverages	leverage	NN2
601953	108644003	21111022607	Brackets	bracket	VVZ@_NN2
601953	108644003	21111022608	full	full	JJ
601953	108644003	21111022609	RTSM		NP1
601953	108644003	21111022610	platform	platform	NN1
601953	108644003	21111022611	,	,	,
601953	108644003	21111022612	but	but	CCB
601953	108644003	21111022613	streamlines	streamline	VVZ
601953	108644003	21111022614	deployment	deployment	NN1
601953	108644003	21111022615	through	through	II
601953	108644003	21111022616	automation	automation	NN1
601953	108644003	21111022617	<p>		NULL
601953	108644003	21111022618	"	"	"
601953	108644003	21111022619	Were	be	VBDR
601953	108644003	21111022620	so	so	RG_RR
601953	108644003	21111022621	pleased	pleased	JJ_VVN@
601953	108644003	21111022622	to	to	TO
601953	108644003	21111022623	introduce	introduce	VVI
601953	108644003	21111022624	CUBE	cube	NN1
601953	108644003	21111022625	to	to	II
601953	108644003	21111022626	the	the	AT
601953	108644003	21111022627	life	life	NN1
601953	108644003	21111022628	sciences	science	NN2
601953	108644003	21111022629	marketplace	marketplace	NN1
601953	108644003	21111022630	and	and	CC
601953	108644003	21111022631	are	be	VBR
601953	108644003	21111022632	confident	confident	JJ
601953	108644003	21111022633	that	that	CST
601953	108644003	21111022634	its	its	APPGE
601953	108644003	21111022635	easy-to-implement		JJ_NN1
601953	108644003	21111022636	nature	nature	NN1
601953	108644003	21111022637	will	will	VM
601953	108644003	21111022638	improve	improve	VVI
601953	108644003	21111022639	the	the	AT
601953	108644003	21111022640	process	process	NN1
601953	108644003	21111022641	of	of	IO
601953	108644003	21111022642	managing	managing	JJ_VVG
601953	108644003	21111022643	clinical	clinical	JJ
601953	108644003	21111022644	supplies	supply	NN2
601953	108644003	21111022645	,	,	,
601953	108644003	21111022646	"	"	"
601953	108644003	21111022647	said	say	VVD
601953	108644003	21111022648	Jeff	jeff	NP1
601953	108644003	21111022649	Kinell		NP1
601953	108644003	21111022650	,	,	,
601953	108644003	21111022651	CEO	ceo	NN1
601953	108644003	21111022652	at	at	II
601953	108644003	21111022653	Bracket	bracket	NN1
601953	108644003	21111022654	.	.	.
601953	108644003	21111022655	"	"	"
601953	108644003	21111022656	@		II
601953	108644003	21111022657	@		II
601953	108644003	21111022658	@		II
601953	108644003	21111022659	@		II
601953	108644003	21111022660	@		II
601953	108644003	21111022661	@		II
601953	108644003	21111022662	@		II
601953	108644003	21111022663	@		II
601953	108644003	21111022664	@		II
601953	108644003	21111022665	@		II
601953	108644003	21111022666	CUBE	cube	NN1
601953	108644003	21111022667	will	will	VM
601953	108644003	21111022668	undoubtedly	undoubtedly	RR
601953	108644003	21111022669	evolve	evolve	VVI
601953	108644003	21111022670	the	the	AT
601953	108644003	21111022671	paradigm	paradigm	NN1
601953	108644003	21111022672	of	of	IO
601953	108644003	21111022673	how	how	RRQ
601953	108644003	21111022674	sponsors	sponsor	NN2
601953	108644003	21111022675	collaborate	collaborate	VV0
601953	108644003	21111022676	to	to	TO
601953	108644003	21111022677	deploy	deploy	VVI
601953	108644003	21111022678	IRT	irt	NN1_NP1
601953	108644003	21111022679	.	.	.
601953	108644003	21111022680	"	"	"
601953	108644003	21111022681	<p>		NULL
601953	108644003	21111022682	The	the	AT
601953	108644003	21111022683	platforms	platform	NN2
601953	108644003	21111022684	iterative	iterative	JJ
601953	108644003	21111022685	UAT		NN1
601953	108644003	21111022686	process	process	NN1
601953	108644003	21111022687	allows	allow	VVZ
601953	108644003	21111022688	study	study	NN1
601953	108644003	21111022689	teams	team	NN2
601953	108644003	21111022690	to	to	TO
601953	108644003	21111022691	visualize	visualize	VVI
601953	108644003	21111022692	the	the	AT
601953	108644003	21111022693	RTSM		NP1
601953	108644003	21111022694	system	system	NN1
601953	108644003	21111022695	during	during	II
601953	108644003	21111022696	the	the	AT
601953	108644003	21111022697	kick	kick	NN1
601953	108644003	21111022698	off	off	II
601953	108644003	21111022699	meeting	meeting	NN1_VVG
601953	108644003	21111022700	.	.	.
601953	108644003	21111022701	This	this	DD1
601953	108644003	21111022702	accelerates	accelerate	VVZ
601953	108644003	21111022703	timelines	timeline	NN2
601953	108644003	21111022704	for	for	IF
601953	108644003	21111022705	sponsors	sponsor	NN2
601953	108644003	21111022706	and	and	CC
601953	108644003	21111022707	improves	improve	VVZ
601953	108644003	21111022708	efficiency	efficiency	NN1
601953	108644003	21111022709	for	for	IF
601953	108644003	21111022710	CROs	cro	NN2
601953	108644003	21111022711	.	.	.
601953	108644003	21111022712	CUBE	cube	VV0@_NN1
601953	108644003	21111022713	also	also	RR
601953	108644003	21111022714	leverages	leverage	NN2
601953	108644003	21111022715	Brackets	bracket	VVZ@_NN2
601953	108644003	21111022716	full	full	JJ
601953	108644003	21111022717	RTSM		NP1
601953	108644003	21111022718	platform	platform	NN1
601953	108644003	21111022719	,	,	,
601953	108644003	21111022720	but	but	CCB
601953	108644003	21111022721	streamlines	streamline	VVZ
601953	108644003	21111022722	the	the	AT
601953	108644003	21111022723	deployment	deployment	NN1
601953	108644003	21111022724	of	of	IO
601953	108644003	21111022725	configuration	configuration	NN1
601953	108644003	21111022726	profiles	profile	NN2_VVZ@
601953	108644003	21111022727	through	through	II
601953	108644003	21111022728	automation	automation	NN1
601953	108644003	21111022729	.	.	.
601953	108644003	21111022730	Its	its	APPGE
601953	108644003	21111022731	intended	intended	JJ@
601953	108644003	21111022732	to	to	TO
601953	108644003	21111022733	support	support	VVI
601953	108644003	21111022734	most	most	DAT
601953	108644003	21111022735	trial	trial	NN1
601953	108644003	21111022736	design	design	NN1
601953	108644003	21111022737	constructs	construct	NN2
601953	108644003	21111022738	.	.	.
601953	108644003	21111022739	<p>		NULL
601953	108644003	21111022740	About	about	II
601953	108644003	21111022741	BracketBracket		NP1_NN1
601953	108644003	21111022742	,	,	,
601953	108644003	21111022743	with	with	IW
601953	108644003	21111022744	nine	nine	MC
601953	108644003	21111022745	offices	office	NN2
601953	108644003	21111022746	and	and	CC
601953	108644003	21111022747	more	more	DAR
601953	108644003	21111022748	than	than	CSN
601953	108644003	21111022749	700	700	MC
601953	108644003	21111022750	employees	employee	NN2
601953	108644003	21111022751	worldwide	worldwide	RL
601953	108644003	21111022752	,	,	,
601953	108644003	21111022753	is	be	VBZ
601953	108644003	21111022754	a	a	AT1
601953	108644003	21111022755	clinical	clinical	JJ
601953	108644003	21111022756	trial	trial	NN1
601953	108644003	21111022757	technology	technology	NN1
601953	108644003	21111022758	and	and	CC
601953	108644003	21111022759	specialty	specialty	NN1
601953	108644003	21111022760	services	service	NN2
601953	108644003	21111022761	provider	provider	NN1
601953	108644003	21111022762	dedicated	dedicate	VVN_VVD
601953	108644003	21111022763	to	to	II
601953	108644003	21111022764	helping	help	VVG
601953	108644003	21111022765	biopharmaceutical	biopharmaceutical	JJ
601953	108644003	21111022766	sponsors	sponsor	NN2
601953	108644003	21111022767	and	and	CC
601953	108644003	21111022768	contract	contract	NN1
601953	108644003	21111022769	research	research	NN1
601953	108644003	21111022770	organizations	organization	NN2
601953	108644003	21111022771	increase	increase	VV0
601953	108644003	21111022772	the	the	AT
601953	108644003	21111022773	power	power	NN1
601953	108644003	21111022774	of	of	IO
601953	108644003	21111022775	their	their	APPGE
601953	108644003	21111022776	clinical	clinical	JJ
601953	108644003	21111022777	research	research	NN1
601953	108644003	21111022778	data	data	NN
601953	108644003	21111022779	by	by	II
601953	108644003	21111022780	leveraging	leverage	VVG_JJ@
601953	108644003	21111022781	core	core	NN1
601953	108644003	21111022782	competencies	competency	NN2
601953	108644003	21111022783	in	in	II
601953	108644003	21111022784	Science	science	NN1
601953	108644003	21111022785	,	,	,
601953	108644003	21111022786	Technology	technology	NN1
601953	108644003	21111022787	,	,	,
601953	108644003	21111022788	and	and	CC
601953	108644003	21111022789	Service	service	NN1
601953	108644003	21111022790	.	.	.
601953	108644003	21111022791	Bracket	bracket	NN1_VV0@
601953	108644003	21111022792	eCOAG		NN1
601953	108644003	21111022793	is	be	VBZ
601953	108644003	21111022794	a	a	AT1
601953	108644003	21111022795	flexible	flexible	JJ
601953	108644003	21111022796	platform	platform	NN1
601953	108644003	21111022797	for	for	IF
601953	108644003	21111022798	electronic	electronic	JJ
601953	108644003	21111022799	clinical	clinical	JJ
601953	108644003	21111022800	outcomes	outcome	NN2
601953	108644003	21111022801	assessments	assessment	NN2
601953	108644003	21111022802	.	.	.
601953	108644003	21111022803	Bracket	bracket	VV0@_NN1
601953	108644003	21111022804	RTSMG		NP1
601953	108644003	21111022805	is	be	VBZ
601953	108644003	21111022806	a	a	AT1
601953	108644003	21111022807	best-in-breed		NN1_JJ
601953	108644003	21111022808	,	,	,
601953	108644003	21111022809	scalable	scalable	JJ
601953	108644003	21111022810	and	and	CC
601953	108644003	21111022811	configurable	configurable	JJ
601953	108644003	21111022812	clinical	clinical	JJ
601953	108644003	21111022813	IRT	irt	NN1
601953	108644003	21111022814	solution	solution	NN1
601953	108644003	21111022815	for	for	IF
601953	108644003	21111022816	the	the	AT
601953	108644003	21111022817	life	life	NN1
601953	108644003	21111022818	sciences	science	NN2
601953	108644003	21111022819	industry	industry	NN1
601953	108644003	21111022820	.	.	.
601953	108644003	21111022821	Bracket	bracket	NN1_VV0@
601953	108644003	21111022822	SmartSuppliesG		NN1_NP1
601953	108644003	21111022823	is	be	VBZ
601953	108644003	21111022824	a	a	AT1
601953	108644003	21111022825	proven	proven	JJ
601953	108644003	21111022826	platform	platform	NN1
601953	108644003	21111022827	for	for	IF
601953	108644003	21111022828	improving	improve	VVG
601953	108644003	21111022829	a	a	AT1
601953	108644003	21111022830	clinical	clinical	JJ
601953	108644003	21111022831	supply	supply	NN1
601953	108644003	21111022832	chain	chain	NN1
601953	108644003	21111022833	.	.	.
601953	108644003	21111022834	Bracket	bracket	VV0@_NN1
601953	108644003	21111022835	Rater	rater	NP1
601953	108644003	21111022836	Training	training	NN1
601953	108644003	21111022837	and	and	CC
601953	108644003	21111022838	Quality	quality	NN1
601953	108644003	21111022839	Assurance	assurance	NN1
601953	108644003	21111022840	improve	improve	VV0
601953	108644003	21111022841	outcomes	outcome	NN2
601953	108644003	21111022842	through	through	II
601953	108644003	21111022843	customized	customized	JJ@
601953	108644003	21111022844	training	training	NN1
601953	108644003	21111022845	and	and	CC
601953	108644003	21111022846	quality	quality	NN1
601953	108644003	21111022847	assurance	assurance	NN1
601953	108644003	21111022848	programs	program	NN2
601953	108644003	21111022849	.	.	.
601953	108644004	21111022869	@@##	----------	----------
601953	108644004	21111022870	@@108644004		FO
601953	108644004	21111022871	@4044004/		VV0
601953	108644004	21111022872	<h>		NULL
601953	108644004	21111022873	The	the	AT
601953	108644004	21111022874	Industry	industry	NN1
601953	108644004	21111022875	's	's	GE
601953	108644004	21111022876	Need	need	NN1
601953	108644004	21111022877	for	for	IF
601953	108644004	21111022878	an	a	AT1
601953	108644004	21111022879	Advanced	advanced	JJ
601953	108644004	21111022880	and	and	CC
601953	108644004	21111022881	Transformative	transformative	JJ_NP1
601953	108644004	21111022882	IRT	irt	NN1_NP1
601953	108644004	21111022883	Solution	solution	NN1
601953	108644004	21111022884	<p>		NULL
601953	108644004	21111022885	June	june	NPM1
601953	108644004	21111022886	5	5	MC
601953	108644004	21111022887	,	,	,
601953	108644004	21111022888	2017	2017	MC
601953	108644004	21111022889	<h>		NULL
601953	108644004	21111022890	By-		NP1
601953	108644004	21111022891	Jim	jim	NP1
601953	108644004	21111022892	Primerano		NP1
601953	108644004	21111022893	,	,	,
601953	108644004	21111022894	Sr.		NNA
601953	108644004	21111022895	Vice	vice	NP1
601953	108644004	21111022896	President	president	NN1
601953	108644004	21111022897	and	and	CC
601953	108644004	21111022898	General	general	JJ_NN1
601953	108644004	21111022899	Manager	manager	NN1
601953	108644004	21111022900	,	,	,
601953	108644004	21111022901	eClinical-		NN1_JJ
601953	108644004	21111022902	at	at	II
601953	108644004	21111022903	Bracket	bracket	NN1
601953	108644004	21111022904	<p>		NULL
601953	108644004	21111022905	Interactive	interactive	JJ
601953	108644004	21111022906	Response	response	NN1
601953	108644004	21111022907	Technology	technology	NN1
601953	108644004	21111022908	(	(	(
601953	108644004	21111022909	IRT	irt	NP1
601953	108644004	21111022910	)	)	)
601953	108644004	21111022911	is	be	VBZ
601953	108644004	21111022912	vital	vital	JJ
601953	108644004	21111022913	in	in	II
601953	108644004	21111022914	managing	manage	VVG
601953	108644004	21111022915	the	the	AT
601953	108644004	21111022916	patients	patient	NN2
601953	108644004	21111022917	and	and	CC
601953	108644004	21111022918	drug	drug	NN1
601953	108644004	21111022919	supplies	supply	NN2
601953	108644004	21111022920	involved	involve	VVN_VVD
601953	108644004	21111022921	throughout	throughout	II
601953	108644004	21111022922	all	all	DB
601953	108644004	21111022923	stages	stage	NN2
601953	108644004	21111022924	of	of	IO
601953	108644004	21111022925	clinical	clinical	JJ
601953	108644004	21111022926	trial	trial	NN1
601953	108644004	21111022927	studies	study	NN2
601953	108644004	21111022928	,	,	,
601953	108644004	21111022929	but	but	CCB
601953	108644004	21111022930	the	the	AT
601953	108644004	21111022931	most	most	RGT
601953	108644004	21111022932	effective	effective	JJ
601953	108644004	21111022933	IRT	irt	NN1
601953	108644004	21111022934	systems	system	NN2
601953	108644004	21111022935	offer	offer	VV0
601953	108644004	21111022936	more	more	RGR_DAR_RRR
601953	108644004	21111022937	advanced	advanced	JJ
601953	108644004	21111022938	functionality	functionality	NN1
601953	108644004	21111022939	and	and	CC
601953	108644004	21111022940	seamless	seamless	JJ
601953	108644004	21111022941	software	software	NN1
601953	108644004	21111022942	integration	integration	NN1
601953	108644004	21111022943	.	.	.
601953	108644004	21111022944	When	when	CS
601953	108644004	21111022945	these	these	DD2
601953	108644004	21111022946	elements	element	NN2
601953	108644004	21111022947	combine	combine	VV0
601953	108644004	21111022948	with	with	IW
601953	108644004	21111022949	innovations	innovation	NN2
601953	108644004	21111022950	in	in	II
601953	108644004	21111022951	user	user	NN1
601953	108644004	21111022952	acceptance	acceptance	NN1
601953	108644004	21111022953	testing	testing	NN1_VVG
601953	108644004	21111022954	(	(	(
601953	108644004	21111022955	UAT		NP1
601953	108644004	21111022956	)	)	)
601953	108644004	21111022957	and	and	CC
601953	108644004	21111022958	standardized	standardized	JJ
601953	108644004	21111022959	delivery	delivery	NN1
601953	108644004	21111022960	integration	integration	NN1
601953	108644004	21111022961	,	,	,
601953	108644004	21111022962	the	the	AT
601953	108644004	21111022963	result	result	NN1
601953	108644004	21111022964	is	be	VBZ
601953	108644004	21111022965	a	a	AT1
601953	108644004	21111022966	next-generation	next-generation	JJ
601953	108644004	21111022967	IRT	irt	NN1
601953	108644004	21111022968	.	.	.
601953	108644004	21111022969	This	this	DD1
601953	108644004	21111022970	must-have	must-have	VH0
601953	108644004	21111022971	technology	technology	NN1
601953	108644004	21111022972	streamlines	streamline	VVZ
601953	108644004	21111022973	automation	automation	NN1
601953	108644004	21111022974	processes	process	NN2_VVZ@
601953	108644004	21111022975	to	to	TO
601953	108644004	21111022976	allow	allow	VVI
601953	108644004	21111022977	for	for	IF
601953	108644004	21111022978	rapid	rapid	JJ
601953	108644004	21111022979	study	study	NN1
601953	108644004	21111022980	deployment	deployment	NN1
601953	108644004	21111022981	that	that	CST_DD1
601953	108644004	21111022982	integrates	integrate	VVZ
601953	108644004	21111022983	standardized	standardized	JJ
601953	108644004	21111022984	delivery	delivery	NN1
601953	108644004	21111022985	requirements	requirement	NN2
601953	108644004	21111022986	,	,	,
601953	108644004	21111022987	supports	support	VVZ
601953	108644004	21111022988	the	the	AT
601953	108644004	21111022989	majority	majority	NN1
601953	108644004	21111022990	of	of	IO
601953	108644004	21111022991	trial	trial	NN1
601953	108644004	21111022992	constructs	construct	NN2
601953	108644004	21111022993	and	and	CC
601953	108644004	21111022994	furthers	further	VVZ
601953	108644004	21111022995	the	the	AT
601953	108644004	21111022996	adoption	adoption	NN1
601953	108644004	21111022997	of	of	IO
601953	108644004	21111022998	digitization	digitization	NN1
601953	108644004	21111022999	in	in	II
601953	108644004	21111023000	the	the	AT
601953	108644004	21111023001	life	life	NN1
601953	108644004	21111023002	science	science	NN1
601953	108644004	21111023003	industry	industry	NN1
601953	108644004	21111023004	.	.	.
601953	108644004	21111023005	<p>		NULL
601953	108644004	21111023006	Today	today	RT
601953	108644004	21111023007	,	,	,
601953	108644004	21111023008	it	it	PPH1
601953	108644004	21111023009	exists	exist	VVZ
601953	108644004	21111023010	in	in	II
601953	108644004	21111023011	the	the	AT
601953	108644004	21111023012	form	form	NN1
601953	108644004	21111023013	of	of	IO
601953	108644004	21111023014	the	the	AT
601953	108644004	21111023015	newly	newly	RR
601953	108644004	21111023016	released	release	VVN_JJ@
601953	108644004	21111023017	Bracket	bracket	NN1
601953	108644004	21111023018	CUBETM		NP1_NN1@
601953	108644004	21111023019	,	,	,
601953	108644004	21111023020	an	a	AT1
601953	108644004	21111023021	IRT	irt	NN1
601953	108644004	21111023022	solution	solution	NN1
601953	108644004	21111023023	that	that	CST_DD1
601953	108644004	21111023024	allows	allow	VVZ
601953	108644004	21111023025	for	for	IF
601953	108644004	21111023026	streamlined	streamlined	JJ
601953	108644004	21111023027	,	,	,
601953	108644004	21111023028	rapid	rapid	JJ
601953	108644004	21111023029	trial	trial	NN1
601953	108644004	21111023030	deployment	deployment	NN1
601953	108644004	21111023031	that	that	CST_DD1
601953	108644004	21111023032	increases	increase	VVZ
601953	108644004	21111023033	the	the	AT
601953	108644004	21111023034	efficiency	efficiency	NN1
601953	108644004	21111023035	of	of	IO
601953	108644004	21111023036	clinical	clinical	JJ
601953	108644004	21111023037	trials	trial	NN2
601953	108644004	21111023038	.	.	.
601953	108644004	21111023039	When	when	CS
601953	108644004	21111023040	selecting	select	VVG
601953	108644004	21111023041	an	a	AT1
601953	108644004	21111023042	IRT	irt	NN1
601953	108644004	21111023043	to	to	TO
601953	108644004	21111023044	manage	manage	VVI
601953	108644004	21111023045	complex	complex	JJ
601953	108644004	21111023046	studies	study	NN2
601953	108644004	21111023047	and	and	CC
601953	108644004	21111023048	connect	connect	VVI
601953	108644004	21111023049	clinical	clinical	JJ
601953	108644004	21111023050	trial	trial	NN1
601953	108644004	21111023051	sites	site	NN2
601953	108644004	21111023052	and	and	CC
601953	108644004	21111023053	supply	supply	VV0_NN1
601953	108644004	21111023054	chains	chain	NN2
601953	108644004	21111023055	,	,	,
601953	108644004	21111023056	consider	consider	VV0
601953	108644004	21111023057	the	the	AT
601953	108644004	21111023058	core	core	NN1
601953	108644004	21111023059	components	component	NN2
601953	108644004	21111023060	and	and	CC
601953	108644004	21111023061	@		II
601953	108644004	21111023062	@		II
601953	108644004	21111023063	@		II
601953	108644004	21111023064	@		II
601953	108644004	21111023065	@		II
601953	108644004	21111023066	@		II
601953	108644004	21111023067	@		II
601953	108644004	21111023068	@		II
601953	108644004	21111023069	@		II
601953	108644004	21111023070	@		II
601953	108644004	21111023071	<p>		NULL
601953	108644004	21111023072	A	a	AT1_ZZ1
601953	108644004	21111023073	feature-rich	feature-rich	JJ
601953	108644004	21111023074	configuration	configuration	NN1
601953	108644004	21111023075	framework	framework	NN1
601953	108644004	21111023076	<p>		NULL
601953	108644004	21111023077	An	a	AT1
601953	108644004	21111023078	advanced	advanced	JJ
601953	108644004	21111023079	IRT	irt	NN1
601953	108644004	21111023080	system	system	NN1
601953	108644004	21111023081	is	be	VBZ
601953	108644004	21111023082	configured	configure	VVN
601953	108644004	21111023083	using	use	VVG
601953	108644004	21111023084	an	a	AT1
601953	108644004	21111023085	iterative	iterative	JJ
601953	108644004	21111023086	UAT		NN1
601953	108644004	21111023087	to	to	TO
601953	108644004	21111023088	lay	lay	VVI
601953	108644004	21111023089	the	the	AT
601953	108644004	21111023090	groundwork	groundwork	NN1
601953	108644004	21111023091	for	for	IF
601953	108644004	21111023092	a	a	AT1
601953	108644004	21111023093	streamlined	streamlined	JJ
601953	108644004	21111023094	deployment	deployment	NN1
601953	108644004	21111023095	process	process	NN1
601953	108644004	21111023096	.	.	.
601953	108644004	21111023097	Its	its	APPGE
601953	108644004	21111023098	capabilities	capability	NN2
601953	108644004	21111023099	allow	allow	VV0
601953	108644004	21111023100	sponsors	sponsor	NN2
601953	108644004	21111023101	to	to	II_TO
601953	108644004	21111023102	effortlessly	effortlessly	RR
601953	108644004	21111023103	leverage	leverage	NN1
601953	108644004	21111023104	RTSM		NP1
601953	108644004	21111023105	benefits	benefit	NN2
601953	108644004	21111023106	without	without	IW
601953	108644004	21111023107	the	the	AT
601953	108644004	21111023108	associated	associated	JJ
601953	108644004	21111023109	constraints	constraint	NN2
601953	108644004	21111023110	of	of	IO
601953	108644004	21111023111	time	time	NNT1
601953	108644004	21111023112	and	and	CC
601953	108644004	21111023113	cost	cost	NN1_VV0
601953	108644004	21111023114	.	.	.
601953	108644004	21111023115	The	the	AT
601953	108644004	21111023116	model	model	NN1
601953	108644004	21111023117	is	be	VBZ
601953	108644004	21111023118	easy	easy	JJ
601953	108644004	21111023119	to	to	TO
601953	108644004	21111023120	implement	implement	VVI
601953	108644004	21111023121	and	and	CC
601953	108644004	21111023122	aims	aim	NN2_VVZ
601953	108644004	21111023123	for	for	IF
601953	108644004	21111023124	increased	increased	JJ
601953	108644004	21111023125	trial	trial	NN1
601953	108644004	21111023126	efficiency	efficiency	NN1
601953	108644004	21111023127	by	by	II
601953	108644004	21111023128	deemphasizing		VVG_JJ@
601953	108644004	21111023129	requirement	requirement	NN1
601953	108644004	21111023130	documentation	documentation	NN1
601953	108644004	21111023131	and	and	CC
601953	108644004	21111023132	instead	instead	RR
601953	108644004	21111023133	prioritizing	prioritize	VVG
601953	108644004	21111023134	unique	unique	JJ
601953	108644004	21111023135	configuration	configuration	NN1
601953	108644004	21111023136	needs	need	VVZ_NN2
601953	108644004	21111023137	to	to	TO
601953	108644004	21111023138	enable	enable	VVI
601953	108644004	21111023139	superior	superior	JJ
601953	108644004	21111023140	statistical	statistical	JJ
601953	108644004	21111023141	outcomes	outcome	NN2
601953	108644004	21111023142	.	.	.
601953	108644004	21111023143	<p>		NULL
601953	108644004	21111023144	Rapid	rapid	JJ_NN1@
601953	108644004	21111023145	and	and	CC
601953	108644004	21111023146	streamlined	streamlined	JJ
601953	108644004	21111023147	study	study	NN1
601953	108644004	21111023148	deployment	deployment	NN1
601953	108644004	21111023149	<p>		NULL
601953	108644004	21111023150	With	with	IW
601953	108644004	21111023151	this	this	DD1
601953	108644004	21111023152	IRT	irt	NN1
601953	108644004	21111023153	solution	solution	NN1
601953	108644004	21111023154	,	,	,
601953	108644004	21111023155	sponsors	sponsor	NN2
601953	108644004	21111023156	can	can	VM
601953	108644004	21111023157	deploy	deploy	VVI
601953	108644004	21111023158	studies	study	NN2
601953	108644004	21111023159	in	in	II
601953	108644004	21111023160	one	one	MC1
601953	108644004	21111023161	to	to	II
601953	108644004	21111023162	two	two	MC
601953	108644004	21111023163	weeks	week	NNT2
601953	108644004	21111023164	through	through	II
601953	108644004	21111023165	a	a	AT1
601953	108644004	21111023166	UAT		NN1
601953	108644004	21111023167	process	process	VV0_NN1
601953	108644004	21111023168	that	that	CST_DD1
601953	108644004	21111023169	let 's		VVZ
601953	108644004	21111023170	a	a	AT1
601953	108644004	21111023171	study	study	NN1
601953	108644004	21111023172	team	team	VVI
601953	108644004	21111023173	fully	fully	RR
601953	108644004	21111023174	visualize	visualize	VV0
601953	108644004	21111023175	the	the	AT
601953	108644004	21111023176	RTSM		NP1
601953	108644004	21111023177	system	system	NN1
601953	108644004	21111023178	.	.	.
601953	108644004	21111023179	This	this	DD1
601953	108644004	21111023180	accelerates	accelerate	VVZ
601953	108644004	21111023181	timelines	timeline	NN2
601953	108644004	21111023182	and	and	CC
601953	108644004	21111023183	improves	improve	VVZ
601953	108644004	21111023184	efficiency	efficiency	NN1
601953	108644004	21111023185	for	for	IF
601953	108644004	21111023186	all	all	DB
601953	108644004	21111023187	those	those	DD2
601953	108644004	21111023188	involved	involve	VVN_VVD
601953	108644004	21111023189	,	,	,
601953	108644004	21111023190	eliminating	eliminate	VVG
601953	108644004	21111023191	the	the	AT
601953	108644004	21111023192	need	need	NN1
601953	108644004	21111023193	for	for	IF
601953	108644004	21111023194	pre-approved	pre-approved	JJ_NN1
601953	108644004	21111023195	system	system	NN1
601953	108644004	21111023196	requirement	requirement	NN1
601953	108644004	21111023197	documentation	documentation	NN1
601953	108644004	21111023198	.	.	.
601953	108644004	21111023199	An	a	AT1
601953	108644004	21111023200	advanced	advanced	JJ
601953	108644004	21111023201	IRT	irt	NN1_NP1
601953	108644004	21111023202	supports	support	VVZ
601953	108644004	21111023203	most	most	DAT
601953	108644004	21111023204	trial	trial	NN1
601953	108644004	21111023205	design	design	NN1
601953	108644004	21111023206	constructs	construct	NN2
601953	108644004	21111023207	and	and	CC
601953	108644004	21111023208	focuses	focus	VVZ
601953	108644004	21111023209	on	on	II_RP@
601953	108644004	21111023210	a	a	AT1
601953	108644004	21111023211	quick	quick	JJ
601953	108644004	21111023212	,	,	,
601953	108644004	21111023213	user-accepted		JJ_NN1
601953	108644004	21111023214	solution	solution	NN1
601953	108644004	21111023215	.	.	.
601953	108644004	21111023216	<p>		NULL
601953	108644004	21111023217	Collaborative	collaborative	JJ
601953	108644004	21111023218	user-centric		JJ
601953	108644004	21111023219	configuration	configuration	NN1
601953	108644004	21111023220	<p>		NULL
601953	108644004	21111023221	A	a	AT1
601953	108644004	21111023222	user	user	NN1
601953	108644004	21111023223	acceptance	acceptance	NN1
601953	108644004	21111023224	build	build	VV0_NN1@
601953	108644004	21111023225	experience	experience	NN1_VV0
601953	108644004	21111023226	that	that	CST_DD1
601953	108644004	21111023227	welcomes	welcome	VVZ
601953	108644004	21111023228	engagement	engagement	NN1
601953	108644004	21111023229	sets	set	VVZ
601953	108644004	21111023230	the	the	AT
601953	108644004	21111023231	new	new	JJ
601953	108644004	21111023232	standard	standard	NN1_JJ
601953	108644004	21111023233	for	for	IF
601953	108644004	21111023234	the	the	AT
601953	108644004	21111023235	way	way	NN1
601953	108644004	21111023236	sponsors	sponsor	NN2
601953	108644004	21111023237	collaborate	collaborate	VV0
601953	108644004	21111023238	to	to	TO
601953	108644004	21111023239	deploy	deploy	VVI
601953	108644004	21111023240	IRT	irt	NN1_NP1
601953	108644004	21111023241	.	.	.
601953	108644004	21111023242	With	with	IW
601953	108644004	21111023243	a	a	AT1
601953	108644004	21111023244	rapid	rapid	JJ
601953	108644004	21111023245	project	project	NN1
601953	108644004	21111023246	lifecycle	life-cycle	NN1
601953	108644004	21111023247	,	,	,
601953	108644004	21111023248	this	this	DD1
601953	108644004	21111023249	IRT	irt	NN1
601953	108644004	21111023250	let 's		VVZ
601953	108644004	21111023251	sponsors	sponsor	NN2
601953	108644004	21111023252	experience	experience	VVI
601953	108644004	21111023253	the	the	AT
601953	108644004	21111023254	system	system	NN1
601953	108644004	21111023255	prior	prior	II21
601953	108644004	21111023256	to	to	II22
601953	108644004	21111023257	requirements	requirement	NN2
601953	108644004	21111023258	approval	approval	NN1
601953	108644004	21111023259	.	.	.
601953	108644004	21111023260	Its	its	APPGE
601953	108644004	21111023261	@		II
601953	108644004	21111023262	@		II
601953	108644004	21111023263	@		II
601953	108644004	21111023264	@		II
601953	108644004	21111023265	@		II
601953	108644004	21111023266	@		II
601953	108644004	21111023267	@		II
601953	108644004	21111023268	@		II
601953	108644004	21111023269	@		II
601953	108644004	21111023270	@		II
601953	108644004	21111023271	an	a	AT1
601953	108644004	21111023272	easy	easy	JJ
601953	108644004	21111023273	to	to	TO
601953	108644004	21111023274	use	use	VVI
601953	108644004	21111023275	,	,	,
601953	108644004	21111023276	productive	productive	JJ
601953	108644004	21111023277	tool	tool	NN1
601953	108644004	21111023278	for	for	IF
601953	108644004	21111023279	clinical	clinical	JJ
601953	108644004	21111023280	trial	trial	NN1
601953	108644004	21111023281	management	management	NN1
601953	108644004	21111023282	.	.	.
601953	108644004	21111023283	<p>		NULL
601953	108644004	21111023284	Bracket	bracket	NN1
601953	108644004	21111023285	has	have	VHZ
601953	108644004	21111023286	recently	recently	RR
601953	108644004	21111023287	introduced	introduce	VVN
601953	108644004	21111023288	CUBE	cube	NN1
601953	108644004	21111023289	,	,	,
601953	108644004	21111023290	a	a	AT1
601953	108644004	21111023291	transformative	transformative	JJ
601953	108644004	21111023292	next-generation	next-generation	JJ
601953	108644004	21111023293	IRT	irt	NN1
601953	108644004	21111023294	solution	solution	NN1
601953	108644004	21111023295	for	for	IF
601953	108644004	21111023296	the	the	AT
601953	108644004	21111023297	life	life	NN1
601953	108644004	21111023298	science	science	NN1
601953	108644004	21111023299	industry	industry	NN1
601953	108644004	21111023300	,	,	,
601953	108644004	21111023301	to	to	II
601953	108644004	21111023302	its	its	APPGE
601953	108644004	21111023303	suite	suite	NN1
601953	108644004	21111023304	of	of	IO
601953	108644004	21111023305	configurable	configurable	JJ
601953	108644004	21111023306	clinical	clinical	JJ
601953	108644004	21111023307	research	research	NN1
601953	108644004	21111023308	solutions	solution	NN2
601953	108644004	21111023309	.	.	.
601953	108644004	21111023310	This	this	DD1
601953	108644004	21111023311	new	new	JJ
601953	108644004	21111023312	product	product	NN1
601953	108644004	21111023313	leverages	leverage	NN2
601953	108644004	21111023314	an	a	AT1
601953	108644004	21111023315	iterative	iterative	JJ
601953	108644004	21111023316	user	user	NN1
601953	108644004	21111023317	acceptance	acceptance	NN1
601953	108644004	21111023318	build	build	VV0_NN1@
601953	108644004	21111023319	experience	experience	NN1
601953	108644004	21111023320	and	and	CC
601953	108644004	21111023321	Bracket	bracket	NN1
601953	108644004	21111023322	's	's	GE_VBZ
601953	108644004	21111023323	full	full	JJ
601953	108644004	21111023324	RTSM		NP1
601953	108644004	21111023325	platform	platform	NN1
601953	108644004	21111023326	to	to	TO
601953	108644004	21111023327	streamline	streamline	VVI
601953	108644004	21111023328	and	and	CC
601953	108644004	21111023329	accelerate	accelerate	VVI
601953	108644004	21111023330	study	study	NN1
601953	108644004	21111023331	deployments	deployment	NN2
601953	108644004	21111023332	.	.	.
601953	108644004	21111023333	Possessing	possess	VVG
601953	108644004	21111023334	all	all	DB
601953	108644004	21111023335	the	the	AT
601953	108644004	21111023336	above	above	JJ@
601953	108644004	21111023337	qualities	quality	NN2
601953	108644004	21111023338	of	of	IO
601953	108644004	21111023339	a	a	AT1
601953	108644004	21111023340	modern	modern	JJ
601953	108644004	21111023341	IRT	irt	NN1
601953	108644004	21111023342	system	system	NN1
601953	108644004	21111023343	,	,	,
601953	108644004	21111023344	CUBE	cube	NN1
601953	108644004	21111023345	is	be	VBZ
601953	108644004	21111023346	an	a	AT1
601953	108644004	21111023347	advanced	advanced	JJ
601953	108644004	21111023348	implementation	implementation	NN1
601953	108644004	21111023349	model	model	NN1
601953	108644004	21111023350	that	that	CST_DD1
601953	108644004	21111023351	balances	balance	VVZ_NN2
601953	108644004	21111023352	cost	cost	NN1_VV0
601953	108644004	21111023353	and	and	CC
601953	108644004	21111023354	value	value	NN1
601953	108644004	21111023355	creation	creation	NN1
601953	108644004	21111023356	for	for	IF
601953	108644004	21111023357	biotech	biotech	NN1
601953	108644004	21111023358	and	and	CC
601953	108644004	21111023359	pharma	pharma	NN1
601953	108644004	21111023360	sponsors	sponsor	NN2
601953	108644004	21111023361	.	.	.
601953	108644004	21111023362	<p>		NULL
601953	108644004	21111023363	For	for	IF
601953	108644004	21111023364	more	more	DAR
601953	108644004	21111023365	information	information	NN1
601953	108644004	21111023366	on	on	II
601953	108644004	21111023367	interactive	interactive	JJ
601953	108644004	21111023368	response	response	NN1
601953	108644004	21111023369	technology	technology	NN1
601953	108644004	21111023370	and	and	CC
601953	108644004	21111023371	Bracket	bracket	NN1_VV0@
601953	108644004	21111023372	CUBE	cube	NN1
601953	108644004	21111023373	,	,	,
601953	108644004	21111023374	click	click	VV0
601953	108644004	21111023375	here	here	RL
601953	108644004	21111023376	.	.	.
601953	108644007	21111023396	@@##	----------	----------
601953	108644007	21111023397	@@108644007		FO
601953	108644007	21111023398	@4044007/		VV0_JJ
601953	108644007	21111023399	<h>		NULL
601953	108644007	21111023400	Upcoming	upcoming	JJ
601953	108644007	21111023401	Bracket	bracket	NN1
601953	108644007	21111023402	and	and	CC
601953	108644007	21111023403	Eisai		NP1
601953	108644007	21111023404	AD	ad	RA
601953	108644007	21111023405	Webinar		NP1
601953	108644007	21111023406	:	:	:
601953	108644007	21111023407	December	december	NPM1
601953	108644007	21111023408	11th	11th	MD
601953	108644007	21111023409	at	at	II
601953	108644007	21111023410	11am	11am	RA
601953	108644007	21111023411	est	est	JJ
601953	108644007	21111023412	<p>		NULL
601953	108644007	21111023413	November	november	NPM1
601953	108644007	21111023414	20	20	MC
601953	108644007	21111023415	,	,	,
601953	108644007	21111023416	2014	2014	MC
601953	108644007	21111023417	<p>		NULL
601953	108644007	21111023418	Join	join	VV0
601953	108644007	21111023419	esteemed	esteemed	JJ@
601953	108644007	21111023420	speakers	speaker	NN2
601953	108644007	21111023421	Dr.		NNB
601953	108644007	21111023422	Veronika	veronika	NP1
601953	108644007	21111023423	Logovinsky		NP1
601953	108644007	21111023424	,	,	,
601953	108644007	21111023425	Executive	executive	NN1_JJ@
601953	108644007	21111023426	Director	director	NN1
601953	108644007	21111023427	at	at	II
601953	108644007	21111023428	Eisai		JJ_NP1
601953	108644007	21111023429	Inc.		JJ
601953	108644007	21111023430	,	,	,
601953	108644007	21111023431	Neuroscience	neuroscience	NP1
601953	108644007	21111023432	&amp;		CC
601953	108644007	21111023433	General	general	JJ_NN1
601953	108644007	21111023434	Medicine	medicine	NN1
601953	108644007	21111023435	,	,	,
601953	108644007	21111023436	and	and	CC
601953	108644007	21111023437	Dr.		NNB
601953	108644007	21111023438	David	david	NP1
601953	108644007	21111023439	Miller	miller	NP1
601953	108644007	21111023440	,	,	,
601953	108644007	21111023441	Clinical	clinical	JJ
601953	108644007	21111023442	Vice	vice	JJ_NN1
601953	108644007	21111023443	President	president	NN1
601953	108644007	21111023444	at	at	II
601953	108644007	21111023445	Bracket	bracket	NN1
601953	108644007	21111023446	,	,	,
601953	108644007	21111023447	as	as	CSA
601953	108644007	21111023448	they	they	PPHS2
601953	108644007	21111023449	present	present	VV0@
601953	108644007	21111023450	their	their	APPGE
601953	108644007	21111023451	upcoming	upcoming	JJ
601953	108644007	21111023452	webinar	webinar	NN1
601953	108644007	21111023453	on	on	II
601953	108644007	21111023454	the	the	AT
601953	108644007	21111023455	challenge	challenge	NN1
601953	108644007	21111023456	of	of	IO
601953	108644007	21111023457	and	and	CC
601953	108644007	21111023458	need	need	VV0_NN1
601953	108644007	21111023459	for	for	IF
601953	108644007	21111023460	developing	develop	VVG
601953	108644007	21111023461	more	more	RGR
601953	108644007	21111023462	sensitive	sensitive	JJ
601953	108644007	21111023463	clinical	clinical	JJ
601953	108644007	21111023464	outcomes	outcome	NN2
601953	108644007	21111023465	in	in	II
601953	108644007	21111023466	Alzheimers	alzheimers	NP1
601953	108644007	21111023467	disease	disease	NN1
601953	108644007	21111023468	(	(	(
601953	108644007	21111023469	AD	ad	RA
601953	108644007	21111023470	)	)	)
601953	108644007	21111023471	clinical	clinical	JJ
601953	108644007	21111023472	trials	trial	NN2
601953	108644007	21111023473	,	,	,
601953	108644007	21111023474	and	and	CC
601953	108644007	21111023475	ensuring	ensure	VVG
601953	108644007	21111023476	that	that	CST
601953	108644007	21111023477	these	these	DD2
601953	108644007	21111023478	clinical	clinical	JJ
601953	108644007	21111023479	outcomes	outcome	NN2
601953	108644007	21111023480	are	be	VBR
601953	108644007	21111023481	administered	administer	VVN
601953	108644007	21111023482	and	and	CC
601953	108644007	21111023483	scored	score	VVN
601953	108644007	21111023484	properly	properly	RR
601953	108644007	21111023485	.	.	.
601953	108644007	21111023486	The	the	AT
601953	108644007	21111023487	development	development	NN1
601953	108644007	21111023488	of	of	IO
601953	108644007	21111023489	one	one	MC1
601953	108644007	21111023490	such	such	DA
601953	108644007	21111023491	composite	composite	NN1@_JJ
601953	108644007	21111023492	will	will	VM
601953	108644007	21111023493	be	be	VBI
601953	108644007	21111023494	discussed	discuss	VVN
601953	108644007	21111023495	.	.	.
601953	108644007	21111023496	Additionally	additionally	RR
601953	108644007	21111023497	,	,	,
601953	108644007	21111023498	real-world	real-world	JJ_NN1
601953	108644007	21111023499	examples	example	NN2
601953	108644007	21111023500	from	from	II
601953	108644007	21111023501	recent	recent	JJ
601953	108644007	21111023502	and	and	CC
601953	108644007	21111023503	on-going	ongoing	JJ
601953	108644007	21111023504	AD	ad	RA_NN1%
601953	108644007	21111023505	clinical	clinical	JJ
601953	108644007	21111023506	trials	trial	NN2
601953	108644007	21111023507	,	,	,
601953	108644007	21111023508	where	where	RRQ_CS
601953	108644007	21111023509	data	data	NN
601953	108644007	21111023510	quality	quality	NN1
601953	108644007	21111023511	programs	program	NN2
601953	108644007	21111023512	were	be	VBDR
601953	108644007	21111023513	employed	employ	VVN
601953	108644007	21111023514	,	,	,
601953	108644007	21111023515	will	will	VM
601953	108644007	21111023516	be	be	VBI
601953	108644007	21111023517	presented	present	VVN
601953	108644007	21111023518	.	.	.
601953	108644010	21111023538	@@##	----------	----------
601953	108644010	21111023539	@@108644010		FO
601953	108644010	21111023540	@4044010/		VV0
601953	108644010	21111023541	<h>		NULL
601953	108644010	21111023542	Most	most	RGT_DAT
601953	108644010	21111023543	Successful	successful	JJ
601953	108644010	21111023544	BikeMS		NN2
601953	108644010	21111023545	in	in	II
601953	108644010	21111023546	33	33	MC
601953	108644010	21111023547	Years	year	NNT2
601953	108644010	21111023548	<p>		NULL
601953	108644010	21111023549	October	october	NPM1
601953	108644010	21111023550	18	18	MC
601953	108644010	21111023551	,	,	,
601953	108644010	21111023552	2013	2013	MC
601953	108644010	21111023553	<h>		NULL
601953	108644010	21111023554	By	by	II
601953	108644010	21111023555	Matt	matt	NP1
601953	108644010	21111023556	Ryan	ryan	NP1
601953	108644010	21111023557	,	,	,
601953	108644010	21111023558	Associate	associate	JJ_VV0
601953	108644010	21111023559	Project	project	NN1
601953	108644010	21111023560	Manager	manager	NN1
601953	108644010	21111023561	<p>		NULL
601953	108644010	21111023562	Bracket	bracket	NN1_VV0@
601953	108644010	21111023563	employees	employee	NN2
601953	108644010	21111023564	joined	join	VVN_VVD
601953	108644010	21111023565	together	together	RL
601953	108644010	21111023566	to	to	TO
601953	108644010	21111023567	raise	raise	VVI
601953	108644010	21111023568	money	money	NN1
601953	108644010	21111023569	for	for	IF
601953	108644010	21111023570	Multiple	multiple	JJ_NN1
601953	108644010	21111023571	Sclerosis	sclerosis	NN1
601953	108644010	21111023572	while	while	CS
601953	108644010	21111023573	challenging	challenge	VVG
601953	108644010	21111023574	themselves	themselves	PPX2
601953	108644010	21111023575	physically	physically	RR
601953	108644010	21111023576	in	in	II
601953	108644010	21111023577	a	a	AT1
601953	108644010	21111023578	75	75	MC
601953	108644010	21111023579	or	or	CC
601953	108644010	21111023580	100	100	MC
601953	108644010	21111023581	mile	mile	NNU1
601953	108644010	21111023582	bike	bike	NN1
601953	108644010	21111023583	ride	ride	NN1_VV0
601953	108644010	21111023584	on	on	II
601953	108644010	21111023585	September	september	NPM1
601953	108644010	21111023586	28th	28th	MD
601953	108644010	21111023587	for	for	IF
601953	108644010	21111023588	the	the	AT
601953	108644010	21111023589	2013	2013	MC
601953	108644010	21111023590	BikeMS		NN2_NP1_VVZ
601953	108644010	21111023591	:	:	:
601953	108644010	21111023592	City	city	NN1
601953	108644010	21111023593	to	to	II
601953	108644010	21111023594	Shore	shore	NP1
601953	108644010	21111023595	Ride	ride	NN1_VV0
601953	108644010	21111023596	.	.	.
601953	108644010	21111023597	This	this	DD1
601953	108644010	21111023598	marks	mark	VVZ
601953	108644010	21111023599	the	the	AT
601953	108644010	21111023600	3rd	3rd	MD
601953	108644010	21111023601	year	year	NNT1
601953	108644010	21111023602	Team	team	NN1
601953	108644010	21111023603	Bracket	bracket	NN1
601953	108644010	21111023604	has	have	VHZ
601953	108644010	21111023605	competed	compete	VVN
601953	108644010	21111023606	in	in	II
601953	108644010	21111023607	the	the	AT
601953	108644010	21111023608	bike	bike	NN1
601953	108644010	21111023609	ride	ride	NN1_VV0
601953	108644010	21111023610	from	from	II
601953	108644010	21111023611	Philadelphia	philadelphia	NP1
601953	108644010	21111023612	to	to	II
601953	108644010	21111023613	Ocean	ocean	NN1
601953	108644010	21111023614	City	city	NN1
601953	108644010	21111023615	,	,	,
601953	108644010	21111023616	NJ	nj	NP1
601953	108644010	21111023617	.	.	.
601953	108644010	21111023618	I	i	PPIS1
601953	108644010	21111023619	've	have	VH0
601953	108644010	21111023620	organized	organize	VVN
601953	108644010	21111023621	this	this	DD1
601953	108644010	21111023622	team	team	NN1
601953	108644010	21111023623	for	for	IF
601953	108644010	21111023624	the	the	AT
601953	108644010	21111023625	past	past	JJ
601953	108644010	21111023626	3	3	MC
601953	108644010	21111023627	years	year	NNT2
601953	108644010	21111023628	and	and	CC
601953	108644010	21111023629	although	although	CS
601953	108644010	21111023630	the	the	AT
601953	108644010	21111023631	team	team	NN1
601953	108644010	21111023632	changes	change	VVZ@_NN2
601953	108644010	21111023633	a	a	AT1
601953	108644010	21111023634	little	little	JJ
601953	108644010	21111023635	bit	bit	NN1
601953	108644010	21111023636	each	each	DD1
601953	108644010	21111023637	year	year	NNT1
601953	108644010	21111023638	,	,	,
601953	108644010	21111023639	it	it	PPH1
601953	108644010	21111023640	always	always	RR
601953	108644010	21111023641	results	result	VVZ@_NN2
601953	108644010	21111023642	in	in	II
601953	108644010	21111023643	a	a	AT1
601953	108644010	21111023644	great	great	JJ
601953	108644010	21111023645	team	team	NN1
601953	108644010	21111023646	bonding	bonding	NN1
601953	108644010	21111023647	event	event	NN1
601953	108644010	21111023648	.	.	.
601953	108644010	21111023649	<p>		NULL
601953	108644010	21111023650	Team	team	NN1_VV0@
601953	108644010	21111023651	Bracket	bracket	NN1
601953	108644010	21111023652	raised	raise	VVD_VVN
601953	108644010	21111023653	over	over	RG
601953	108644010	21111023654	$3,000		NNU
601953	108644010	21111023655	to	to	TO
601953	108644010	21111023656	support	support	VVI
601953	108644010	21111023657	research	research	NN1
601953	108644010	21111023658	for	for	IF
601953	108644010	21111023659	MS	ms	NN1
601953	108644010	21111023660	.	.	.
601953	108644010	21111023661	Overall	overall	RR_NN1
601953	108644010	21111023662	,	,	,
601953	108644010	21111023663	the	the	AT
601953	108644010	21111023664	2013	2013	MC
601953	108644010	21111023665	BikeMS		NN2_NP1_VVZ
601953	108644010	21111023666	:	:	:
601953	108644010	21111023667	City	city	NN1
601953	108644010	21111023668	to	to	II
601953	108644010	21111023669	Shore	shore	NP1
601953	108644010	21111023670	Ride	ride	NN1
601953	108644010	21111023671	reached	reach	VVD_VVN
601953	108644010	21111023672	their	their	APPGE
601953	108644010	21111023673	goal	goal	NN1
601953	108644010	21111023674	of	of	IO
601953	108644010	21111023675	$5.6		NNU
601953	108644010	21111023676	million	million	NNO
601953	108644010	21111023677	;	;	;
601953	108644010	21111023678	the	the	AT
601953	108644010	21111023679	most	most	RGT
601953	108644010	21111023680	successful	successful	JJ
601953	108644010	21111023681	in	in	II
601953	108644010	21111023682	its	its	APPGE
601953	108644010	21111023683	33	33	MC
601953	108644010	21111023684	year	year	NNT1
601953	108644010	21111023685	history	history	NN1
601953	108644010	21111023686	.	.	.
601953	108644010	21111023687	The	the	AT
601953	108644010	21111023688	event	event	NN1
601953	108644010	21111023689	welcomes	welcome	VVZ
601953	108644010	21111023690	cyclists	cyclist	NN2
601953	108644010	21111023691	of	of	IO
601953	108644010	21111023692	all	all	DB
601953	108644010	21111023693	ages	age	NN2
601953	108644010	21111023694	and	and	CC
601953	108644010	21111023695	cycling	cycle	VVG_NN1
601953	108644010	21111023696	abilities	ability	NN2
601953	108644010	21111023697	.	.	.
601953	108644010	21111023698	It	it	PPH1
601953	108644010	21111023699	is	be	VBZ
601953	108644010	21111023700	an	a	AT1
601953	108644010	21111023701	amazing	amazing	JJ
601953	108644010	21111023702	feeling	feeling	NN1
601953	108644010	21111023703	to	to	TO
601953	108644010	21111023704	cross	cross	VVI
601953	108644010	21111023705	the	the	AT
601953	108644010	21111023706	finish	finish	NN1
601953	108644010	21111023707	line	line	NN1
601953	108644010	21111023708	,	,	,
601953	108644010	21111023709	but	but	CCB
601953	108644010	21111023710	even	even	RR
601953	108644010	21111023711	more	more	RGR
601953	108644010	21111023712	rewarding	rewarding	JJ
601953	108644010	21111023713	to	to	TO
601953	108644010	21111023714	know	know	VVI
601953	108644010	21111023715	you	you	PPY
601953	108644010	21111023716	are	be	VBR
601953	108644010	21111023717	helping	help	VVG
601953	108644010	21111023718	those	those	DD2
601953	108644010	21111023719	affected	affect	VVN
601953	108644010	21111023720	by	by	II
601953	108644010	21111023721	MS.		NN1
601953	108644013	21111023741	@@##	----------	----------
601953	108644013	21111023742	@@108644013		FO
601953	108644013	21111023743	@4044013/		VV0_NN1_JJ
601953	108644013	21111023744	<h>		NULL
601953	108644013	21111023745	Outsourcing	outsource	VVG_NP1
601953	108644013	21111023746	in	in	II
601953	108644013	21111023747	Clinical	clinical	JJ
601953	108644013	21111023748	Trials	trial	NN2
601953	108644013	21111023749	"	"	"
601953	108644013	21111023750	Southern	southern	JJ
601953	108644013	21111023751	California	california	NP1
601953	108644013	21111023752	<p>		NULL
601953	108644013	21111023753	September	september	NPM1
601953	108644013	21111023754	25	25	MC
601953	108644013	21111023755	,	,	,
601953	108644013	21111023756	2013	2013	MC
601953	108644013	21111023757	157706		MC
601953	108644013	21111023758	@qwx1017706		FO
601953	108644013	21111023759	<p>		NULL
601953	108644013	21111023760	The-	the--	NN1_JJ
601953	108644013	21111023761	Outsourcing		VVG_NN1@_NP1
601953	108644013	21111023762	in	in	II
601953	108644013	21111023763	Clinical	clinical	JJ
601953	108644013	21111023764	Trials	trial	NN2
601953	108644013	21111023765	Southern	southern	JJ
601953	108644013	21111023766	California-		JJ_NN1
601953	108644013	21111023767	conference	conference	NN1
601953	108644013	21111023768	in	in	II
601953	108644013	21111023769	La	la	NP1
601953	108644013	21111023770	Jolla	jolla	NP1
601953	108644013	21111023771	wrapped	wrap	VVD
601953	108644013	21111023772	up	up	RP
601953	108644013	21111023773	today	today	RT
601953	108644013	21111023774	.	.	.
601953	108644013	21111023775	The	the	AT
601953	108644013	21111023776	conference	conference	NN1
601953	108644013	21111023777	began	begin	VVD
601953	108644013	21111023778	on	on	II
601953	108644013	21111023779	Tuesday	tuesday	NPD1
601953	108644013	21111023780	,	,	,
601953	108644013	21111023781	September	september	NPM1
601953	108644013	21111023782	25	25	MC
601953	108644013	21111023783	,	,	,
601953	108644013	21111023784	with	with	IW
601953	108644013	21111023785	opening	opening	NN1_VVG_JJ@
601953	108644013	21111023786	remarks	remark	VVZ_NN2
601953	108644013	21111023787	from	from	II
601953	108644013	21111023788	Sarah	sarah	NP1
601953	108644013	21111023789	Carter	carter	NP1
601953	108644013	21111023790	,	,	,
601953	108644013	21111023791	Executive	executive	NN1_JJ@
601953	108644013	21111023792	Director	director	NN1
601953	108644013	21111023793	,	,	,
601953	108644013	21111023794	Planning	plan	VVG_NN1
601953	108644013	21111023795	&amp;		CC
601953	108644013	21111023796	Platform	platform	NN1
601953	108644013	21111023797	Services	service	NN2
601953	108644013	21111023798	,	,	,
601953	108644013	21111023799	Amgen	amgen	NP1_NN1
601953	108644013	21111023800	.	.	.
601953	108644013	21111023801	A	a	AT1
601953	108644013	21111023802	few	few	DA2
601953	108644013	21111023803	of	of	IO
601953	108644013	21111023804	the	the	AT
601953	108644013	21111023805	session	session	NNT1
601953	108644013	21111023806	topics	topic	NN2
601953	108644013	21111023807	included	include	VVD_VVN
601953	108644013	21111023808	:	:	:
601953	108644013	21111023809	achieving	achieve	VVG
601953	108644013	21111023810	successful	successful	JJ
601953	108644013	21111023811	CRO/sponsor		NN1
601953	108644013	21111023812	collaboration	collaboration	NN1
601953	108644013	21111023813	;	;	;
601953	108644013	21111023814	investigating	investigate	VVG
601953	108644013	21111023815	different	different	JJ
601953	108644013	21111023816	outsourcing	outsourcing	JJ@_NN1@
601953	108644013	21111023817	models	model	NN2
601953	108644013	21111023818	for	for	IF
601953	108644013	21111023819	different	different	JJ
601953	108644013	21111023820	types	type	NN2
601953	108644013	21111023821	of	of	IO
601953	108644013	21111023822	companies	company	NN2
601953	108644013	21111023823	;	;	;
601953	108644013	21111023824	and	and	CC
601953	108644013	21111023825	generating	generating	JJ_VVG
601953	108644013	21111023826	strategies	strategy	NN2
601953	108644013	21111023827	for	for	IF
601953	108644013	21111023828	dealing	deal	VVG
601953	108644013	21111023829	with	with	IW
601953	108644013	21111023830	a	a	AT1
601953	108644013	21111023831	merger	merger	NN1
601953	108644013	21111023832	or	or	CC
601953	108644013	21111023833	acquisition	acquisition	NN1
601953	108644013	21111023834	so	so	RR
601953	108644013	21111023835	as	as	CSA
601953	108644013	21111023836	not	not	XX
601953	108644013	21111023837	to	to	TO
601953	108644013	21111023838	disrupt	disrupt	VVI
601953	108644013	21111023839	ongoing	ongoing	JJ
601953	108644013	21111023840	clinical	clinical	JJ
601953	108644013	21111023841	trials	trial	NN2
601953	108644013	21111023842	.	.	.
601953	108644013	21111023843	<p>		NULL
601953	108644013	21111023844	Day	day	NNT1_NP1@
601953	108644013	21111023845	2	2	MC
601953	108644013	21111023846	offered	offer	VVD_VVN
601953	108644013	21111023847	several	several	DA2
601953	108644013	21111023848	more	more	DAR
601953	108644013	21111023849	informative	informative	JJ
601953	108644013	21111023850	sessions	session	NNT2
601953	108644013	21111023851	and	and	CC
601953	108644013	21111023852	ended	end	VVN_VVD
601953	108644013	21111023853	with	with	IW
601953	108644013	21111023854	a	a	AT1
601953	108644013	21111023855	speaker	speaker	NN1
601953	108644013	21111023856	hosted	host	VVD_VVN
601953	108644013	21111023857	roundtable	roundtable	JJ
601953	108644013	21111023858	enabling	enabling	JJ@_VVG
601953	108644013	21111023859	attendees	attendee	NN2
601953	108644013	21111023860	to	to	TO
601953	108644013	21111023861	share	share	VVI
601953	108644013	21111023862	insight	insight	NN1
601953	108644013	21111023863	and	and	CC
601953	108644013	21111023864	solutions	solution	NN2
601953	108644013	21111023865	to	to	II
601953	108644013	21111023866	critical	critical	JJ
601953	108644013	21111023867	challenges	challenge	NN2
601953	108644013	21111023868	facing	face	VVG
601953	108644013	21111023869	the	the	AT
601953	108644013	21111023870	industry	industry	NN1
601953	108644013	21111023871	.	.	.
601953	108644013	21111023872	<p>		NULL
601953	108644013	21111023873	We	we	PPIS2
601953	108644013	21111023874	are	be	VBR
601953	108644013	21111023875	looking	look	VVG
601953	108644013	21111023876	forward	forward	RL
601953	108644013	21111023877	to	to	II
601953	108644013	21111023878	another	another	DD1
601953	108644013	21111023879	round	round	NN1
601953	108644013	21111023880	of	of	IO
601953	108644013	21111023881	insightful	insightful	JJ
601953	108644013	21111023882	conversation	conversation	NN1
601953	108644013	21111023883	at	at	II
601953	108644013	21111023884	next	next	MD
601953	108644013	21111023885	week	week	NNT1
601953	108644013	21111023886	's	be	VBZ_GE
601953	108644013	21111023887	Outsourcing		VVG_NN1@_NP1
601953	108644013	21111023888	in	in	II
601953	108644013	21111023889	Clinical	clinical	JJ
601953	108644013	21111023890	Trials	trial	NN2
601953	108644013	21111023891	conference	conference	NN1
601953	108644013	21111023892	in	in	II
601953	108644013	21111023893	Boston	boston	NP1
601953	108644013	21111023894	.	.	.
601953	108644013	21111023895	Visit	visit	VV0
601953	108644013	21111023896	us	us	PPIO2
601953	108644013	21111023897	at	at	II
601953	108644013	21111023898	booth	booth	NN1
601953	108644013	21111023899	40.		MC
601953	108644014	21111023919	@@##	----------	----------
601953	108644014	21111023920	@@108644014		FO
601953	108644014	21111023921	@4044014/		JJ_NN1_VV0
601953	108644014	21111023922	<h>		NULL
601953	108644014	21111023923	Tech	tech	NN1
601953	108644014	21111023924	Tools	tool	NN2
601953	108644014	21111023925	To	to	II_TO
601953	108644014	21111023926	Help	help	NN1_VV0
601953	108644014	21111023927	You	you	PPY
601953	108644014	21111023928	Survive	survive	VV0
601953	108644014	21111023929	Conference	conference	NN1
601953	108644014	21111023930	Season	season	NNT1
601953	108644014	21111023931	<p>		NULL
601953	108644014	21111023932	June	june	NPM1
601953	108644014	21111023933	14	14	MC
601953	108644014	21111023934	,	,	,
601953	108644014	21111023935	2013	2013	MC
601953	108644014	21111023936	<h>		NULL
601953	108644014	21111023937	By	by	II
601953	108644014	21111023938	Jen	jen	NP1
601953	108644014	21111023939	Burstedt		NP1
601953	108644014	21111023940	,	,	,
601953	108644014	21111023941	Marketing	marketing	NN1_VVG@
601953	108644014	21111023942	&amp;		CC
601953	108644014	21111023943	Communications	communication	NN2
601953	108644014	21111023944	<p>		NULL
601953	108644014	21111023945	Were	be	VBDR
601953	108644014	21111023946	in	in	II
601953	108644014	21111023947	the	the	AT
601953	108644014	21111023948	midst	midst	NN1
601953	108644014	21111023949	of	of	IO
601953	108644014	21111023950	conference	conference	NN1
601953	108644014	21111023951	season	season	NNT1
601953	108644014	21111023952	for	for	IF
601953	108644014	21111023953	many	many	DA2
601953	108644014	21111023954	of	of	IO
601953	108644014	21111023955	us	us	PPIO2
601953	108644014	21111023956	,	,	,
601953	108644014	21111023957	mid	mid	JJ
601953	108644014	21111023958	June	june	NPM1_NP1@
601953	108644014	21111023959	through	through	II
601953	108644014	21111023960	late	late	JJ
601953	108644014	21111023961	August	august	NPM1
601953	108644014	21111023962	is	be	VBZ
601953	108644014	21111023963	the	the	AT
601953	108644014	21111023964	summer	summer	NNT1
601953	108644014	21111023965	vacation	vacation	NN1
601953	108644014	21111023966	that	that	CST
601953	108644014	21111023967	we	we	PPIS2
601953	108644014	21111023968	,	,	,
601953	108644014	21111023969	as	as	CSA
601953	108644014	21111023970	adults	adult	NN2
601953	108644014	21111023971	,	,	,
601953	108644014	21111023972	finally	finally	RR
601953	108644014	21111023973	get	get	VV0
601953	108644014	21111023974	from	from	II
601953	108644014	21111023975	the	the	AT
601953	108644014	21111023976	often	often	RR
601953	108644014	21111023977	brutal	brutal	JJ
601953	108644014	21111023978	and	and	CC
601953	108644014	21111023979	exhausting	exhausting	JJ_VVG
601953	108644014	21111023980	conference	conference	NN1
601953	108644014	21111023981	season	season	NNT1
601953	108644014	21111023982	.	.	.
601953	108644014	21111023983	Perhaps	perhaps	RR
601953	108644014	21111023984	you	you	PPY
601953	108644014	21111023985	have	have	VH0
601953	108644014	21111023986	that	that	DD1
601953	108644014	21111023987	one	one	MC1
601953	108644014	21111023988	important	important	JJ
601953	108644014	21111023989	annual	annual	JJ
601953	108644014	21111023990	conference	conference	NN1
601953	108644014	21111023991	looming	loom	VVG
601953	108644014	21111023992	ahead	ahead	RL
601953	108644014	21111023993	.	.	.
601953	108644014	21111023994	<p>		NULL
601953	108644014	21111023995	For	for	IF
601953	108644014	21111023996	Bracket	bracket	NN1
601953	108644014	21111023997	,	,	,
601953	108644014	21111023998	the	the	AT
601953	108644014	21111023999	Drug	drug	NN1
601953	108644014	21111024000	Information	information	NN1
601953	108644014	21111024001	Association	association	NN1
601953	108644014	21111024002	(	(	(
601953	108644014	21111024003	DIA	dia	NN1
601953	108644014	21111024004	)	)	)
601953	108644014	21111024005	conference	conference	NN1
601953	108644014	21111024006	is	be	VBZ
601953	108644014	21111024007	one	one	MC1
601953	108644014	21111024008	of	of	IO
601953	108644014	21111024009	the	the	AT
601953	108644014	21111024010	biggest	big	JJT
601953	108644014	21111024011	of	of	IO
601953	108644014	21111024012	the	the	AT
601953	108644014	21111024013	year	year	NNT1
601953	108644014	21111024014	,	,	,
601953	108644014	21111024015	and	and	CC
601953	108644014	21111024016	its	its	APPGE
601953	108644014	21111024017	quickly	quickly	RR
601953	108644014	21111024018	approaching	approach	VVG
601953	108644014	21111024019	in	in	II_RP@
601953	108644014	21111024020	a	a	AT1
601953	108644014	21111024021	week	week	NNT1
601953	108644014	21111024022	in	in	II
601953	108644014	21111024023	a	a	AT1
601953	108644014	21111024024	half	half	NN1@_DB
601953	108644014	21111024025	.	.	.
601953	108644014	21111024026	<p>		NULL
601953	108644014	21111024027	How	how	RRQ
601953	108644014	21111024028	can	can	VM
601953	108644014	21111024029	you	you	PPY
601953	108644014	21111024030	make	make	VVI
601953	108644014	21111024031	the	the	AT
601953	108644014	21111024032	most	most	DAT
601953	108644014	21111024033	of	of	IO
601953	108644014	21111024034	your	your	APPGE
601953	108644014	21111024035	time	time	NNT1
601953	108644014	21111024036	at	at	II
601953	108644014	21111024037	a	a	AT1
601953	108644014	21111024038	conference	conference	NN1
601953	108644014	21111024039	like	like	II
601953	108644014	21111024040	DIA	dia	NN1
601953	108644014	21111024041	or	or	CC
601953	108644014	21111024042	any	any	DD
601953	108644014	21111024043	other	other	JJ
601953	108644014	21111024044	overwhelming	overwhelming	JJ
601953	108644014	21111024045	large	large	JJ
601953	108644014	21111024046	and	and	CC
601953	108644014	21111024047	fast	fast	RR
601953	108644014	21111024048	paced	pace	VVN_VVD
601953	108644014	21111024049	event	event	NN1
601953	108644014	21111024050	?	?	?
601953	108644014	21111024051	You	you	PPY
601953	108644014	21111024052	want	want	VV0
601953	108644014	21111024053	to	to	TO
601953	108644014	21111024054	maximize	maximize	VVI
601953	108644014	21111024055	your	your	APPGE
601953	108644014	21111024056	time	time	NNT1
601953	108644014	21111024057	,	,	,
601953	108644014	21111024058	because	because	CS
601953	108644014	21111024059	this	this	DD1
601953	108644014	21111024060	is	be	VBZ
601953	108644014	21111024061	the	the	AT
601953	108644014	21111024062	time	time	NNT1
601953	108644014	21111024063	when	when	RRQ
601953	108644014	21111024064	you	you	PPY
601953	108644014	21111024065	can	can	VM
601953	108644014	21111024066	cement	cement	VVI
601953	108644014	21111024067	relationships	relationship	NN2
601953	108644014	21111024068	with	with	IW
601953	108644014	21111024069	vendors	vendor	NN2
601953	108644014	21111024070	,	,	,
601953	108644014	21111024071	mingle	mingle	VV0
601953	108644014	21111024072	with	with	IW
601953	108644014	21111024073	industry	industry	NN1
601953	108644014	21111024074	colleagues	colleague	NN2
601953	108644014	21111024075	,	,	,
601953	108644014	21111024076	and	and	CC
601953	108644014	21111024077	share	share	VV0
601953	108644014	21111024078	a	a	AT1
601953	108644014	21111024079	few	few	DA2
601953	108644014	21111024080	dinners	dinner	NN2
601953	108644014	21111024081	with	with	IW
601953	108644014	21111024082	company	company	NN1
601953	108644014	21111024083	co-workers	co-worker	NN2
601953	108644014	21111024084	from	from	II
601953	108644014	21111024085	offices	office	NN2
601953	108644014	21111024086	in	in	II
601953	108644014	21111024087	other	other	JJ
601953	108644014	21111024088	parts	part	NN2
601953	108644014	21111024089	of	of	IO
601953	108644014	21111024090	the	the	AT
601953	108644014	21111024091	country	country	NN1
601953	108644014	21111024092	or	or	CC
601953	108644014	21111024093	world	world	NN1
601953	108644014	21111024094	.	.	.
601953	108644014	21111024095	<p>		NULL
601953	108644014	21111024096	Here	here	RL
601953	108644014	21111024097	are	be	VBR
601953	108644014	21111024098	some	some	DD
601953	108644014	21111024099	great	great	JJ
601953	108644014	21111024100	tech	tech	NN1
601953	108644014	21111024101	tools	tool	NN2
601953	108644014	21111024102	to	to	TO
601953	108644014	21111024103	simplify	simplify	VVI
601953	108644014	21111024104	your	your	APPGE
601953	108644014	21111024105	conference	conference	NN1
601953	108644014	21111024106	experience	experience	NN1_VV0
601953	108644014	21111024107	:	:	:
601953	108644014	21111024108	<p>		NULL
601953	108644014	21111024109	Above	above	II
601953	108644014	21111024110	all	all	DB
601953	108644014	21111024111	@		II
601953	108644014	21111024112	@		II
601953	108644014	21111024113	@		II
601953	108644014	21111024114	@		II
601953	108644014	21111024115	@		II
601953	108644014	21111024116	@		II
601953	108644014	21111024117	@		II
601953	108644014	21111024118	@		II
601953	108644014	21111024119	@		II
601953	108644014	21111024120	@		II
601953	108644014	21111024121	,	,	,
601953	108644014	21111024122	make	make	VV0
601953	108644014	21111024123	sure	sure	JJ
601953	108644014	21111024124	to	to	TO
601953	108644014	21111024125	enjoy	enjoy	VVI
601953	108644014	21111024126	yourself	yourself	PPX1
601953	108644014	21111024127	at	at	II
601953	108644014	21111024128	the	the	AT
601953	108644014	21111024129	conference	conference	NN1
601953	108644014	21111024130	.	.	.
601953	108644014	21111024131	Though	though	CS
601953	108644014	21111024132	you	you	PPY
601953	108644014	21111024133	might	might	VM
601953	108644014	21111024134	be	be	VBI
601953	108644014	21111024135	tired	tired	JJ
601953	108644014	21111024136	and	and	CC
601953	108644014	21111024137	over	over	II_RP_NN1%
601953	108644014	21111024138	caffeinated	caffeinated	JJ@_VVD
601953	108644014	21111024139	,	,	,
601953	108644014	21111024140	making	make	VVG
601953	108644014	21111024141	a	a	AT1
601953	108644014	21111024142	concerted	concerted	JJ
601953	108644014	21111024143	effort	effort	NN1
601953	108644014	21111024144	to	to	TO
601953	108644014	21111024145	enjoy	enjoy	VVI
601953	108644014	21111024146	the	the	AT
601953	108644014	21111024147	opportunity	opportunity	NN1
601953	108644014	21111024148	of	of	IO
601953	108644014	21111024149	these	these	DD2
601953	108644014	21111024150	face-to-face	face-to-face	JJ
601953	108644014	21111024151	interactions	interaction	NN2
601953	108644014	21111024152	is	be	VBZ
601953	108644014	21111024153	essential	essential	JJ
601953	108644014	21111024154	.	.	.
601953	108644014	21111024155	You	you	PPY
601953	108644014	21111024156	may	may	VM
601953	108644014	21111024157	not	not	XX
601953	108644014	21111024158	be	be	VBI
601953	108644014	21111024159	ecstatic	ecstatic	JJ
601953	108644014	21111024160	to	to	TO
601953	108644014	21111024161	be	be	VBI
601953	108644014	21111024162	there	there	RL
601953	108644014	21111024163	,	,	,
601953	108644014	21111024164	but	but	CCB
601953	108644014	21111024165	you	you	PPY
601953	108644014	21111024166	do	do	VD0
601953	108644014	21111024167	have	have	VHI
601953	108644014	21111024168	the	the	AT
601953	108644014	21111024169	power	power	NN1
601953	108644014	21111024170	to	to	TO
601953	108644014	21111024171	choose	choose	VVI
601953	108644014	21111024172	to	to	TO
601953	108644014	21111024173	make	make	VVI
601953	108644014	21111024174	the	the	AT
601953	108644014	21111024175	time	time	NNT1
601953	108644014	21111024176	spent	spend	VVN
601953	108644014	21111024177	away	away	II21_RL
601953	108644014	21111024178	from	from	II22_II
601953	108644014	21111024179	home	home	NN1
601953	108644014	21111024180	and	and	CC
601953	108644014	21111024181	family	family	NN1
601953	108644014	21111024182	worth	worth	II
601953	108644014	21111024183	it	it	PPH1
601953	108644014	21111024184	by	by	II
601953	108644014	21111024185	enjoying	enjoy	VVG
601953	108644014	21111024186	yourself	yourself	PPX1
601953	108644014	21111024187	and	and	CC
601953	108644014	21111024188	seeking	seek	VVG
601953	108644014	21111024189	out	out	RP
601953	108644014	21111024190	conversations	conversation	NN2
601953	108644014	21111024191	or	or	CC
601953	108644014	21111024192	interactions	interaction	NN2
601953	108644014	21111024193	that	that	CST
601953	108644014	21111024194	are	be	VBR
601953	108644014	21111024195	meaningful	meaningful	JJ
601953	108644014	21111024196	to	to	II
601953	108644014	21111024197	you	you	PPY
601953	108644014	21111024198	.	.	.
601953	108644017	21111024218	@@##	----------	----------
601953	108644017	21111024219	@@108644017		FO
601953	108644017	21111024220	@4044017/		JJ_NN1_VV0
601953	108644017	21111024221	<h>		NULL
601953	108644017	21111024222	Bracket	bracket	NN1
601953	108644017	21111024223	at	at	II
601953	108644017	21111024224	the	the	AT
601953	108644017	21111024225	BNA	bna	NN1_NP1
601953	108644017	21111024226	2013	2013	MC
601953	108644017	21111024227	:	:	:
601953	108644017	21111024228	Festival	festival	NN1
601953	108644017	21111024229	of	of	IO
601953	108644017	21111024230	Neuroscience	neuroscience	NP1
601953	108644017	21111024231	,	,	,
601953	108644017	21111024232	London	london	NP1
601953	108644017	21111024233	<p>		NULL
601953	108644017	21111024234	The-		JJ
601953	108644017	21111024235	British	british	JJ
601953	108644017	21111024236	Neuroscience	neuroscience	NP1_NN1@
601953	108644017	21111024237	Associations-		JJ_NN1
601953	108644017	21111024238	biennial	biennial	NN1
601953	108644017	21111024239	meeting	meet	VVG_NN1
601953	108644017	21111024240	in	in	II
601953	108644017	21111024241	2013	2013	MC
601953	108644017	21111024242	involved	involve	VVD
601953	108644017	21111024243	18	18	MC
601953	108644017	21111024244	learned	learned	JJ@_VVD
601953	108644017	21111024245	societies	society	NN2
601953	108644017	21111024246	with	with	IW
601953	108644017	21111024247	neuroscience	neuroscience	NN1
601953	108644017	21111024248	interests	interest	NN2
601953	108644017	21111024249	who	who	PNQS
601953	108644017	21111024250	contributed	contribute	VVD
601953	108644017	21111024251	symposia	symposia	NN1
601953	108644017	21111024252	to	to	II
601953	108644017	21111024253	the	the	AT
601953	108644017	21111024254	programme	program	NN1
601953	108644017	21111024255	,	,	,
601953	108644017	21111024256	creating	create	VVG
601953	108644017	21111024257	a	a	AT1
601953	108644017	21111024258	meeting	meeting	NN1
601953	108644017	21111024259	with	with	IW
601953	108644017	21111024260	56	56	MC
601953	108644017	21111024261	scientific	scientific	JJ
601953	108644017	21111024262	sessions	session	NNT2
601953	108644017	21111024263	and	and	CC
601953	108644017	21111024264	7	7	MC
601953	108644017	21111024265	plenary	plenary	JJ
601953	108644017	21111024266	lectures	lecture	NN2
601953	108644017	21111024267	involving	involve	VVG
601953	108644017	21111024268	more	more	DAR
601953	108644017	21111024269	than	than	CSN
601953	108644017	21111024270	240	240	MC
601953	108644017	21111024271	speakers	speaker	NN2
601953	108644017	21111024272	,	,	,
601953	108644017	21111024273	over	over	RG
601953	108644017	21111024274	80	80	MC
601953	108644017	21111024275	from	from	II
601953	108644017	21111024276	outside	outside	RL_II
601953	108644017	21111024277	the	the	AT
601953	108644017	21111024278	U.K.	uk	NP1
601953	108644017	21111024279	I	i	PPIS1
601953	108644017	21111024280	presented	present	VVD
601953	108644017	21111024281	four	four	MC
601953	108644017	21111024282	papers	paper	NN2
601953	108644017	21111024283	on	on	II
601953	108644017	21111024284	the	the	AT
601953	108644017	21111024285	contribution	contribution	NN1
601953	108644017	21111024286	of	of	IO
601953	108644017	21111024287	Bracket	bracket	NN1
601953	108644017	21111024288	's	's	GE_VBZ
601953	108644017	21111024289	proprietary	proprietary	JJ
601953	108644017	21111024290	CDR	cdr	NP1
601953	108644017	21111024291	System	system	NN1
601953	108644017	21111024292	to	to	II
601953	108644017	21111024293	current	current	JJ
601953	108644017	21111024294	research	research	NN1
601953	108644017	21111024295	in	in	II
601953	108644017	21111024296	cognitive	cognitive	JJ
601953	108644017	21111024297	neuroscience	neuroscience	NN1
601953	108644017	21111024298	,	,	,
601953	108644017	21111024299	including	include	VVG@_II
601953	108644017	21111024300	:	:	:
601953	108644017	21111024301	a	a	AT1
601953	108644017	21111024302	review	review	NN1
601953	108644017	21111024303	of	of	IO
601953	108644017	21111024304	the	the	AT
601953	108644017	21111024305	system	system	NN1
601953	108644017	21111024306	's	's	GE
601953	108644017	21111024307	unique	unique	JJ
601953	108644017	21111024308	record	record	NN1
601953	108644017	21111024309	in	in	II
601953	108644017	21111024310	detecting	detect	VVG
601953	108644017	21111024311	cognition	cognition	NN1
601953	108644017	21111024312	enhancement	enhancement	NN1
601953	108644017	21111024313	in	in	II
601953	108644017	21111024314	volunteers	volunteer	NN2
601953	108644017	21111024315	and	and	CC
601953	108644017	21111024316	over	over	RG
601953	108644017	21111024317	30	30	MC
601953	108644017	21111024318	clinical	clinical	JJ
601953	108644017	21111024319	conditions	condition	NN2
601953	108644017	21111024320	;	;	;
601953	108644017	21111024321	the	the	AT
601953	108644017	21111024322	development	development	NN1
601953	108644017	21111024323	and	and	CC
601953	108644017	21111024324	validation	validation	NN1
601953	108644017	21111024325	of	of	IO
601953	108644017	21111024326	the	the	AT
601953	108644017	21111024327	platform	platform	NN1
601953	108644017	21111024328	for	for	IF
601953	108644017	21111024329	administering	administer	VVG
601953	108644017	21111024330	the	the	AT
601953	108644017	21111024331	system	system	NN1
601953	108644017	21111024332	via	via	II
601953	108644017	21111024333	the	the	AT
601953	108644017	21111024334	internet	internet	NN1
601953	108644017	21111024335	;	;	;
601953	108644017	21111024336	and	and	CC
601953	108644017	21111024337	the	the	AT
601953	108644017	21111024338	latest	late	JJT
601953	108644017	21111024339	exciting	exciting	JJ
601953	108644017	21111024340	developments	development	NN2
601953	108644017	21111024341	with	with	IW
601953	108644017	21111024342	a	a	AT1
601953	108644017	21111024343	CDR	cdr	NP1
601953	108644017	21111024344	System	system	NN1
601953	108644017	21111024345	task	task	NN1
601953	108644017	21111024346	which	which	DDQ
601953	108644017	21111024347	can	can	VM
601953	108644017	21111024348	detect	detect	VVI
601953	108644017	21111024349	changes	change	NN2
601953	108644017	21111024350	in	in	II
601953	108644017	21111024351	the	the	AT
601953	108644017	21111024352	activity	activity	NN1
601953	108644017	21111024353	of	of	IO
601953	108644017	21111024354	the	the	AT
601953	108644017	21111024355	hippocampal	hippocampal	JJ
601953	108644017	21111024356	dentate	dentate	NN1
601953	108644017	21111024357	gyrus	gyrus	NN1
601953	108644017	21111024358	,	,	,
601953	108644017	21111024359	one	one	MC1
601953	108644017	21111024360	of	of	IO
601953	108644017	21111024361	the	the	AT
601953	108644017	21111024362	two	two	MC
601953	108644017	21111024363	brain	brain	NN1
601953	108644017	21111024364	regions	region	NN2
601953	108644017	21111024365	responsible	responsible	JJ
601953	108644017	21111024366	for	for	IF
601953	108644017	21111024367	neurogenesis	neurogenesis	NN1
601953	108644017	21111024368	in	in	II
601953	108644017	21111024369	man	man	NN1
601953	108644017	21111024370	.	.	.
601953	108644018	21111024390	@@##	----------	----------
601953	108644018	21111024391	@@108644018		FO
601953	108644018	21111024392	@4044018/		JJ_VV0_NN1
601953	108644018	21111024393	<h>		NULL
601953	108644018	21111024394	Findings	finding	NN2
601953	108644018	21111024395	at	at	II
601953	108644018	21111024396	the	the	AT
601953	108644018	21111024397	11th	11th	MD
601953	108644018	21111024398	International	international	JJ
601953	108644018	21111024399	Conference	conference	NN1
601953	108644018	21111024400	on	on	II
601953	108644018	21111024401	Alzheimer	alzheimer	NP1
601953	108644018	21111024402	's	's	GE
601953	108644018	21111024403	and	and	CC
601953	108644018	21111024404	Parkinson	parkinson	NP1
601953	108644018	21111024405	's	's	GE
601953	108644018	21111024406	Disease	disease	NN1
601953	108644018	21111024407	<p>		NULL
601953	108644018	21111024408	On	on	II
601953	108644018	21111024409	Day	day	NP1_NNT1
601953	108644018	21111024410	1	1	MC1
601953	108644018	21111024411	of	of	IO
601953	108644018	21111024412	the	the	AT
601953	108644018	21111024413	11th	11th	MD
601953	108644018	21111024414	International	international	JJ
601953	108644018	21111024415	Conference	conference	NN1
601953	108644018	21111024416	on	on	II
601953	108644018	21111024417	Alzheimer	alzheimer	NP1
601953	108644018	21111024418	's	's	GE
601953	108644018	21111024419	and	and	CC
601953	108644018	21111024420	Parkinson	parkinson	NP1
601953	108644018	21111024421	's	's	GE
601953	108644018	21111024422	Disease	disease	NN1
601953	108644018	21111024423	(	(	(
601953	108644018	21111024424	AD/PD		FU
601953	108644018	21111024425	)	)	)
601953	108644018	21111024426	,	,	,
601953	108644018	21111024427	I	i	PPIS1
601953	108644018	21111024428	delivered	deliver	VVD
601953	108644018	21111024429	an	a	AT1
601953	108644018	21111024430	oral	oral	JJ_NN1
601953	108644018	21111024431	presentation	presentation	NN1
601953	108644018	21111024432	in	in	II
601953	108644018	21111024433	a	a	AT1
601953	108644018	21111024434	Symposium	symposium	NN1
601953	108644018	21111024435	on-		JJ_NN1
601953	108644018	21111024436	Cognitive	cognitive	JJ
601953	108644018	21111024437	Deficits	deficit	NN2
601953	108644018	21111024438	in	in	II
601953	108644018	21111024439	Parkinsons	parkinson	NP2
601953	108644018	21111024440	Disease	disease	NN1
601953	108644018	21111024441	.	.	.
601953	108644018	21111024442	My	my	APPGE
601953	108644018	21111024443	paper	paper	NN1
601953	108644018	21111024444	,	,	,
601953	108644018	21111024445	entitled-		NN1_JJ
601953	108644018	21111024446	The	the	AT
601953	108644018	21111024447	Prevalence	prevalence	NN1@_NP1
601953	108644018	21111024448	of	of	IO
601953	108644018	21111024449	Mild	mild	JJ
601953	108644018	21111024450	Cognitive	cognitive	JJ
601953	108644018	21111024451	Impairment	impairment	NN1
601953	108644018	21111024452	in	in	II
601953	108644018	21111024453	Parkinsons	parkinson	NP2
601953	108644018	21111024454	Disease	disease	NN1
601953	108644018	21111024455	Appears	appear	VVZ
601953	108644018	21111024456	Greater	great	JJR_NP1
601953	108644018	21111024457	with	with	IW
601953	108644018	21111024458	Automated	automated	JJ
601953	108644018	21111024459	Cognitive	cognitive	JJ
601953	108644018	21111024460	Testing	testing	NN1_NP1
601953	108644018	21111024461	,	,	,
601953	108644018	21111024462	was	be	VBDZ
601953	108644018	21111024463	based	base	VVN
601953	108644018	21111024464	on	on	II
601953	108644018	21111024465	an	a	AT1
601953	108644018	21111024466	analysis	analysis	NN1
601953	108644018	21111024467	of	of	IO
601953	108644018	21111024468	research	research	NN1
601953	108644018	21111024469	conducted	conduct	VVN_VVD
601953	108644018	21111024470	with	with	IW
601953	108644018	21111024471	my	my	APPGE
601953	108644018	21111024472	co-author	co-author	NN1
601953	108644018	21111024473	,	,	,
601953	108644018	21111024474	David	david	NP1
601953	108644018	21111024475	Burn	burn	NP1
601953	108644018	21111024476	MD	md	NNA
601953	108644018	21111024477	,	,	,
601953	108644018	21111024478	Newcastle	newcastle	NP1
601953	108644018	21111024479	University	university	NN1
601953	108644018	21111024480	,	,	,
601953	108644018	21111024481	UK	uk	NP1
601953	108644018	21111024482	.	.	.
601953	108644018	21111024483	We	we	PPIS2
601953	108644018	21111024484	found	find	VVD
601953	108644018	21111024485	that	that	CST_DD1
601953	108644018	21111024486	in	in	II
601953	108644018	21111024487	380	380	MC
601953	108644018	21111024488	PD	pd	NP1
601953	108644018	21111024489	patients	patient	NN2
601953	108644018	21111024490	,	,	,
601953	108644018	21111024491	speeded	speed	VVD_VVN
601953	108644018	21111024492	cognitive	cognitive	JJ
601953	108644018	21111024493	test	test	NN1
601953	108644018	21111024494	scores	score	NN2
601953	108644018	21111024495	were	be	VBDR
601953	108644018	21111024496	more	more	RGR
601953	108644018	21111024497	sensitive	sensitive	JJ
601953	108644018	21111024498	than	than	CSN
601953	108644018	21111024499	accuracy	accuracy	NN1
601953	108644018	21111024500	scores	score	NN2_VVZ@
601953	108644018	21111024501	in	in	II
601953	108644018	21111024502	identifying	identify	VVG
601953	108644018	21111024503	MCI	mci	MC
601953	108644018	21111024504	in	in	II
601953	108644018	21111024505	PD	pd	NP1
601953	108644018	21111024506	;	;	;
601953	108644018	21111024507	and	and	CC
601953	108644018	21111024508	that	that	CST_DD1
601953	108644018	21111024509	using	use	VVG
601953	108644018	21111024510	the	the	AT
601953	108644018	21111024511	latest	late	JJT
601953	108644018	21111024512	MDS	md	NN2
601953	108644018	21111024513	criteria	criteria	NN2
601953	108644018	21111024514	,	,	,
601953	108644018	21111024515	up	up	RG21
601953	108644018	21111024516	to	to	RG22
601953	108644018	21111024517	82%		NNU
601953	108644018	21111024518	of	of	IO
601953	108644018	21111024519	PD	pd	NP1
601953	108644018	21111024520	patients	patient	NN2
601953	108644018	21111024521	could	could	VM
601953	108644018	21111024522	be	be	VBI
601953	108644018	21111024523	identified	identify	VVN
601953	108644018	21111024524	as	as	CSA_II@_RG@
601953	108644018	21111024525	PD-MCI		JJ_NN1
601953	108644018	21111024526	with	with	IW
601953	108644018	21111024527	the-	the--	JJ_NN1
601953	108644018	21111024528	CDR	cdr	NP1
601953	108644018	21111024529	System	system	NN1
601953	108644018	21111024530	.	.	.
601953	108644018	21111024531	This	this	DD1
601953	108644018	21111024532	contrasts	contrast	VVZ
601953	108644018	21111024533	to	to	II
601953	108644018	21111024534	detection	detection	NN1
601953	108644018	21111024535	rates	rate	NN2
601953	108644018	21111024536	of	of	IO
601953	108644018	21111024537	PD-MCI		NN1
601953	108644018	21111024538	of	of	IO
601953	108644018	21111024539	around	around	RG
601953	108644018	21111024540	25%		NNU
601953	108644018	21111024541	in	in	II
601953	108644018	21111024542	previous	previous	JJ
601953	108644018	21111024543	large	large	JJ
601953	108644018	21111024544	surveys	survey	NN2
601953	108644018	21111024545	,	,	,
601953	108644018	21111024546	which	which	DDQ
601953	108644018	21111024547	had	have	VHD
601953	108644018	21111024548	largely	largely	RR
601953	108644018	21111024549	relied	rely	VVN
601953	108644018	21111024550	on	on	II
601953	108644018	21111024551	traditional	traditional	JJ
601953	108644018	21111024552	pencil	pencil	NN1
601953	108644018	21111024553	and	and	CC
601953	108644018	21111024554	paper	paper	NN1
601953	108644018	21111024555	scales	scale	NN2
601953	108644018	21111024556	.	.	.
601953	108644018	21111024557	This	this	DD1
601953	108644018	21111024558	incidence	incidence	NN1
601953	108644018	21111024559	is	be	VBZ
601953	108644018	21111024560	more	more	RGR
601953	108644018	21111024561	realistic	realistic	JJ
601953	108644018	21111024562	considering	considering	II_CS
601953	108644018	21111024563	the	the	AT
601953	108644018	21111024564	rapid	rapid	JJ
601953	108644018	21111024565	conversion	conversion	NN1
601953	108644018	21111024566	to	to	II
601953	108644018	21111024567	dementia	dementia	NN1
601953	108644018	21111024568	in	in	II
601953	108644018	21111024569	PD	pd	NP1
601953	108644018	21111024570	,	,	,
601953	108644018	21111024571	compared	compare	VVN
601953	108644018	21111024572	to	to	II
601953	108644018	21111024573	the	the	AT
601953	108644018	21111024574	much	much	RR
601953	108644018	21111024575	slower	slower	JJR
601953	108644018	21111024576	conversion	conversion	NN1
601953	108644018	21111024577	of	of	IO
601953	108644018	21111024578	MCI	mci	MC
601953	108644018	21111024579	to	to	II
601953	108644018	21111024580	Alzheimer	alzheimer	NP1
601953	108644018	21111024581	's	's	GE
601953	108644018	21111024582	@		II
601953	108644018	21111024583	@		II
601953	108644018	21111024584	@		II
601953	108644018	21111024585	@		II
601953	108644018	21111024586	@		II
601953	108644018	21111024587	@		II
601953	108644018	21111024588	@		II
601953	108644018	21111024589	@		II
601953	108644018	21111024590	@		II
601953	108644018	21111024591	@		II
601953	108644018	21111024592	that	that	CST_DD1_RG%
601953	108644018	21111024593	one	one	MC1
601953	108644018	21111024594	of	of	IO
601953	108644018	21111024595	the	the	AT
601953	108644018	21111024596	major	major	JJ
601953	108644018	21111024597	cognitive	cognitive	JJ
601953	108644018	21111024598	deficits	deficit	NN2
601953	108644018	21111024599	in	in	II
601953	108644018	21111024600	PD	pd	NP1
601953	108644018	21111024601	is	be	VBZ
601953	108644018	21111024602	to	to	II
601953	108644018	21111024603	attention	attention	NN1
601953	108644018	21111024604	and	and	CC
601953	108644018	21111024605	information	information	NN1
601953	108644018	21111024606	processing	processing	NN1
601953	108644018	21111024607	capability	capability	NN1
601953	108644018	21111024608	;	;	;
601953	108644018	21111024609	deficits	deficit	NN2
601953	108644018	21111024610	are	be	VBR
601953	108644018	21111024611	not	not	XX
601953	108644018	21111024612	well	well	RR
601953	108644018	21111024613	detected	detect	VVN
601953	108644018	21111024614	by	by	II
601953	108644018	21111024615	non-automated	non-automated	JJ
601953	108644018	21111024616	tasks	task	NN2
601953	108644018	21111024617	,	,	,
601953	108644018	21111024618	which	which	DDQ
601953	108644018	21111024619	though	though	RR@
601953	108644018	21111024620	able	able	JK
601953	108644018	21111024621	to	to	TO
601953	108644018	21111024622	measure	measure	VVI
601953	108644018	21111024623	response	response	NN1
601953	108644018	21111024624	accuracy	accuracy	NN1
601953	108644018	21111024625	can	can	VM
601953	108644018	21111024626	not	not	XX
601953	108644018	21111024627	properly	properly	RR
601953	108644018	21111024628	assess	assess	VVI
601953	108644018	21111024629	the	the	AT
601953	108644018	21111024630	speed	speed	NN1
601953	108644018	21111024631	of	of	IO
601953	108644018	21111024632	the	the	AT
601953	108644018	21111024633	various	various	JJ
601953	108644018	21111024634	cognitive	cognitive	JJ
601953	108644018	21111024635	processes	process	NN2
601953	108644018	21111024636	involved	involved	JJ
601953	108644018	21111024637	in	in	II
601953	108644018	21111024638	task	task	NN1
601953	108644018	21111024639	performance	performance	NN1
601953	108644018	21111024640	.	.	.
601953	108644018	21111024641	The	the	AT
601953	108644018	21111024642	clear	clear	JJ
601953	108644018	21111024643	recommendation	recommendation	NN1
601953	108644018	21111024644	of	of	IO
601953	108644018	21111024645	the	the	AT
601953	108644018	21111024646	Symposium	symposium	NN1
601953	108644018	21111024647	was	be	VBDZ
601953	108644018	21111024648	to	to	TO
601953	108644018	21111024649	include	include	VVI
601953	108644018	21111024650	more	more	RGR_DAR
601953	108644018	21111024651	sophisticated	sophisticated	JJ
601953	108644018	21111024652	cognitive	cognitive	JJ
601953	108644018	21111024653	test	test	NN1
601953	108644018	21111024654	procedures	procedure	NN2
601953	108644018	21111024655	in	in	II
601953	108644018	21111024656	therapeutic	therapeutic	JJ
601953	108644018	21111024657	trials	trial	NN2
601953	108644018	21111024658	in	in	II
601953	108644018	21111024659	PD	pd	NP1
601953	108644018	21111024660	and	and	CC
601953	108644018	21111024661	related	related	JJ
601953	108644018	21111024662	areas	area	NN2
601953	108644018	21111024663	.	.	.
601953	108644018	21111024664	<p>		NULL
601953	108644018	21111024665	I	i	PPIS1
601953	108644018	21111024666	also	also	RR
601953	108644018	21111024667	had	have	VHD
601953	108644018	21111024668	the	the	AT
601953	108644018	21111024669	opportunity	opportunity	NN1
601953	108644018	21111024670	to	to	TO
601953	108644018	21111024671	present	present	VVI
601953	108644018	21111024672	two	two	MC
601953	108644018	21111024673	posters	poster	NN2
601953	108644018	21111024674	revealing	reveal	VVG
601953	108644018	21111024675	the	the	AT
601953	108644018	21111024676	first	first	MD
601953	108644018	21111024677	human	human	JJ_NN1
601953	108644018	21111024678	evidence	evidence	NN1
601953	108644018	21111024679	of	of	IO
601953	108644018	21111024680	impaired	impaired	JJ
601953	108644018	21111024681	neurogenesis	neurogenesis	NN1
601953	108644018	21111024682	in	in	II
601953	108644018	21111024683	both	both	DB2
601953	108644018	21111024684	PD	pd	NP1
601953	108644018	21111024685	and	and	CC
601953	108644018	21111024686	AD	ad	NN1%_RA
601953	108644018	21111024687	patients	patient	NN2
601953	108644018	21111024688	using	use	VVG
601953	108644018	21111024689	a	a	AT1
601953	108644018	21111024690	CDR	cdr	NP1
601953	108644018	21111024691	System	system	NN1
601953	108644018	21111024692	object	object	NN1_VV0
601953	108644018	21111024693	pattern	pattern	NN1
601953	108644018	21111024694	separation	separation	NN1
601953	108644018	21111024695	task	task	NN1
601953	108644018	21111024696	.	.	.
601953	108644018	21111024697	Both	both	DB2
601953	108644018	21111024698	posters	poster	NN2
601953	108644018	21111024699	confirmed	confirm	VVD_VVN
601953	108644018	21111024700	preclinical	preclinical	JJ
601953	108644018	21111024701	data	data	NN
601953	108644018	21111024702	(	(	(
601953	108644018	21111024703	much	much	RR
601953	108644018	21111024704	of	of	IO
601953	108644018	21111024705	which	which	DDQ
601953	108644018	21111024706	was	be	VBDZ
601953	108644018	21111024707	presented	present	VVN
601953	108644018	21111024708	at	at	II
601953	108644018	21111024709	the	the	AT
601953	108644018	21111024710	conference	conference	NN1
601953	108644018	21111024711	)	)	)
601953	108644018	21111024712	showing	show	VVG
601953	108644018	21111024713	compromised	compromised	JJ
601953	108644018	21111024714	dentate	dentate	NN1
601953	108644018	21111024715	gyrus	gyrus	NN1
601953	108644018	21111024716	hippocampal	hippocampal	JJ
601953	108644018	21111024717	neurogenesis	neurogenesis	NN1
601953	108644018	21111024718	in	in	II
601953	108644018	21111024719	animal	animal	NN1
601953	108644018	21111024720	models	model	NN2
601953	108644018	21111024721	of	of	IO
601953	108644018	21111024722	PD	pd	NP1
601953	108644018	21111024723	and	and	CC
601953	108644018	21111024724	AD	ad	RA
601953	108644018	21111024725	.	.	.
601953	108644018	21111024726	The	the	AT
601953	108644018	21111024727	poster	poster	NN1
601953	108644018	21111024728	in	in	II
601953	108644018	21111024729	PD	pd	NP1
601953	108644018	21111024730	,	,	,
601953	108644018	21111024731	co-authored	co-author	VVN
601953	108644018	21111024732	by	by	II
601953	108644018	21111024733	David	david	NP1
601953	108644018	21111024734	Burn	burn	NN1_VV0
601953	108644018	21111024735	and	and	CC
601953	108644018	21111024736	David	david	NP1
601953	108644018	21111024737	Miller	miller	NP1_NN1@
601953	108644018	21111024738	of	of	IO
601953	108644018	21111024739	Bracket	bracket	NN1
601953	108644018	21111024740	,	,	,
601953	108644018	21111024741	showed	show	VVD
601953	108644018	21111024742	that	that	CST
601953	108644018	21111024743	a	a	AT1
601953	108644018	21111024744	task	task	NN1
601953	108644018	21111024745	measure	measure	NN1
601953	108644018	21111024746	shown	show	VVN
601953	108644018	21111024747	previously	previously	RR
601953	108644018	21111024748	in	in	II
601953	108644018	21111024749	man	man	NN1
601953	108644018	21111024750	to	to	TO
601953	108644018	21111024751	be	be	VBI
601953	108644018	21111024752	sensitive	sensitive	JJ
601953	108644018	21111024753	to	to	TO
601953	108644018	21111024754	dentate		VVI
601953	108644018	21111024755	gyrus	gyrus	NN1
601953	108644018	21111024756	(	(	(
601953	108644018	21111024757	DG	dg	NP1
601953	108644018	21111024758	)	)	)
601953	108644018	21111024759	activity	activity	NN1
601953	108644018	21111024760	was	be	VBDZ
601953	108644018	21111024761	selectively	selectively	RR
601953	108644018	21111024762	impaired	impair	VVN_VVD
601953	108644018	21111024763	in	in	II
601953	108644018	21111024764	348	348	MC
601953	108644018	21111024765	PD	pd	NP1
601953	108644018	21111024766	patients	patient	NN2
601953	108644018	21111024767	,	,	,
601953	108644018	21111024768	and	and	CC
601953	108644018	21111024769	that	that	CST
601953	108644018	21111024770	the	the	AT
601953	108644018	21111024771	impairments	impairment	NN2
601953	108644018	21111024772	could	could	VM
601953	108644018	21111024773	not	not	XX
601953	108644018	21111024774	be	be	VBI
601953	108644018	21111024775	accounted	account	VVN
601953	108644018	21111024776	for	for	IF
601953	108644018	21111024777	by	by	II
601953	108644018	21111024778	either	either	DD1_RR
601953	108644018	21111024779	disrupted	disrupted	JJ
601953	108644018	21111024780	attention/information		NN1
601953	108644018	21111024781	processing	processing	NN1_VVG
601953	108644018	21111024782	@		II
601953	108644018	21111024783	@		II
601953	108644018	21111024784	@		II
601953	108644018	21111024785	@		II
601953	108644018	21111024786	@		II
601953	108644018	21111024787	@		II
601953	108644018	21111024788	@		II
601953	108644018	21111024789	@		II
601953	108644018	21111024790	@		II
601953	108644018	21111024791	@		II
601953	108644018	21111024792	here-		NN1_JJ
601953	108644018	21111024793	.	.	.
601953	108644018	21111024794	<p>		NULL
601953	108644018	21111024795	The	the	AT
601953	108644018	21111024796	other	other	JJ
601953	108644018	21111024797	poster	poster	NN1
601953	108644018	21111024798	in	in	II
601953	108644018	21111024799	a	a	AT1
601953	108644018	21111024800	well	well	NN1
601953	108644018	21111024801	characterised	characterize	VVD_VVN
601953	108644018	21111024802	AD	ad	NN1%
601953	108644018	21111024803	sample	sample	NN1
601953	108644018	21111024804	confirmed	confirm	VVD_VVN
601953	108644018	21111024805	preclinical	preclinical	JJ
601953	108644018	21111024806	data	data	NN
601953	108644018	21111024807	by	by	II
601953	108644018	21111024808	demonstrating	demonstrate	VVG
601953	108644018	21111024809	that	that	CST
601953	108644018	21111024810	this	this	DD1
601953	108644018	21111024811	DG	dg	NP1
601953	108644018	21111024812	sensitive	sensitive	JJ
601953	108644018	21111024813	measure	measure	NN1
601953	108644018	21111024814	correlated	correlate	VVD_VVN
601953	108644018	21111024815	selectively	selectively	RR
601953	108644018	21111024816	with	with	IW
601953	108644018	21111024817	the	the	AT
601953	108644018	21111024818	CSF	csf	NP1
601953	108644018	21111024819	levels	level	NN2
601953	108644018	21111024820	of	of	IO
601953	108644018	21111024821	A+42		FO
601953	108644018	21111024822	,	,	,
601953	108644018	21111024823	as	as	II31_RG
601953	108644018	21111024824	well	well	II32_RR
601953	108644018	21111024825	as	as	II33_CSA
601953	108644018	21111024826	being	be	VBG
601953	108644018	21111024827	selectively	selectively	RR
601953	108644018	21111024828	impaired	impair	VVN_VVD
601953	108644018	21111024829	in	in	II
601953	108644018	21111024830	AD	ad	RA_NN1%
601953	108644018	21111024831	patients	patient	NN2
601953	108644018	21111024832	with	with	IW
601953	108644018	21111024833	double	double	JJ
601953	108644018	21111024834	APOE		NN1
601953	108644018	21111024835	-4	-4	MC
601953	108644018	21111024836	alleles	allele	NN2
601953	108644018	21111024837	.	.	.
601953	108644018	21111024838	To	to	TO
601953	108644018	21111024839	view	view	VVI
601953	108644018	21111024840	the	the	AT
601953	108644018	21111024841	poster	poster	NN1
601953	108644018	21111024842	,	,	,
601953	108644018	21111024843	-	-	-
601953	108644018	21111024844	click	click	VV0_NN1
601953	108644018	21111024845	here-		NN1_JJ
601953	108644018	21111024846	.	.	.
601953	108644018	21111024847	<p>		NULL
601953	108644018	21111024848	Both	both	DB2
601953	108644018	21111024849	posters	poster	NN2
601953	108644018	21111024850	have	have	VH0
601953	108644018	21111024851	important	important	JJ
601953	108644018	21111024852	implications	implication	NN2
601953	108644018	21111024853	for	for	IF
601953	108644018	21111024854	new	new	JJ
601953	108644018	21111024855	therapies	therapy	NN2
601953	108644018	21111024856	in	in	II
601953	108644018	21111024857	PD	pd	NP1
601953	108644018	21111024858	and	and	CC
601953	108644018	21111024859	AD	ad	RA
601953	108644018	21111024860	as	as	CSA
601953	108644018	21111024861	many	many	DA2
601953	108644018	21111024862	target	target	NN1_VV0@
601953	108644018	21111024863	neurogenesis	neurogenesis	NN1
601953	108644018	21111024864	,	,	,
601953	108644018	21111024865	and	and	CC
601953	108644018	21111024866	this	this	DD1_RG%
601953	108644018	21111024867	4	4	MC
601953	108644018	21111024868	minute	minute	JJ@_NNT1
601953	108644018	21111024869	task	task	NN1
601953	108644018	21111024870	will	will	VM
601953	108644018	21111024871	not	not	XX
601953	108644018	21111024872	only	only	RR
601953	108644018	21111024873	provide	provide	VVI
601953	108644018	21111024874	a	a	AT1
601953	108644018	21111024875	non-invasive	noninvasive	JJ
601953	108644018	21111024876	human	human	JJ_NN1
601953	108644018	21111024877	proof	proof	NN1
601953	108644018	21111024878	of	of	IO
601953	108644018	21111024879	concept	concept	NN1
601953	108644018	21111024880	of	of	IO
601953	108644018	21111024881	this	this	DD1
601953	108644018	21111024882	mechanism	mechanism	NN1
601953	108644018	21111024883	of	of	IO
601953	108644018	21111024884	action	action	NN1
601953	108644018	21111024885	,	,	,
601953	108644018	21111024886	but	but	CCB
601953	108644018	21111024887	will	will	VM
601953	108644018	21111024888	also	also	RR
601953	108644018	21111024889	serve	serve	VVI
601953	108644018	21111024890	as	as	II
601953	108644018	21111024891	a	a	AT1
601953	108644018	21111024892	treatment	treatment	NN1
601953	108644018	21111024893	outcome	outcome	NN1
601953	108644018	21111024894	for	for	IF
601953	108644018	21111024895	such	such	DA
601953	108644018	21111024896	therapies	therapy	NN2
601953	108644018	21111024897	.	.	.
601953	108644024	21111024958	@@##	----------	----------
601953	108644024	21111024959	@@108644024		FO
601953	108644024	21111024960	@4044024/		JJ_NN1_VV0
601953	108644024	21111024961	<h>		NULL
601953	108644024	21111024962	Bracket	bracket	NN1
601953	108644024	21111024963	Presents	present	VVZ_NN2
601953	108644024	21111024964	at	at	II
601953	108644024	21111024965	CTAD		NP1_NN1
601953	108644024	21111024966	2013	2013	MC
601953	108644024	21111024967	<p>		NULL
601953	108644024	21111024968	November	november	NPM1
601953	108644024	21111024969	13	13	MC
601953	108644024	21111024970	,	,	,
601953	108644024	21111024971	2013	2013	MC
601953	108644024	21111024972	157706		MC
601953	108644024	21111024973	@qwx1017706		FO
601953	108644024	21111024974	<p>		NULL
601953	108644024	21111024975	The-	the--	NN1_JJ
601953	108644024	21111024976	-	-	-
601953	108644024	21111024977	6th	6th	MD
601953	108644024	21111024978	Annual	annual	JJ
601953	108644024	21111024979	Clinical	clinical	JJ
601953	108644024	21111024980	Trials	trial	NN2
601953	108644024	21111024981	on	on	II
601953	108644024	21111024982	Alzheimer	alzheimer	NP1
601953	108644024	21111024983	's	's	GE
601953	108644024	21111024984	Disease	disease	NN1
601953	108644024	21111024985	(	(	(
601953	108644024	21111024986	CTAD		NP1
601953	108644024	21111024987	)	)	)
601953	108644024	21111024988	-	-	-
601953	108644024	21111024989	conference	conference	NN1
601953	108644024	21111024990	is	be	VBZ
601953	108644024	21111024991	taking	take	VVG
601953	108644024	21111024992	place	place	NN1
601953	108644024	21111024993	in	in	II
601953	108644024	21111024994	sunny	sunny	JJ
601953	108644024	21111024995	San	san	NP1
601953	108644024	21111024996	Diego	diego	NP1
601953	108644024	21111024997	from	from	II
601953	108644024	21111024998	November	november	NPM1
601953	108644024	21111024999	14-16	14-16	MCMC
601953	108644024	21111025000	.	.	.
601953	108644024	21111025001	The	the	AT
601953	108644024	21111025002	conference	conference	NN1
601953	108644024	21111025003	will	will	VM
601953	108644024	21111025004	cover	cover	VVI
601953	108644024	21111025005	every	every	AT1
601953	108644024	21111025006	stage	stage	NN1
601953	108644024	21111025007	of	of	IO
601953	108644024	21111025008	clinical	clinical	JJ
601953	108644024	21111025009	trials	trial	NN2
601953	108644024	21111025010	in	in	II
601953	108644024	21111025011	AD	ad	RA
601953	108644024	21111025012	and	and	CC
601953	108644024	21111025013	provide	provide	VV0
601953	108644024	21111025014	an	a	AT1
601953	108644024	21111025015	opportunity	opportunity	NN1
601953	108644024	21111025016	for	for	IF
601953	108644024	21111025017	industry	industry	NN1
601953	108644024	21111025018	leaders	leader	NN2
601953	108644024	21111025019	to	to	TO
601953	108644024	21111025020	share	share	VVI
601953	108644024	21111025021	innovative	innovative	JJ
601953	108644024	21111025022	research	research	NN1
601953	108644024	21111025023	with	with	IW
601953	108644024	21111025024	their	their	APPGE
601953	108644024	21111025025	peers	peer	NN2
601953	108644024	21111025026	.	.	.
601953	108644024	21111025027	<p>		NULL
601953	108644024	21111025028	See	see	VV0
601953	108644024	21111025029	below	below	RL
601953	108644024	21111025030	for	for	IF
601953	108644024	21111025031	a	a	AT1
601953	108644024	21111025032	list	list	NN1
601953	108644024	21111025033	of	of	IO
601953	108644024	21111025034	our	our	APPGE
601953	108644024	21111025035	subject	subject	NN1_JJ@
601953	108644024	21111025036	matter	matter	NN1
601953	108644024	21111025037	experts	expert	NN2
601953	108644024	21111025038	'	'	GE
601953	108644024	21111025039	presentations	presentation	NN2
601953	108644024	21111025040	taking	take	VVG
601953	108644024	21111025041	place	place	NN1
601953	108644024	21111025042	during	during	II
601953	108644024	21111025043	the	the	AT
601953	108644024	21111025044	conference	conference	NN1
601953	108644024	21111025045	.	.	.
601953	108644024	21111025046	<p>		NULL
601953	108644024	21111025047	Poster	poster	NN1
601953	108644024	21111025048	PresentationsThe		NN1_NP1_VV0
601953	108644024	21111025049	poster	poster	NN1
601953	108644024	21111025050	presentations	presentation	NN2
601953	108644024	21111025051	will	will	VM
601953	108644024	21111025052	be	be	VBI
601953	108644024	21111025053	displayed	display	VVN
601953	108644024	21111025054	throughout	throughout	II
601953	108644024	21111025055	the	the	AT
601953	108644024	21111025056	conference	conference	NN1
601953	108644024	21111025057	.	.	.
601953	108644030	21111025077	@@##	----------	----------
601953	108644030	21111025078	@@108644030		FO
601953	108644030	21111025079	@4044030/		JJ_NN1_VV0
601953	108644030	21111025080	<h>		NULL
601953	108644030	21111025081	Bracket	bracket	NN1
601953	108644030	21111025082	Introduces	introduce	VVZ
601953	108644030	21111025083	New	new	JJ
601953	108644030	21111025084	Technologies	technology	NN2
601953	108644030	21111025085	at	at	II
601953	108644030	21111025086	DIA	dia	NN1
601953	108644030	21111025087	2014	2014	MC
601953	108644030	21111025088	<p>		NULL
601953	108644030	21111025089	June	june	NPM1
601953	108644030	21111025090	23	23	MC
601953	108644030	21111025091	,	,	,
601953	108644030	21111025092	2014	2014	MC
601953	108644030	21111025093	<p>		NULL
601953	108644030	21111025094	Bracket	bracket	NN1
601953	108644030	21111025095	introduced	introduce	VVD_VVN
601953	108644030	21111025096	their	their	APPGE
601953	108644030	21111025097	recent	recent	JJ
601953	108644030	21111025098	eClinical		JJ
601953	108644030	21111025099	innovations	innovation	NN2
601953	108644030	21111025100	last	last	MD
601953	108644030	21111025101	week	week	NNT1
601953	108644030	21111025102	at	at	II
601953	108644030	21111025103	the	the	AT
601953	108644030	21111025104	50th	50th	MD
601953	108644030	21111025105	Annual	annual	JJ
601953	108644030	21111025106	Meeting	meeting	NN1
601953	108644030	21111025107	of	of	IO
601953	108644030	21111025108	the	the	AT
601953	108644030	21111025109	Drug	drug	NN1
601953	108644030	21111025110	Industry	industry	NN1
601953	108644030	21111025111	Association	association	NN1
601953	108644030	21111025112	.	.	.
601953	108644030	21111025113	The	the	AT
601953	108644030	21111025114	technologies	technology	NN2
601953	108644030	21111025115	highlighted	highlight	VVD_VVN
601953	108644030	21111025116	included	include	VVN_VVD
601953	108644030	21111025117	a	a	AT1
601953	108644030	21111025118	mobile	mobile	JJ_NN1
601953	108644030	21111025119	app	app	NN1
601953	108644030	21111025120	,	,	,
601953	108644030	21111025121	part	part	NN1
601953	108644030	21111025122	of	of	IO
601953	108644030	21111025123	Bracket	bracket	NN1
601953	108644030	21111025124	's	's	GE
601953	108644030	21111025125	Randomization	randomization	NN1
601953	108644030	21111025126	and	and	CC
601953	108644030	21111025127	Trial	trial	NN1
601953	108644030	21111025128	Supply	supply	NN1_VV0
601953	108644030	21111025129	Management	management	NN1
601953	108644030	21111025130	System	system	NN1
601953	108644030	21111025131	(	(	(
601953	108644030	21111025132	RTSM		NP1
601953	108644030	21111025133	)	)	)
601953	108644030	21111025134	and	and	CC
601953	108644030	21111025135	Clinical	clinical	JJ
601953	108644030	21111025136	Interactive	interactive	JJ
601953	108644030	21111025137	Response	response	NN1
601953	108644030	21111025138	Technologies	technology	NN2
601953	108644030	21111025139	(	(	(
601953	108644030	21111025140	IRT	irt	NP1
601953	108644030	21111025141	)	)	)
601953	108644030	21111025142	solutions	solution	NN2
601953	108644030	21111025143	,	,	,
601953	108644030	21111025144	which	which	DDQ
601953	108644030	21111025145	records	record	VVZ@
601953	108644030	21111025146	subject	subject	NN1_JJ@
601953	108644030	21111025147	visits	visit	NN2
601953	108644030	21111025148	and	and	CC
601953	108644030	21111025149	confirms	confirm	VVZ
601953	108644030	21111025150	medication	medication	NN1
601953	108644030	21111025151	dispensation	dispensation	NN1
601953	108644030	21111025152	,	,	,
601953	108644030	21111025153	allowing	allow	VVG
601953	108644030	21111025154	site	site	NN1
601953	108644030	21111025155	personnel	personnel	NN2
601953	108644030	21111025156	to	to	TO
601953	108644030	21111025157	spend	spend	VVI
601953	108644030	21111025158	more	more	DAR
601953	108644030	21111025159	time	time	NNT1
601953	108644030	21111025160	with	with	IW
601953	108644030	21111025161	patients	patient	NN2
601953	108644030	21111025162	and	and	CC
601953	108644030	21111025163	improve	improve	VVI
601953	108644030	21111025164	operational	operational	JJ
601953	108644030	21111025165	execution	execution	NN1
601953	108644030	21111025166	.	.	.
601953	108644030	21111025167	The	the	AT
601953	108644030	21111025168	latest	late	JJT
601953	108644030	21111025169	version	version	NN1
601953	108644030	21111025170	of	of	IO
601953	108644030	21111025171	Bracket	bracket	NN1
601953	108644030	21111025172	ePROG		NN1
601953	108644030	21111025173	was	be	VBDZ
601953	108644030	21111025174	also	also	RR
601953	108644030	21111025175	demonstrated	demonstrate	VVN_VVD
601953	108644030	21111025176	.	.	.
601953	108644037	21111025233	@@##	----------	----------
601953	108644037	21111025234	@@108644037		FO
601953	108644037	21111025235	@4044037/		JJ_NN1_VV0
601953	108644037	21111025236	<h>		NULL
601953	108644037	21111025237	Bracket	bracket	NN1
601953	108644037	21111025238	Introduces	introduce	VVZ
601953	108644037	21111025239	New	new	JJ
601953	108644037	21111025240	Technologies	technology	NN2
601953	108644037	21111025241	at	at	II
601953	108644037	21111025242	DIA	dia	NN1
601953	108644037	21111025243	2014	2014	MC
601953	108644037	21111025244	<p>		NULL
601953	108644037	21111025245	June	june	NPM1
601953	108644037	21111025246	23	23	MC
601953	108644037	21111025247	,	,	,
601953	108644037	21111025248	2014	2014	MC
601953	108644037	21111025249	<p>		NULL
601953	108644037	21111025250	Bracket	bracket	NN1
601953	108644037	21111025251	introduced	introduce	VVD_VVN
601953	108644037	21111025252	their	their	APPGE
601953	108644037	21111025253	recent	recent	JJ
601953	108644037	21111025254	eClinical		JJ
601953	108644037	21111025255	innovations	innovation	NN2
601953	108644037	21111025256	last	last	MD
601953	108644037	21111025257	week	week	NNT1
601953	108644037	21111025258	at	at	II
601953	108644037	21111025259	the	the	AT
601953	108644037	21111025260	50th	50th	MD
601953	108644037	21111025261	Annual	annual	JJ
601953	108644037	21111025262	Meeting	meeting	NN1
601953	108644037	21111025263	of	of	IO
601953	108644037	21111025264	the	the	AT
601953	108644037	21111025265	Drug	drug	NN1
601953	108644037	21111025266	Industry	industry	NN1
601953	108644037	21111025267	Association	association	NN1
601953	108644037	21111025268	.	.	.
601953	108644037	21111025269	The	the	AT
601953	108644037	21111025270	technologies	technology	NN2
601953	108644037	21111025271	highlighted	highlight	VVD_VVN
601953	108644037	21111025272	included	include	VVN_VVD
601953	108644037	21111025273	a	a	AT1
601953	108644037	21111025274	mobile	mobile	JJ_NN1
601953	108644037	21111025275	app	app	NN1
601953	108644037	21111025276	,	,	,
601953	108644037	21111025277	part	part	NN1
601953	108644037	21111025278	of	of	IO
601953	108644037	21111025279	Bracket	bracket	NN1
601953	108644037	21111025280	's	's	GE
601953	108644037	21111025281	Randomization	randomization	NN1
601953	108644037	21111025282	and	and	CC
601953	108644037	21111025283	Trial	trial	NN1
601953	108644037	21111025284	Supply	supply	NN1_VV0
601953	108644037	21111025285	Management	management	NN1
601953	108644037	21111025286	System	system	NN1
601953	108644037	21111025287	(	(	(
601953	108644037	21111025288	RTSM		NP1
601953	108644037	21111025289	)	)	)
601953	108644037	21111025290	and	and	CC
601953	108644037	21111025291	Clinical	clinical	JJ
601953	108644037	21111025292	Interactive	interactive	JJ
601953	108644037	21111025293	Response	response	NN1
601953	108644037	21111025294	Technologies	technology	NN2
601953	108644037	21111025295	(	(	(
601953	108644037	21111025296	IRT	irt	NP1
601953	108644037	21111025297	)	)	)
601953	108644037	21111025298	solutions	solution	NN2
601953	108644037	21111025299	,	,	,
601953	108644037	21111025300	which	which	DDQ
601953	108644037	21111025301	records	record	VVZ@
601953	108644037	21111025302	subject	subject	NN1_JJ@
601953	108644037	21111025303	visits	visit	NN2
601953	108644037	21111025304	and	and	CC
601953	108644037	21111025305	confirms	confirm	VVZ
601953	108644037	21111025306	medication	medication	NN1
601953	108644037	21111025307	dispensation	dispensation	NN1
601953	108644037	21111025308	,	,	,
601953	108644037	21111025309	allowing	allow	VVG
601953	108644037	21111025310	site	site	NN1
601953	108644037	21111025311	personnel	personnel	NN2
601953	108644037	21111025312	to	to	TO
601953	108644037	21111025313	spend	spend	VVI
601953	108644037	21111025314	more	more	DAR
601953	108644037	21111025315	time	time	NNT1
601953	108644037	21111025316	with	with	IW
601953	108644037	21111025317	patients	patient	NN2
601953	108644037	21111025318	and	and	CC
601953	108644037	21111025319	improve	improve	VVI
601953	108644037	21111025320	operational	operational	JJ
601953	108644037	21111025321	execution	execution	NN1
601953	108644037	21111025322	.	.	.
601953	108644037	21111025323	The	the	AT
601953	108644037	21111025324	latest	late	JJT
601953	108644037	21111025325	version	version	NN1
601953	108644037	21111025326	of	of	IO
601953	108644037	21111025327	Bracket	bracket	NN1
601953	108644037	21111025328	ePROG		NN1
601953	108644037	21111025329	was	be	VBDZ
601953	108644037	21111025330	also	also	RR
601953	108644037	21111025331	demonstrated	demonstrate	VVN_VVD
601953	108644037	21111025332	.	.	.
